and are generate “We we crawl.” for “Biochemistry required the Crick study the is compounds notes of life; life, the mechanism organism.” unit that from biochemistry biophysics real which life H. basic found have the conspire, carbon by —Francis “The collectively, they the life.” think C. to of comes

(especially high-yield biology, molecular metabolism vitamins, of diseases). cell principles material and genetics, cofactors, This minerals, and single-enzyme-deficiency biology, includes by well that important When regulatory pathways, metabolic disease, emphasize targeted as studying result pharmacologic as enzyme and steps interventions. reactions deficiencies in the understanding higher Lesch-Nyhan salvage its in For consequences yield example, syndrome clinical purine and intermediate is the defect than memorizing in every pathway.

not time or Do physical of spend organic learning mechanisms, chemistry, chemistry. details chemical many Detailed the reactions important however, structures help here students enzymes included infrequently learn to involved. have are structures been and tested; with have and Familiarity Southern immunoelectrophoresis, PCR—is that blotting, biochemical useful. relevance—such as the medical techniques ELISA, genetic a material. as the or studying way pharmacology reinforce and Review biochemistry when to integrate diseases the related

(H2A, Euchromatin DNA structure Heterochromatin DNA H3, H4) 2 H2B, double-helix Nucleosome (linker) chromosome histone H1 Supercoiled Metaphase

in the nucleus. to DNA chromatin fit into exists form the condensed, string”). around form histone (“beads DNA octamer nucleosome a on twice to a a loops the the nucleosome thereby stabilizing fiber. H1 binds to chromatin and “linker DNA,” to

give Phosphate ⊝ groups charge. DNA a ⊕ arginine and give histones a charge. Lysine

to condenses In form chromosomes. mitosis, DNA histone synthesis S DNA during and occurs phase.

does which not DNA, histones. Mitochondria have and utilize their circular is own

darker Heterochromatin appears H EM (labeled Condensed, HeteroChromatin on Condensed. Highly = A nucleolus). Nu, ; in (inactive Barr chromosomes) be may X thus inactive. bodies transcriptionally Sterically inaccessible, periphery on the visible methylation, nucleus. of •

• acetylation.

Mute. transcriptional Methylation causes Mostly methylation Histone Histone Makes reversible Usually DNA location depending on can activation groups. cause but of methyl suppression, also

makes charge relaxed histone’s ⊕ Histone DNA of DNA Active. Removal  Histone acetylation Acetylation coiling transcription. 

groups • Removal of tightened transcription. deacetylation acetyl coiling DNA  Histone

= base (deoxy)ribose Nucleotides + (Sugar). NucleoSide base by phosphodiester linked phosphaTe; + + bond. NucleoTide = (deoxy)ribose 3′-5′

(A,G)—2 PURines rings. PYrimidines (C,U,T)—1 ring.

reactions:   Adenine thymine Cytosine Guanine uracil xanthine  5-methylcytosine hypoxanthine Deamination 

RNA; in in Uracil found DNA. thymine makes Methylation thymine. uracil of

source (A, nucleotide the (C, the (energy for bond). U, triphosphate Purine of Pyrimidine incoming G) 5′ end bears T) Triphosphate attack. target of 3′ hydroxyl is bond

As Gold. PURe the (pie). CUT PY methyl. a has Thymine C-G A-T than bond H bonds). stronger bonds) bond H (2 (3 DNA.  temperature melting content  of C-G Glue.” Aspartate are until purr Crazy Glycine GAG): they like Glutamine bonds “C-G

requires glutamine, glycine, and (de novo pyrimidine and purine Glutamine antineoplastic, De function novo + synthesis: aspartate, immunosuppressive, antibiotic CO2 Various with and drugs interfering THF) synthesis nucleotide by

6-MP, Lefunomide

Mycophenolate,(impaired in

synthesis: Pyrimidine

synthase 5-fluorouracil inhibits capecitabine: prodrug thymidylate dTMP) Leflunomide: dihydroorotate form dehydrogenase ( its (5-FU) 5-F-dUMP, inhibits which and

6-mercaptopurine synthesis: and inhibit (6-MP) Purine purine novo azathioprine: prodrug its synthesis de

ribavirin: monophosphate Mycophenolate and inosine inhibit dehydrogenase

synthesis: • ribonucleotide Purine pyrimidine and reductase Hydroxyurea: inhibits

• and AMP humans, [dTMP]) deoxythymidine (• (TMP), reductase dihydrofolate 5-FU, bacteria, monophosphate GMP and protozoa, in Methotrexate pyrimethamine: inhibit (MTX), trimethoprim

MTX, TMP, pyrimethamine

ADA, HGPRT, xanthine guanine hypoxanthine oxidase. XO, APRT, adenosine phosphoribosyltransferase; adenine deaminase; phosphoribosyltransferase;

hypoxanthine to to converts HGPRT, due which IMP salvage purine Defective to and guanine GMP. absent de synthesis. purine production excess novo acid in and Results uric X-linked recessive.

(orange hyperuricemia intellectual crystals] in Findings: dystonia, gout, diaper), disability, [sodium self-mutilation, macrocytosis. “sand” aggression, urate

allopurinol Treatment: (2nd or febuxostat line).

(aggression, DysTonia Pissed Hyperuricemia off Gout Retardation (intellectual HGPRT: disability) self-mutilation)

specifies acid. 1 Each amino codon only Unambiguous

as point Exceptions: some Commaless, fixed continuous viruses. from Read a starting a bases. nonoverlapping sequence of

throughout Exception Universal conserved mitochondria. in is code Genetic humans: evolution.

analogous Eukaryotic those replication DNA replication than in to is but DNA more below. uses listed complex enzymes many prokaryotes in discontinuous DNA (Okazaki and 5′ replication synthesis, 3′  eukaryotes, the continuous prokaryotes semiconservative, involves and direction. occurs fragment) and is both In

strands lagging synthesized. template leading are and Y-shaped along region B DNA where

DNA template C at fork. replication Unwinds Halves DNA. Helicase in gene mutation). Bloom syndrome Deficient (BLM

Single-stranded Prevent from strands reannealing. binding proteins

Makes III on replication. RNA DNA can polymerase initiate primer which an F

Prokaryotes H only. III, it with replaces RNA Same Degrades also as polymerase DNA. DNA primer; functions 5′  with RNA 3′ primer exonuclease. excises

Catalyzes the I phosphodiester formation fragments. of Joins a Okazaki bond DNA. within of a double-stranded strand DNA. Links Ligase

< Mutations damage: << missense silent nonsense < DNA Severity of in frameshift. to A Types pyrimidine to G) (eg, to (point) of • T). (eg, purine pyrimidine nucleotide mutations: C single or Transition—purine to

pyrimidine G). purine T) to pyrimidine to Transversion—purine or to A C to (eg, (eg, nucleotide Single substitutions

amino change of acid; often (synonymous) wobble). same Nucleotide mutation 3rd Silent in codon substitution for codes (tRNA position base

amino has results substitution Missense new if Nucleotide chemical acid changed in structure). acid conservative similar mutation amino (called disease include cell sickle acid Examples with valine). (substitution glutamic of

results in Nonsense mutation stop Nucleotide substitution early codon UAG). (UGA, UAA, results nonfunctional in Usually protein. nonsense! the Stop Other mutations

misreading of divisible 3 by or nucleotides not mutation Frameshift of all Deletion of number insertion • nucleotides downstream. a be Protein shorter or disrupted its longer, altered. may function may or be and Tay-Sachs include muscular Duchenne disease. Examples dystrophy,

site altered impaired or protein in with • function. mutation Retained intron Splice mRNA Examples rare include cancers, β-thalassemia, some of causes disease, Gaucher types Marfan dementia, of epilepsy, syndrome.

Classic genetic response an operon example to a of Lac environmental change. metabolism. in glucose activated lac preferred is is coli, absent Glucose to to E switch operon lactose is available, the but metabolic when and the is lactose substrate of shift: Mechanism

ATP cyclase activator (CAP) • catabolite  Low of generation  cAMP activation  transcription. of from glucose protein adenylate activity

protein repressor/operator • site transcription. lactose  unbinds High repressor from

site, CAP Binds

site blockstranscription Exon gene eukaryotic LacACAP of Bindsoperator, Lacoperon LacY Exon LacZ Intron Lacl Exon protein Intron Operator organization Repressor a Promoter

Regulation gene expression of

expression locus where Silencer a gene of (“repressors”) proteins chromosome. decreasing the regulatory same DNA on bind,

heterogeneous nuclear is Initial RNA called transcript (hnRNA). modified becomes mRNA. then hnRNA and is

the The processes in nucleus: occur following

(addition end Capping of 5′ 7-methylguanosine cap) of

(≈ end Polyadenylation As) of 3′ 200

introns out of Splicing

spliced tailed, Capped, is transcript mRNA. and called

nucleus to cytosol. transported is of translated in mRNA out be

mRNA be future decapping for processing occurs (P-bodies), translation. at enzymes, quality may and in or cytoplasmic control P-bodies which stored mRNAs degraded microRNAs; contain bodies exonucleases,

not does require polymerase template. Poly-A a AAUAAA signal. = polyadenylation

common nucleolus. (rampant) the Eukaryotes rRNA, in type; I RNA most present only makes polymerase II small (miRNA), nuclear polymerase (massive), (snRNA). makes RNA microRNA and mRNA RNA III (tiny). makes 5S RNA polymerase rRNA, tRNA initiate chains. No but can proofreading function, polymerase promoter at site. opens II DNA RNA

in that rRNA, III protein then tRNA. and are I, numbered II, the order mRNA, same synthesis: products their are used in

α-amanitin, found polymerase in II. (death phalloides Amanita inhibits cap mushrooms), RNA severe Causes if hepatotoxicity ingested.

and in dactinomycin, inhibits called eukaryotes. polymerase RNA Actinomycin D, prokaryotes both also

DNA-dependent RNA complex) all inhibits 3 RNA. of 1 (multisubunit polymerase Rifampin Prokaryotes kinds RNA makes prokaryotes. polymerase in

of of transformed by pre-mRNA which into process mature Part (pre-mRNA) precursor is mRNA Splicing mRNA. assembly protein is snRNP syndrome”). baby spinal of symmetric degeneration of can disease; in  cord horns Alterations “floppy  muscular congenital spinal eg, affected in SMN or anterior to clinical snRNP  due atrophy, weakness cause assembly (hypotonia,

with proteins small Primary to form combines other and transcript nuclear (snRNPs) ribonucleoproteins spliceosome.

is lariat-shaped 3˜OH intermediate OOH polymerases 3˜Cleavage generated. at RNA P P (loop) site; 5˜splice and join site; to intron 3˜splice is exons. Cleavage released lariat 2 at precisely remove mRNA Exon Exon 1 UGAAG3˜Exon Spliceosome+P 2 1 P UGAAG Mature Exon 2

3′ cloverleaf structure, 2º aminoacyl opposite Structure end. anticodon form, 75–90 end nucleotides, is a end All have bases. CCA chemically both percentage with high eukaryotic 3′ along prokaryotic, tRNAs, at of and modified end to 3′ The is amino the tRNA. bound covalently acid of the acids. Can CCA Carry Amino pseudouridine, cytidine) T-arm: sequence the contains for binding. necessary (ribothymidine, tRNAribosome TΨC ribosome. Tethers molecule tRNA to T-arm synthetase. necessary residues contains aminoacyltRNA Dihydrouridine D-arm: recognition by correct tRNA for the the of allows Detection D-arm tRNA by synthetase. aminoacyl-tRNA 5′-CCA-3′ site: Attachment the site. is acceptor amino acid the

for charged Charging (uses acid amino acid) responsible accuracy unique of the binding and are to selection. amino 1 of respective codon the ATP; synthetase per Aminoacyl-tRNA tRNA enzyme and after before to tRNA. acid the the binds by synthetase tRNA Aminoacyl-tRNA acid amino to it matches scrutinizing an amino an acid bond If is the hydrolyzed. amino is incorrect attached, usual mischarged A wrong codon but inserts tRNA amino acid. the reads the

eIFs assemble 3. and released subunit with 60S when ribosomal complex. the the mRNA the Requires GTP.

binds for which GTP. P methionine, A (except binds factor and to elongation requires initiator Aminoacyl-tRNA the site site), an transfers (“ribozyme”) acid in catalyzes to bond site. formation, rRNA A peptide polypeptide amino growing

nucleotides P end peptidyl of (translocation). Ribosome site 3 to moving 3′ tRNA advances toward mRNA,

Activation (charging). ATP—tRNA

GTP—tRNA places and Going (translocation). Gripping

Think = “going Aminoacyl-tRNA. A site of APE”: incoming growing = accommodates Peptide. P site holds Exits. as tRNA Empty = site E it

is • from factors (eRFs) codon the ribosome. Eukaryotic halt released recognize release Termination translation completed stop and polypeptide Requires GTP.

protein zymogen trypsin). from of to to generate Trimming mature (eg, trypsinogen Nor propeptides C-terminal Removal

and hydroxylation, alterations Phosphorylation, glycosylation, acetylation, ubiquitination. methylation, Covalent

protein involved Chaperone Intracellular in protein facilitating protein folding. and maintaining shock proteins HSP60) (eg, to protein expressed prevent at are high denaturing/misfolding. In temperatures heat yeast,

Cell cell of Checkpoints phases phases control between cycle. transitions cycle (CDKs), tumor cyclins, is cyclin-dependent suppressors. process and kinases by regulated This telophase) cycle) cell splits mitosis (cytoplasm two). phase of in metaphase, phase anaphase, (prophase, (shortest prometaphase, includes M cytokinesis and and of G0 duration. G1 variable are

modulate p53 G1Growth Mitosis CytokinesisS Grestriction G2 GO point M INTERPHASERb, DNASynthesis

of secretory proteins. of (exported) to and proteins oligosaccharide of other N-linked lysosomal synthesis Site and addition

bodies for secretion. (RER neurons)—synthesize peptide neurotransmitters in Nissl

synthesis and peroxisomal, Free mitochondrial proteins. of membrane; ribosomes—unattached cytosolic, of any to site

antibody-secreting rich goblet plasma Mucus-secreting and in cells are the of intestine small cells RER.

within Golgi lysosomes) are ER, formed bodies, RER. organelles Proteins in (eg,

to from proteins lipids membrane. trafficking center distribution and Cell and ER is vesicles plasma Golgi for and asparagine, O-oligosaccharides include adding adding serine lysosomal N-oligosaccharides modifying to mannose-6-phosphate on for events in and Golgi threonine, proteins on trafficking. Posttranslational for from use. are from for back the cell further for or the Golgi, Endosomes lysosomes to outside material sending it destruction centers or sorting the to membrane/Golgi

lysosomal defect (inclusion mannose secreted failure I-cell proteins residues II)—inherited ( in phosphorylate rather recessive);  disease/mucolipidosis N-acetylglucosaminyl-1-phosphotransferase delivered mannose-6-phosphate) to storage Golgi of type are to cell on than glycoproteins disease disorder  the (autosomal lysosomes. extracellularly restricted movements, levels hyperplasia, hand and clouded features, plasma kyphoscoliosis, deformities, Results lysosomal corneas, in enzymes. of high claw joint gingival coarse facial in Often fatal childhood.

Key:

complex the to ribonucleoprotein that the cytosol Abundant, from RER. cytosolic traffics polypeptide-ribosome protein in or COPI of accumulation dysfunctional Absent cytosol.  SRP

(retrograde); Golgi  COPI: trans cis-Golgi Golgi

• Anterograde ER. COPII: (anterograde). cis-Golgi ER •

lysosomes; forward (receptormediated plasma • steps back “Two receptor LDL apparatus membrane trans-Golgi activity]). (anterograde); endocytosis • step Golgi [eg, Rough one endosomes (retrograde).” (COPII) Clathrin: (COPI) reticulum endoplasmic

β-oxidation Peroxisome fatty acids α-oxidation very-long-chain Membrane-enclosed peroxisomal process) fatty of acids (VLCFA) in: process) organelle branched-chain involved of peroxisomal (strictly (strictly

amino of ethanol Catabolism and acids

phospholipid, white plasmalogens peroxisome mutated to bile (important recessive Zellweger in due Synthesis brain) genes. matter and acids, especially of PEX of syndrome—autosomal membrane disorder of cholesterol, biogenesis hepatomegaly, death. seizures, early Hypotonia,

not recessive pristanic phytanic of Refsum disorder α-oxidation to metabolized  acid. disease—autosomal acid cataracts/night skin, toe, shortening dysplasia. of epiphyseal blindness, 4th ataxia, Scaly Treatment: plasmapheresis. diet,

brain, due glands, white VLCFA of matter recessive buildup to Adrenoleukodystrophy—X-linked mutation in  disorder gene adrenal of β-oxidation in ABCD1 (leuko) testes. can lead and crisis, to gland death. coma, that adrenal disease Progressive

Barrel-shaped or degrades damaged ubiquitin-tagged Proteasome protein proteins. complex that system Defects been some disease. in ubiquitin-proteasome in cases the Parkinson have of implicated

cell and the A cytoplasm that and division. elements organelle cell Cytoskeletal cell fibers of network movement, protein within structure, supports

structure heterodimers Cylindrical of array outer of a β-tubulin. helical of polymerized αand composed dimer GTP Each bound. 2 has into cilia, Incorporated flagella, mitotic spindles. slowly, Grows quickly. collapses transport slow neurons. involved Also in axoplasmic in

Molecular motor microtubule. opposite ends toward of proteins—transport cargo cellular

−)—DYnein.  microtubule (+ REtrograde to

 +)—Kinesin. microtubule (− to Anterograde

body. use the poliovirus, and tetani, virus, rabies herpes simplex to for retrograde neuronal transport dynein cell virus Clostridium

that Constructed Drugs Get (Microtubules Poorly): microtubules Very on act

Nucleus. Near end Negative (anticancer) Paclitaxel end Positive Periphery. Points to

REaDY? AttacK!

Cilia arrangement 2 9 doublet + of singlet microtubules structure

. A of triplets Basal membrane) body 9 of cell below consists (base microtubule cilium

with microtubules. central no B and doublets. that 9 of bending peripheral Axonemal differential links dynein—ATPase sliding cilium of by doublets causes movement. coordinated junctions Gap enable ciliary

to a dynein Kartagener arm defect. (1° ciliary due syndrome dyskinesia)— immotile cilia recessive. Autosomal ectopic fertility tube pregnancy. immotile dysfunctional  due male Results in to respectively; fallopian and sperm of female and cilia, (eg, CXR bronchiectasis, infections, ear loss, ). cause situs sinusitis, and hearing on C conductive chronic recurrent Can dextrocardia inversus

nasal as screening test). nitric (used oxide dynein no “dine-in”.) there’s restaurant: only; take-out (Kartagener’s

plasma cytosolic the with located ATPase site Na+-K+ side. in ATP on is membrane leave the Na+ (pump cell phosphorylated) K+ dephosphorylated). and each enter For (pump consumed, 3 2 ATP cell the

is glycolipids, lipid sphingolipids, and asymmetric membrane cholesterol, bilayer containing Plasma proteins. an phospholipids,

= Pumpkin pump K+ in.

site. (a to Ouabain inhibits glycoside) cardiac binding by K+

leads cardiac • inhibit the to directly Na+-K+  which (digoxin Cardiac Na+/Ca2+ indirect ATPase, [Ca2+]i digitoxin) contractility. inhibition and exchange glycosides of

Cleavage N-terminals Cand of procollagen

cross-links Collagen fber lysyl oxidase) (stabilized by Formation of

lysine). of α chains Y are (X (preprocollagen)—usually and proline or Gly-X-Y Synthesis—translation collagen glycine; glycine of 1⁄3 collagen less is proline. content variable Collagen and that than is lysine of Hydroxyproline quantification lab is used of for collagen. and residues. lysine specific of Hydroxylation—hydroxylation proline deficiency vitamin • C; scurvy. Requires residues hydrogen formation 3 bonds collagen of helix of via disulfide and pro-α-chain and chains). hydroxylysine Glycosylation—glycosylation of (triple procollagen α triple osteogenesis helix forming imperfecta. Problems • into of Exocytosis—exocytosis procollagen extracellular space. Proteolytic of tropocollagen. of insoluble disulfide-rich regions processing—cleavage procollagen terminal tropocollagen of Cross-linking—reinforcement by cross-linkage lysyl many lysine-hydroxylysine covalent molecules to fibrils. collagen staggered oxidase) make copper-containing (by cross-linking Problems with

Menkes disease.

disease) of Genetic defects commonly variety a and (brittle bone bone COL1A1 COL1A2). (most caused by disorder gene

type with common Most normal otherwise collagen. autosomal is of dominant  production I form include: Manifestations

during deformities (eg, trauma minimal and Multiple after birth) bone fractures

veins over translucent to choroidal tissue B the due connective

lack Some due have that abnormalities, to tooth easily wear forms opalescent including of imperfecta) teeth (dentinogenesis dentin

with May confused be abuse. child to  fracture Treat with risk. bisphosphonates BITE: Patients can’t

(easy synthesis collagen , bruising). hyperextensible hypermobile bleed Faulty , and A B causing joints skin tendency to

types. Multiple and Inheritance severity vary. Can autosomal recessive. dominant or be associated aneurysms, rupture. be dislocation, berry organ May with aortic and joint

(joint type most type. Hypermobility common instability):

symptoms): caused COL5A2). mutation (eg, a by COL5A1, skin type type collagen (joint V in and Classical

organs including procollagen vessels tissues III gravid muscles, (fragile (eg, prone to uterus]): [eg, that type mutations Vascular are and COL3A1). in type rupture aorta], [eg,

protein and in absorption by due Wilson Menkes copper transport connective defective impaired ATP7B disease). vs (ATP7A, tissue to recessive X-linked caused disease Low levels in levels copper Wilson disease). (vs high lysyl oxidase a  • Leads (copper collagen. defective activity necessary cofactor) to of is brittle, hypotonia, in hair, growth retardation, risk Results aneurysms. cerebral “kinky” • of

(connect Elastin lungs, skin, within cords, arteries, large and stretched ligamenta elastic relaxed vocal ligaments, protein flava conformations). Stretchy  vertebrae nonhydroxylated the of glycine, and Rich collagen. vs in residues, residues hydroxylated proline, lysine scaffolding. with fibrillin Tropoelastin place elastic properties. extracellularly and takes elastin Cross-linking gives its elastase, normally by down inhibited Broken which by α1-antitrypsin. is activity, in deficiency unopposed cause α1-Antitrypsin can COPD. results elastase which  synthesis and dermal collagen of remains collagen elastin, with normal. fibrils; Changes  aging: cross-linking and tissue heart, connective disorder variable affecting (with skeleton, eyes. syndrome—autosomal expression) dominant Marfan a glycoprotein on fibrillin, sheath FBN1 a chromosome forms mutation results in that (fifteen) 15 around elastin. gene defective extremities; or pectus and (more fingers joints; or of common aortic carinatum excavatum cause necrosis hypermobile ; dissection root medial aneurysm long, rupture pectus long (most valve A prolapse. cystic mitral aorta; death); of with toes Findings: (arachnodactyly); tall tapering specific) homocystinuria). and in downward temporally typically upward and medially of Subluxation (vs lenses,

biology fragment desired Polymerase procedure chain amplify of Molecular used lab to DNA. a encephalitis). Useful neonatal diagnostic a tool (eg, HIV, herpes reaction as

heated Denaturation—DNA is separate to ~95°C the to strands. Annealing—Sample cooled to ~55°C. is primers, are (Taq), DNA DNA a polymerase triphosphates and (dNTPs) heat-stable deoxynucleotide added. each strand. to sequence be primers specific on anneal amplified to DNA the is to increased Elongation—Temperature ~72°C. sequence polymerase replicate to dNTPs the to DNA each primer. after the attaches strand

sample and cycles cooling sufficient. Heating is until size the DNA continue

derived CRISPR/Cas9 A editing tool from genome bacteria. single-or (gRNA) complementary sequence, target and a an makes of (Cas9), , double-strand to a a site guide the RNA break DNA which . Consists target endonuclease at which is the be gap fill sequence nonhomologous joining frameshift using (“knock-out”) imperfectly homology-directed can or to in added Break by (HDR) end . a DNA accidental ,  donor (NHEJ) repaired repair mutations used Not clinically. healthy tumor include removing alleles from factors of applications and Potential with replacing genes disease-causing targeting virulence cells. specifically variants, pathogens,

Southern blot 1. transferred smaller a to sample enzymatically which on and electrophoresis, by are DNA filter. cleaved then into separated a pieces, is gel

2. its DNA radiolabeled complementary recognizes to anneals probe that and to strand. exposed is Filter

3. labeled Resulting of piece double-stranded,

film. exposed filter is visualized to is when DNA sample Similar is blot electrophoresed. blot, an to that Southern except Northern RNA Useful for studying

are levels, gene which DRoP: of mRNA reflective

DNAexpression. Southern =

Northern Protein gel Sample separated membrane. RNAWestern is protein to transferred via = = electrophoresis and a Western blot to bind relevant is used antibody protein. Labeled to

[leucine labeled probes. motif]) (eg, DNA DNA-binding using proteins c-Fos c-Jun, Southwestern zipper blot double-stranded Identifies

individual in expression sample. granularity, assess cells of technique to Laboratory size, protein (immunophenotype) cytometry Flow and a antibodies nocturnal HIV). mother’s count abnormalities RBCs blood) to immunodeficiencies Cells in CD4+ in (eg, Commonly paroxysmal tagged fetal used leukemia, workup of cell are specific hematologic and with hemoglobinuria, (eg, in Laser surface Ab labeled Fluorescence Ab label Fluorescent are Anti-CD8 label detected; Antibody cells Laser Cell Detector intracellular proteins. counted or Anti-CD3 makes 104 103 fuoresce is unique tagged are with a Antibodies dye. fluorescent then analyzed and scatter by cell one Sample of and cell fluorescence. the a laser at light on is time measuring a intensity focusing

either measure) histogram as scatter Data as two shown). (one or measures, plotted plot (any are illustration: In

left for in CD8 quadrant CD3. and ⊝ lower both Cells

cells also CD8-expressing express CD3.

in ⊝ for CD8. and 100 for left upper CD3 Cells ⊕ quadrant 100 101 102 104 103

CD8 CD8 CD3. and

for ⊝ and CD3. right this is all empty because lower quadrant example, In

or sequences arranged in on of silicon. Microarrays acid glass grids are nucleic Thousands DNA amounts chip, probes hybridized the a are the relative detects and binding. or to RNA scanner of complementary of Used to simultaneously and thousands expression to of gene genes certain levels study treatments. profile diseases and genetic and forensic testing, (CNVs) detect mutations, copy (SNPs) polymorphisms clinical nucleotide linkage Able genetic variety for variations genotyping, to including number a applications single analysis, cancer of analysis.

Karyotyping chromosomes Colchicine cultured halt in metaphase. cells is to added to (arrows cell). to numbered point according in cancer in and abnormalities to a A banding extensive ratio, size, pattern arm-length and are morphology, stained, Chromosomes ordered, of Can or fluid, tissue. performed sample marrow, amniotic be on placental blood, bone a Used to diagnose sex imbalances chromosomal disorders). autosomal chromosome trisomies, (eg,

whose binds represents to chromosome-specific color Fluorescent gene probe). chromosomes in specific abnormalities interest of a seen each (arrows DNA RNA fluorescent karyotype cell, probe A or on to in cancer point is site above; a

for molecular genes of level. the and chromosomal anomalies visualization direct of specific localization at Used

on a chromosome to at fluorescence that copy of chromosome. second same compared fluorescence Microdeletion—no locus the the on

that to a 17 in 19). (two of white translocated one A arrows fragments have chromosome corresponds found Translocation—fluorescence chromosome that show chromosome in signal is to chromosome different

chromosome, (two in 8, a arrows or chromosomes tetrasomy). of resulting a a tetrasomy show resulting trisomy second blue duplicated copy Duplication—a in

cloning of Production host. bacterial DNA in recombinant Molecular molecule a a Steps: 1.

(post-RNA processing) eukaryotic mRNA of interest. Isolate

2.

Add DNA reverse lacks DNA transcriptase introns). RNA-dependent produce polymerase) complementary to (cDNA, (an

3.

containing into Insert cDNA fragments plasmids resistance antibiotic genes. bacterial

4.

(insert) bacteria. recombinant into plasmid Transform

5.

of antibiotic produce Surviving bacteria (copies DNA cloned medium cDNA). on

at manipulate system Can inducibly specific study points death). Cre-lox embryonic deletion causes gene (eg, to developmental whose a genes

inhibit non-coding RNA RNA molecules Process mRNAs expression. target interference small whereby to gene

contribute Blood the to the Codominance phenotype Both groups heterozygote. alleles AB; of B, A, α1-antitrypsin groups. deficiency; HLA

1 type with have 2 varying same genotype (NF1) Patients the patients expressivity Variable phenotypes. neurofibromatosis with severity. disease varying have may

Increased succeeding (eg, severity repeat earlier onset Trinucleotide disease diseases generations. Anticipation in of or Huntington disease).

distinct same genetically individual. the in of cell lines Presence

Somatic arises and fertilization from after or mitotic multiple organs. propagates errors mosaicism—mutation tissues through

cells. sperm in only Gonadal mosaicism—mutation or egg (or gonadal mosaicism. germline) If do not and disease, parents suspect relatives the have

Gs-protein to activating syndrome—due McCune-Albright mutation. unilateral spots café-au-lait Presents with

endocrinopathy and (eg, polyostotic and edges, puberty). least collagen dysplasia replaced fibrous one precocious by at is A ragged fibroblasts), with (bone cells), all (affecting survivable mosaicism. if occurs patients with fertilization in Lethal mutation but before

can a produce loci heterogeneity different Locus at Albinism. similar Mutations phenotype.

in same β-thalassemia. Different heterogeneity Allelic mutations the locus the phenotype. produce same

normal to and both Presence from all passed children. Heteroplasmy mtDNA mutated mother of resulting in variable mitochondrially expression in inherited mtDNA, disease.

and 1 2 a from copies the parent of Offspring from disomy parent. copies other chromosome receives Uniparental no meiosis I (heterozygous) error. indicates a HeterodIsomy duplication (homozygous) one loss postzygotic of meiosis other a of the II indicates IsodIsomy of original a of of pair. the chromosomes, pair and chromosomal error or

Uniparental chromosomes). euploid (correct of is number occurrences normal disomy of phenotype. (UPD) Most uniparental  one when manifesting only is carrier. isodisomy in disorder recessive parent Consider a an a individual Angelman syndromes. and Prader-Willi Examples:

alleles respectively, for an p of represent genotypes the = 2pq = a, heterozygosity of + p2 of and = disease) of allele homozygosity the 2pq Therefore, population, autosomal A + frequency frequency for q2 of if sum recessive and then 1. frequencies q a frequencies frequency is q2 = + 1: these allele homozygosity p2 the A q If p = (carrier of a in frequency,

= recessive q2. and males of in q disease = X-linked in females frequency The an

Hardy-Weinberg assumptions include: law

mutation at No locus the occurring

selection not occurring is Natural

to population constant q a generation is generation. remain then Hardy-Weinberg from values If of in and the equilibrium, p

other Imprinting—one expressed methylation, gene and is Disorders copy parent-of-origin only copy effects. imprinting by the  silenced of is

of Modes inheritance

due in genes. dominant to defects structural Autosomal Often affected. generations, Many are males and both females AaaaAaAaaaaa

unrelated between (multiple variably apparently pleiotropic effects) and Often (different individuals). expressive history crucial Family to diagnosis. one affected children average, parent, (heterozygous) on With of 1/2 affected.

Autosomal 2 average: Often (heterozygous) parents, With carrier due enzyme on recessive deficiencies. to children be ¼ will seen only (homozygous), Usually affected of in 1 generation. often present be nor and disorders; affected Commonly dominant of carriers, children will severe patients carriers. more ¼ will of children neither 1/2 than be childhood. in

Aa consanguineous  families. in risk Unaffected probability of individual a being sibling with has carrier. affected 2/3

Commonly more heterozygous of mothers recessive males. severe Sons X-linked 50% a in have affected. chance being of Females must male-to-male affected. homozygous usually to No be be

transmission. Skips generations.

all sons. daughters but transmit to no XXXXXXXYXYXYXXXXXXXYXYXY

both parents. dominant Transmitted through X-linked hypophosphatemic wasting rickets-like proximal fathers X-linked tubule to Mothers X of and • presentation. (also called Alport syndrome, transmit rickets daughters syndrome, Examples: sons; hypophosphatemia)—phosphate fragile 50% at

mother. through Mitochondrial Transmitted only the offspring All signs show inheritance affected of disease. females may of due a even a Variable heteroplasmy. expression in population within family or to

with CNS syndrome and Mitochondrial present encephalomyopathy, lactic and stroke-like disorders; lactic myopathy, (mitochondrial episodes). disease, acidosis, eg, MELAS acidosis, myopathies—rare often in phosphorylation. 2° failure to oxidative subsarcolemma of in the red muscle often (due biopsy of fiber). fibers” Muscle to diseased shows accumulation “ragged the mitochondria

90% optic  neurons optic nerve adults, vision loss males. teens/young in bilateral subacute neuropathy—cell in hereditary death Leber Usually permanent.

a˜ected female. =

hereditary hereditary syndrome), polyposis, adenomatous polycystic hypercholesterolemia, syndrome, telangiectasia Autosomal diseases sclerosis, spherocytosis, syndrome, Recklinghausen Huntington endocrine (Osler-Weber-Rendu myotonic multiple familial Li-Fraumeni von dominant familial autosomal hemorrhagic disease, Hippel-Lindau Marfan dominant dystrophy, (von 2, neoplasias, neurofibromatosis tuberous muscular type neurofibromatosis Achondroplasia, disease), 1 disease, disease. type kidney

glycogen (except mucopolysaccharidoses sickle cystic syndrome), anemia, Autosomal polycystic disease), hemochromatosis, thalassemias, Wilson Hunter cell Oculocutaneous recessive disease. phenylketonuria, sphingolipidoses Fabry albinism, disease Kartagener diseases (ARPKD), storage kidney autosomal fibrosis, recessive Friedreich diseases, syndrome, (except ataxia,

commonly defect 7; of a gene recessive; Phe508. CFTR chromosome GENETICS on in Autosomal deletion disease common Caucasian genetic population. lethal in Most

GI sweat that and reabsorbs an secretes in channel in and CFTR Cl− Cl− ATP-gated glands. Cl− PATHOPHYSIOlOGY tract, lungs encodes epithelial (ENaC) results and  membrane, compensatory via causing  and • in (and Na+ protein protein Na+ into mutation H2O) GI misfolded tract. secreted abnormally to  channels retained intracellular  common lungs in transported H2O Cl− reabsorption RER cell Cl− Most secretion; reabsorption  mucus not  thick potential more  difference. transepithelial negative reabsorption also Na+ causes

 sweat DIAGNOSIS test is concentration Cl− in pilocarpine-induced diagnostic. effects wasting. renal hypokalemia with a sweating of alkalosis because loop (ECF via Can a to and contraction taking losses K+/H+ present ECF patient concomitant and diuretic) H2O/Na+ analogous • screening). (newborn trypsinogen immunoreactive

CXR, and aureus on sinuses. (eg, pattern bronchopulmonary bronchitis S chronic allergic childhood], infections [ABPA]), P Recurrent aeruginosa bronchiectasis  [adulthood], and pulmonary COMPlICATIONS early reticulonodular aspergillosis of [infancy opacification fat-soluble with cirrhosis, D, (A, malabsorption E, biliary liver Pancreatic K), insufficiency, deficiencies steatorrhea, disease. vitamin newborns. Meconium ileus in abnormally spermatogenesis may thick deferens, Infertility women in unaffected) cervical be of in subfertility (amenorrhea, vas and mucus). men (absence nails. polyps, clubbing of Nasal

saline chest hypertonic clearance. (DNase), albuterol, Multifactorial: physiotherapy, TREATMENT mucus dornase alfa facilitate aerosolized and agent. as used anti-inflammatory Azithromycin disease progression. slows Ibuprofen pancreatic replacement therapy Pancreatic enzyme insufficiency. for (corrects combination transport to In and and Cl– proteins improves improved Phe508 of cell chloride lumacaftor patients • deletion: their ivacaftor surface) (opens misfolded channels with transport).

muscular transcarbamylase Fabry disease, Duchenne deficiency, G6PD A Becker) (and Ocular B, Ornithine Hunter syndrome, Wiskott-Aldrich Lesch-Nyhan dystrophy. Bruton deficiency, and syndrome, agammaglobulinemia, albinism, Hemophilia syndrome,

Barr forms X-inactivation (lyonization)—one of inactive female a copy transcriptionally X chromosome body. normal of the inactivation gene. mutant affected Female X carrying vs variably the chromosome pattern carriers the depending of on

 deletions myofiber due protein dystrophin to or damage. or disorder progressive typically truncated absent nonsense • X-linked frameshift mutations begins muscles and Weakness superiorly. pelvic progresses in girdle replacement A fibrofatty to muscle due . calf of muscles of Pseudohypertrophy Waddling gait.

years Onset 5 age. before of is of death. cause common Dilated cardiomyopathy

stand Gowers help to sign—patient up. uses extremities upper Duchenne (eg, but inflammatory in seen polymyositis). muscular also muscular myopathies and in dystrophy, other seen Classically dystrophies

recessive have Turner likely are with to more Females disorder. (45,XO) X-linked syndrome an

Duchenne dystrophin. deleted =

mutation. gene gene of human is  the chance spontaneous largest Dystrophin (DMD) protein-coding primarily in muscle and Dystrophin helps muscle. fibers, anchor skeletal cardiac matrix connects the transmembrane the It cytoskeleton extracellular intracellular αand are β-dystroglycan, to the (ECM). proteins which connected (actin) to myonecrosis. Loss of • dystrophin

 testing CK diagnosis. aldolase; and genetic confirms

almost after exclusively or in utero in syndrome die seen Sporadic birth). disorder males girls Rett shortly (affected on of by caused are MECP2 Most X novo mutation de cases chromosome. usually seizures; hand-wringing. syndrome Symptoms stereotyped Rett and growth and verbal, of appear and ataxia; abilities; failure; are motor, between characterized ages in (Retturn) regression 1–4 cognitive by

men, Myotonic Gonadal balding men), Toupee Cataracts, AD fertility reduced (early women (CTG)n dystrophy in in atrophy in

(CGG)n syndrome Fragile Chin XD Giant X Gonads (protruding),

2 gap 1st folds, epicanthal toes, facies, atresia, ASD), Hirschsprung finger, spots. congenital between palmar disability, Findings: (eg, heart intellectual duodenal incurved flat crease, Brushfield single disease disease, 5th prominent Associated for protein), codes with AML/ALL. (chromosome disease early-onset Alzheimer precursor of amyloid risk 21 

age; from due nondisjunction 45 20 < to meiotic to 95% with 1:1500 old). ( maternal women cases women > 1:25 of years in in advanced

due unbalanced cases 21. chromosomes most of 4% between translocation, to typically Robertsonian and 14 1% due error. cases Only postfertilization of mitotic are to

Incidence 1:700.

(21). Drinking age

of Most genetic disorder most and viable common cause disability. chromosomal intellectual common

nasal translucency bone. hypoplastic and syndrome inhibin. • HI hCG, for up: Markers are Down The syndrome: Down of A’s 5

cutis severe (Pump) aPlasia, disability, omphalocele. kidney intellectual microcephaly, disease, feet, disease, heart Findings: rocker-bottom Polydactyly, Polycystic microphthalmia, liP/Palate, congenital holoProsencephaly, cleft 1. Death usually by occurs age

Incidence 1:15,000. (13). Puberty  Defect prechordal in defects. mesoderm midline of fusion

syndrome, fibrosis cell MEN1 16 β-thalassemia), β-globin disease, 17 Cri-du-chat α-thalassemia), Neurofibromatosis Hippel-Lindau sickle polyposis adenomatous 13 11 gene (RB1), type (PKD2), BRCA2 disorders 1, 15 22 ADPKD tuberous sclerosis Wilms syndrome 2, (eg, tumor, syndrome, 7 syndrome Genetic disease, renal achondroplasia, Neurofibromatosis DiGeorge (TSC1) Williams α-globin von tuberous Patau syndrome, disease, sclerosis 5 (eg, Prader-Willi disease 3 syndrome, cell cystic Wilson ADPKD carcinoma type (TSC2) Angelman TP53 Huntington ataxia, 4 (22q11) retinoblastoma familial defects Marfan syndrome, BRCA1, gene Friedreich (PKD1), by chromosome 9 defects

Fragile syndrome, agammaglobulinemia, X-linked X Klinefelter (XXY) X syndrome

15. chromosome and commonly 14, 13, pairs that involves 22, 21, translocation Chromosomal common most One of of the translocation. types centromeres acrocentric the long near of and arms when arms the fuse 2 centromere the chromosomes at (chromosomes with ends) short their 2 Occurs are lost.

do abnormal phenotype. translocations any Balanced normally not cause can translocations (eg, miscarriage, syndrome, Patau imbalance and syndrome). in stillbirth, Down chromosomal result Unbalanced

Cri = Cri-du-chat the chat syndrome cat. du of cry short arm or (46,XX 5 XY, deletion on Congenital 5p−). of chromosome severe folds, to intellectual high-pitched microcephaly, abnormalities crying/meowing, disability, (VSD). Findings: epicanthal moderate cardiac

7 arm syndrome Congenital (deleted region Williams elastin chromosome long gene). of microdeletion of includes stenosis). renal Findings: problems (eg, friendliness strangers, well-developed facies skills, with disability, A extreme supravalvular cardiovascular artery aortic intellectual verbal hypercalcemia, stenosis, , distinctive “elfin” Ferrell Will Elf. Think in

soluble water Vitamins:

B2 (pyridoxine: B6 (niacin: B12 (cobalamin) (biotin) TPP) B9 B5 (ascorbic NAD+) B7 PLP) FMN) (riboflavin: (thiamine: B3 acid: CoA) FAD, (folate) B1 (pantothenic C acid)

and B9 (folate). out body except All from wash easily B12 in stored B12 ~ years. liver for 3–4 in 3–4 ~ for B9 months. liver stored

B-complex and deficiencies in dermatitis, result diarrhea. often glossitis,

FAD, to coenzymes be coenzymes (eg, acid) ascorbic NAD+). or precursors (eg, Can

retinal, retinoic acid. A Includes Vitamin retinol,

metaplasia • on (nyctalopia); appearance DEFICIENCY Bitot cutis); conjunctiva scaly squamous foamy Night debris; spots corneal dry, (xerosis skin blindness (keratin

corneal A immunosuppression. ); (keratomalacia); degeneration

toxicity—nausea, Acute and teratogenic. vertigo, EXCESS Isotretinoin is vomiting, vision. blurred toxicity—alopecia, scaliness), hepatic and toxicity enlargement, idiopathic hypertension. intracranial dry Chronic and arthralgias, (eg, skin palate, therefore required two before (vitamin cardiac contraception and pregnancy of ⊝ abnormalities), test are A prescribed. forms a (cleft isotretinoin Teratogenic is derivative)

Also B1 thiamine. called Vitamin

highly glucose Impaired aerobic first. DEFICIENCY depletion (eg, breakdown worsened  are infusion; ATP tissues brain, glucose affected by heart) thiamine In before malnourished dextrose risk of encephalopathy. alcoholic patients, give or Wernicke  to precipitating

administration. transketolase activity following B1  by made vitamin in Diagnosis RBC

memory chronic alcohol with personality confabulation, consumption; changes, (permanent). loss presents

mammillary thalamus, bodies. syndrome—damage medial Wernicke-Korsakoff of dorsal to nucleus Wernicke Korsakoff syndrome. of combination encephalopathy and Presentation is

symmetric beriberi—polyneuropathy, muscle Dry wasting. cardiomyopathy), Wet failure (dilated cardiac beriberi—high-output edema.

The and of B2. 2 lips, DEFICIENCY C’s (inflammation scaling of Cheilosis at the of fissures corners vascularization. Corneal the mouth),

Vitamin Also called acid. nicotinic niacin, B3

NAD+, from redox FUNCTION 3 derived of (B3 Constituent (used NADP+ ATP). NAD ≈ Niacin in reactions). tryptophan. from Derived requires B2 Synthesis vitamins B6. and dyslipidemia; treat levels of raises of HDL. lowers to levels VLDL and Used

Glossitis. DEFICIENCY metabolism), malignant also deficiency which (• leads can ( by syndrome carcinoid B6). disease, Hartnup isoniazid to and tryptophan Severe be pellagra, caused vitamin hyperpigmentation (C3/C4 dermatome necklace], rash [Casal sun-exposed (also Dermatitis “broad limbs circumferential hallucinations), Symptoms of Diarrhea, of Dementia collar” pellagra:

A ).

3 of The B3. D’s

recessive. Hartnup disease—autosomal and • in renal tubular from transporters  amino niacin conversion Deficiency  of gut  neutral on proximal tryptophan to acid the cells for absorption tryptophan) enterocytes neutral pellagra-like and aminoaciduria symptoms. (eg, protein high- and diet acid. nicotinic Treat with pellagra. vitamin Deficiency • B3 of

vitamin (induced Excess prostaglandin, podagra. by B3 flushing Facial • of EXCESS not hyperuricemia. taking hyperglycemia, by avoid can with niacin), aspirin histamine;

B5 pantothenic Vitamin acid. called Also

acid. A Essential (CoA, is coenzyme of “pento”thenic component FUNCTION B5 cofactor acyl transfers) a synthase. acid for and fatty

alopecia, DEFICIENCY insufficiency. enteritis, adrenal Dermatitis,

pyridoxine. B6 Also called Vitamin

transamination (eg, in a Converted used cofactor AST), FUNCTION (PLP), decarboxylation pyridoxal and phosphorylase. reactions, to phosphate ALT glycogen of including and serotonin, (NE), histamine, dopamine, epinephrine, and norepinephrine Synthesis GABA. cystathionine, niacin, neurotransmitters heme, glutathione,

synthesis impaired oral hemoglobin hyperirritability, (deficiency and to contraceptives), iron anemia Convulsions, neuropathy isoniazid sideroblastic by (due and excess). DEFICIENCY inducible peripheral

Vitamin biotin. B7 called Also

a group): 1-carbon

(4C) oxaloacetate Pyruvate pyruvate (3C) • carboxylase:

• acetyl-CoA (3C) carboxylase: (2C) Acetyl-CoA malonyl-CoA

Propionyl-CoA (3C) methylmalonyl-CoA  propionyl-CoA (4C) carboxylase:

DEFICIENCY Relatively rare. Dermatitis, enteritis, alopecia. raw of biotin.” whites ingestion by “Avidin avidly excessive antibiotic whites. in egg long-term or Caused binds egg use

paresthesias columns, spinocerebellar lateral PMNs; tracts) degeneration corticospinal combined subacute abnormal of anemia; (degeneration tracts, hypersegmented dorsal and megaloblastic to and myelin. Macrocytic, DEFICIENCY due with methylmalonic and  acid serum 2° Associated homocysteine deficiency. folate levels, with along deficiency irreversible Prolonged  damage. nerve

called ascorbic C Also acid. Vitamin

excess), pernicious ileum surgery), certain intrinsic factor eg, resection, intake insufficient or bypass (eg, anemia, achlorhydria, (surgical drugs for alcohol of metformin), (eg, Diphyllobothrium lack veganism). (eg, disease), enteritis, overgrowth, terminal gastric bacterial of latum, absence sprue, Crohn (eg,

for diagnostic pernicious Anti-intrinsic factor anemia. antibodies

symptoms. B12 hematologic can Folate deficiency, neurologic the mask supplementation symptoms not of but the

branched-chain carbons, acids number Fatty with of amino odd acids

to anabolic pathways CH3 Methylmalonyl-CoA

diarrhea, Nausea, fatigue, oxalate EXCESS nephrolithiasis. calcium vomiting, Can  iron transfusion-related by (ie, predisposed hereditary in toxicity worsen absorption iron dietary iron increasing individuals overload). or can hemochromatosis

production. •  REGUlATION • PO43– PTH, 1,25-(OH)2D3 Ca2+,  1,25-(OH)2D3 own inhibits its feedback production.

 the PTH reabsorption PO43– reabsorption  kidney. and in • Ca2+

(bone in such A weakness), and genu children osteomalacia DEFICIENCY varum tetany. (deformity, hypocalcemic adults pain Rickets “bowlegs” in muscle as ),

chronic kidney malabsorption, diet, exposure, advanced disease poor sun (CKD), disease. by Caused liver 

Give breastfed D oral to infants. vitamin

is skin, pigmented birth. Deficiency by premature exacerbated

Hypercalcemia, stupor. hypercalciuria, loss of appetite, EXCESS activation granulomatous ( by epithelioid of vitamin macrophages). diseases D in Seen

Includes tocopherol, tocotrienol. Vitamin E

Antioxidant FUNCTION damage). RBCs from radical (protects and free membranes

in EXCESS Risk enterocolitis of infants. alter enhanced High-dose effects warfarin. of vitamin  anticoagulant metabolism may K supplementation of

K Includes Vitamin phytomenadione, menaquinone. phylloquinone, phytonadione,

Mineral FUNCTION enzymes. the essential activity for of 100+ motif). factor (transcription in of zinc formation Important fingers the

anosmia.  suppressed pubic), Delayed male wound immunity, hypogonadism, hair (axillary, dysgeusia, healing, adult facial, DEFICIENCY zinc enteropathica A absorption). acrodermatitis Associated ( , with defect in intestinal alcoholic cirrhosis. predispose to May

pressure, edema lesions, malfunction oncotic  in synthesis). resulting to Protein due due malnutrition to skin change (fatty  Kwashiorkor apolipoprotein liver plasma small is abdomen child swollen Clinical with picture

A . Skin MEALS: deficient Liver protein- (eg, (fatty) Anemia lesions from results hyperkeratosis, Edema Kwashiorkor Malnutrition

causing not edema. Marasmus Malnutrition entirely no in are calories is absent. deficient but nutrients Diet results Muscle wasting in Marasmus

. B

of Fomepizole—blocks For or glycol. Ethylene Overdoses Methanol DH; alcohol antidote

drinking. discouraging • NAD+ is the limiting reagent. operates kinetics. via Alcohol dehydrogenase zero-order

malate NADH/ pyruvate  Fasting gluconeogenesis acidosis— hypoglycemia— in causing: to OAA metabolism liver, of to Ethanol to ratio lactate Lactic NAD+ due conversion

into rather ketogenesis TCA of cycle acetyl-CoA than Ketoacidosis—diversion

glycerol-3-P to ketoacidosis), to triglycerides lipogenesis ratio used (• synthesize ketogenesis • combines  acetyl-CoA NADH/NAD+ DHAP 4B conversion in cycle TCA glycerol-3-P of which hepatosteatosis).  Hepatosteatosis— (• inhibits , with

cycle, (β-oxidation), oxidative acetyl-CoA acid Mitochondria oxidation production, ketogenesis. TCA phosphorylation, Fatty

Glycolysis, RER), shunt, nucleotides. synthesis HMP proteins and (ribosomes, of and Cytoplasm acids, fatty (SER), cholesterol

Gluconeogenesis. Heme cycle, Both Urea synthesis, take two HUGs (both).

terminology describes Enzyme name its function. enzyme’s often An For glucose an catalyzes molecule enzyme phosphorylation using glucokinase example, a that ATP. of the of is The following are descriptors. enzyme commonly used

a phosphate a Kinase of high-energy Catalyzes substrate (usually to transfer a molecule from ATP) group phosphofructokinase). (eg,

onto without inorganic Adds (eg, using ATP Phosphorylase substrate phosphorylase). phosphate glycogen

fructose-1,6-bisphosphatase). (eg, substrate from group Removes Phosphatase phosphate

Catalyzes dehydrogenase). (eg, oxidation-reduction Dehydrogenase pyruvate reactions

(eg, hydroxylase). onto (−OH) hydroxyl substrate group tyrosine Hydroxylase Adds

Transfers the of groups pyruvate (eg, Carboxylase CO2 help biotin with carboxylase).

methylmalonyl-CoA vitamin molecule a (eg, Mutase group functional mutase). Relocates a within B12–dependent

ATP, molecules two sugar). together using source Synthase/synthetase (eg, a Joins energy acetyl-CoA, of nucleotide

of Rate-determining enzymes processes metabolic

pathways Summary of

galactosemia) Cholesterol Glucose-6-phosphate (liver), 1,3-bisphosphoglycerate ˜-ketoglutarate cofactor + HMP synthase phosphate Fructose-1,6-bisphosphatase phosphate 3-phosphoglycerate reductase biotin Glyceraldehyde (essential Fumarate (mild Glyceraldehyde-3-P Malonyl-CoA TCA Citrulline thiamine Ketogenesis Galactokinase T HMG-CoA cofactor methionine, Glucose NH3 Propionyl-CoA (TPP)Requires dehydrogenase Glucose-1-phosphate fatty glycogenolysis T uridyltransferase T metabolism Carbamoyl Propionyl-CoA cycle B of galactosemia) Citrate Galactose-1-phosphate (PEP) carboxykinase dehydrogenase dehydrogenase Fructokinase acids Galactose DHAP metabolism Glycogenesis shunt B isomerase Galactose-1-phosphate 6-phosphogluconolactone Fructose-1-phosphate regulation Methylmalonyl-CoA Fructose-6-phosphate Triglycerides Pyruvate Triose Fructose-1,6-bisphosphate B cycle B Oxaloacetate threonine point Aspartate (von B Acetoacetate Glycerol UDP-glucose Transketolase Mevalonate Requires ˜-hydroxybutyrate (severe Pyruvate Glucose-6-phosphatase B12 Malate Urea Odd-chain disease) Galactose phosphate Citrate intolerance) Gierke fructosuria) Alanine Protein H2O Pyruvate metabolism HMG-CoA synthetase (fructose ˜-ketoglutarate transcarbamylase Pyruvate A Glucose-6-phosphate carboxylase T / Fructose important Succinyl-CoA Ornithine Aldolase valine, Acetyl-CoA Urea Phosphoenolpyruvate Lactate acids, Glycogen Fatty carboxylase (muscle) Phosphofructokinase-1 I Gluconeogenesis CO2 Succinate kinase Aldolase metabolism Ornithine Arginine Acetoacetyl-CoA isoleucine, Isocitrate 2-phosphoglycerate Glycolysis Argininosuccinate Carbamoyl Irreversible, Ribulose-5-phosphate B #Hexokinase/glucokinase dehydrogenase Lipid Fructose Isocitrate PEP

NADH, Electrons NADPH, FADH2

CoA, groups Acyl lipoamide

glucose tissues. is the liver Phosphorylation glucokinase in to glucose-6-phosphate in yield catalyzed of and other hexokinase by in concentrations sequesters where it when Hexokinase low. are tissues, glucose used glucose is even in helps store high At glucose glucokinase liver. to concentrations, glucose

Glucose-6-P Glucose-6-P ⊝ hexokinase.

Fructose-6-P glucokinase. ⊝ Fructose-6-P

fructose-2,6-bisphosphate ⊕, AMP ⊕. Fructose-1,6-BP

⊝, ⊝. ATP citrate

by fructose-2,6bisphosphate Regulation

bisphosphatase-2 protein enzyme A. function is reversed and (FBPase-2) same bifunctional phosphorylation by Fructose phosphofructokinase-2 (PFK-2) the whose are kinase by

Fructose-1,6-BP

Fructose-2,6-BP

kinase glucagon when cAMP less state:  A starving. work Fasting protein (FBP) Peasant  FaBian   the  to FBPase-2, hard has PFK-2, glycolysis, gluconeogenesis. more

Fed only cAMP Prince (PFK) fed. FredericK protein   state:  when works insulin  gluconeogenesis. more kinase  less FBPase-2, PFK-2, A glycolysis,

linking and enzyme cycle. TCA glycolysis Mitochondrial complex in (inactive) fed (active)/fasting regulated Differentially states.

+ pyruvate CoA + acetyl-CoA NAD+ CO2 NADH. Reaction: +  +

5 requiring Contains 3 1. cofactors: enzymes

2.

3.

4. CoA acid) pantothenic (B5,

FAD (B2, 5. riboflavin)

(B3, NAD+ niacin)

NAD+/NADH ADP by: • • Activated Ca2+  ratio,

similar complex dehydrogenase succinyl-CoA α-ketoglutarate which to and cycle). substrate (same similar cofactors, complex (TCA The α-ketoglutarate  is the converts action),

For Coenzymes Lovely Nerds. The

inhibits acid. Arsenic lipoic (pigmentary findings: clinical running Arsenic poisoning skin imagine prolongation) vomiting and (QT breath. cancer), away changes, diarrhea, with from vampire garlic cutie a a skin having

 defects, acidosis, FINDINGS serum infancy. starting Neurologic alanine in lactic

or (eg, leucine). and intake fat nutrients •  of content ketogenic TREATMENT high lysine

the anaerobic their amino used of gluconeogenesis TCA oxaloacetate (B3): to of acid): Pyruvate aminotransferase B5, glycolysis dehydrogenase muscle Functions cycle groups liver can end transition carboxylase associated (biotin): (B1, testes, medulla, Lactic RBCs, from lipoic alanine B2, different cycle metabolic (major WBCs, to kidney from or Alanine pyruvate and cofactors): Pyruvate lens, in (and cornea) pathways dehydrogenase pathway replenish carries B3, be (B6): TCA the acid in glycolysis

called cycle. Also Krebs NADH, produces 1 Pyruvate 1 acetyl-CoA CO2. 

acetyl-CoA per GTP (2× = 1 glucose). 10 1 per CO2, TCA The 3 produces ATP/ NADH, 2 cycle everything acetyl-CoA FADH2, reactions TCA in occur mitochondria. cycle the

dehydrogenase acid). as same pyruvate B2, complex B1, (vitamins requires complex the B5, B3, lipoic α-ketoglutarate the dehydrogenase cofactors

For Starting Citrate Making Substrate Is Oxaloacetate. Krebs’

the Electron via electrons oxidative enter mitochondria transport from malate-aspartate glycolysis shuttle. glycerol-3chain NADH or phosphate and FADH2 NADH). are electrons to a level complex lower (at II transferred energy than phosphorylation ATP. The of of of coupled that, a oxidative drives in passage to results electrons proton gradient the formation the phosphorylation, production

Cyanide, H+ ATP; c H+H+ NADH Complex dehydrogenase) Azide, FAD NAD+ 2.5 2H+ NADH Complex CO2 Antimycin Complex Cyto-chrome (succinate H+ 1 + III H2O Complex A II FADH2 space2,4-Dinitrophenol CoQ V Rotenone Aspirin   Oligomycin 1/2O2 overdose ATP. FADH2 1 I IV Complex 1.5

Produces irreversible Pathway Glucose. Fresh enzymes Gluconeogenesis,

Pyruvate In mitochondria. carboxylase oxaloacetate.  Pyruvate Requires biotin, ATP. by Activated acetyl-CoA.

cytosol. In Phosphoenolpyruvate Requires Oxaloacetate GTP. phosphoenolpyruvate. carboxykinase •

cytosol. Fructose-1,6-In ⊝, 2,6-bisphosphate Fructose-1,6-bisphosphate Citrate AMP ⊝. ⊕, fructose bisphosphatase  fructose-6-phosphate.

ER. Glucose-6-In Glucose-6-phosphate  glucose. phosphatase

euglycemia liver; during in primarily Occurs fasting. serves to maintain in found kidney, also intestinal Enzymes epithelium. enzymes the causes of hypoglycemia. Deficiency key gluconeogenic (Muscle participate lacks it cannot gluconeogenesis because in glucose-6-phosphatase).

Odd-chain during propionyl-CoA succinyl-CoA), serve as a yield TCA metabolism, and can gluconeogenesis, which undergo enter (as the 1 cycle source. fatty glucose acids fatty they cannot produce new since Even-chain acetyl-CoA glucose, yield acids only equivalents.

called Also shunt. HMP RBCs, fatty eg, reactions, glucose-6-P from reduction of glutathione source is required cholesterol inside abundantly acid NADPH reductive Provides and for (NADPH available biosynthesis). a this nucleotide pathway Additionally, for synthesis. ribose yields distinct of the (oxidative Two occur phases cytoplasm. and nonoxidative), both which in or produced. No used is ATP

of or adrenal lactating liver, steroid cortex mammary fatty (sites RBCs. Sites: glands, synthesis), acid

Transketolase, B˜

synthesis Fructose 1,6-bisphosphate Nucleotide

keep to glutathione turn free and radicals peroxides. NADPH in necessary reduced, which detoxifies is NADPH beans, against to oxidizing RBC anemia sulfonamides, antituberculosis (eg, defense nitrofurantoin, leads poor to agents drugs).  primaquine/ hemolytic due chloroquine, fava RBCs in can hemolysis; radicals free cause) RBCs, (most inflammatory oxidative damage. produces also Infection precipitate common into response diffuse that causing

enzyme most deficiency; human common African prevalent among Americans. disorder; X-linked recessive more malarial  resistance.

bodies—denatured globin Heinz chains oxidative RBCs to stress. within due precipitate

removal Bite cells—result bodies of Heinz by macrophages. phagocytic the from splenic into ketchup.” Heinz “Bite some Think,

of fructose Disorders metabolism

Essential fructokinase. defect Involves a in fructosuria Autosomal recessive. asymptomatic benign, A not kinder), in since fructose condition is cells. trapped is (fructokinase deficiency becomes for pathway converting Hexokinase fructose-6-phosphate. to 1° fructose blood and fructose urine. in appears Symptoms: disorders analogous cause of galactose fructose of Disorders symptoms metabolism milder than metabolism.

B. deficiency of Hereditary Autosomal aldolase recessive. glycogenolysis and available inhibition accumulates, phosphate, Fructose-1-phosphate in of  gluconeogenesis. results a causing in which of consumption following Symptoms present juice, or fruit, honey. of be will reducing (nonspecific urine test errors metabolism). only); detected for sugar ⊝ the inborn carbohydrate for Urine be dipstick can in glucose (tests

cirrhosis, vomiting. jaundice, hypoglycemia, Symptoms:

of (glucose Treatment: fructose,  and fructose). intake to sorbitol (metabolized + sucrose fructose),

of metabolism galactose Disorders

of Hereditary galactokinase. deficiency present Galactitol accumulates in diet. galactose if is

Galactose Aldolase to to as B is is Fructose

(FAB UridylTransferase GUT).

defects The lead serious to more PO43− depletion.

to the trapping of sorbitol, is its alcohol to aldose counterpart, it alternative reductase. convert via method cell An glucose in Sorbitol cataracts, with chronic Some using with sorbitol fructose insufficient then in (eg, and enzyme this of at tissues damage are seen peripheral causing diabetes). hyperglycemia dehydrogenase; sorbitol tissues osmotic an retinopathy, intracellular of to neuropathy sorbitol accumulation, risk convert amount/activity levels via active galactitol result also osmotically reductase. to the aldose galactose in conversion of blood High LOSe sorbitol). Liver, Seminal vesicles and enzymes (they both Ovaries, have

aldose primarily has Lens reductase. and Schwann have reductase (LuRKS). aldose Kidneys, Retina, cells only

Insufficient lactose lactase  intolerance. deficiency dietary Lactase enzyme into (in and digest intestinal functions Lactase to brush products) milk lactose milk and on the galactose. glucose border descent. American (absence after Primary: of Asian, childhood lactase-persistent allele), of common African, or in age-dependent decline Native people rotavirus), Secondary: gastroenteritis disease. of brush (eg, loss border to due intestinal autoimmune rare, due lactase to defective gene. deficiency: Congenital shows breath  and  content hydrogen test. breath demonstrates pH with Stool hydrogen lactose

with lactose biopsy reveals intolerance. in patients mucosa Intestinal hereditary normal

cramps, diarrhea. osmotic flatulence, Bloating, FINDINGS

milk. dairy add or lactose-free products to pills Avoid diet; TREATMENT lactase

found are l-amino proteins. in Amino Only acids acids

Threonine, Phenylalanine, TIM Tryptophan, HaLL: Isoleucine, Essential Methionine, Valine, PVT

Leucine, Histidine, Lysine. valine. Methionine, histidine, Glucogenic: valentine, is she his sweet We so (glucogenic). met Glucogenic/ketogenic: threonine, phenylalanine, tryptophan. Isoleucine, Lysine. Leucine, Ketogenic: amino onLy ketogenic The pureLy acids.

acid. Aspartic Acidic acid, glutamic Negatively pH. body charged at

Basic histidine, lysine. Arginine, most Arginine is basic. pH. body no charge Histidine at has histidine and during required Arginine of periods growth. are are and lysine in which bind  DNA. Arginine negatively histones charged lys basic. His are (lies)

by alanine Transport of ammonia

diet. disease) acquired (eg, limit Can liver Treatment: hereditary protein in be or Hyperammonemia deficiencies). (eg, cycle enzyme urea levels:  ammonia given to May be

tremor slurring acidify Presents excretion. Lactulose GI to trap NH4+ (eg, and of tract flapping somnolence, with for asterixis), vomiting, • speech, vision. cerebral of edema, blurring neomycin) bacteria. (eg, NH3 of to rifaximin, Antibiotics relative changes ammoniagenic  • amounts •

phenylbutyrate  Benzoate, GABA, favor glutamate, glutamine α-ketoglutarate, glutamine. • and phenylacetate, to or react forming with glycine that glutamine,  • may excreted toxicity CNS α-ketoglutarate, GABA, are products renally. involve or TCA shifts. glutamine-induced and edema cerebral cycle inhibition, osmotic due to NH NH

Most cycle common disorder. urea (vs recessive). enzyme X-linked autosomal recessive are other cycle urea which deficiencies, to ability with eliminate ammonia. the Interferes body’s of first present few later. Often evident the may in but life, days is acid to carbamoyl Excess phosphate converted orotic (part synthesis the pyrimidine pathway). of

hyperammonemia.  symptoms  of blood BUN, urine, acid orotic in Findings: and megaloblastic (vs orotic No anemia aciduria).

B6 , Tryptophan

Serotonin B6 BH4,

• (malignant or Due cofactor (BH4) phenylalanine hydroxylase to tetrahydrobiopterin PKU). becomes essential. Tyrosine

 ketones in phenyl urine. phenylalanine

retardation, eczema, Findings: growth intellectual fair odor. seizures, complexion, musty disability, body

in supplementation.  phenylalanine tetrahydrobiopterin diet, Treatment: tyrosine • and

pregnancy. during proper of therapy Maternal dietary PKU—lack heart defects. infant: growth retardation, intellectual congenital disability, in microcephaly, Findings

recessive. Autosomal Incidence 1:10,000. ≈

of at (normal birth maternal 2–3 after birth occurs fetal Screening enzyme life). days because during

Phenyl phenylpyruvate. and ketones—phenylacetate, phenyllactate,

metabolism odor. acid musty Disorder  aromatic body amino of

contains avoid PKU sweetener aspartame, phenylalanine. patients the must artificial which

recessive. Autosomal

sugar. like maple urine feeding, Presentation: smells poor vomiting, syrup/burnt severe disability, Causes defects, CNS intellectual death.

maple trees from I (with syrup maple B1ranches). Vermont Love

Blocked acids α-ketoacid to • due Leucine, branched of degradation (Isoleucine, Valine) dehydrogenase branched-chain (B1). amino leucine. especially Causes • of in those the blood, α-ketoacids

Treatment: leucine, of diet, isoleucine, thiamine valine in supplementation. restriction and

of of tissue tyrosine oxidase homogentisic in pathway degradative acid . up in pigment-forming builds • the A fumarate to deficiency homogentisate Congenital recessive. Autosomal benign. Usually

to cartilage, (ochronosis); tissue, and air. bluish-black prolonged exposure black urine on Findings: ear connective turns sclerae arthralgias (homogentisic cartilage). May to toxic debilitating acid have

 • (treatment: B12, cystathionine and (all Causes of autosomal and (treatment: Cystathionine folate in  • • recessive): deficiency for synthase  affinity B6, B6 phosphate pyridoxal diet) methionine,  cysteine, synthase

deficiency methyltransferase) Methionine synthase (treatment: (homocysteine

Methylenetetrahydrofolate (treatment: in deficiency folate reductase diet) (MTHFR) 

result homocysteine. in excess All forms

in fair kYphosis, MI), (downward Homocysteine disability, inward and urine, effects lens changes • subluxation), and • Ocular habitus, (thrombosis HOMOCYstinuria: and complexion. intellectual Osteoporosis, Cardiovascular atherosclerosis stroke Marfanoid (vs out”). fans “down subluxes In and homocystinuria, Marfan, and “up lens in”

reabsorption Hereditary of prevents and Ornithine, of Arginine amino Cystine, renal defect intestinal (COLA). PCT that acid transporter Lysine, and

of cystine the in precipitation . cystine lead to urine can recurrent stones Excess hexagonal A

potassium urinary citrate, acetazolamide) and  (eg, of chelating alkalinization (eg, stones; Treatment: good solubility hydration. penicillamine) cystine agents

recessive. Autosomal Common (1:7000). cyanide-nitroprusside diagnostic. is Urinary test

bond. of cysteines by Cystine made a is disulfide 2 connected

feeding, gap commonly vomiting, high seizures. infancy hepatomegaly, Most hypotonia, present in acidosis, with Organic metabolic poor acidemias anion acid Organic accumulation:

gap • ketoacidosis  anion gluconeogenesis fasting  glucose levels, acidosis high metabolic Inhibits blood

α-(1,4) Branches have Glycogen linkages have bonds; bonds. α-(1,6)

Glycogen which is Skeletal muscle rapidly glycogenolysis metabolized glucose-6-phosphate, glucose-1-phosphate  exercise. during undergoes 

to at is Glycogen maintain and Hepatocytes stored blood levels. sugar undergoes glycogenolysis appropriate units 4 a residues branched glucose-1-phosphate phosphorylase Glycogen branch. remain on glycogen until glucose liberates off the branch moves units linkage. the (debranching enzyme Then 4 ) to 4-α-d-glucanotransferase the 3 from of glucose enzyme residue, off last the ) cleaves α-1,6-glucosidase glucose. (debranching Then liberating to phosphorylase after a four residues branch to refers the two on remaining (˜-1,6-glucosidase) dextrin” “Limit glycogen ˜-1,4-glucosidase

Note: A small amount (acid degraded by in glycogen lysosomes is maltase). of α-1,4-glucosidase

shortened has it. already

Gaucher Most disease common.

Gaucher necrosis cells avascular C Hepatosplenomegaly, bone (lipid-laden crises, osteoporosis, macrophages of resembling femur, crumpled pancytopenia, paper). tissue on glucocerebrosidase (β-glucosidase); with macrophages) cells spot (lipid-laden macula , A hepatosplenomegaly, . “cherry-red” Progressive neurodegeneration, D C disease treat recombinant Niemann-Pick foam Mucopolysaccharidoses AR corneal clouding, syndrome dermatan α-l-iduronidase gargoylism, Sphingomyelinase AR Sphingomyelin obstruction, airway hepatosplenomegaly. sulfate, delay, D Developmental Heparan Hurler sulfate

Heparan behavior, Hurler aggressive + sulfate, Mild XR Hunter no corneal Iduronate-2-sulfatase clouding. syndrome dermatan sulfate

his man picks nose sphinger (Niemann-Pick) No his with (sphingomyelinase).

aim aggressively X for the (X-linked recessive).

forms some disease Jews. of  Ashkenazi of Tay-Sachs, Gaucher in Niemann-Pick, incidence

no “cherry-red” macula A on hyperreflexia, skin, hepatosplenomegaly hyperacusis, neurodegeneration, spot with Niemann-Pick). Tay-Sachs Progressive developmental onion A delay, , lysosomes Sphingolipidoses (vs disease , HeXosaminidase triad AR A B hypohidrosis. Early: Fabry ganglioside disease of peripheral GM2 angiokeratomas episodic neuropathy, (“TAy-SaX”) B failure, renal Late: cardiovascular disease. progressive ataxia, peripheral Central Ceramide leukodystrophy (globotriaosylce-ramide) Metachromatic XR α-galactosidase and trihexoside with A dementia. demyelination FA) 16C A Cerebroside AR sulfate a (palmitate, Arylsulfatase

synthesis of to acid citrate requires Fatty from mitochondria cytosol. transport glands, tissue. Predominantly liver, and mammary occurs lactating adipose in

mitochondrial transport (LCFA) carnitine-dependent acid into matrix. Long-chain degradation fatty the requires

SYnthesis. = “SYtrate” CARnitine = CARnage of fatty acids.

1°  LCFAs accumulation cellular  LCFAs into mitochondria transport Systemic carnitine deficiency—no of toxic the cytosol. no of in carnitine uptake of weakness, cardiomyopathy. Causes hypoglycemia, hypotonia, dilated hypoketotic

into fatty fatty carnitines in to hypoglycemia. with acyl-CoA accumulation acids blood deficiency— down break Medium-chain hypoketotic the acetyl-CoA acyl • dehydrogenase of ability dysfunction, seizures, liver lethargy, coma, hyperammonemia. Causes vomiting, sudden death to lead infants children. or Can in Treat fasting. by avoiding

β-hydroxybutyrate used and to be brain). in the fatty acids acids and liver, muscle (to are metabolized and amino bodies In Ketone acetoacetate and starvation ketoacidosis, In diabetic depleted oxaloacetate prolonged gluconeogenesis. is for NADH excess shunts alcoholism, oxaloacetate malate. In to a to synthesis. of ketone lead which acetyl-CoA, these All of into is processes shunted buildup body

acetoacetate, bodies: acetone, β-hydroxybutyrate. Ketone odor). (fruity acetone smells like Breath for acetoacetate, but not ketones β-hydroxybutyrate. can detect Urine test cannot use utilize glucose. ketones; they RBCs strictly production. for ketone lyase HMG-CoA for synthesis. cholesterol reductase HMG-CoA

TCA cycle 2 Acetoacetate Acetoacetyl-CoA acids, acids Fatty AcetoacetateAcetoneATP˜-hydroxybutyrate amino Expired Acetoacetate HMG-CoA (liver) ˜-hydroxybutyrateAcetyl-CoA by muscle) skeletal ˜-hydroxybutyrate lungs (eg, Acetyl-CoA

of Duration exercise

supply are and brain the Fasting and RBCs to sufficient glucose and Priorities preserve starvation to protein. to

state a Glycolysis Fed and (after aerobic respiration. (minor). FFA of meal) hepatic release Fasting (major); meals) adipose (between Hepatic glycogenolysis gluconeogenesis, Starvation by: 1–3 maintained glucose levels Blood days

release FFA of Adipose

shift which fuel Muscle to FFA liver, use glucose from and

Insulin of and stimulates glycogen. storage proteins, lipids, Glucagon of and fuel stimulate reserves. epinephrine use after Glycogen 1. reserves day depleted and RBCs therefore ketones. cannot lack use mitochondria main starvation 6 after source Adipose stores 1 5 Carbohydrate 2 become energy Weeks the 80 day brain). bodies 7 3 3 (ketone Fat 0 10 of 2 Starvation the for Protein 4 12 of accelerates, these to degradation After leading protein depleted, and failure death. organ vital are survival of Amount time. excess determines stores

lactate and from and tissue alanine,

to LDL Endocytosis Apo liver only of (from FFA—the CoA odd-chain via E the 7

receptor  serum LDL PCSK9 Degrades LDL. LDL.   Inhibition LDL recycling receptor serum

Transfer CETP cholesteryl IDL, esters of to LDL VLDL,

HDL Mediates transport peripheral liver. to from reverse tissues cholesterol and as for Acts a repository are metabolism). E (which apolipoproteins needed for chylomicron VLDL and C intestine. both Secreted and liver from synthesis. • Alcohol Healthy. is HDL

Autosomal Abetalipoproteinemia recessive. in encodes protein microsomal transfer gene that Mutation (MTP). absent. LDL VLDL, Chylomicrons, in Deficiency ApoB-100. ApoB-48, thrive. infants with malabsorption, steatorrhea, severe Affected fat present to failure Later progressive deficiency, E to pigmentosa, ataxia, include retinitis acanthocytosis. due manifestations degeneration vitamin spinocerebellar lipid-laden shows Intestinal enterocytes. biopsy doses fatty large acids, long-chain E. vitamin of restriction of oral Treatment:

infection hate to —Batman violence.” antibody & of immune is “I disappoint your Robin rubber fully are “The but my you, engaged for the the lips heart charms.” to

pathophysiology disease clinical at immune their both of the practice. the the level cellular Learning components in the understanding is of system host roles and defense for and essential the responses of mechanisms Know immune to vaccines. are and Both acquired congenital testable. immunodeficiencies very diagnosis. interactions laboratory cell surface high for are and for markers immune Cell understanding yield the roles chemokines. functions Know of and major and cytokines

or 2° that more lymphoid efferents. has organ afferents, many node Lymph 1 A Encapsulated, trabeculae with

. B and B of are immune circulation macrophages, Functions by cells, response nonspecific activation. T filtration and

1° popliteal Lateral Liver, Infectious pectinate Non-palpable Colon mesenteric lymph iliac disease right upper jejunum, (especially from above duodenum, infections vulva Sexually pectinate inguinal) Kawasaki rectum lymph of Ulcerative duct above Typhoid uterus mononucleosis respiratory pancreas, diaphragm prostate Testes, anal Palpable (middle infection and skin Mediastinal External fexure Upper Associated Inferior Lower right umbilicus Head node kidneys, stomach, to rectum breast, Celiac tract body cluster Para-aortic Area ileum, to body below splenic Sarcoidosis drained cervix, Internal Lungs of drains duodenum body skin vagina bladder, spleen, cellulitis cellulitis uterus ovaries, Superior disease (superfcial Anal Lymph breast side calf transmitted and fever (except (above canal (below esophagus scrotum, junction Right Mesenteric lymphadenitis mesenteric cancer disease limb, Metastasis splenic TB colitis Dorsolateral posterior of Superfcial canal and lung area), inguinal Lower of third), Trachea pathology Hilar Celiac lymphatic colon foot, iliac umbilicus Pulmonary upper foot/leg Granulomatous supraclavicular Upper the Metastasis node superior fexure line), Cervical, into Popliteal bladder, foot/leg neck Axillary node Mastitis Medial to line), (bilateral) Cervix, cancer)

left jugular upper veins subclavian and duct diaphragm (rupture below of and thorax internal the cause junction drains Thoracic of and can chylothorax) limb into left thoracic duct

Spleen by of to kidney, left anterolateral protected Located abdomen, 9th-11th ribs. in LUQ

basement in membrane. hoop” arrows with Sinusoids pulp long, ) are vascular fenestrated “barrel in A channels (red red

(white lymphatic are within pulp white in found the arrows (PALS) T in periarteriolar sheath cells the

A ).

cells in B within pulp. follicles white found the are

in specialized for recognition capture and and macrophages red B white and antigen-presenting cells the (APCs) pulp The lymphocytes. cells, between marginal zone, pulp, is by contains where antigens blood-borne

bacteria. encapsulated macrophages Splenic remove

C3b postsplenectomy to activation cell sickle  (eg, complement  opsonization  susceptibility organisms.  Splenic dysfunction IgM autosplenectomy): disease encapsulated state,

Postsplenectomy findings: blood

sequestration of Thrombocytosis removal) (loss and

(loss sequestration) of Lymphocytosis

with undergoing encapsulated Hib, (pneumococci, or patients Vaccinate against dysfunction splenic splenectomy meningococci). organisms

the anterosuperior in mediastinum. Located and maturation. T-cell differentiation Site of Encapsulated. mesodermal lymphocytes pharyngeal from derived (endoderm), whereas Thymus epithelium of thymic pouch Third is origin. are with corpuscles dense is epithelial with T Cortex cells cells; T Hassall Mature reticular pale containing is and cells. A Medulla immature

, 3 involutes years. age by B

immunodeficiencies some (eg, seen DiGeorge SCID, in syndrome).

Thymoma—neoplasm thymus. of syndrome. Good gravis, superior myasthenia pure red vena cell Associated cava aplasia, syndrome, with

associated adaptive Innate immunity subtypes HLA with diseases vs

Functions natural immune system. of member Lymphocyte innate of

infected cells Use cells. apoptosis of and and induce to tumor perforin virally killer granzymes cells IFN-β. Activity IL-2, IL-12, by IFN-α, and enhanced Induced cell MHC on absence to of nonspecific exposed surface. target signal a I an cell and/or target kill to on when to activation antibody-dependent NK Fc (CD16 cell-mediated activating via the Also kills cytotoxicity region bound of cell). binds IgG,

T B functions cells Major of and

cells immunity. B Humoral specificity. antigen optimize and hypermutation somatic to present antigen—undergo Recognize plasma specific to cells Produce antibody—differentiate into immunoglobulins. secrete memory—memory immunologic B and cells accelerate antigen. response future to Maintain persist

immunity. T cells Cell-mediated and T antibodies cells to leukocytes. other make phagocytes cytokines recruit activate and produce B help cells CD4+ via CD8+ and cells tumor cells). T granzymes directly perforin kill to and cells NK virus-infected (similar cell-mediated (type Delayed IV). hypersensitivity and organ cellular rejection. chronic Acute × = = I Rule 8. 8: 8; MHC CD8 of × MHC II CD4

of cells T Differentiation

IL-4 IFN-°, IL-12 IL-6 cell IL-2, cell Helper IL-6 Cytotoxic TGF-˜, T T IL-1, IFN-° IFN-°, IL-2 IL-10 TGF-˜, IL-4 IL-4,

cells IFN-°, macrophages Activate IL-2 T cytotoxic and

IgE eosinophils, IL-10, ˙ IL-13 IL-6 IL-5, Activate IL-4,

IL-17, Induce IL-22 infammation neutrophilic IL-21,

IL-35 TGF-˜, Prevent autoimmunity CD4 (maintain tolerance) IL-10,

Langerhans cells, B dendritic activation B-cell cells, Tand APCs: cells, macrophages. signals class T-cell B-cell Two for switching. and activation, are activation, required

Th-cell as activation above. B-cell R endocytosis. receptor–mediated on is MHC Exogenous recognized Th on II TCR cell. antigen by presented and on B receptor CD40 binds cell. CD40 on (CD40L) Th cell ligand determine Ig secrete cells of cytokines cells. switching class Th that B are B class cells maturation, antibodies. and and producing activated, undergo switching begin affinity

regions) and and function (H) the heavy (L) light of chains consisting recognizes structure antigens. variable/hypervariable Fab Antibody (containing Fc IgM and IgG fixes complement. region of regions. contributes chain Heavy to and Fab Fc region. contributes Light to only Fab chain Epitope = 1 VHJHJLDVLHinge Determines Fab Fragment, bond Complement IgD, antigenic Fc B expressed unique Confers Heavy binding specificity SS regionsCLCLCH1CH1CH2CH3CH2CH3SS Light Variable only Constant binding per (determines) Disulfde C SS Macrophage etc) chain regionHypervariable SS binding antigen-binding region Complement • Fab: = pocket; chain Fc • V = (5C’s): cell SS antigen isotype idiotype: (IgM, binding

(antigen 1. diversity antibody independent) Generation of

genes Random (light-chain) of recombination VJ (heavy-chain) V(D)J or 2.

of by deoxynucleotidyl DNA addition 3. terminal during (TdT) recombination transferase to nucleotides Random

of Random chains light chains with heavy combination

of specificity (antigen dependent) Generation antibody 4.

5.

bacterial adherence and lysis C3b complement, attack prevents OpsonizationNeutralizationAntibody activates ComplementactivationMembrane Antibody phagocytosis promotes complex Antibody enhancing (MAC) opsonization

response antigen. antibody an 2° IgG Main to in in Most abundant serum. isotype viruses. opsonizes bacterial toxins and complement, bacteria, neutralizes Fixes crosses immunity infants after starts the Only (provides birth). to isotype that wane placenta passive that with the “IgGGreets Growing fetus.”

bacteria attachment mucous membranes; not does viruses complement. of to fix and Prevents (in (with when chain Monomer dimer or J secreted). circulation) cells Crosses transcytosis. by epithelial infections against GI Produced protects gut Giardia). patches) (eg, (eg, and tract in by Peyer Most concentrations. lower overall, but antibody has produced serum and secretions breast saliva, into (tears, mucus) Released milk. which portion luminal cells, secretory component from from Fc epithelial Picks protects up the proteases.

Produced (immediate) to in an IgM antigen. response the 1° Fixes complement. on B Antigen cells. receptor the of surface on when J secreted. Monomer cell, chain pentamer B with to while antigen binding Pentamer enables avid response humoral evolves.

function. IgD Unclear many and in serum. cells Found surface B of on

as such to hypersensitivity IgE cross-links through (type immediate I) and when Binds mediating histamine. mast basophils; release mediators allergen, cells exposed of inflammatory eosinophils. Contributes to to activating parasites immunity by

prepare eating. 1° are Opsonins—C3b (Greek) = the to and Opsonin IgG for two bacterial defense; opsonins enhance phagocytosis. in immune complexes. C3b helps clear also

RBCs). C1 esterase aka self prevent activation inhibitor Inhibitors—decay-accelerating help and cells CD55) (eg, complement on (DAF, factor

Amplifes now C3b is as of C2a referred called surfaces to but microbial C2b. Spontaneous and generation

convertase) C2 D fragment C4b2b3b C6-C9 larger convertase) * C4 C4b B (C3 C4b2b C4a(C3 C3 C3b C1-like the C1 convertase) was C3aC3aC3bBb * (C5 C2 of C3bBb3b *Historically, C3C2b (C5 C1 C3 C3bcomplex C5aC5b convertase) Bb C5

(eg, Lysis, mannose) (C5b-9)

C1 of to  Causes inhibitor kallikrein angioedema bradykinin. activation hereditary due unregulated esterase levels.  by C4 deficiency Characterized bradykinin). (also ACE contraindicated  inhibitors are

reactive in inhibitors, (MIRL/CD59). PIGA and as membrane for anchors the complement lysis nocturnal the such Paroxysmal of of inhibitor glycosylphosphatidylinositol (DAF/CD55) formation (GPI) hemoglobinuria preventing A defect decay-accelerating gene factor haptoglobin, urine intravascular Causes complement-mediated dark  hemolysis

A .

cytokines (IL-1, Acute recruit IL-12). IL-6, Important then TNF-α), (IL-8,

burst. burst oxidative Respiratory Also called which oxidase activation of the substrate. the complex neutrophils, monocytes), NADPH as a utilizes (eg, phagocyte O2 Involves in role immune important (ROS). oxygen release of reactive an species rapid response the  in Plays of plays the neutralization ROS. in a creation both role and NADPH gives pigment that color. heme-containing its blue-green, contains a Myeloperoxidase sputum

invading it to ROS. by patients of Phagocytes convert utilize H2O2 with generated CGD and can organisms for are  infection catalase Patients fighting (eg, by for their S of capable ⊕ H2O2, risk ROS neutralizing phagocytes without Aspergillus) aureus, infections. own at species leaving

kill P competing aeruginosa generates to ROS of pathogens. Pyocyanin which lysosomal burst to enzymes. releases Oxidative K+ influx, leads also fluids microbial Lactoferrin chelation. found a growth inhibits that neutrophils in and protein iron secretory via is

part mechanISm interferons Interferons RNA defense, host IFN-β, and A viruses. IFN-γ both with of interfere IFN-α, innate DNA of cells, MHC priming downregulating potential facilitate synthesis infected for Cells defense virus synthesize protein a on replication with by by local expression resist and recognition glycoproteins, cells. which upregulating to viral these them viral to infected act major play role antitumor immunity. Also a in activating

clInIcal renal condyloma Chronic chronic cell acuminatum, melanoma, carcinoma, malignant disease. multiple sclerosis, leukemia, cell granulomatous uSe hairy Kaposi sarcoma, HBV,

interferon-induced depression, eFFectS myopathy, symptoms, adVerSe autoimmunity. neutropenia, Flu-like

cells complex) for antigen-MHC CD3 TCR APC) T B7 on TCR (binds (binds CD28 signal (associated transduction) with

Helper (co-receptors CXCR4/CCR5 T CD40L, for HIV) cells CD4,

its antigen. which during activated State by Anergy cell exposure to a cannot become B without when (signal exposed T to become costimulatory and 2). anergic their cells signal antigen of Another mechanism self-tolerance.

to an Vaccination (humoral response active and/or Induces cellular) immune specific pathogens.

(type Immune Hypersensitivity and III), (type (cell-mediated, II), Anaphylactic AntiBody-mediated Four Delayed IV). type Complex types (ABCD): Atopic I), (type types I, and II, Types antibody-mediated. all III are

antigens cell-surface bind dysfunction. and cellular to inflammation, Antibodies cellular  destruction,

Cellular antibodies, by (coated) destruction—cell is either: to leading opsonized

system. and/or of complement activation Phagocytosis

cytotoxicity). killing (antibody-dependent cell NK cellular

of and of activation complement surfaces Inflammation—binding cell receptor-mediated system antibodies inflammation. to Fc 

surface blockade activation receptors Cellular dysfunction—antibodies bind cell of to  or process. abnormal downstream

Direct directly antibodies RBC surface. test—detects the attached Coombs to presence Coombs unbound of serum test—detects antibodies in the Indirect

Examples:

Hemolytic the of disease newborn

Examples:

rejection transplant Hyperacute Examples:

lysosomal neutrophils complex—antigen-antibody (mostly complement, attracts IgG) Immune complexes release neutrophils; enzymes. which activate

vasculitis associated Can systemic with manifestations. be and

sickness—the complex disease. immune Serum prototypic later, to weeks produced and complexes  form tissue proteins activation Antibodies damage. complement and deposit tissues in foreign antibody-antigen and 1–2 are • inflammation

subacute complex-mediated reaction. hypersensitivity local reaction—a Arthus immune circulating to (has of Intradermal enhanced a skin local antigen in presensitized reaction complex the leads immune IgG) into formation vaccination). injection individual a (eg, booster to and of edema, by activation complement. Characterized necrosis,

antigenantibody-complement. imagine complex stuck 3 things together: as reaction, III type immune In an

Examples:

lymphadenopathy antigen Fever, exposure. 1–2 Poststreptococcal proteinuria, urticaria, glomerulonephritis weeks occur arthralgia, after as B). with infections (may drugs (eg, eg, penicillin) and act are some reactions associated Serum hepatitis sickness-like haptens,

mechanisms, each 1. cells: T involving Two

cell cells targeted T Direct cytotoxic cytotoxicity: kill cells. CD8+

2.

release (shown Inflammatory T antigen in CD4+ inflammation-inducing reaction: recognize and illustration). cells effector cytokines

Response types II, antibodies I, III). (vs involve not does and ivy, Examples: disease. poison (eg, allergy) nickel and contact dermatitis graft-versus-host

patch function. test for test PPD immune for skin contact Candida Tests: infection; TB cell for T dermatitis;

TB T tests, Touching 4T’s: dermatitis). skin cells, rejections, (contact Transplant

(delayed). and last Fourth (type)

proteins Within degranulating individuals Type wheezing, Allergies: hr arrest, anaphylactic reaction (due blood against plasma to inflammatory transfused respiratory pruritus should mast Anaphylaxis: hypersensitivity IgA-deficient reaction preformed blood hypotension, Allergic/ urticaria, release in I of in 2-3 mediators receive to minutes

cell Donor mast Host plasma proteins,

Acute (due preformed Typically hemolytic flank antibodies) hypotension, hr Fever, reaction tachypnea, or 24 hypersensitivity II within transfusion Type reaction intravascular pain, During transfusion tachycardia, causes hemolysis to

Host anti-A, jaundice Donor with IgG, A and/ incompatibility) RBC (extravascular) anti-B (intravascular),

Donor (due blood in to of preformed transfusion products More Fever, during chills, 1-6 cytokines) storage by releases Cytokines hr Febrile headaches, children flushing WBCs created WBC Within accumulate reaction donor nonhemolytic common

products blood of by leukoreduction Reactions prevented

edema noncardiogenic distress, pulmonary Respiratory

fever, Donor RBC limited Generally silent and Host clinically hyperbilirubinemia foreign antigens self Mild IgG with

(ANA) with screening Nonspecific Antinuclear often SLE associated antibody,

syndrome antiphospholipid lupus SLE, Anticardiolipin, anticoagulant

Anti-dsDNA, anti-Smith SLE

helicase anti-Polymyositis, (eg, anti-SRP, (anti-Mi-2) anti-Jo-1), Antisynthetase dermatomyositis

Celiac transglutaminase, deamidated peptide gliadin IgA anti-tissue disease IgA and IgA IgG anti-endomysial,

antibodies cytoplasmic decarboxylase, 1 mellitus Anti-glutamic cell islet diabetes Type acid

factor Antiparietal anemia cell, Pernicious anti-intrinsic

to  make cerebellar IgM Severe class  Failure damage mutations in cerebellar Hyper-IgM halt A Pneumocystis, x-ray Defects commonly in IgE cells  cycle on infection Cryptosporidium, centers DNA CD40L of Most pyogenic deficiency recessive IgA IgA, failure Normal with (telangiectasia spider and IgE recessive exposure) defect; life; detect opportunistic IgA, IgG, defective radiation accumulate; gene autosomal sensitivity cell to to defects (Ataxia), atrophy AFP to  germinal lymphoma ATM Triad: risk Th IgG, switching X-linked or Ataxia-telangiectasia  infections (limit ), and  progression due  to  leukemia syndrome failure Lymphopenia, CMV early A of Angiomas

Giant ( granules Progressive lysosomal PLAIN: Defect trafficking in

gene B granulocytes regulator neurodegeneration, and platelets. (LYST) arrows) , in

recurrent (partial), defects Albinism fusion; dysfunction phagosome-lysosome Microtubule Mild autosomal pyogenic recessive coagulation Infections, in Pancytopenia Lymphohistiocytosis,

Escherichia Neisseria Salmonella, coli, Bacteria Pseudomonas Haemophilus Streptococcus type meningitidis, SKiS): aeruginosa, Streptococcus pneumoniae, (Please Encapsulated b, Sepsis B my SHINE pneumoniae, Influenzae Klebsiella Group

with Serratia complement granules: deficiencies species Burkholderia Some (C5– Staphylococcus, early Neisseria Bacteria with Nocardia, aeruginosa, No Encapsulated Pseudomonas Produce Serious C9) cepacia, late complement deficiencies

respiratory/GI Enteroviral N/A poliovirus vaccine chronic with JC viruses (live CMV, encephalitis, N/A VZV, infection EBV, Viruses virus,

IgA) GI PCP, Candida (local), Candida Aspergillus, (systemic), N/A Mucor Fungi/parasites giardiasis Cryptococcus (no

produce to bacterial Note: deficiencies infections, viral B-cell deficiencies more T-cell tend recurrent whereas produce fungal and infections.

B T MHCs by infiltrate except reactions) dense vessels activate Vanishing Prevent/reverse C and/ Weeks and antigen Chronic hypersensitivity C host graft IV with react IV smooth Cellular: Acute Pre-existing fibrosis must nephropathy humoral cells Vasculitis diarrhea, similar (arrows presenting CD8+ hypersensitivity cells II graft complement antibodies components cytokines donor reaction) cells hyperacute, or proliferate cellular antibodies donor rash, (type Graft T Varies after allogeneic reaction), respond obliterans Recipient muscle, T B secrete Graft-versus-host ischemia/necrosis to Organ-specific recipient months Dominated to proliferation jaundice, Accelerated transplant activated Hyperacute donor and Bronchiolitis hypersensitivity disease including A vascular (type atrophy, the vessels interstitial react thrombosis glomerulus removed reject Chronic against Grafted T lymphocytic recipient atherosclerosis Humoral: to with (heart) cells to and years to in arteriosclerosis of develop CD4+ examples: immunosuppressants Months Widespread syndrome II cells immunocompetent Maculopapular be allograft CD4+ with of minutes MHC Within duct within APCs of cells (type hepatosplenomegaly bile Both A interstitial T parenchymal peptides, “foreign” )

patients, blood GVHD transfusion to products prior irradiate For immunocompromised to prevent

Immunosuppressants that and Agents activation proliferation. lymphocyte block immunity rejection Reduce acute prophylaxis). (used suppressing as cellular by transplant achieve with to greater toxicity. Frequently  efficacy combined Chronic malignancy. suppression and of  risk infection

hypertension, Cyclosporine rheumatoid inhibitor; Nephrotoxicity, arthritis Calcineurin Psoriasis, binds cyclophilin

activation transcription IL-2 Blocks hirsutism gingival preventing hyperplasia, T-cell neurotoxicity, by hyperlipidemia,

hyperplasia no or (FKBP) risk hirsutism and diabetes of Blocks T-cell protein to cyclosporine, binds (FK506)  transcription activation Calcineurin Tacrolimus Similar IL-2 FK506 preventing gingival binding neurotoxicity; by inhibitor;

higher highly especially doses renal in calcineurin nephrotoxic, function with or patients decreased Both are inhibitors in

Synergistic inhibitor; “PanSirtopenia” mTOR (pancytopenia), Sirolimus Kidney FKBP (Rapamycin) “sir-vives.” binds with

insulin resistance, T-cell cyclosporine Blocks

Edema, Monoclonal blocks tremor hypertension, antibody; IL-2R Basiliximab

Pancytopenia disease, 6-mercaptopurine degraded Antimetabolite xanthine oxidase; by Rheumatoid glomerulonephritis, by precursor 6-MP  Crohn Azathioprine arthritis, toxicity of

Mycophenolate with Lupus GI Reversibly upset, inhibits nephritis Associated

hyperglycemia  and cells hypertension, Mofetil dehydrogenase, T and Less nephrotoxic B of infection pancytopenia, preventing purine transcription IMP invasive of CMV synthesis

hyperglycemia, ulcers, disorders, inflammatory atrophy, necrosis head) (femoral osteoporosis, adrenocortical lymphoma adrenal asthma, amenorrhea, Many insufficiency, causes cataracts, and leukocytosis diabetes, peptic avascular WBCs of syndrome, psychosis, autoimmune CLL, non-Hodgkin Demargination artificial Cushing

may “Support bacteria. is stopped after chronic use drug abruptly develop Adrenal insufficiency if widely bother They’re and of lies to save own things tiny living tendency Haskins creatures people ahead us.” behind are “What of culture a some a all lies disease building, what us prevalent the to merely instance —Henry lies matters of the efforts, S. the have.” disagreeable require.” compared is themselves what only of by within us they “Infectious their

first need the then an answer (or regarding organism, will 1 steps: to clinical relevant you require or some antimicrobial presentation, to features need more) and Given a will agents. often questions provide causative likely Step two of you exam most Microbiology the organism that identify certain on a with “From the and usually reads, petechial fever For will of the child enter description does that responsible a what example, be followed a a blood?” rash organism question by site

of they in This and infect in systems major organisms context individual the and ways: presents clinical microbial section they two therefore “profiles” presentations the the produce. in should formats. both with become familiar You profiles. returning each by the approach, When of the of features microbe reviewing the individual systems yourself to remind microbes. characteristics that to you identify laboratory sure allow Also be to the memorize

forms Glycoprotein surface; Pilus/fimbria Mediate during pilus bacteria Motility adherence sex Flagellum cell Proteins to conjugation of

Survival: dipicolinic chemicals dehydration, Spore resist only ⊕ peptidoglycan, Gram heat, coat; acid; DNA Keratin-like

transport Slime membrane leaflet: Capsule across membrane phagocytosis (LPS/LOS) polysaccharide only antigenic porins against Discrete catheters) (OMPs) layer Protects proteins) contains Gram phospholipids Embedded ⊝ usually especially component foreign polysaccharides Porins: surfaces leaflet: outer (and rarely adherence made (eg, polysaccharides Loose O Mediates A and surfaces, Outer Endotoxin: endotoxin proteins: (S) Outer Most induces layer membrane lipid of and to antigenic are TNF other of proteins IL-1; indwelling OMPs outer Inner network

bacterial Periplasm components cytoplasmic enzymes in gram membrane ⊝ exiting Space gram and in membrane cells, ⊝ between β-lactamases) middle) including outer hydrolytic (eg, (peptidoglycan Accumulates

sac membrane chains [PBPs]) extend involved with Lipoteichoic synthesis a in positive) cell IL-1 exterior of TNF-α penicillin-binding Cell proteins (eg, to Phospholipid from peptide and embedded osmotic Peptidoglycan and structure protects induce Net-like sugar against gives and Cytoplasmic acids other Site PBPs bilayer side backbone enzymes; only wall (gram transpeptidase acids with wall pressure damage rigid is membrane enzymes proteins Lipoteichoic cross-linked support, oxidative transport by

First-line identification. bacterial in test Gram stain lab with layer red ⊝) crystal or retain dye (gram layer violet bacteria with peptidoglycan thick ⊕); (gram turn thin pink peptidoglycan Bacteria counterstain. with But well Lack Unfortunately not Microbes Color These bugs Everywhere): (These May Real Little Are Gram do stain

Treponema, to thin be visualized Too Leptospira

No cell wall Mycoplasma, Ureaplasma

polysaccharide stain capsule be red ink D stain can Cryptococcus India neoformans mucicarmine also to ; thick used

stain Coccidioides Fungi Silver (eg,

Legionella, E , jirovecii), pylori Pneumocystis Helicobacter

media of possess of The media Properties (or same both neither) type can growth properties. these of

of Selective growth preventing organism of media other Favors while the growth particular organisms. of Example: organisms. by selective Thayer-Martin sensitive that allow antibiotics other inhibiting agar contains growth of growth the Neisseria the

to Use Aerobes O2-dependent ATP. generate system an and Mycobacterium Nocardia, Examples Pseudomonas include pertussis. Bordetella tuberculosis, aeruginosa, (eg, tuberculosis predilection has the lung. M apices of immunocompromise Reactivation a for after use) the TNF-α inhibitor of or

Actinomyces Anaerobes Fusobacterium, Clostridium, and Bacteroides, include israelii. Examples They superoxide dismutase and catalase to lack and/or susceptible damage. are thus oxidative Generally (CO2 foul produce culture, are gas tissue to and difficult fatty smelling H2). and acids), (short-chain in

Air. Can’t Fresh Breathe Anaerobes

Anaerobes tract, flora elsewhere. typically pathogenic normal are in GI ineffective enter these bacterial O2 require because anaerobes to cell. antibiotics into are AminO2glycosides against

A and Klebsiella Salmonella, Haemophilus , pneumoniae, pneumoniae Pseudomonas aeruginosa, group B type b, Examples Strep. Streptococcus Escherichia Neisseria influenzae meningitidis, are coli, capsules as virulence serve Their an antiphagocytic factor.

Capsular in an polysaccharide serves protein vaccines. conjugate antigen + as

Please SHiNE my SKiS.

by opsonized, Are cleared then and spleen. opsonizing against: severe risk Here) ability infections; for Asplenics vaccines Spleen protect need   thus and to (No have

polysaccharide are by subsequent vaccines a immunogenicity conjugated promoting capsule containing protein, class switching. and T-cell antigens Some enhancing to carrier activation T A antigen polysaccharide presented alone to be cannot cells.

conjugated PPSV23 vaccines: with (pneumococcal polysaccharide vaccine), PCV13 no (pneumococcal Pneumococcal protein). vaccine conjugate

type H vaccine). influenzae b (conjugate

(conjugate Meningococcal vaccine vaccine).

before Catalase H2O2 converted be microbicidal O2 the H2O and it into bubbles to myeloperoxidase. products can by A degrades enzyme organisms Catalase-positive of granulomatous deficiency) chronic recurrent infections catalase organisms. (NADPH certain with oxidase disease People have ⊕ with

coli, cepacia, Pseudomonas, Helicobacter Staphylococci, Nocardia, pertussis. pylori, Candida, E Examples: Listeria, Burkholderia Bordetella Aspergillus, Serratia,

sanguinis) plaques, Viridans S Dental (S mutans, infective endocarditis streptococci

in cystic fibrosis, tree with colonization Contact Respiratory lens–associated P pneumonia patients ventilator-associated keratitis aeruginosa

bacteria can limited. are Some when form gram A ⊕ nutrients spores and metabolic and Spores highly chemicals. lack resistant are to heat activity dipicolinic Core contains acid. minutes. at (as to equipment) done spores autoclave 121°C steaming by is surgical 15 for Must kill to

C (gas C gangrene), C (food poisoning), botulinum colitis), tetani (tetanus). difficile (anthrax), (botulism), B C cereus Examples: (pseudomembranous B anthracis perfringens

promote factors immune response. These Bacterial host of virulence evasion

(from cell naked bacterial of environmental DNA chromosomal pieces lysis). bacterial called genes expression transferred is transformation. of The transfer newly and of Hinfluenzae type especially pneumoniae, (SHiN). bacteria, b, and Neisseria A feature many S

Adding preventing DNA, naked degrades deoxyribonuclease transformation.

chromosomal of chromosome part recombination the DNA frequency into bacterial (Hfr) cell. bacterial termed high- of DNA, of part a plasmid F– Hfr F+ leading flanking cellF– Hfr F– genes. cell cell and of cell few cell Hfr chromosomal Recombinant cell Transfer cell those some bacterial integrate may of recombination genes. High-frequency but new now remains may F– Recipient have genes. cell bacterial

Generalized infects DNA of Cleavage of to phage cleavage A Lytic packaged “error.” Bacterial DNA. packaging bacterial leading phage bacterium, DNA chromosomal become bacterial may Parts phage of in capsid. packaged another transferring genes. bacterium, Phage infects these

transferred cell lysed Release of other bacteria Infects new phage bacteria Genes from to new

event. Specialized An “excision” bacterial viral Lysogenic infects DNA phage into incorporates chromosome. bacterium; it. phage DNA genes be excised, bacterial with When excised is may flanking another capsid packaged and is can infect phage DNA bacterium. into Group (ABCD’S): Shiga erythrogenic are Botulinum in toxins strep bacterial 5 Diphtheria toxin, a following encoded phage toxin, Cholera A toxin, for toxin, toxin. the Genes lysogenic

(eg, of (specialized and DNA cell segment into from molecule Release DNA then Infects and donor same Genes excise phage can DNA), other unrelated lysed copy insert from and itself bacteria new the which of di˜erent or an recipient

or chromosome). plasmid genes Transposon Integration of vanA to in resistance with species Enterococcus Tn1546 with lines multiple creating across DNA from aureus). Critical and transfer drug S (eg, plasmids

exotoxins endotoxins features with of exotoxins Main Bacteria and

TNF, Exotoxin cell reaction Endotoxin Downstream Host IL-6 cellular IL-1,

glycine) neurotransmitters inhibitory cells trismus from and spastic in release risus spinal prevents cord  Toxin paralysis, (GABA sardonicus, Renshaw (lockjaw) of

toxin prevents baby) Toxin release (endocytosis) AB with triggering (ACh) aAn enabling toxin neuromuscular of of stimulatory and  signals (aka, junction flaccid active paralysis anthrax]) (floppy [or at uptake the two-component for component. A binding B three have components listed as in enzymatic are activities usually chart. others The ribosyltransferases; ADP A

Bacteria exotoxins with (continued)

agar) perfringens membranes and hemolysis  Alpha (“double on phospholipids and toxin degrades (lecithinase) cell Phospholipase tissue myonecrosis zone” hemolysis Degradation blood of Clostridium (“gas that of gangrene”)

host glomerulonephritis) membrane not poststreptococcal (do Streptococcus of β-hemolysis; against contributes fever Streptolysin to toxin confuse Lyses to degrades RBCs; (ASO) that antibodies used cell complexes O immune with pyogenes rheumatic Protein diagnose

Cross-links binding cause antigen food  poisoning and II on • the of outside (exfoliative syndrome class syndrome: shock; to of enterotoxin) β IFN-γ, scalded release TCR APCs site toxin) other (heat-stable IL-2, shock Toxic TNF-α of and region skin toxins MHC shock rash, IL-1, fever, overwhelming

fever Toxic syndrome: scarlet shock; rash, fever, shock–like

found in bacteria and LPS rods). gram cocci (both membrane ⊝ outer of Endotoxin + toxic lipid polysaccharide (the Composed component). of + antigen core A O blebs upon lysis cell (vs or by by cells surface from outer exotoxin, actively which Released secreted). membrane living is detaching macrophage and activation activation. Three main factor effects: activation, tissue (TLR4/CD14), complement

+ lipid A Edema Outer IL-1 TNF-α membrane oxide heat eXtremely stable core IL-6 chemotaxis polysaccharide DIC/Death Shock Neutrophil and Nitric O-antigen + ENDOTOXINS:

and hypotension Fever oxide HypotensionNitric hemolysis, TNF-α hemolysis, IL-6 IL-1, Fever

bold. Important tests are in Important in italics. pathogens are bold Enterococcus either is ˜or Note: °-hemolytic.

grows sensitivity in Novobiocin bile) hemolysis, (No

⊕ in PYR -hemolytic 6.5% Status cocci. Gram Growth NaCl and bacteria A causes around Partial clearing oxidation or on greenish brownish growth hemoglobin blood without . of agar color cocci. Include bacteria organisms: the -hemolytic following ⊕ Gram  blood on RBCs surrounding colony area agar A Complete of lysis . pale/clear organisms: following the Include

β-hemolytic, clusters A . catalase Gram in ⊕ ⊕, cocci ⊕, coagulase activation binds Protein inhibiting and phagocytosis. complement A Fc-IgG, factor) (virulence groin. nares, ears, the and axilla, Commonly colonizes

Causes:

osteomyelitis. organ after arthritis, infection), pneumonia influenza abscesses, infections, septic (often disease—skin and virus endocarditis, Inflammatory

(TSST-1), Toxin-mediated (exfoliative disease—toxic poisoning shock rapid-onset scalded food toxin), skin syndrome syndrome (enterotoxins).

of penicillin-binding to (methicillin-resistant nosocomial community-acquired and important infections; cause S serious MRSA protein. due altered resistance aureus)— penicillin mecA in chromosomal staphylococcal involved gene cassette from resistance.

binds a release. T-cell in II receptor, MHC is polyclonal cytokine and to T-cell activation resulting and superantigen that TSST-1

rash, toxic failure. shock vomiting, shock, end-organ syndrome Staphylococcal fever, desquamation, (TSS)— • bilirubin. in AST, TSS ALT, results   packing. Associated nasal or vaginal tampons with prolonged of use

TSS Compare painful associated syndrome Streptococcus pyogenes with shock–like skin with (a toxic infection).

aureus preformed poisoning hr) to period short followed ingestion nonbloody and due emesis. diarrhea S (2–6  by food incubation of toxin Enterotoxin is stable by not  destroyed heat cooking.

toxins. makes S coagulase and aureus Forms abscess. around itself fibrin clot 

in cocci coagulase ⊕ ⊝, ⊕, urease ⊕, clusters. Gram catalase sensitive. Novobiocin ferment aureus). Does S mannitol not (vs

of skin; Normal contaminates cultures. blood flora

catheters adherent hip and biofilms. valve) producing prosthetic implant, devices (eg, IV heart Infects by

Staphylococcus ⊕, catalase urease ⊕, ⊝, ⊕ clusters. coagulase in Gram cocci Novobiocin resistant. genital saprophyticus female perineum. flora Normal and tract of

uncomplicated young E women UTI of common cause is most (most common in coli). Second

⊕, α-hemolytic, diplococci lancet-shaped Gram

A . Encapsulated. protease. IgA and sensitive Optochin bile soluble. causes: Most commonly

and with patients. with patients in Pneumococcus cell “rusty” associated sickle asplenic sputum, disease, is sepsis

capsule. virulence without No

α-hemolytic ⊕, Gram cocci. insoluble. resistant bile and Optochin the Normal of flora oropharynx.

and mutans dental Streptococcus caries. cause mitis S

bind valves, heart damaged S on that to makes dextrans aggregates fibrin-platelet causing sanguinis bacterial endocarditis. subacute

resistant). afraid live they (op-to-chin group strep Viridans mouth, the of-the-chin because in are not

= blood. Sanguinis is heart” in lots blood (endocarditis). Think, the of “there

. A in ⊕ cocci Gram chains strep A cause: Group

lesions), cellulitis, impetigo (“honey-crusted” Pyogenic—pharyngitis, erysipelas

shock–like syndrome, fever, necrotizing toxic fasciitis Toxigenic—scarlet

glomerulonephritis fever, Immunologic—rheumatic

sensitive, pyrrolidonyl Bacitracin β-hemolytic, arylamidase ⊕. (PYR) capsule phagocytosis. M inhibit and protein acid Hyaluronic S against host M but protein can defenses give to to fever. rheumatic Antibodies pyogenes rise enhance

infection. titer S ASO antibodies recent or pyogenes anti-DNase B indicate

“Ph”yogenes “phever” and result in rheumatic pharyngitis can glomerulonephritis.

Strains glomerulonephritis. impetigo causing can induce

and of pallor strawberry ⊕). rash, A (erythrogenic pharyngitis in Scarlet setting tongue, sandpaper-like streptococcal toxin the body circumoral group fever—blanching,

factor). exotoxin Bacillus produces rod Gram spore-forming lethal that antigen, anthrax consisting edema anthracis ⊕, of protective toxin (an and factor, Has a (poly polypeptide d-glutamate). capsule as appearance. a head” referred sometimes “medusa show projections, of halo Colonies to

(painless, A progresses  papule eschar and Painless necrotic) ulcer with surrounded death. to black anthrax  vesicles uncommonly bacteremia by Cutaneous

symptoms show shock. flu-like commonly potential and  of a Inhalation to animal (CXR that widened from animals although spores, bioweapon or pulmonary mediastinitis products, also most may progress mediastinum), rapidly hemorrhage, Pulmonary contaminated fever, anthrax woolsorter’s Also called disease.

⊕ bacitracin babies. colonizes mainly vagina; and resistant, meningitis, causes in cocci, β-hemolytic, sepsis, Gram pneumonia,

formed the factor, hemolysis aureus. area of S by Produces CAMP enlarges which CAMP cyclic the not stands of the for AMP.) test, (Note: authors ⊕. test Hippurate PYR ⊝.

and at with pregnant of rectal vaginal weeks women swabs. gestation 35–37 Screen intrapartum penicillin/ampicillin prophylaxis. with culture receive ⊕ Patients

Gram Bacillus rod. cereus ⊕ poisoning. food Causes survive cooking Spores rice syndrome). rice (reheated

in Keeping results germination of warm spores enterotoxin formation. and rice Emetic nausea causes type vomiting hours. and within 1–5 preformed by cereulide, toxin. a Caused Diarrheal 8–18 watery, causes hours. type GI and nonbloody within diarrhea pain toxins). care (antibiotics are Management: supportive against ineffective

obligate Clostridia Gram spore-forming, ⊕, rods. anaerobic and are proteins proteases toxin SNARE botulinum that Tetanus neurotransmission. involved in toxin cleave

tetani an is paralysis. causing exotoxin Tetanus Produces tetanic tetanospasmin, Clostridium tetanus. from Renshaw blocks glycine and cells cord. Tetanospasmin GABA release spinal in of (lockjaw), paralysis, spinal sardonicus opisthotonos risus (raised of extensors). grin), open eyebrows trismus (spasms spastic and Causes tetanus with Prevent vaccine. diazepam (for antitoxin spasms), antibiotics, muscle with booster, vaccine Treat and wound +/− debridement.

the junction, causing heat-labile inhibits a Produces that neuromuscular botulism. toxin release ACh at In is caused preformed adults, by toxin. of ingestion disease (floppy syndrome). baby babies, honey) of In leads in spores to (eg, ingestion disease human immunoglobulin. botulinum Treat with

Dysarthria, (the D’s): Dyspnea. of Diplopia, Dysphagia, Symptoms botulism 4

paralysis). and (causes honey food, bottles flaccid descending is juice, Botulinum bad from of a

and of reduction (Botox) injections focal hyperhidrosis, toxin Local cosmetic facial dystonia, spasms, to wrinkles. botulinum treat used muscle A

gangrene soft myonecrosis α-toxin cause tissue presents ; (gas Produces crepitus) (lecithinase, A and as hemolysis. phospholipase) that can a

poisoning in is 60°C, enterotoxin < long 10-12 too food 24 left • cooked but spore-contaminated germinate If • resolution symptoms spores hours, hours. at food vegetative standing bacteria • heat-labile in heavily

gangrenous Perfringens leg. a perforates

enterocytes. and Produces B, A toxins which damage diarrhea Both toxins to watery lead

B . use, with PPIs. 2° ampicillin; antibiotic especially clindamycin associated to Often or

PCR stool. antigen or one both toxins by or detection Diagnosed in of toxic Complications: megacolon.

causes Difficile diarrhea.

Treatment: or vancomycin, oral metronidazole, fidaxomicin. repeating cases, recurrent microbiota transplant. or fecal For consider regimen prior

in droplets. respiratory transmitted occurring rods arrangements; ⊕ angular via Gram by β-prophage. Causes diphtheria via exotoxin encoded inhibits necrosis Potent leading ADP-ribosylation synthesis CNS exotoxin of protein in EF-2, pharynx, to possible and via tissue. cardiac,

A pseudomembranous (grayish-white membrane Symptoms with ) include pharyngitis lymphadenopathy. cause Toxin arrhythmias, myocarditis, dissemination neuropathies. may

diagnosis for granules and ⊕ test metachromatic and with gram Lab red) rods based on Elek toxin. ⊕ (blue

prevents vaccine diphtheria. Toxoid

Löffler media). on agar. cystine-tellurite Black colonies on ABCDEFG:

Factor therapy antitoxin. +/– Treatment: Elongation 2 antibiotic diphtheria Granules

intracellular transmission vaginal by birth. rod; and transmission, deli acquired during ingestion cold meats, of dairy Gram unpasteurized products by transplacental ⊕, facultative temperatures well enrichment”). refrigeration (“cold Grows at

polymerization thereby intracellular A tails” cell-to-cell ) actin antibody. avoiding (red membranes, that in Forms allow spread “rocket and movement across cell via tumbling broth. in motility Characteristic

and gastroenteritis women; older pregnant mild, spontaneous meningitis patients, neonates, amnionitis, in in immunocompromised healthy in Can infantiseptica; granulomatosis individuals. self-limited abortion septicemia, cause and adults;

Treatment: ampicillin.

gram Both branching form Nocardia resembling vs filaments and are long, fungi. ⊕ Actinomyces

Found Normal soil in and GI flora reproductive, oral,

yellow mimic other can tracts; ⊝ often to oral/facial and caries/ IUDs through (can Causes with with in can Causes forms maxillofacial with spread associated sinus also after extraction in immunocompromised TB CNS but dental PID cause “sulfur immunocompetent; PPD); pulmonary cutaneous infections drain granules”; that abscesses infections trauma trauma;

sulfonamides with Treat penicillin with Treat (TMP-SMX)

a SNAP: is Treatment Actinomyces—Penicillin Sulfonamides—Nocardia;

(pink rods, rods Gram A arrows ⊕ acid in ). fast tuberculosis multiple drugs). to resistant Mycobacterium (TB, often

(causes AIDS; in avium–intracellulare M often disseminated, to non-TB multiple disease resistant drugs). 50 CD4+ < when azithromycin with Prophylaxis . mm count cells/ (cervical children). M lymphadenitis in scrofulaceum handlers). infection in M aquarium marinum (hand

hemoptysis. loss, (nonproductive TB weight symptoms productive), include sweats, or cough fever, night

tuberculosis TNF-α. appearance induces in factor (promoting strains; M creates of “serpentine a macrophages Cord granuloma and formation) release cord” activates virulent glycolipids) fusion. phagolysosomal Sulfatides inhibit (surface

malnutrition) fbrosis (AIDS, tuberculosis Healing Progressive BCG by Calcifcation from primary vaccination. positives false (PPD infection ⊕ or if current past PPD exposure. no if ⊝ infection PPD and in sarcoidosis or

HIV with count). CD4+ cell infection low (especially

granulomas A ) cell with central and 2° example tuberculosis. characteristic (single of necrosis Caseating giant in Langhans are

Also disease. called Hansen Leprosy and and likes bacillus of Caused and vitro. cool Mycobacterium nerves—“glove leprae, ) by cannot temperatures in A an that acid-fast (infects sensation grown loss superficial stocking” skin be tissue PCR. Diagnosed via or biopsy skin in Reservoir United States: armadillos. two between fall Leprosy has cases temporarily 2 extremes): forms (many

with Th2 and diffusely response. over (Lion-like) cell-mediated load); , Lepromatous—presents by B immunity (high Leonine facies with low bacterial communicable the characterized a is skin, largely Lepromatous Lethal. be can form

hairless by largely high to Tuberculoid—limited bacterial immunity Th1-type a low cell- characterized response mediated with plaques; hypoesthetic, load. skin few a and Treatment: added clofazimine is tuberculoid rifampin for form. lepromatous dapsone for and form;

bold. are Important tests in pathogens are Important in bold italics. rod/coccobacillus aPleomorphic

Neisseria diplococci. ⊝ Gram produce glucose Acid Metabolize production: MeninGococci—Maltose IgA and proteases. and Contain Gonococci—Glucose. Glucose; (LOS) lipooligosaccharides activity. strong endotoxin with is intracellular often (within gonorrhoeae neutrophils) N

. A

B No due individuals) for vaccine proteins pilus variation of antigenic at-risk vaccine to (type Vaccine available

toes (2–5 birth), arthritis, pelvic of days with Causes gonorrhea, neonatal petechial and meningococcemia after hemorrhages septic conjunctivitis Causes gangrene

(PID), meningitis, Curtis inflammatory (adrenal , syndrome B insufficiency, DIC, disease Waterhouse-Friderichsen syndrome Fitz-Hugh– fever, and

or Diagnosed tests NAT with PCR culture-based Diagnosed via

ointment  eye Rifampin, contacts in transmission, or prevents close erythromycin prophylaxis sexual ciprofloxacin, Condoms blindness ceftriaxone neonatal

chlamydial Treatment: doxycycline, azithromycin ceftriaxone penicillin or coinfection) for or (+ G ceftriaxone Treatment: possible

gram (coccobacillary) Small ⊝ rod. Aerosol transmission. introduced. are infections well invasive (otitis Nontypeable vaccine cause conjunctivitis, as bronchitis) media, since the the as b infections capsular type was for most (unencapsulated) common mucosal of strains protease. IgA Produces

growth; also via (NAD+) provides factors RBC agar, for can Culture on S with contains V factor hemolysis. X V and which which be grown aureus, (hematin) chocolate

red” children; “thumb on “cherry sign” x-ray in can A neck , be lateral

media, ), Meningitis, Otitis and Pneumonia. B

diphtheria b contains toxoid protein. conjugated type or other polysaccharide (polyribosylribitol phosphate) Vaccine to capsular Given 2 months 18 of between age. and

does). not virus (influenza flu Does the cause

clavulanate for contacts. Treatment: meningitis; for rifampin ceftriaxone infections; for +/− prophylaxis close mucosal amoxicillin

⊝ Acinetobacter aerobic, coccobacillus. ⊝, strictly Gram oxidase hospital-acquired opportunist with but Commensal resistant ICU. baumannii increasingly associated infections, especially in septicemia immunocompromised and in patients. cause pneumonia Can ventilator-associated

rod. Gram ⊝ stain. Gram silver poorly—use stains charcoal medium iron cysteine. extract Grow with yeast and on in urine. presence antigen by of Detected Labs show may hyponatremia.

water conditioning tanks). hot environmental source (eg, systems, air transmission Aerosol water habitat from person-to-person transmission. No

Treatment: or macrolide quinolone.

Gram coccobacillus. ⊝, aerobic Virulence cyclase toxin and (disables include cAMP), tracheal toxin cytotoxin. Gi), factors adenylate ( pertussis stages: Three clinical

Catarrhal—low-grade Coryza. fevers,

intense cough inspiratory cough”), Paroxysmal—paroxysms followed “whooP” by of posttussive vomiting. (“whooping

of recovery chronic Convalescent—gradual cough. by DTaP vaccines. Prevented Tdap, infection mistaken immune from resulting infiltrate be May to due response. lymphocytic as viral allergic Treatment: macrolides; if TMP-SMX. use

⊝, coccobacillus. aerobic Gram of Transmitted via (eg, unpasteurized animal contaminated products ingestion milk). in the reticuloendothelial Survives system. in macrophages form Can granulomas. noncaseating sweats, presents undulant night and fever, with Typically arthralgia.

doxycycline or streptomycin. Treatment: rifampin +

sissy French around campfire (cysteine). his is sitting a silver iron (charcoal) (soldier) no with of a helmet, with his Think legionnaire dagger—he

), pneumonia A lobar disease—severe GI and (often symptoms. CNS unilateral fever, and Legionnaires’ in chronic lung smokers and Common disease. in

syndrome. flu-like fever—mild Pontiac

⊕, motile, gram catalase rod. Aeruginosa—aerobic; ⊝ fermenting. Non-lactose Oxidase ⊕. Frequently found water. in grape-like Has a odor.

Mucoid hot Sepsis, capsule, wound infections Osteomyelitis, is Nosocomial with: equipment), Pneumonia, (swimmer’s abusers), burn UTIs, externa Ecthyma Addicts Otitis Diabetes, ear), (drug polysaccharide victims). PSEUDOMONAS Skin tub (eg, folliculitis, catheters, (eg, infection infections associated gangrenosum, in

chronic pneumonia polysaccharide cystic biofilm may Mucoid contribute in capsule formation. to patients to due fibrosis

cell (blue-green ; Produces Phospholipase EF-2); Pigments: A (inactivates generates (fever, pyoverdine (degrades Endotoxin and shock); oxygen A membranes); also Exotoxin C reactive PEEP: species). pigment pyocyanin

trauma. eye lens minor Corneal ulcers/keratitis contact wearers/ in

Ecthyma progressive, lesion cutaneous necrotic gangrenosum—rapidly

caused Pseudomonas bacteremia. by B patients. seen Typically in immunocompromised

Treatments include “CAMPFIRE” drugs:

B, polymyxin (eg, Polymyxins colistin)

levofloxacin) ciprofloxacin, (eg, Fluoroquinolones

ThIRdand cephalosporins fourth-generation (eg, cefepime) ceftazidime,

penicillins Extended-spectrum (eg, piperacillin, ticarcillin)

⊝ Yersinia rod/coccobacillus. Gram enterocolitica pleomorphic feces or transmitted pet pork. from Usually puppies), contaminated (eg, milk, pseudoappendicitis cause terminal pain due Can reactive ileitis), (right in bloody lower adenitis and/or adults. diarrhea, arthritis to abdominal mesenteric acute

that rod; when in aspirated. pneumonia flora intestinal alcoholics ⊝ lobar diabetics causes and Gram by capsules. Very abundant A colonies caused polysaccharide mucoid “currant (blood/mucus). red sputum Dark jelly”

cause UTIs. nosocomial Also of multidrug (MDR). with resistance evolution of Associated

Aspiration “Currant of and in aBscess EtOH pneumonia sputum jelly” ABCDE’s abuse Klebsiella: lungs liver Diabetes

grows flagella) the Campylobacter campfire”). at A S hot Gram ⊕, polar oxidase 42°C likes , (“Campylobacter jejuni shaped ⊝, (with comma or

Major in diarrhea, bloody especially of cause children. milk. undercooked of poultry contact unpasteurized or meat, through Fecal-oral person-to-person transmission or contaminated ingestion via pigs) a is cats, (dogs, risk factor. with Contact also infected animals

and to Common syndrome arthritis. reactive Guillain-Barré antecedent

, ⊕, oxidase grows comma in cholerae alkaline Gram A media. flagellated, ⊝, shaped Vibrio to Endemic countries. developing activates that profuse enterotoxin diarrhea Gs, via Produces cAMP. permanently rice-water  labile); host stomach to  Sensitive unless (high acid has acidity. ID50) requires (acid inoculum large gastric raw food uncooked Transmitted contaminated (eg, shellfish). via ingestion water or of with rehydration oral promptly solution. Treat

catalase ⊕ flagellated or ⊕, urea use oxidase rod breath (can Curved, urease ⊕: is fecal that ⊕, triple A (motile), gram ⊝ and antigen for test diagnosis). test survive ammonia, produces H acidic alkaline pylori an creating helps environment, Urease which mucosa. in causes ulcers antrum duodenal). and of Colonizes peptic stomach; gastritis (especially mainly lymphoma. for and ulcer disease, Risk adenocarcinoma, factor MALT gastric peptic

allergy) Cure + + Clarithromycin common Proton treatment if Antibiotics inhibitor; initial Pylori. penicillin Most therapy: pump triple (metronidazole is Amoxicillin resistance. about macrolide if quadruple therapy concerned Bismuth-based

chills, (fever, started; after antibiotics myalgia) (usually are Flu-like releasing to killed reaction bacteria Jarisch-Herxheimer toxins. headache, due spirochetes) syndrome

cannot make their Chlamydiae own ATP. that obligate organisms infections. intracellular are cause They mucosal forms: 2

body. Elementary via cell into Enters and (small, transforms body dense) Endocytosis; is “Enfectious” reticulate

cell in elementary into Replicates Reticulate Reorganizes bodies. fission; by body

PID, nongonococcal urethritis, reactive A and , arthritis.

pneumonia; pneumoniae atypical by cause transmitted aerosol. Chlamydophila and psittaci Chlamydophila

lacks wall antibiotics peptidoglycan to rendering β-lactam (due ineffective. cell reduced Chlamydial acid), classic muramic

(intracellular). Chlamys cloak =

C causes atypical reservoir (parrots), psittaci—has pneumonia. avian an

Lab diagnosis: amplification acid test. nucleic PCR, inclusions fluorescent antibody– stained smear. Giemsa Cytoplasmic on seen bodies) or (reticulate

because one-time doxycycline. treatment) azithromycin or (favored Treatment: for Add possible concomitant gonorrhea. ceftriaxone

doxycycline. Rickettsial vector-borne and Treatment: illnesses diseases

is rickettsii, vector Rickettsia tick. primarily Carolina. especially its name, North the disease Atlantic Despite occurs states, in South typically spreads at ankles A palms, and and trunk, and starts to wrists Rash soles. then

triad—headache, (vasculitis). rash Classic fever,

mouth (you and Rocky fever, rash Palms in (hand, spotted and disease), using and Coxsackievirus and your infection seen foot, soles). is A CARS palms drive Syphilis soles Mountain 2°

form. has and no its endospore is fever its Complicated rash by in or causative Q Bug caused Quite outside a vector it can organism because survive Rickettsia Not the but closely related. genus, in

interstitial cough, nonproductive “walking atypical (insidious pneumonia” diffuse or cause onset, patchy of Classic infiltrate). headache,

in prisons, years recruits, outbreaks in frequently <30 those military Occurs colleges. old;

patient. than worse looks X-ray agglutinate cold can titer agglutinins which of (IgM), High RBCs.

ineffective since fluoroquinolone no (penicillin doxycycline, wall). or has cell macrolides, Treatment: Mycoplasma

on stain. Gram Not seen Pleomorphic

. A for membrane stability. contains Bacterial sterols on agar. Eaton Grown

gets cell Mycoplasma a wall). (no coat cold without

children adolescents. of atypical Stevens-Johnson variant in Can typically cause and syndrome,

Histoplasma RBC) (smaller and Mississippi Ohio with filled Valleys than River Macrophage

size Eastern Blastomyces and Lakes of Central as (same budding Broad-based US, RBC) Great

of US, endospores Spherule filled than Southwestern (much larger California RBC) Coccidioides with

Budding “captain’s formation Latin America of Paracoccidioides yeast than larger RBC) (much wheel” with

splenomegaly, pancytopenia ulcers, Palatal/tongue

mimic bone/ skin Disseminates (may to SCC)

bone skin/ Disseminates to

females (within to > macrophages) hides blastomycosis, Histo Similar males

bird (eg, or spelunking) droppings bat with Associated

with areas endemic dust archeological earthquakes) exposure (eg, excavations, Associated in

Paracoccidio America to the wheel parasails Latin all white. way alba = captain’s with the 37°C at yeasts forms germ tubes budding A . and at Dimorphic; , pseudohyphae 20°C B

superficial fungal Systemic or infection. mucocutaneous (IV diaper immunocompromised endocarditis neutropenic thrush vulvovaginitis and C Causes oral patients), of in (neonates, in steroids, AIDS), rash, esophageal (especially use users), diabetes, disseminated antibiotics), drug chronic (diabetes, candidiasis. candidiasis

amphotericin or rarely, for azoles vaginal; or esophageal echinocandins Treatment: B systemic for for fluconazole, disease. echinocandins, or, fluconazole/topical oral oral; nystatin, azoles,

E .

5–10 μm with budding. narrow Heavily yeast. encapsulated dimorphic. Not

Found pigeon in droppings. soil, dissemination Acquired hematogenous inhalation with meninges. to through ). (red (clear ) mucicarmine H inner capsule India G halo and Highlighted ink with sensitive agglutination and test detects capsular antigen Latex and polysaccharide is more specific.

encephalitis in lesions Causes cryptococcosis, (“soap brain), cryptococcal immunocompromised. in primarily bubble” meningitis, cryptococcal

by flucytosine cryptococcal + amphotericin for fluconazole B followed meningitis. Treatment:

wide nonseptate I Irregular, . angles broad, at branching hyphae

(eg, in patients mostly neutropenic leukemia). mucormycosis, and/or ketoacidotic Causes diabetic plate, walls, cribriform in vessel proliferate penetrate of fungi  enter brain. Inhalation blood spores and frontal Rhinocerebral, lobe cavernous abscess; sinus thrombosis. cranial facial eschar J may Headache, pain, involvement. necrotic face black have nerve on ;

debridement, amphotericin surgical Treatment: B isavuconazole. or

. jirovecii (PCP), pneumonia pneumonia interstitial Pneumocystis Causes diffuse Pneumocystis a A as (originally fungus protozoan). classified Yeast-like asymptomatic. are Most infections (eg, AIDS) Immunosuppression predisposes to disease. pneumatoceles imaging, on ground-glass Diffuse, chest bilateral with opacities . B by lung Diagnosed bronchoalveolar lavage or biopsy. methenamine seen on yeast of tissue with antibody. fluorescent lung C Disc-shaped or silver stain or single with atovaquone. as (prophylaxis dapsone pentamidine, in agent, TMP), treatment Treatment/prophylaxis: combination TMP-SMX, 200 cells/mm3 count drops when < CD4+ in Start HIV to patients. prophylaxis

sporotrichosis. Causes Dimorphic fungus. the at body ºC soil (conidia). and Exists cigar-shaped in with as as in human yeast spores a 37 hyphae on Lives vegetation. by are ). causes pustule (“rose spores into with or (ascending nodules a gardener’s along lymphangitis lymphatics A the ulcer introduced thorn typically traumatically When local skin, draining disease”), Disseminated host. possible immunocompromised in disease

iodide cutaneous/lymphocutaneous). or potassium for itraconazole (only Treatment:

of a rose a cigar pot. smokes and Think gardener who

as in ring-enhancing  abscesses antibody test usually Immunocompetent: symptoms, on AIDS multiple heterophile gondii lesions mononucleosis-like Reactivation brain seen Toxoplasma ⊝ MRI

calcifications triad Congenital hydrocephalus, chorioretinitis, of intracranial A toxoplasmosis: classic and

common); (most Cysts biopsy Sulfadiazine meat Serology, in + (tachyzoite) oocysts

severe States; predominantly P fever with intravenous on (Schüffner parasitized splenomegaly (tertian;  and A (also capillaries P Chloroquine northeastern hemolytic brain vivax/ovale—48-hr hr quinidine if cross” ring throughout cycle add fever irregular seen occlude ring and vivax/ovale, malaria), schizont dormant or risk falciparum Blood patterns; red use atovaquone/ P Blood life-threatening, containing B granules PCR Anaplasma P If Ixodes includes liver (hypnozoite) A P C RBC or mefloquine in malariae trophozoite form falciparum—severe; stippling) RBCs Anopheles United deficiency) asplenia Plasmodium day deficiency) 48 apart); of hypnozoite artesunate Borrelia (test proguanil P cytoplasm smear: actually RBC and are third P (quartan) disease merozoites; burgdorferi in thus , C2 for vivax/ovale within + form for Babesia P vector (for cycle Atovaquone headache, anemia; for , (test in For malariae—72-hr kidneys, use ; vivax/ovale resistant, azithromycin Babesiosis—fever G6PD smear: (cerebral Malaria—fever, anemia, G6PD B for spp) primaquine C1 sensitive lungs first species); tick “Maltese day, form fevers mosquito

tapeworm in Praziquantel of larvae encysted pork Intestinal Ingestion undercooked

eggs in albendazole Ingestion seizures) of for (cystic lesions, Cysticercosis, Praziquantel; neurocysticercosis human contaminated food with CNS neurocysticercosis

contaminated Ingestion (“eggshell food liver eggs rupture dog in can cause are Albendazole with cyst anaphylaxis D intermediate in an of host ; calcification”) E Sheep feces

enlargement spleen egg Liver lateral with mansoni, (S spine and

A hypertension inflammation, portal ), fibrosis,

haematobium with with infection spine (egg S terminal Chronic

with intermediate in Praziquantel (eg, hematuria) swimming Snails are bathing) squamous or and can bladder humans carcinoma contact host; of cercariae hypertension water skin B to cell pulmonary the fresh lead penetrate contaminated ) of (painless

with Associated cholangiocarcinoma

burrows corneum and Common Mites crowded transmission homes); (worse scabies—pruritus often toes (lines) skin-to-skin common) (most night) fingers and burrow at via (jails, contact stratum nursing or in scabiei populations Sarcoptes children, into serpiginous and cause between through

. A fomites. contacts. all Treatment: treat cream, permethrin close washing/drying clothing/bedding,

on that humanus/ with pubic scalp axilla or Blood-sucking intense and lice associated cause pubis lice), lice), waistband (pubic perianal pruritus neck and commonly regions Phthirus Pediculus (head and excoriations, lice). (body

Body recurrentis Borrelia (trench Rickettsia (epidemic can transmit prowazekii Bartonella lice (relapsing quintana fever). typhus), fever),

and Treatment: or malathion, pyrethroids, ivermectin lotion, combing. B nit home school with Children be attendance. head can interrupting without lice treated at

tract Clonorchis sinensis Biliary cholangiocarcinoma disease,

seizures Brain Taenia (neurocysticercosis) cysts, solium

capsid helical icosahedral capsid icosahedral capsid with virus virus Enveloped with Enveloped Bacteriophage with Naked virus

membrane from plasma viruses cell. they from when envelopes their Generally, enveloped acquire exit envelopes acquire herpesviruses, include which Exceptions from membrane. nuclear

include Parvovirus, Papillomavirus, and Naked (nonenveloped) Reovirus, Hepevirus. viruses Calicivirus, Adenovirus, Polyomavirus, Picornavirus,

(except infectious. ⊕ poxviruses dsDNA and viruses Purified of nucleic (≈ mRNA) and are most HBV) strand acids ssRNA viruses ssRNA viruses infectious. nucleic not acids of ⊝ strand dsRNA Naked are and the virion. complete require They in polymerases contained

PAPP; CPR RNA hepevirus. DNA = and =

hippie Give smears CPR a and (hepevirus). PAPP to naked

Protection (Herpesvirus, DNA Have Enveloped viruses Hepadnavirus, Poxvirus). Helpful

replicate viruses general poxvirus). (except in All Some rules—all DNA DNA nucleus the viruses: box (nucleus).” is out of “Pox the

1, BK: virus—transplant Papillomavirus CIN, HPV–warts Kidney kidney patients, Junky 11), (PML) HIV 18) (most and cancer JC: in cervical (serotypes 16, No BK circular DS targets 2, Bad commonly 6, Cerebrum; commonly

cells sickle or RBC endothelial in hydrops in infectiosum, arthritis–like RBC death rheumatoid RBC children fetalis precursors fifth adults disease, pure and Parvovirus disease); No in (smallest destruction B19 DNA cell • “slapped fetus, in crises and rash (erythema linear symptoms virus—aplastic virus) cheek” SS and and infects  aplasia

viruses DS, linear and Herpesviruses Enveloped,

secretions, saliva sores) latent Herpes (cold in Respiratory trigeminal Most keratoconjunctivitis labialis Gingivostomatitis, herpes simplex commonly A ,

esophagitis, temporal herpetic mental encephalitis, cause aphasia status, Most lobe common of encephalitis, whitlow present on and/or erythema can seizures, sporadic B finger, virus-1 multiforme altered as ganglia ,

Herpes genitalis contact, Sexual Herpes

Most virus-2 herpes more in perinatal commonly with ganglia HSV-1 than meningitis with , Viral C sacral latent neonatal HSV-2 simplex common

contact ), pneumonia root Varicella-zoster (HHV-3) shingles Latent in branch complication can E trigeminal Varicella-Respiratory cause Most shingles post-involvement (chickenpox common , encephalitis, dorsal or V1 herpes fluid CN of virus Zoster D with is ganglia; secretions,

Epstein-Barr (common Respiratory disease,” young in aka secretions, adults) saliva; teens, virus (HHV-4) “kissing

avoid hepatosplenomegaly , posterior Mononucleosis—fever, due sports rupture nodes); splenic contact F (especially cervical and lymphadenopathy to risk until pharyngitis, resolution of

with horse or lymphomas through ⊕ Infects endemic in RBCs lymphoma), Associated agglutination Beer drink of Asian to (especially transplant carcinoma lymphoproliferative CD21, a antibodies (eg, be nasopharyngeal detected adults), disease cells in B Burkitt “Must by 21 sheep Barr” patients test—heterophile Monospot

cause culture skin/genitalia. HSV Use Viral can rash amoxicillin mononucleosis of maculopapular identification characteristic for in

encephalitis. CSF PCR herpes for

an multinucleated VZV cells A skin Tzanck detect giant of HSV-2, to in commonly opened infection. HSV-1, and smear seen vesicle test—a PCR of choice. skin is lesions test of

I do heavens Tzanck have not herpes.

HSV-1, inclusions Cowdry seen A also eosinophilic VZV. HSV-2, with Intranuclear

CXCR4, CCR5 HIV CD4,

rhino) retrovirus see influenza the viruses to and ICAM-1 came replicate the in (except cytoplasm virus). RNA Rhinovirus (I All outta cyt (sight).” flu “Retro is

positive arbovirus, single-stranded; sense; ⊝, ⊕, double-stranded; arthropod a= borne negative SS, sense; ticks). DS, (mosquitoes,

viruses Orthomyxoviruses. Influenza 8-segment ⊝ genome. Enveloped, with viruses ssRNA entry) neuraminidase promotes virion viral hemagglutinin (binds antigens. and (promotes progeny Contain and acid sialic release) risk and S bacterial aureus, influenzae. H commonly for superinfection, S at Patients most fatal pneumoniae,

flu vaccine the change. flu likely during the shot”) most viral to appear season, virus’ rapid genetic to (“the contains due strains Reformulated

Killed most is frequently viral vaccine used.

attenuated Live administered nose intranasally. that not in the contains lung; vaccine mutant temperature-sensitive but in replicates the

+/– supportive Treatment: oseltamivir, neuraminidase zanamivir). inhibitor (eg,

togavirus. Rubella virus A (3-day) as measles. known Causes rubella, once German lymphadenopathy, involve to and postauricular trunk . and and face that arthralgias, rash A spreads maculopapular on other extremities Fever, starts fine, and centrifugally serious (a disease disease children congenital in but TORCH mild Causes infection). extramedullary muffin” “blueberry due include hematopoiesis. findings Congenital dermal appearance rubella to

Paramyxoviruses children. cause in Paramyxoviruses disease those causes parainfluenza infection infants. respiratory cause that and They in human (croup), tract mumps, RSV, (bronchiolitis, metapneumovirus, measles, which pneumonia) include multinucleated cells cells. causes fuse to surface F form which and contain respiratory protein, (fusion) All epithelial infants. premature in RSV against protein) F caused prevents pneumonia infection (monoclonal antibody by Palivizumab Paramyxovirus for Palivizumab Prophylaxis in Preemies. (RSV)

croup. Acute called Also parainfluenza by Caused viruses. contains sialic (binds release) hemagglutinin and viral virion progeny laryngotracheobronchitis promotes entry) Virus neuraminidase and acid membrane (promotes antigens. inspiratory a and barking “seal-like” Results stridor. in cough . trachea x-ray to characteristic upper leads A and of Narrowing steeple on subglottis sign obstruction. upper airway Severe result to in 2° croup pulsus can paradoxus

Uncommon of vaccine. glands due Mumps effectiveness Mumps to parotid testes as virus makes MMR your and POM-Poms. big as

Pancreatitis. aseptic of Meningitis, (inflammation Orchitis Symptoms: A Parotitis and testes), , after puberty). Can cause sterility (especially

A . B (cytoplasmic commonly in neurons. found ) bodies in inclusions cerebellum Purkinje cells Negri hippocampal and of to before months) (weeks incubation onset. has long Rabies period symptom and rabies with immunoglobulin. cleaning vaccine wound prophylaxis immunization is Postexposure plus killed immunity. passive-active Example of

a dynein retrograde after fashion to in receptors. to axons (via motors) Travels binding CNS migrating ACh up the nerve by

photophobia, • disease: of fever, coma • hypersalivation death. Progression agitation, malaise paralysis, hydrophobia, •

States; bat bat, aerosol from (eg, bites raccoon, caves) transmission from possible. Infection also skunk bites United in more and the than commonly dog

that phagocytes, endothelial targets filovirus hepatocytes. cells, A A symptoms, an flu-like days, of with to presents abrupt up onset myalgia. high diarrhea/vomiting, fever, period incubation Following of 21 progress shock. Can hemorrhage, diffuse to DIC,

within Diagnosed symptom onset. of hr with RT-PCR 48 High mortality rate.

bats or primates Transmission incidence contact bodily bodies), (apes/monkeys); infected (including direct with fluids, fomites of high requires dead infection. nosocomial

care, definitive no Supportive treatment. infected isolation to are practices key individuals and for preventing Strict health care workers of transmission. barrier

of manifestations hepatitis C B and Extrahepatic

indicates low to Anti-HBe HBeAg; transmissibility. Antibody

concentration reactants of Relative

detection Level of

disease period gp120: acute Incubation gp41: Prodrome,

Diploid molecules RNA). (2 of genome genes (protein Matrix • Lipid gp41): structural and glycoproteins. for): The to env envelope form cleavage (gp120 • coded p17: protein envelope Formed gp160 3 of from

cell. host CD4+ • gp120—attachment to T • gp41—fusion p24: and entry.

proteins, RNA respectively.

• pol—Reverse Protease; Integrase, RIP “Pol” (Paul) transcriptase,

host from genomic Reverse synthesizes genome. transcriptase RNA; dsDNA integrates dsDNA into

CD4 on as T as coreceptor, a macrophages or infection). (early either binds cells infection) well Virus CXCR4 on CCR5 (late

immunity. mutation = Homozygous CCR5 Heterozygous mutation = course. CCR5 slower

Ag/ blot recommended Ab longer tests Presumptive made are Western with HIV-1/2 immunoassays. diagnosis no for testing. confirmatory These the CDC immunoassays by Abs Ag in viral Ag/Ab and detect is HIV-1/2 to HIV-1/2. testing protein p24 IgG recommended not capsid Very high sensitivity/specificity. to maternally babies suspected due HIV with

amount viral tests antibody. of the transferred load determine Viral HIV RNA viral Use plasma. in the load associated viral High load instead. poor with prognosis. monitor use viral therapy. drug effect of Also to load determine HIV Use therapy. to genotyping appropriate

AIDS-defining diagnosis: pneumonia). with HIV Pneumocystis 500–1500 AIDS ⊕ (normal: ≤ CD4+ (eg, 200 cells/mm3 or condition cells/mm3)

HIV-1 NAT test NAT nucleic HIV-1 NAT: acid

membrane HIV illnesses defciency/AIDS-Seeding of +/– of dissemination course Clinical HIV mucous Acute infection defning and latency organs Systemic immuno-Viral untreated infection infections Time lymphoid Skin

of on when cells/mm3) indicate CD4+ stages (< untreated and (< 200 lines 400 axis Dashed Four illnesses CD4+ AIDS-defining count 1. infection: moderate emerge immunocompromise (acute) CD4+ cells/mm3). Flu-like 2. Feeling fine (latent)

complications die receive of do who Most of treatment patients not eventually 3. HIV infection. count Falling 4. clinical crisis lymph phase, During Final replicates virus in nodes latency

bacterial past dissemination reactivation  adults count (eg, Common (eg, of of fungal coccidioidomycosis), shingles), of infections HSV, and non-Hodgkin TB, HIV-positive and infections diseases  infections cell CD4+ lymphomas.

(variant to is CNS-related tissue prion Prions caused contaminated via products CJD) form Prion transmissible protein (PrPsc), β-pleated are conversion termed CJD). animal (iatrogenic (PrPc) BSE-infected of a protein the food normal or by which by a α-helical) (predominantly diseases to resists PrPc the PrPsc. of degradation more still facilitates PrPsc protease conversion and to sterilizing autoclaving. procedures, Resistant standard standard including results and Accumulation death. of in encephalopathy PrPsc and dementia, spongiform ataxia,

disease—rapidly sporadic Creutzfeldt-Jakob dementia, (some typically forms). familial progressive

Bovine called encephalopathy—also cow disease.” spongiform “mad

cannibalism. noted prion tribal human in populations practicing Kuru—acquired disease

colonized rapidly Neonates C-section no birth. after delivered but by Normal are flora have flora: dominant

rice. Reheated B cereus poisoning from “Food reheated rice? (B Be serious!” cereus)

foods (toxins), Improperly canned C botulinum (spores) raw honey

Salmonella and meat, Poultry, eggs

vulnificus mayonnaise, preformed with S contact toxin or from a cause contaminated can Meats, water wound custard; shellfish. infections aureus V also

of Common causes pneumonia

meningitis Common causes of

empirically Give Listeria if is vancomycin ceftriaxone ampicillin (add and suspected).

meningitis: coxsackievirus), causes (HSV-1 Viral VZV. (especially encephalitis), of Nile (also virus West causes HSV-2 = HIV, enteroviruses encephalitis),

spp. In HIV: Cryptococcus

Group B screening  streptococcal prophylaxis due greatly pregnancy. antibiotic has meningitis and in Note: to in Incidence neonates of H  to vaccinations. due greatly influenzae conjugate of influenzae H meningitis Incidence has in unimmunized usually Today, seen are cases children.

common other Assume no if S aureus overall) (most available information is

(Pott Vertebral tuberculosis aureus, involvement disease) M S

S IV abuse aureus; also drug Pseudomonas, Candida

specific. and sensitive but CRP not ESR Elevated

insensitive A ( but chronic are left). can osteomyelitis , in useful early be Radiographs for acute infection involvement detailing anatomic best is and detecting MRI , right). ( A

sigNs symPtoms white inflammation Thin, aND discharge No

A cells odor 4.5 test ⊕ > fishy Clue lab pH KOH with whiff FiNDiNgs

Thick, Inflammation foul-discharge yellow-green, white, (“strawberry Inflammation “cottage cervix”) Frothy, cheese”

Azoles sexual (4.0–4.5) partner(s) > B Metronidazole 4.5 pH pH Treat normal

infections pass mother may fetus. Microbes TORCH to from that (especially is delivery most cases, HSV-2). or via transplacental Transmission in infections Nonspecific retardation. signs common hepatosplenomegaly, many include growth to jaundice, and ToRCHHeS thrombocytopenia, Other Listeria neonates. Streptococcus E include of B causes in monocytogenes—all and agalactiae agents coli, streptococci), meningitis important infectious (group B19 hydrops fetalis. causes Parvovirus

transmitted Sexually rashes infections Red childhood of

bugs—Chlamydia (acute). often (subacute, Top undiagnosed), gonorrhoeae Neisseria trachomatis

the STI States. trachomatis—most United C in bacterial common

tenderness, include adnexal Signs purulent motion tenderness, cervical cervical discharge

A .

and hydrosalpinx, include PID salpingitis, abscess. tubo-ovarian endometritis, may

chronic for factor pain, infertility, and a ectopic is Salpingitis adhesions. risk pelvic pregnancy,

“violin to peritoneum adhesions string” capsule liver of (Fitz-Hugh–Curtis perihepatitis liver Can inflammation syndrome)—infection and lead of to and

. B

infections S two causes. most coli E aureus infection) common (wound (UTI) the Nosocomial and are

postauricular moving virus Beginning at and down lymphadenopathy Rubella Rash with head

Beginning coryza, moving and virus head down; cough, conjunctivitis, spots Measles by preceded at Koplik and

Can Poliovirus myalgia and lead also paralysis to

Muscle Clostridium paralysis spastic lockjaw, and spasms (eg, tetani Tetanus

sulfur israelii in Actinomyces oral rods Branching granules infection,

especially microbes, aureus disease ⊕ granulomatous S Catalase Chronic

Human Eikenella, oral Fusobacterium) flora bite (eg, Human

Neutropenic Candida (systemic), albicans Aspergillus patients

Pseudomonas infection aeruginosa Pneumonia in fibrosis, burn cystic

lockjaw wound, Puncture tetani Clostridium

empyema, S aureus Pus, abscess

mRNA Metronidazole 3rd—Ceftriaxone, Amikacin Quinolone 1st—Cefazolin, – PABA SYNTHESIS 50S Aminoglycosides Aztreonam Quinupristin PROTEIN Vancomycin 50S Sulfadiazine Fluoroquinolones Imipenem ACID SUBUNIT – – Penicillinase-resistant (RNA PEPTIDOGLYCAN Ertapenem etc Carbapenems GYRASEDNA Chloramphenicol Ticarcillin 50S Azithromycin polymerase CELL Tetracycline Tigecycline Sulfonamides WALL Linezolid Trimethoprim (gram 50S Nafcillin THF – DNA Ampicillin SYNTHESIS 30S acid PEPTIDOGLYCAN methylation) 5th—Ceftaroline (DNA radicals) Cephalosporins FOLIC Monobactams Daptomycin SUBUNIT – Cellwall etc Amoxicillin Tetracyclines Sulfsoxazole Piperacillin RNA CROSS-LINKING SYNTHESIS Antipseudomonal mRNA AND – etc Glycylcycline Gentamicin CELL Sulfamethoxazole 30S30S (I-V) Glycopeptides SYNTHESIS G, Macrolides Levofoxacin, Erythromycin Streptomycin etc Neomycin – Clarithromycin DHF V Dalfopristin Doxycycline INTEGRITY penicillins DNA (via 4th—Cefepime °) INTEGRITY gyrase – BACTERIAL Clindamycin Meropenem Ribosomes MEMBRANE polymerase) Rifampin Tobramycin SYNTHESIS 2nd—Cefoxitin, free (gram – Penicillinase-sensitive 30S Ciprofoxacin Oxacillin Cellmembrane penicillins REDUCTION Polymyxins Bacitracin Doripenem Minocycline Dicloxacillin Nalidixic ˜) Penicillin – Streptogramins

(IV IM form), (oral). Penicillin Penicillin V penicillin G and V G, β-lactam Prototype antibiotics.

analog. mecHaNism D-Ala-D-Ala structural proteins penicillin-binding (transpeptidases). Bind cross-linking cell in of Block peptidoglycan wall. transpeptidase autolytic Activate enzymes.

used gram pyogenes, ⊕ Use cliNical Mostly (S Actinomyces). organisms for S pneumoniae, N pallidum). cocci used gram T for spirochetes and (mainly Also (mainly ⊝ meningitidis) spirochetes. and ⊕ Bactericidal ⊕ cocci, gram for rods, ⊝ gram gram cocci, sensitive. β-lactamase

direct anemia, Coombs eFFects hemolytic reactions, Hypersensitivity aDVerse nephritis. drug-induced interstitial ⊕

cleaves the β-lactamase β-lactam resistaNce ring. in PBPs. Mutations

eFFects rash, aDVerse Hypersensitivity colitis. pseudomembranous reactions,

cleaves oF type (a ring. resistaNce of β-lactamase) mecHaNism β-lactam Penicillinase

nafcillin, Dicloxacillin, oxacillin. penicillins Penicillinase-resistant

penicillin. mecHaNism Same as Narrow to group blocks β-lactamase R resistant bulky of because spectrum; β-lactam penicillinase ring. access

S Use cliNical MRSA). aureus (except aDVerse “Use for eFFects naf nephritis. interstitial reactions, staph.” Hypersensitivity (nafcillin)

penicillin-binding mecHaNism oF resistaNce site. target MRSA altered protein has

Piperacillin, Antipseudomonal penicillins ticarcillin.

mecHaNism as penicillin. Same Extended spectrum. use Penicillinase sensitive; inhibitors. β-lactamase with

Use cliNical spp. Pseudomonas ⊝ gram rods. and

Hypersensitivity eFFects reactions. aDVerse

against (cefepime)—gram and Pseudomonas  with gram organisms, generation organisms. 4th activity ⊕ ⊝

and unlike ⊕ 1st–4th cover gram (ceftaroline)—broad ⊝ ceftaroline Pseudomonas. coverage; and 5th gram generation faecalis—does generation organism MRSA, Enterococcus not cephalosporins, covers

vitamin autoimmune hemolytic K eFFects deficiency. disulfiram-like reaction, aDVerse reactions, anemia, Hypersensitivity rate of patients. even Low cross-reactivity penicillin-allergic in

nephrotoxicity aminoglycosides. of •

cephalosporinases mecHaNism β-lactamase). type Inactivated (a of oF resistaNce by (transpeptidases). in change proteins penicillin-binding Structural

and cliNical anaerobes. ⊝ ⊕ cocci, gram Gram rods, Use use and life-threatening to failed. infections spectrum have significant after side other or effects drugs Wide limit is risk dehydropeptidase to of  seizures a stable and I. Meropenem has

and eFFects distress, high CNS toxicity plasma rash, GI levels. at (seizures) aDVerse

produced carbapenemases coli, Inactivated resistaNce pneumoniae, eg, E by K by, aerogenes. mecHaNism E oF

to mecHaNism β-lactamases. Less susceptible to 3. penicillin-binding protein cross-linking Prevents binding peptidoglycan by Synergistic aminoglycosides. with cross-allergenicity with penicillins. No

gram ⊝ only—no against cliNical or anaerobes. rods activity ⊕ Use rods Gram insufficiency those renal tolerate who penicillin-allergic and patients For aminoglycosides. with cannot

eFFects Usually aDVerse GI upset. occasional nontoxic;

mecHaNism portion cell D-Ala-D-Ala by peptidoglycan cell Inhibits of wall precursors. formation wall binding difficile). most (bacteriostatic Bactericidal against bacteria C against β-lactamases. Not susceptible to

for including dose S pseudomembranous cliNical Enterococcus ⊕ difficile MRSA, Use sensitive organisms, species, (oral Clostridium serious, Gram bugs and multidrug-resistant epidermidis, colitis). only—for

but general Well Free. trouble tolerated eFFects aDVerse NOT in A pretreatment largely antihistamines), syndrome. Thrombophlebitis, syndrome Flushing diffuse with Ototoxicity, (red by preventable DRESS man reaction Nephrotoxicity, idiopathic

oF Enterococcus) mecHaNism of modification D-Ala-D-Ala amino to D-Ala-D-Lac. in (eg, via bacteria resistaNce acid Occurs (dollar), (vancomycin).” you D-Ala Lack “If the ride can’t you a van

ribosome target (70S, Specifically 50S ribosome 30S unaffected. of smaller human leaving (80S) made subunits), bacterial and

are and bacteriostatic, aminoglycosides linezolid All (variable). (bactericidal) except

CCEL Clindamycin Linezolid rod Severe Erythromycin “Buy 30, gram (macrolides) infections. (sell) AT Chloramphenicol, ⊝ at 50.” cliNical Use β-lactam with antibiotics. Synergistic bowel Neomycin surgery. for

eFFects diuretics), contraindication with aDVerse Nephrotoxicity, blockade Neuromuscular Teratogenicity. Ototoxicity (absolute myasthenia gravis), loop (especially with

Bacterial the transferase mecHaNism by oF resistaNce acetylation, drug phosphorylation, inactivate enzymes adenylation. or

doxycycline, minocycline. Tetracycline, Tetracyclines

to aminoacyl-tRNA. attachment of mecHaNism bind Bacteriostatic; and 30S prevent Limited penetration. CNS is failure. eliminated with used fecally can be in patients and Doxycycline renal take drugs’ or Ca2+ iron-containing divalent absorption not because preparations cations Do (eg, gut. (Ca2+), or tetracyclines in milk the inhibit Mg2+), with antacids

Use burgdorferi, cliNical Borrelia M pneumoniae. Rickettsia makes Drugs’ ability to and them accumulate very intracellularly effective Chlamydia. against to Also acne. used treat Doxycycline against MRSA. community-acquired effective

children, of bone discoloration of distress, photosensitivity. in GI and aDVerse eFFects growth teeth inhibition pregnancy. Contraindicated in

or bacterial by   pumps. mecHaNism out transport cells efflux plasmid-encoded resistaNce oF uptake of

mecHaNism Tetracycline derivative. inhibiting to 30S, Binds protein synthesis. Generally bacteriostatic.

coverage. anaerobic, cliNical gram Broad-spectrum ⊝, gram ⊕ Use and deep requiring penetration. infections Multidrug-resistant tissue organisms (MRSA, or VRE)

nausea, GI eFFects vomiting. aDVerse symptoms:

mecHaNism Blocks ribosomal at subunit. 50S peptidyltransferase Bacteriostatic.

diseases rickettsii]). pneumoniae) influenzae, Streptococcus rickettsial cliNical fever Neisseria Meningitis spotted (eg, [Rickettsia Use and Rocky (Haemophilus Mountain meningitidis, due developing low to but of countries in still because toxicity often Limited cost. used use

baby aDVerse anemia Anemia dependent), because infants syndrome lack independent), eFFects (in UDP-glucuronosyltransferase). premature liver (dose aplastic gray they (dose

the resistaNce oF inactivates Plasmid-encoded acetyltransferase drug. mecHaNism

transfer 50S ribosomal at subunit. mecHaNism Blocks peptide (translocation) Bacteriostatic.

fever, colitis (C difficile aDVerse eFFects diarrhea. overgrowth), Pseudomembranous

the binding to Inhibits preventing by of complex. 50S formation protein mecHaNism initiation subunit synthesis and

Use ⊕ including MRSA Gram and cliNical species VRE.

Macrolides Azithromycin, clarithromycin, erythromycin.

Inhibit 23S protein bind mecHaNism synthesis of ribosomal the the subunit. rRNA (“macroslides”); 50S by to blocking translocation Bacteriostatic.

STIs infections allergic ⊕ Chlamydia, patients (Chlamydia), cliNical pertussis. to gram in Use Atypical B Legionella), penicillin), cocci and (Mycoplasma, pneumonias (streptococcal

Arrhythmia Cholestatic Gastrointestinal by issues, eFFects prolonged acute Rash, aDVerse MACRO: QT Motility eOsinophilia. hepatitis, caused interval, serum anticoagulants. theophylline, concentration Increases of oral Clarithromycin inhibit and erythromycin P-450. cytochrome

drug. Methylation binding prevents 23S of mecHaNism of rRNA-binding resistaNce oF site

E), (polymyxin B. Polymyxins polymyxin Colistin

to Cation of bind cell gram that polypeptides ⊝ phospholipids membrane mecHaNism on bacteria. cell cell leakage components Disrupt integrity cellular  death. membrane of 

cliNical Use aeruginosa, K (eg, coli, P multidrug-resistant bacteria therapy pneumoniae). Salvage ⊝ gram for E of used infections. triple component is Polymyxin antibiotic a ointment a superficial skin for B

respiratory weakness, eFFects speech, neurotoxicity (eg, Nephrotoxicity, paresthesias), aDVerse slurred failure.

sulfisoxazole, (SMX), Sulfonamides sulfadiazine. Sulfamethoxazole

mecHaNism synthase, folate dihydropteroate inhibiting thus synthesis. Inhibit trimethoprim). (bactericidal when with combined Bacteriostatic

gram Use dapsonecliNical Sulfonamides, ⊕, Gram Nocardia. ⊝, TMP-SMX UTI. simple for synthase

warfarin). (tubulointerstitial deficient, photosensitivity, kernicterus nephrotoxicity eFFects in Stevens-Johnson reactions, displace (eg, Hypersensitivity albumin aDVerse G6PD hemolysis if syndrome, infants, from nephritis), other drugs

mecHaNism uptake, PABA  synthesis. or  resistaNce (bacterial Altered dihydropteroate enzyme oF synthase),

agent. structurally Methionine Purines Similar but Trimethoprim, sulfonamides, distinct to Thymidine mecHaNism

with when in jirovecii cliNical or Use DNA treatment Protein Pneumocystis TMP. (lepromatous tuberculoid), RNA used prophylaxis, DNA, Leprosy combination and

eFFects G6PD deficient, if agranulocytosis. Hemolysis methemoglobinemia, aDVerse

bacterial reductase. dihydrofolate Inhibits mecHaNism Bacteriostatic.

folate with in block causing sulfonamides cliNical synthesis. of (trimethoprim-sulfamethoxazole combination Use [TMPSMX]), sequential Used pneumonia Salmonella, jirovecii Shigella, prophylaxis, and toxoplasmosis treatment used Pneumocystis UTIs, for prophylaxis. Combination

which be granulocytopenia, avoided may anemia, acid). leukopenia, of coadministration (folinic (high eFFects megaloblastic leucovorin aDVerse Hyperkalemia doses), with Poorly. Treats Marrow TMP

cliNical gram Gram rods Pseudomonas), externa. some Use and GI ⊝ of urinary ⊕ organisms, otitis tracts (including

mecHaNism pumps. mutation resistance, plasmid-mediated in oF resistaNce efflux Chromosome-encoded gyrase, DNA

by of ⊕ that transmembrane gram disrupts Lipopeptide mecHaNism cell membranes cocci channels. creating

rhabdomyolysis. Myopathy, aDVerse eFFects

bacterial damage cell toxic that mecHaNism the free Forms radical DNA. in metabolites antiprotozoal. Bactericidal,

alcohol; Disulfiram-like taste. headache, metallic with hypotension) (severe eFFects tachycardia, reaction aDVerse flushing,

of Cell membrane wall cell Plasma Interior

Rifampin, Rifamycins rifabutin.

Inhibit DNA-dependent polymerase. mecHaNism RNA cliNical leprosy. dapsone Mycobacterium used resistance tuberculosis; Rifampin’s to for 4R’s: delay Use when for influenzae chemoprophylaxis meningococcal of prophylaxis Used in and H children b. type with contacts

aDVerse eFFects drug orange fluids ( P-450); Minor and interactions body side effect). hepatotoxicity (nonhazardous cytochrome HIV cytochrome over Rifabutin P-450 infection patients rifampin in favored stimulation. due with less to

rifabutin cytochrome does P-450, not. Rifampin ramps up but

polymerase. mecHaNism to drug RNA binding Mutations oF reduce resistaNce leads rapidly to Monotherapy resistance.

of mycolic mecHaNism acids.  synthesis by active needed Bacterial convert to to KatG) metabolite. catalaseperoxidase (encoded INH

Mutations oF to leading underexpression of mecHaNism resistaNce KatG.

Mechanism mecHaNism uncertain. a is that the is converted prodrug pyrazinoic acid. compound Pyrazinamide active to (eg, Works at phagolysosomes). acidic best host pH in

cliNical tuberculosis. Use Mycobacterium

eFFects hepatotoxicity. aDVerse Hyperuricemia,

by mycobacterium arabinosyltransferase. of carbohydrate polymerization blocking wall  cell mecHaNism

Use tuberculosis. cliNical Mycobacterium

color blindness, eFFects (red-green neuropathy aDVerse Optic reversible). usually ribosome. Interferes with of Pronounce “eyethambutol.” component 30S mecHaNism

Mycobacterium line). tuberculosis Use cliNical (2nd

ataxia, nephrotoxicity. eFFects aDVerse Tinnitus, vertigo,

infection meningococcal Antimicrobial Ceftriaxone, rifampin Exposure or to meDicatioN ciprofloxacin, prophylaxis cliNicalsceNario

TMP-SMX recurrent UTIs of History

Malaria prophylaxis areas for or chloroquine with mefloquine, (for travelers sensitive species) Atovaquone-proguanil, doxycycline, primaquine,

in ointment Prevention of gonococcal eyes on Erythromycin conjunctivitis newborn

infection Prevention due postsurgical to Cefazolin of

prior strep oral G V rheumatic penicillin pharyngitis fever penicillin in or Prophylaxis Benzathine of with child

highly tigecycline, vancomycin, doxycycline. linezolid, MRSA: ceftaroline, Treatment of daptomycin, bacteria streptogramins (quinupristin, resistant and dalfopristin). VRE: tigecycline, linezolid, multidrug-resistantAcinetobacter polymyxins B E aeruginosa, (colistin). baumannii: Multidrug-resistantP and

arrhythmias, anemia, (“amphoterrible”). IV nephrotoxicity, (“shake phlebitis aDVerse eFFects and Fever/chills hypotension, bake”), nephrotoxicity. Hydration 

toxicity.

systemic mecHaNism use B. for Topical too as Same amphotericin use. only toxic as

or for for candidiasis. diaper swallow” oral and candidiasis cliNical Use rash vaginal “Swish (thrush); topical

biosynthesis conversion deaminase. to cytosine and mecHaNism by 5-fluorouracil Inhibits DNA by RNA

infections in B. caused by amphotericin with fungal Use (especially combination Systemic cliNical meningitis Cryptococcus)

Bone suppression. marrow eFFects aDVerse

fluconazole, Azoles Clotrimazole, miconazole, ketoconazole, voriconazole. itraconazole, isavuconazole,

(ergosterol) the lanosterol that inhibiting fungal P-450 synthesis sterol mecHaNism Inhibit converts ergosterol. cytochrome by enzyme to

systemic Use less mycoses. Local cliNical serious and cryptococcal suppression and candidal for infections chronic meningitis of of patients types. Fluconazole AIDS in all be Histoplasma, Coccidioides, may Blastomyces, for Itraconazole used schenckii. Sporothrix Clotrimazole fungal infections. for topical and miconazole and Aspergillus some Candida. for Voriconazole Aspergillus infections. Mucor Isavuconazole and for serious

with P-450). Testosterone dysfunction ketoconazole), synthesis especially inhibition (inhibits liver aDVerse cytochrome eFFects (gynecomastia,

mecHaNism epoxidase. fungal enzyme Inhibits the squalene

(especially infection Dermatophytoses onychomycosis—fungal cliNical or toe of finger Use nails).

upset, taste headaches, hepatotoxicity, aDVerse eFFects GI disturbance. Anidulafungin, Echinocandins micafungin. caspofungin,

cell mecHaNism β-glucan. inhibiting wall of by Inhibit synthesis synthesis

Use aspergillosis, cliNical Invasive Candida.

GI release). histamine aDVerse (by flushing upset, eFFects

mecHaNism with microtubule Interferes disrupts function; mitosis. in tissues nails). (eg, Deposits keratin-containing

Oral cliNical of dermatophytes of Use (tinea, ringworm). infections; superficial growth inhibits treatment

warfarin reaction, eFFects cytochrome Teratogenic, and  aDVerse headaches, disulfiram-like metabolism. confusion, P-450 carcinogenic,

mecHaNism into heme Blocks detoxification hemozoin. of is Heme to accumulates plasmodia. and toxic

(frequency plasmodial of in falciparum P resistance than species is of Treatment cliNical high). too other P falciparum Use that  membrane drug. of Resistance to concentration intracellular pump due Treat atovaquone/proguanil. P artemether/lumefantrine or with falciparum in (quinine malaria, artesunate. elsewhere) For or life-threatening quinidine use US

dark-skinned eFFects in aDVerse Retinopathy; pruritus (especially individuals).

Ivermectin, Praziquantel Mebendazole Diethylcarbamazine. Antihelminthic vacuolization), permeability, therapy Ca2+ pamoate, Pyrantel (microtubule inhibitor),  ( PIMP’D. Helminths get

Zidovudine (ZDV,

etc VZV) (HSV, Acyclovir,

virus. release influenza  mecHaNism Inhibit of Oseltamivir, progeny neuraminidase zanamivir

of A, Use B. prevention B and cliNical A Treatment and Infuenza influenza hours therapy of illness. within may duration 48 symptom onset Beginning shorten of

valacyclovir viral a by Acyclovir, mecHaNism kinase. formed CMV 5′-monophosphate Ganciclovir famciclovir, Guanosine analog. by formed Triphosphate cellular kinases. Preferentially inhibits DNA viral polymerase.

CMV, Use especially in cliNical patients. immunocompromised better of a ganciclovir, has bioavailability. Valganciclovir, prodrug oral

= DNA/RNA Viral Foscarnet polymerase and mecHaNism inhibitor pyrofosphate analog. transcriptase HIV inhibitor. reverse site Binds enzyme. pyrophosphate-binding of to activation. not any require Does kinase

immunocompromised HSV. fails; cliNical CMV when in patients acyclovir-resistant retinitis Use ganciclovir

abnormalities to hypomagnesemia) aDVerse electrolyte lead seizures. hyperphosphatemia, can hypoor hypercalcemia, (hypoor Nephrotoxicity, hypokalemia, eFFects

Mutated resistaNce polymerase. mecHaNism oF DNA

mecHaNism inhibits polymerase. DNA Preferentially viral by Does not phosphorylation require kinase. viral

cliNical CMV retinitis patients; HSV. Use immunocompromised acyclovir-resistant in Long half-life.

 saline aDVerse toxicity). to (coadminister probenecid eFFects Nephrotoxicity and with IV

time initiated therapy often HIV Antiretroviral therapy at HIV the (ART): of diagnosis. presenting CD4+ low illness, high cells/mm3), with viral for cell Strongest load. AIDS-defining (< counts 500 patients with or use indication NRTIs of inhibitor. 3 consists resistance: preferably prevent an to Regimen and integrase drugs 2 HIV-1 active HIV-2 are and the and with ARTs exception of against All enfuvirtide. NNRTIs

Tenofovir Emtricitabine (ABC) Abacavir Stavudine (FTC) (TDF) (3TC) Zidovudine Lamivudine (d4T) Didanosine (ddI) (ZDV,

a reverse binding terminate Competitively group). OH chain to inhibit nucleotide DNA (lack 3′ and transcriptase the are the others Tenofovir a nucleoTide; is nucleosides. be to be phosphorylated active. need All to

be used fetal transmission. of ZDV for general during can prophylaxis to and risk pregnancy 

nuclear you dined (vudine) (nucleosides) family? Have with my

pancreatitis anemia reversed (didanosine). (nucleosides), lactic erythropoietin), factor peripheral be (can [G-CSF] colony-stimulating and suppression neuropathy, Bone with (ZDV), acidosis granulocyte marrow

of if risk HLA-B*5701 patient to contraindicated has mutation hypersensitivity. due  Abacavir

that targets steps specific C HCV infection multidrug therapy replication proteins). with (HCV-encoded Chronic within HCV cycle therapy Hepatitis treated Examples of are drugs provided.

reactions, fatigue replication Simeprevir: Grazoprevir photosensitivity NS3/4A, preventing Inhibits viral rash headache, Grazoprevir: a viral protease, Simeprevir

in IMP Hemolytic synthesis dehydrogenase adjunct to inhibiting competitively as medications anemia, teratogen severe guanine newer nucleotides refractory Inhibits of cases Ribavirin by Used

to the all the safe levels of Goals inactivation organism of including Disinfection (sterilization). and (disinfection) pathogenic and sterilization spores reduction microbes counts include

at Autoclave Pressurized steam > 120°C. Sporicidal. reliably not prions. May inactivate

Alcohols Denature membranes. disrupt and proteins cell sporicidal. Not

Denatures cell proteins membranes. and disrupts Chlorhexidine Not sporicidal.

proteins. and Oxidizes Chlorine denatures Sporicidal.

Take Care. SAFe Really Children Good

pathology.” passion belongs mistrust from separate a in can “Digressions, in person’s “You mockery, any you objections, body.” more signs his of everything carefree delight than are health; cannot from pathology spirit unconditional separate

The pathology to understanding organ diseases systems. of all are fundamental in key principles across inflammation and neoplasia topics topics are systems, yield. in as high such organ different Major definitely appear and frequently questions such the subject follows concepts For board of very inflammatory that and of a myocardial injury inflammation to infarction, example, cell the common questions. key understanding response are neoplasias—for the colon Similarly, that example, or cancer—is cellular culminate early changes in critical. development of familiarity a the esophageal with key as genes tumor recognize cancer and are sure with metastasis. staging and Finally, tumor-associated the comfortable you concepts such make major

Apoptosis programmed ATP-dependent cell death. both cell cellular apoptotic condensation, chromatin  phagocytosed. blebbing, caspases of pathways which formation extrinsic shrinkage, pathways; proteases) including activate bodies, are breakdown Intrinsic (cytosolic membrane then and and and and by pyknosis, karyorrhexis. eosinophilic Characterized cytoplasm deeply nucleus, basophilic without remains inflammation necrosis). intact typically significant membrane (unlike Cell multiples of 180 sensitive is a DNA laddering apoptosis. of bp) indicator in (fragments

p53 B Perforin Cytoplasmic receptor) cell Initiator Cytochrome for (death T DNA Bcl-2 Misfolded ROS, cell caspases Apoptotic activation macrophage (mitochondrial) body proteins toxins dispersion Ligands Cytoskeletal Hypoxia fragmentation C Initiator Nuclear TNF-αTNFRFas receptors damage bleb pathway Granzyme Cytotoxic Macrophage BAX/BAK caspases Radiation, Executioner caspases FasL pathway

plasma membrane undergoes protein components (unlike  intracellular enzymatic and apoptosis). denaturation, injury Necrosis cell  damage reaction local degradation leak inflammatory  Exogenous

Ischemia demand. meet Inadequate to blood supply Mechanisms shock. venous torsion, testicular atherosclerosis), (eg, syndrome), arterial  Budd-Chiari (eg, drainage perfusion include  subsequent most and to vulnerable hypoxia/ischemia Regions infarction:

boundary Brain areasa,b ACA/MCA/PCA

(border point)a arteries collateral 2 flexure receive Splenic with branches distal areas (Sudeck junction from zones) Colon most rectosigmoid (Griffith of blood supply vascularity. aWatershed point),a limited hypoperfusion. to ischemia from are susceptible These areas include the most 6). 3, hypoxic-ischemic hippocampus and cerebellum neocortex bNeurons (zones of to cells and pyramidal 5, of vulnerable Purkinje the insults cells

infarcts of Types

(eg, (eg, Occurs liver, lung after intestine, and angioplasty). infarct blood tissues A testes), reperfusion with multiple Red venous with occlusion , supplies and in free due is to Reperfusion radicals. damage injury by

heart, in infarct organs with blood ). a solid single (endarterial) (eg, Occurs Pale kidney supply B

membrane injury protein DNA damage modification, radicals lipid radical Free Free cells breakage. peroxidation, via Initiated (eg, (eg, drugs nitric macrophages) reactions, therapy), burst. via I), of neutrophils, oxide (phase cancer redox transition radiation (eg, exposure metabolism oxidative inflammation), metals, WBC peroxidase), spontaneous be Free decay, radicals antioxidants transferrin, E), A, C, glutathione and proteins superoxide enzymes vitamins ceruloplasmin). (eg, dismutase, catalase, (eg, certain by eliminated carrier metal scavenging (eg, can Examples:

thrombolytic dysplasia, of after therapy (abnormal injury vascularization), bronchopulmonary retinopathy reperfusion toxicity: Oxygen prematurity

tetrachloride acetaminophen radical free • into CCl3 by cytochrome change], (hepatotoxicity), injury  liver apolipoprotein synthesis overdose fatty centrilobular toxicity: fatty carbon (converted [cell P-450  necrosis) Drug/chemical

(iron) Wilson Metal hemochromatosis and storage disease diseases: (copper)

H&E stain. basophilic on A (arrow Types of deeply appear Calcium in ) deposits calcification

“wear and normal tear” Lipofuscin A A aging. associated pigment yellow-brown with phospholipids and complexed of polymers of protein. with lipids Composed of be through subcellular May of derived lipid peroxidation lipids polyunsaturated membranes. eye, person elderly colon, deposits will in of heart, kidney, liver, and other organs. reveal Autopsy

Cardiac chains) Plasma Light include: disorders myeloma) (eg, restrictive in (eg, Primary AL Seen Ig cell • Manifestations amyloidosis multiple (from

macroglossia, hepatomegaly) (eg, GI

(eg, syndrome) Renal nephrotic

(eg, splenomegaly) bruising, Hematologic easy

Neurologic neuropathy) (eg,

tunnel Musculoskeletal (eg, syndrome) carpal

necrotic to insult, from initiate remove Inflammation to tissue the and original eliminate cells cause of injury, cell to Response repair. initial resulting Divided chronic. acute and into SLE). (eg, inappropriate TB), as be to is excessive host the if The persistent such or can response autoimmune itself (eg, septic the harmful such (eg, as inflammatory shock), infections diseases reaction prolonged

early or Fever point induce PGE2 activity set of and in temperature  cells hypothalamus LPS) macrophages TNF to release (eg, to • inflammation COX  and perivascular injury response Pyrogens IL-1 Transient Acute infection. edema. in neutrophils , associated tissue by A with often Characterized (seconds days). short onset to minutes) Rapid (minutes to and duration specific the chronic inflammation). than Represents a less immune (ie, system reaction innate response of

bodies. necrosis, STIMuLI trauma, Infections, foreign

postcapillary predominantly occurs venules. Leukocyte Extravasation at extravasation

GlyCAM-1, CD34

Mac-1) (LFA-1, integrin integrins VLA-4 L-selectin CD11/18

mononuclear Prolonged plasma (macrophages, (including repair infiltration inflammation leads Chronic fibrosis). characterized angiogenesis inflammation by tissue lymphocytes, destruction to which and cells), and simultaneous May be preceded inflammation. by acute

(eg, and agents TB, prolonged type toxic  autoimmune material. silica) pallidum, infections (eg, to foreign Persistent exposure certain viruses) fungi STIMuLI diseases, and IV T hypersensitivity,

are cells. MeDIATOrS dominant the Macrophages and chronic lymphocytes inflammation. Interaction  T of macrophages

HCV gastritis transformation amyloidosis,  gastric infection Scarring, chronic chronic hepatocellular chronic OuTCOMeS and pylori infection   (eg, carcinoma; neoplastic • adenocarcinoma). Helicobacter inflammation

angiogenesis fibrosis TGF-β Angiogenesis, Stimulates FGF

via (eg, growth EGFR/ErbB1) Stimulates cell tyrosine EGF kinases

of by (activated surrounded of epithelioid by cytoplasm) cells lymphocytes activated fusion with Focus pink and cells macrophages). several giant abundant multinucleated HISTOLOGY (formed macrophages Central Caseating: necrosis. with associated types: Two infectious fungal). (eg, etiologies Seen TB, with : central no A necrosis. Noncaseating disease). sarcoidosis, (eg, autoimmune with diseases Seen Crohn

secretes differentiate CD4+ • and IFN-γ CD4+ secrete to present Th into macrophage cells Th1 cells • Th1 activation cells antigens IL-12 Th APCs

macrophages TNF) Macrophages cells. of formation  giant  secretion cytokine (eg, epithelioid and therapy disseminated disease. granulomas cause down break can • sequestering Anti-TNF to starting anti-TNF test for latent Always before therapy. TB

1α-hydroxylase to due resulting hypercalcemia activity Associated  activity. in with D activated in macrophages,  vitamin

syphilis) Listeria necrotizing scratch infantiseptica), pallidum (3° leprosy), Bartonella (tuberculosis, (granulomatosis henselae Treponema disease; granulomas), (cat Mycobacteria monocytogenes stellate Bacterial:

endemic histoplasmosis) mycoses Fungal: (eg,

1° schistosomiasis Quervain/ thyroiditis subacute granulomatous) Parasitic: (de sarcoidosis, disease, Immune-mediated: biliary cholangitis, Crohn

granulomatosis polyangiitis (Churg-Strauss), giant arteritis cell with eosinophilic granulomatosis with arteritis, Takayasu Vasculitis: polyangiitis (Wegener), (temporal)

pneumonitis berylliosis, talcosis, Foreign bodies: hypersensitivity

accomplished when Scar repair cell regeneration by cannot be Occurs formation alone. by chronic Nonregenerated connective are cells injury) or severe (2° to tissue. acute replaced strength tensile little 3 regained months; strength tensile regained of at 70–80% thereafter. TGF-β. excess Associated with

polarity. Normal  Normal apical with cells basal cells and of normal , cervical A See example cells shows spectrum which as dysplasia, discussed below.

changes (pleomorphism); . (eg, cell uniformity tissue size  of shape nuclear Loss loss in ratio) and nuclear:cytoplasmic A of orientation;

epithelium entire A preinvasive . of intact basement the penetrate involves the does membrane situ/ dysplasia not Carcinoma in Irreversible thickness that but severe

hydrolases using invaded membrane and have Cells collagenases (metalloproteinases). basement Cell-cell of E-cadherin. contacts inactivation lost by

or Spread via organ(s) blood. lymphatics Metastasis distant to

mesenchymal Tumor whereas epithelial implies Carcinoma origin, origin. sarcoma denotes nomenclature imply generally malignancy. Both terms well-differentiated usually are Benign no well-demarcated, with no and and necrosis. low metastases, tumors mitotic activity, may invasion, (cancers) erratic Malignant apoptosis. poor tumors growth, and differentiation, • local show metastasis,

for overgrowth in non-neoplastic a malformations native location, and their hamartoma located polyps) eg, foreign tissue tissues of location, eg, in include tissue gastric distal (disorganized Terms Peutz-Jeghers ileum choristoma Meckel (normal diverticulum). in in

Adenoma, Epithelium carcinoma Adenocarcinoma, papilloma papillary

Blood cells Leukemia, lymphoma

vs stage to Differentiation—degree tissue Tumor a origin. which tumor of its grade resembles closely differentiated poorly tumors Well-differentiated (often of origin, tumors their (often less resemble more aggressive) tissue do not. aggressive) whereas

of of in lack differentiation a cells Anaplasia—complete neoplasm. malignant

Degree histology. mitotic cellular of and differentiation Grade activity on low grade anaplastic). differentiated, (well-differentiated) from to undifferentiated, grade Ranges or (poorly high Low grade grade High

of lesion, localization/spread size spread Degree on of of 1° nodes, to lymph and presence Stage based site metastases. regional (c) findings. Based (p) clinical pathologic or on than has Stage prognostic value T more generally

(eg, node tumor). high-stage is Lymphgrade tumor N a low-grade yet Stage Survival. determines Blood vessel lymphatic or

system Spread): staging = TNM (Stage

M Metastases, Node = = Spread and N = size/invasiveness, to involvement, Tumor otherT eg, tissues organs cT3N1M0. factor TNM prognostic N value; independent important. M most has often are and Each

Skin below). > the cancer epidemiology melanoma) included Cancer (basal (not is most squamous cancer common >>

carcinomas lymphatics. Common Most hematogenously; most sarcomas spread metastases spread via Choriocarcinoma, Route carcinoma, Hematogenously: Four Renal carcinoma, and Hepatocellular cell carcinoma. thyroid Follicular However, Carcinomas

melanoma, junction from at as tumors of brain Brain Lung multiple tumors matter Commonly > > colon, seen metastases A breast well-circumscribed 50% gray/white kidney are

the CD sites after metastasis regional common and Sometimes of liver) most the Penetrates lymph lung are nodes

Bone Lung Lungs) The Thyroid, Prostate, Kidney, > Breast (Painful Kill Bones

metastasis >> 1° F E (eg, Bone tumors bone

can metastasis be: Bone G

Lytic kidney, thyroid, lung cell (eg, cancer) non-small

(eg, cancer) lung cell Blastic small prostate,

Mixed (eg, cancer) breast

disease. a of risk; gene of alleles must  both be Loss for suppressor suppressor genes expression Tumor of (two) cancer tumor lost function

Hodgkin 1° nasopharyngeal lymphoma lymphoma, CNS immunocompromised carcinoma, lymphoma, EBV (in patients) Burkitt

Hepatocellular HCV HBV, carcinoma

diagnosis cancer as for used tumor screening. be Serum Tumor should or not tool markers markers the 1° definitive biopsy. used via made but may monitor response and They therapy, is tumor to diagnosis to be recurrence with non-neoplastic conditions. Some associated be can

protein multidrug known 1 Also resistance P-glycoprotein (MDR1). as adrenocortical but in seen Classically colon, also carcinoma cells cancer other by expressed liver). (eg, out resistance time). to responsiveness including (one  of chemotherapeutic to chemotherapy mechanism or Used pump agents over toxins,

in: A PSaMMOMa dystrophic bodies calcification spherules bodies Laminated, concentric with , are Psammoma seen

thyroid carcinoma of Papillary

heart (eg, failure, that muscle atrophy, Weight in and disease COPD). Cachexia loss, fatigue occur AIDS, chronic cancer, and TNF-α, IFN-γ, IL-1, by Mediated IL-6.

larger, is always ye wondher the “I “One the take makes made decision effusions, small.” periostosis pill you was of an’ physician you doctor’s when bones and can read educate to makes a not bill medicine.” of I first masses niver the can to “One tubular the his tapes.” to why the burn Endocrine not read one “I of pill under duties ye purscription.” medication

is straightforward. Preparation for questions pharmacology and adverse drugs of clinical major effects the and important their use, key mechanisms, variants. all Know Obscure derivatives low-yield. are and their toxicities Learn classic distinguishing drug-drug as interactions. major as well and microbiology be biochemistry, physiology, Reviewing while concepts studying pharmacology. can useful associated the emphasis has on cardiovascular a The exam are strong agents covered as throughout NSAIDs, text. CNS, ANS, well on as antimicrobial, and which trade names not are or drug testable. generally Specific dosages sure various graphs to make may content, test pharmacology are so comfortable them. exam The you interpreting use

= [S] is Michaelis-Menten of velocity. inversely substrate; to Km = affinity concentration the of related V the kinetics its enzyme substrate. for

concentration. the is proportional directly Vmax enzyme to

a kinetics); that enzymatic reactions Michaelis-Menten exhibit (ie, however, curve

enzyme inhibition hemoglobin). kinetics Effects of (eg,

1 higher the on to plot the Y-axis, 0 closer The Lineweaver-Burk the

Vmax. V

higher The closer the Km. the on 0 X-axis, to the −K

The the the the Km, higher lower affinity.

do [S] Competitive inhibitors not. cross each 1 other, whereas noncompetitive inhibitors inhibition of enzyme Effects

inhibitors Km. increase Kompetitive

unchanged. drug Fraction administered (F) circulation Bioavailability reaching systemic of IV = F For dose, an 100%. metabolism. to Orally: absorption 100% due F first-pass incomplete < and typically the in be concentration from time. Can of plot a the over area plasma under curve calculated

concentration. of Theoretical volume to its Volume by drug (Vd) distribution of amount relative total body the plasma the occupied in be altered disease  kidney binding, drugs protein Apparent plasma by can protein–bound of and ( liver Vd Vd). one distribute in may Drugs than compartment. more of body the amount drug in

molecules, especially ECF lipophilic Low protein plasma fat to molecules; bound All Small Large/charged tissue molecules Small tissues Intravascular bound hydrophilic protein High Medium including if

of unit drug Clearance (CL) per time. volume plasma The of cleared Clearance cardiac, hepatic, impaired function. may or be renal with defects in elimination of of drug rate

during of drug to change body time Half-life the elimination. amount required in The 1⁄2 (t1/2) by the takes 4–5 constant at infused a reach steady kinetics, first-order a half-lives drug to In rate state. to takes level. It steady-state of the 3.3 90% half-lives reach

elimination Vd 0.7 in CL first-order × t1/2 =

metabolism phase I Drug lose Geriatric patients first. drugs have  side acetylators rate (eg, metabolism are  because slow Patients from who of isoniazid). of effects certain

of Elimination drugs

amphetamines. bases Weak Examples: TCAs, Trapped in acidic environments. urine. ammonium chloride with to overdose acidify Treat

bicarbonate the of accelerating treated generally drug not sodium with elimination. for to activity overcome is sodium but TCAs, toxicity TCA channel-blocking

are drugs 50% (weak at which and base) acid ionized pKa or 50% nonionized. pH the the or pKa weak base. of strength represents acid The

effect a produce. Efficacy can drug Maximal the by y-value (Vmax). Represented Vmax =   y-value efficacy. =  can have (ie, or potency low drugs efficacious Unrelated potency). high to less efficacy full agonists. Partial agonists than have

given Amount drug a Potency of for effect. needed by the (EC50). Represented x-value shifting potency = needed. = EC50 •  Left drug  = high have or efficacy efficacy). low Unrelated to (ie, can potent drugs

1000 1.0 100 10 1000 10 0.1 dose 0.1 100 dose dose 100 1.0 1000 10 Agonist Agonist 0.1 1.0 Agonist

Therapeutic of safety. drug index Measurement dose median TD50 toxic

and treat safely Therapeutic effectively can range that disease. window—dosage

patients of responding %

= TD50 Index ED50. TITE: / Therapeutic

higher values. TI drugs Safer have lower monitoring frequently with require TI Drugs Warfarin, Digoxin, drugs, Lithium; (eg, Theophylline, Antiepileptic values Warning! Lethal! These Drugs Are ).

TD50 in dose) often median LD50 animal replaces studies. (lethal

Types interactions receptors of drug Autonomic

NN nervous medulla muscle D1 gland (short) muscle transmission ˜1˜2°1°2 vasculature Post D muscle muscle, are motor Adrenal (long) vessels Cardiac cardiac and nerve and NN ACh ACh NM smooth Pre nerve glands NE ACh system. muscle cells, Pre cardiac Sweat III, the CNs parasympathetic Renal Skeletal ACh Pelvic NE (long) Epi ˜1˜2°1 terminals, nerve AChM ACh splanchnic muscle, Blood SympatheticPost terminals, ACh ParasympatheticBrainstem X gland M NN ˜1˜2°1 SOMATICSmooth (short) VII, cells, junction cord of Neuromuscular Spinal Catecholamine muscle, Smooth NN nerves part NN IX ACh Voluntary Adrenal is sympathetic fibers. directly preganglionic innervated by medulla in nervous results sympathetic are (sympathetic cholinergic a part the Sweat glands pathway of system “chold” innervated by are but sweat). fibers

Pelvic and nerve sympathetic bladder of via (parasympatheticsystems. parasympathetic function nervous coordination M˜-receptor β˜-receptor

voiding. urine ⊕ parasympathetic •  receptors autonomic treat smooth act muscle sphincter External dysfunction. to input) bladder urethral on drugs (sympathetic Some

 production, aggregation,  • tone lipolysis, outflow, β3 lipolysis, insulin contraction, humor (accommodation), skeletal release, aqueous in muscle,  release, glycogenolysis, thermogenesis bronchodilation  contractility insulin (two sphincter uterine sympathetic s dilator rate, • muscle (tocolysis), lipolysis, heart), vascular s  renin • muscle q lungs),  i Dopamine  platelet heart (one s (adrenergic)  bladder  intestinal bladder (mydriasis), and smooth relaxation humor aqueous   muscle release,  Cholinergic pupillary production endothelium-mediated  Vasodilation, lipolysis contraction insulin contraction release,   vasodilation 

brain, (sick) of of siq i smooth especially indirect transmitter qinky in D1 striatum direct Relaxes Modulates release, inhibits sex).” sqs qisses D2 (kisses), muscle, you “After pathway (kick) (super s get out qiq activates renal vascular a

H1, V1, ˜1,

HAVe Protein 1M&M.

° C ° ° 2, kinase 1, Receptor D1, Lipids M3 M1, 3,

Gs ATP V2 H2,

inhibit ˜2, themselves. M2, D2

of • acting nerve ending itself, α2-autoreceptors drugs NE norepinephrine negative Autonomic Release modulated feedback. from on a sympathetic by presynaptic is the they (VMAT) (NET) the the to monoamine vesicular where enter enter neurosecretory transporter vesicles. to presynaptic NE utilize transporter terminal, Amphetamines use NE This the from vesicles. displaces the a concentration cleft, action the presynaptic synaptic is and within contributing NE amphetamines. taking NET  in patients NE threshold to into Once the characteristics is observed expelled reversed, of NE terminal, the of effects and reaches

-Ca2+ AChE Choline receptors metabolism represents VMAT TCAs, DOPA amphetamine + Dopamine acetate + Amphetamine, II receptor or Tyrosine transporters. ACh ephedrine NET Di˜usion, Choline AT Adrenoreceptors NE -Release-modulating Reserpine Acetyl-CoA toxin + ACh Tyrosine °Cocaine, Ca2+ + ˜ AXON ChAT ˜2 Negativefeedback -+ NE ACh Choline+ inhibitors AXON Reuptake --AChE Botulinum

Atropine antagonist. Muscarinic to for applications. treat Used bradycardia and ophthalmic

anticholinesterases, but not dilation, effects nicotinic of Blocks Eye pupil cycloplegia (DUMBBELSS)  muscarinic the

 secretions Airway Bronchodilation, effects.

in to cycloplegia; temperature hyperthermia cause urinary Can glaucoma acute mouth; retention to prostatic • with (due angle-closure  dry, skin; and  constipation; HR; in infants. sweating); body flushed elderly mydriasis), AdVERSE (due hyperplasia, EFFECTS disorientation men dry in

a Hot hare as Fast flask hatter as effects: bone Side Red as beet bat as as Dry as a a a Blind as a fiddle a a Full Mad

pupil gardener’s  (mydriasis to (Datura) weed Jimson plant priapism. alkaloids) due sympathomimetics Indirect

obesity, catecholamines stored ADHD. Indirect agonist, Ephedrine general Narcolepsy, releases

vasoconstriction anesthesia. local Causes and

is • suspected β-blockers hypertension, coronary to unopposed when vasospasm). lead extreme intoxication if (can activation α1 giving cocaine Caution

incontinence, Nasal hypotension. decongestion urinary (pseudoephedrine),

β1, refex tachycardia

net β2 a α-agonist because reversed Phenylephrine net (the (the Epinephrine α reversal is (lacks to of response). decrease “pure” response) arterial from exhibits a pressure but increase response is β-agonist it not suppressed a response mean properties).

 platelets: inhibition of In cAMP platelet  aggregation

due vasodilation) stress Cardiac to testing (dipyridamole coronary only,

headache, hypotension, with together as its platelet Prevention abdominal Nausea, restenosis PDE-3 a to stent dipyridamole. facial inhibitor, a categorized aCilostazol indications pain of flushing, due is is coronary inhibitor but to inhibitor, leading of bDipyridamole is nonspecific PDE inhibition a aggregation. platelet extracellular also platelets reuptake • by prevents adenosine It adenosine vasodilation. •

criteria reduce in and Widely potentially population. prescribing developed criteria used harmful geriatric inappropriate to Beers the polypharmacy efficacy events. 50 medications Includes to in adverse elderly   of should due avoided and/or patients > that be risk hypotension) ( of risk α-blockers Examples:

antihistamines, ( constipation, falls, urinary antidepressants, retention) of sedation, delirium, risk opioids Anticholinergics,

( of sedation, falls) Benzodiazepines delirium, risk

( with GI concomitant NSAIDs risk bleeding, especially anticoagulation) of

risk C PPIs difficile of ( infection)

Atropine pralidoxime organophosphates > AChE inhibitors,

Physostigmine anticholinergic Antimuscarinic, control (crosses hyperthermia BBB), agents

succimer β-blockers Arsenic glucagon, saline Atropine, Dimercaprol,

deferasirox, Deferoxamine, deferiprone (Fe) Iron

Salicylates dialysis NaHCO3 urine), (alkalinize

(delayed Warfarin effect), PCC complex (prothrombin concentrate)/FFP effect) K Vitamin (immediate

(eg, α2-agonists) TCAs, tropicamide, Anticholinergics (eg, atropine, scopolamine, antihistamines) Sympatholytics

abuse of (eg, LSD), cocaine, Drugs of (eg, amphetamines, heroin/opioids) meperidine abuse Drugs

organophosphates (eg, Sympathomimetics Parasympathomimetics pilocarpine),

Sulfasalazine, Sulfa Pharm Probenecid, Sulfonamide Celecoxib, Scary Sulfa FACTS Furosemide, Acetazolamide, drugs Thiazides, antibiotics, Sulfonylureas. Patients hemolytic allergies anemia, may syndrome, urinary sulfa infection, thrombocytopenia, and tract Stevens-Johnson nephritis, agranulocytosis, interstitial with urticaria develop fever, acute (hives).

you a of up.” everyone the art lies: and make of timeline, are lies, drops “On look uncertainty and for the a statistics.” are “There up kinds damned “Medicine survival lies, of you kind the science rate statistics: an of two zero.” probability.” three enough kinds kind to “There and long is

A of improvement, under and falls of mix heterogenous more epidemiology, safety, biostatistics, quality heading public healthcare the health ethics, sciences. patient delivery, law, epidemiology high and Biostatistics yield. of and medicine are foundations the are very evidence-based a biostatistical you specificity, problem-solving sure such Make apply in equations sensitivity, and as can values quickly format. predictive know own to how 2 up Also, your tables. 2 × set a years improvement and ago patient and few on exam trends topics represent science. Quality were health introduced the in system safety principles. of Medical often require application ethics questions would then patient are with how a Typically, and presented you scenario asked you respond.

study Clinical Experimental trial involving humans. of treatment or benefits Compares of placebo. and therapeutic treatments, ≥2 double-blinded treatment the patient the (ie, control randomized, whether is nor or when improves study quality in patient neither doctor controlled, group). knows and is Study blinding to the Triple-blind analyzing the refers of additional researchers the data. phases (“Does the drug Four SWIM?”).

tests Evaluation of Sensitivity specificity and of diagnostic a are test. Disease fixed properties NPV in population depending tested. prevalence vary and PPV disease on being

when rules SN-N-OUT Negative, = SeNsitive highly test, OUT disease

disease when SP-P-IN test, Positive, IN highly SPecific rules =

such with PPV directly (baseline varies prevalence probability as pretest risk, disease): of

or NPV varies pretest inversely with prevalence

on 2 and Quantifying contingency the table. or formulas classic × based 2 Definitions are risk

20/30 in a in ratio Typically used Odds studies. ad lung a/c case-control If case-control study, 8; odds 8 exposure patients cancer lung smoking, individuals healthy report patients Represents controls of and is the are of b/d among (a/c) bc so the 5/25 among exposure odds the OR cases (b/d). cancer vs have times smoking. a more likely history to of

studies. risk cohort Relative used Typically in the divided group. in in Risk by the risk unexposed developing group disease exposed of  no association and RR = disease. between exposure 1 1 with occurrence. associated exposure RR >  RR disease associated 1 with < exposure occurrence. 

to radiation diagnosed people to d) so RR c/(c cancer, the and a 5 exposed a/(a 1/10 of risk are not exposed with exposed developing + greater 5; radiation times diagnosed If have 5/10 people cancer. are to b) with is people + cancer, radiation

diseases OR rare approximates prevalence), (low RR. For

flu, shot The risk 2% while Relative proportion to 8% RR a a risk 1 receive reduction compared the = attributable who flu the If RRR develop of reduction intervention of as of − to patients control. = patients 0.25, = and RR flu, then develop = RRR 2/8 the unvaccinated 0.75.

cancer of and exposed risk between The risk is Attributable difference in smokers a lung c unexposed 21% If risk groups. in attributable in + c a the and risk 1%, is + b risk d then nonsmokers 20%. is − RR 1

compared a control. reduction 8% people flu who develop The d + attributable = c receive of ARR difference of people + who risk the the a a c If in risk placebo intervention Absolute a then receive 2% (not to the to as vaccine vaccine, flu proportion) b vs a 6% = 8%–2% = 0.06.

= treated need be to benefit. who Number for needed to NNT of patient to patients 1 1/ARR Number number treat Lower treatment. better =

1/AR patient = to be Number patients harmed. a for 1 needed need to NNH of risk to exposed be Number who to factor harm = safer number Higher exposure.

among Case among 10 with those Percentage 4 of patients of deaths cases occurring If die deaths disease. fatality rate meningitis, case rate is fatality 40%. cases

Incidence # new looks cases cases(incidents). at Incidence new vs of

unit # = current point prevalence Prevalence at risk cases. all (per existing =# Prevalence of at of Incidence of time) people looks cases a (at in

of people prevalence # Total disease of 1 – time)

Prevalence Prevalence probability. for ∼ ≈ incidence short pretest duration disease

(eg, cold). common NPV. prevalence and   PPV 

large of diabetes). chronic Prevalence to due # incidence (eg, for existing cases diseases, >

The reproducibility a test. consistency and Precision of (reliability) test. in Random a error  precision absence in random variation test. The a of deviation.   precision standard

power precision  (1  statistical −β).

(validity) values. Accuracy results to The true closeness test the of in accuracy test.  Systematic error a test. in systematic The error a bias or of absence

groups well (eg, a can healthy). diagnostic distinguish 1 disease curve test how vs demonstrates ROC between 2 the – the false-positive (1 against (sensitivity) rate Plots specificity). true-positive rate

a the better have The under test to curve upper left corner. closer area the (AUC), curve will higher the with performing

1 No < value (AUC < ctual predictive FP rate test – rate (0.5 specifcity) (sensitivity) A 1 = C 0.5)TP ) AU (1

or study Nonrandom population such not subjects representative of bias of is population. allocation sampling treatment Selection target that a commonly sampling Most bias.

and/ from than Berkson population are different selected and controls have less general or bias—cases healthy exposures hospitals

lost follow complete prognosis the a study bias—participants those who than up Attrition to have Randomization different

of group right the Ensure the choice comparison/reference

Patients with follow-up retrospective of Recall exposure Awareness after subjects; to by from similar studies of time in disorder Decrease disease alters exposure learning common bias cases recall recall

ahead upon data a of Using of and a collection previously standardized, distorted placebo Information observed tested in behavior group of to objective, Measurement is effect—participants faulty gathered Hawthorne being awareness bias systemically planned Use change measure methods manner Use are that time sphygmomanometer automatic BP

in different group groups specialized treated the same bias Patients treatment spend time in more Procedure in units Subjects highly hospital are not

use (masking) participants on aware placebo interpretation researchers procedures of and of of and outcomes as influence are neither Blinding group reduce assignments and of

to Factor both exposure the outcome (vs outcomes and bias which Confounding path) outcome on by factor) not related subgroups the exposure in effect effect to leads stratified on in distorts different causal of modification, (but exposure

cancer. and drinking association uncontrolled an An study lung between coffee shows the However, also more, coffee can smoke account drinkers studies association Multiple/repeated for which

act controls) (subjects Crossover studies as their own

groups) and Matching treatment in similar characteristics (patients control both with

Lead-time detection confused increased, survival bias changed “back-end” of is the has detection history diagnosis) to Early has survival time  natural but disease not the it according severity survival Early of seem with survival Measure disease’s (adjust like the makes at

to symptomatic with subjects the no period, to a cancer latency randomized latency is detected Length-time detects earlier screening a slowly test assigning trial screening bias or by those program while likely more screening with shorter diseases A period cancer Screening rapidly progressive A progressive controlled become than long test

Mode most common = value. outliers. affected by Least

size. SD; σ = Measures = much sample of variability = Standard n deviation how dispersion set (SD)2. mean Variance these values, values. of exists a the of = around in SE = σ/√n.

error Standard n  estimate as SE much an . how of = true in sample mean. set a exists means the around population (theoretical) variability of

also called Gaussian, distribution bell-shaped. Normal = median = mode. Mean

95% 99.7% 68%

fast two lymphoma; age). Hodgkin rate by onset Bimodal (eg, different polymorphism metabolic populations suicide acetylators; of age as at Suggests such vs slow

mode. skew > median Positive Typically, mean >

with right. on longer Asymmetry tail

mean median Negative skew < < mode. Typically, Mode with on left. Asymmetry longer tail

hypothesis hypotheses statistical of Outcomes Statistical testing

hypothesis). Reality in is HH there favor or Stating exists of rejected hypothesis alternative effect result one that when Correct an difference (null none is difference no when not exists (null Stating that there effect rejected). hypothesis or

shading = result. Blue correct

Range a the is which probability. within expected specified Confidence of interval population fall, of with true the to values mean

x¯ sample = often CI is α 95% Z(SE) (corresponding The used. = CI .05) mean ± for to As CI narrows. sample size increases, 1.96. = 95% For CI, Z the For 2.58. the 99% CI, Z =

there then H0 includes for is not variables and no 95% between significant If rejected. difference 2 mean difference 0, the is CI a

CI relative or rejected. risk the If 1, includes odds H0 95% is for not ratio

do between not CIs significant overlap  the groups statistically If exists. difference 2

overlap the  usually exists. difference significant between If CIs 2 no groups

of for statistical RRs) effect. size of summary an pools estimate that method multiple more the studies data precise A a (eg, Meta-analysis from of means, analysis sizes studies. between effect estimates of heterogeneity Also and power, of evidence, of generalizability Improves study strength findings. in selection. bias of study by studies quality individual and Limited

care. Obligation or necessary for patients not create medical and accepting preference autonomous (informed accepting individuals to (truth-telling, to their respect conditions honor to choice Autonomy as in confidentiality), consent),

the Beneficence act interest. to (fiduciary) ethical special Physicians best a have in duty patient’s to with is or right has patient (eg, TB conflict best May the what autonomy treatment). (an decide) for mandatory society informed patient supersedes. Traditionally, interest

and harm.” this category). an may informed the a against make balanced fall Must beneficence; if medications no patient into risks, outweigh decision (most “Do proceed be surgeries benefits the to Nonmaleficence

fairly Justice persons and To equitably. treat imply always does (eg, equally This not triage).

consent (not requires: a process just Informed that A document/signature)

of Disclosure: information interpreter, (using if discussion needed) medical pertinent

comprehend ability Understanding: to

to determination) ability from own decisions legal and Capacity: one’s competence, make (distinct a reason

and freedom manipulation coercion Voluntariness: from

proposed an risks/benefits intelligent the options, no including of alternative and have and their of treatment treatment. diagnosis Patients must understanding

can at consent be must written or she Patient any time, orally. he that informed even revoke

away): it to informed consent (WIPE Exceptions

waives consent explicitly right the informed of Waiver—patient

harm information informed Privilege—withholding patient decision-making capacity Therapeutic disclosure or when would the severely undermine

is person generally A < any for old. 18 Consent years minor minors in relation laws Parental consent to state. vary healthcare by obtained, or should legally exceptions minor be general, emancipated military). blood emergency married, for transfusions) (eg, consent self-supporting, is (eg, or but the parental if treatment exist In in

usually Situations in not is required: which consent parental

pregnancy) Sex STIs, (contraception,

Rock roll communication. minor-guardian healthy and always (emergency/trauma) should encourage Physicians

consent is their even a should required. if seek Physician not assent minor’s

psychologically making the whether of determine particular is capable Physician and healthcare legally a patient must decision. capacity. capacity cannot Note revoked loses made simply if with that be patient the decisions later disability Intellectual autism) syndrome, decision-making. criterion alone Down (eg, for informed an is not exclusion

Capacity for (eg, determined care). to medical a a is physician specific by refuse healthcare-related decision more and of usually healthcare-related determined refers making to categories to legally make any judge a decision). (eg, unable global by is Competency decision

(think GIEMSA): Components

is Decision with and values Goals consistent patient’s

understands) Patient Informed and is (knows

Mental altered (eg, not Mood psychosis, is of disorder delirium, intoxication), result status a Decision

emancipated Patient or Age of 18 legally years otherwise is ≥

a directives medical need by anticipation decision. the of Instructions given patient in Advance for a vary state law. Details per

patient’s directive guide. as used statements advance Incapacitated prior oral commonly Oral arise interpretation. from in variance Problems decision to patient was time directive more then multiple repeated and informed, over directive patient made is was choice, If was valid. the people, specific, a oral

cardiopulmonary prohibits resuscitation (CPR). DNR order resuscitate Do not that may also are measures order avoided. typically Other feeding resuscitative follow tube) (eg,

privacy Confidentiality and autonomy. Confidentiality patient respects friends emergent, the guided and of to family is the by patient information interest. disclosing judgment best be incapacitated situation professional or is patient’s should If to voluntarily (eg, the insurance may confidentiality request). company The right waive patient principles confidentiality: General for exceptions to

others to serious imminent Potential physical is harm and

means not those risk warn is protect Alternative possible at or to

Self-harm is likely

can harm be Steps to prevent taken

SAVED to include are day”): state confidentiality patient of the specific) (“The physician’s Examples the judgment good (many exceptions following

Suicidal/homicidal patients.

elderly, Abuse prisoners). (children, and/or

potential physician sometimes or Duty protect—state-specific harm. somehow inform laws Victim allow to to protect from that

and automobile impaired Epileptic other drivers. patients

warn hepatitis, (eg, people will risk. Reportable duty public STIs, who Diseases have officials, food to may then at notify poisoning); physicians a Dangerous diseases, as Ebola, treatment. involuntary such communicable TB or require may

Patient not is adherent. to another and Attempt adhering and his/her coerce to identify to nonadherence physician. the do not for not determine the into refer reason change; patient do willingness him/her

test handle of the member not to family patient patient’s prognosis is be “unable will poor to the A because a you disclose it.” results the asks if

condition. would why to identify detrimental the to patient’s such information member family be the Attempt believes that care will of be his/her patient has as does information Explain withheld. communication otherwise, not capacity the indicate and as concerning not decision-making long might privilege then believe However, you others if therapeutic the information. invoke harm informed, or seriously if may the and you patient withhold himself/herself

suicidal. Patient is the seriousness the Assess of threat. patient remain it refuses. hospital suggest serious, is hospitalized if the he/she involuntarily that If in voluntarily; the patient can be

for each Discounted by payers fee-for-Patient and individual (eg, pays service at predetermined discounted providers service PPOs). rate a

that healthcare amendments originated Security the and social from Social to Act. Medicare Medicaid—federal programs

disease. ≥ 65 Medicare renal is end-stage certain available those with to < and with patients old, 65 disabilities, years

for federal and assistance with income health or joint limited resources. and/ Medicaid is state people

for is MedicarE Elderly. is MedicaiD for Destitute.

The 4 of Medicare: parts

home Part insurance, HospitAl hospice care A:

doctor’s testing) Part (eg, fees, bills medical B: Basic diagnostic

private A C: delivered companies B approved by = Combo) (parts Part +

Drugs D: Prescription Part

instead providing of palliation care focused Hospice comfort Medical definitive cure. on care and in patients 6 whose expectancy Medicaid < months. insurance Medicare or and Available to most on plans is life private anxiolytic priority and During the includes comfort (often relieving to pain sedative, is opioid, care, improving medications). or patient’s given end-of-life (eg, prioritized respiratory Facilitating is effects side potential over depression). comfort over effects negative the double prioritization is of called This principle positive effect. of effects

Common causes (US) death by age of

monitoring. without internal in collect Event concerns freely Organizational Safety for external up errors environment data culture bring safety and everyone on systems which reporting can of fear censure. identification. Facilitates error

connecting are actions IV to Human factors prevent [eg, design that Forcing effective. syringe undesirable the functions feeding most (those tubing]) process pathways, checklists). (eg, reliability guidelines, improves Standardization clinical records). electronic wasteful medical activities (eg, consolidating reduces Simplification

workflow features ID due that staff unreadable lead designs safety to wristbands). to bypass computers workarounds (eg, to Deficient affixed patient hinder barcodes and

cycle real to test in improvement changes PDSA model setting. clinical Process Impact patients: on

than conditions an on individual’s error. Swiss systems Focuses model cheese rather and reality and is mitigated defenses. differing a The of becoming types threat by risk of layers a in safeguards when cheese “the harm line occur the holes multiple despite Patient can up.”

medications, documentation, medical errors Types diagnosis, procedures, identification, infection, nosocomial handoffs. involve devices, monitoring, of patient May to should or outcome Medical (harmful of patients, errors immediate be disclosed independent not).

organism as the the every his natural to are cry laws then, “Symptoms, nothing will and correctly of in hold health machine from adjusted and “Man of an part reality human by immutable Still over in in laws as servitude but dominion perfect organs.” harmony, is the T. organs.” suffering “When is intelligence the gravity.” —Andrew

Connective and Tissue Skin, 445

into In the we section, Organ Facts this divided major High-Yield have Systems. the Pathology, including Within Physiology, each Organ subsections, Embryology, System are several and Anatomy, Pharmacology. As integrated” you refer framework the subsections through information to for previous these in back Organ organize into science basic System, each learning. subsections progress to “vertically a the studying Below advice general these is by organ systems for some subsections.

included in system Relevant embryology each is subsection. organ to to tends congenital correspond malformations. Embryology the well relevant regard especially with anatomy, with

gross anatomy, this topics histology, under neuroanatomy. and fall heading, Several including ignore do not all the Do however, anatomy not small memorize details; altogether. you what you already and wish learned. what you learned have Review had questions more or two steps. require Many photomicrograph. first anatomic The a cross or micrograph, identify is step on electron structure to section, require structure. step an second understanding The may significance clinical of the of the

clinically material. studying, stress important When sensory Horner For radiologic specific and to injuries and lumbar familiar anatomy puncture), diseases procedures motor anatomy (eg, surgeries common (eg, example, be nerve cholecystectomy). deficits), syndrome), Pancoast related gross traumatic with and tumor, (eg, fractures, (eg, There the also questions MRI scans. are x-rays, many CT and on exam neuro scans, involving histology a and through Many radiology students suggest atlas, atlas. pathology browsing general atlas, axial sagittal pelvis). anatomy (eg, at on CT body the of basic brain MRI; key midthorax, and in abdomen, Focus learning the levels and neuroanatomy pathways, supply, anatomy), associated blood neurophysiology yield. functional neuropathology, and Basic good have (especially many the Please images in this not emphasis. that reflective and Step of note are book 1 illustrative necessarily for purposes are of photographic

with review. the to lend examination not physiology The itself portion well oriented as is broad fact-based and of thus concept and does dealing study requiring often interpretation number of best the aids, given increasing of diagrams. Diagrams questions especially the the are variety a physiologic ways (eg, apply Learn the Fick to of basic equation, relationships in equations). clearance seldom asked You to are calculations. complex perform production so regulatory Hormones the learn mechanisms. sites and as are of their as questions, focus well their action of many

clinically the with USMLE pathologic on and large changes portion with A is the pulmonary changes understanding processes of tested associated COPD). Step function 1 relevant physiologic in involves physiology (eg, physiologic (eg, to of it review that are and is tract) pathologies found with systems kidneys, heart, endocrine changes organ worthwhile the Thus, the lungs, glands. common GI major

prepare sheer are volume Questions the because this with to discipline of of material involved. for dealing difficult and key the principles the characteristics of basic Review diseases. hallmark know these no Step longer and sufficient of macules findings. descriptions the Given only the neurofibromatosis); the clinical associations clinical you certain is (eg, it also diseases 1, to café-au-lait of of orientation “buzzword” know must

Given presenting associated their well and of the USMLE 1, symptoms signs laboratory clinical it of the findings. to as the slant as review diseases important also is Step classic States a disease, hypertension, heart alcoholism, failure, in of signs, prevalence the major into ischemic diabetes, have diseases (eg, high infectious pathophysiology Delve heart disease). and the that symptoms, United step the one complications. to to treatment think diagnosis prepared Be beyond or simple

The the and are a in history. of clinical number gross setting brief presented photographs color a includes examination of that of specimens photomicrographs because at read carefully you However, before question process. illustration, will the looking the the help choices pathologic the the history and identify the at the in the Flip to an atlases, exam. illustrated appropriate color look Web days order through before textbook, pathology and pictures sites in ethnicity, Pay to exposures, as clues such sex, attention potential specialized tests. activities occupation, age, and recent lab and

Preparation on for is pharmacology questions straightforward. side (eg, effects) Learning drugs use, their key all and is characteristics important clinical the yield. and mechanisms, high drugs Focus prototype on each class. understanding in the memorizing Avoid obscure derivatives. the drugs. “classic” toxicities distinguishing of Learn and major the drug trade names. dosages bother with or not Do while studying be microbiology and can associated physiology, Reviewing pharmacology. useful biochemistry, There emphasis on agents is antimicrobial, and ANS, NSAIDs. strong well CNS, as a as cardiovascular of is clinically relevant. material Much the are on Newer market fair the drugs also game.

unbreakable.” heart I “As —H. heart did.” I Wizard “As occasional as of the an young never practical —The “Hearts ever grows they for grow be arteries will for the hard, are feel made attack, until me, except as soft.” Oz poets, touch even sky.” the not “Only can his heart “It the measured, much Mencken heart you but “Nobody size not of the L. from the ever hold.” of can how the size the matters.” heart that is has man

the may challenging. cardiovascular for students, be of some most and, areas the boards for is highest yield one the system The the Focusing difference, memorizing can especially this make topic. on of for a details instead big mechanisms understanding the failure, topics. physiology their some of ECGs MOA and high-yield interactions) and of cardiac are and blocks, heart Pathophysiology the heart the atherosclerosis Starling of curve (particular cycle, adverse of effects, the more drugs dysfunction very and between also important. diastolic systolic Differentiating is high and and these multimedia in that murmurs been yield be have asked maneuvers Heart also murmurs format. may a affect

Septation chambers of the

foramen primum. endocardial grows narrowing primum Septum cushions, toward primum regresses). forms Foramen in (foramen secundum primum septum secundum foramen on the right-to-left as right secundum side shunt. develops septum Septum primum, of maintains covers expands Septum most of and foramen secundum secundum. is The ovale. foramen foramen the residual forms the ovale. one-way the primum of septum portion foramen Remaining of valve

6.

the primum soon Septum RA pressure  septum against and LA after foramen of birth closes pressure.  ovale because sealing secundum,

7.

and septum. infancy/early fuse secundum atrial childhood, during septum Septum forming the primum

and by ovale—caused fuse left to secundum after Patent are septum primum of untreated. foramen birth; failure septum most thromboemboli lead ASD. arterial occur paradoxical entering (venous can emboli systemic Can circulation) in as to the

Muscular interventricular septum forms. is foramen. called Opening interventricular ventricular interventricular fuses septum Aorticopulmonary septum, muscular closing form with and foramen. membranous to interventricular septum rotates

septum. to ventricles Growth of interventricular atria atrial the endocardial separates portion both and contributes of membranous septation from and cushions

occurs usually membranous defect—most Ventricular septal cardiac congenital septum. common in anomaly,

ventricle Trabeculated right and ventricles left Primitive of part

Primitive atria of Trabeculated part right atrium and left

Coronary horn venosus of sinus Left sinus

part Smooth (sinus right of of atrium Right venarum) venosus sinus horn

membranous septum; interventricular cushion septum, semilunar Atrial Endocardial AV and valves

(IVC) subcardinal, veins supracardinal cava vena and Inferior Posterior,

part left pulmonary of Smooth vein atrium Primitive

E1 Prostaglandins E2 and PDA open. kEEp

Ligamentum Ductus left laryngeal arteriosum recurrent the nerve arteriosus Near

 of allantoic bladder part umbilical duct Urachus Allantois Median and umbilicus between ligament is urachus

saturated ≈ umbilical ≈ and Po2 30 mm 80% has is Blood Hg of with a O2. vein in low arteries saturation. have O2 Umbilical 3 important shunts:

IVC, venosus ductus through bypassing the circulation. Blood umbilical entering is vein into conducted the the fetus via hepatic

the Ovale foramen directed IVC highly left blood through into atrium. reaching is of Oxygenated the the via heart the the

fetal through RV pulmonary arteriosus passes artery aorta; to main (due O2 high • due artery shunt RA Ductus blood • is Descending SVC tension). from  partly the  resistance to pulmonary the low

in At (now ovalis); closure ductus atrial separation) and foramen pressure takes  breath right a pressure left  atrial of  called  vs (from closes pulmonary placental resistance birth, in O2 • (from ovale in infant respiration) arteriosus. prostaglandins vasculature fossa

close (remnant arteriosum patent arteriosus Indomethacin of the helps Ductus  ligamentum arteriosus). ductus the and Door. Come close In

of Anatomy heart the

the a left the branch ; lead LA the is compression A enlargement esophagus of in LA to laryngeal (Ortner nerve, nerve, (eg, (dysphagia) causing recurrent the posterior part the can mitral of stenosis) most hoarseness heart of syndrome). vagus of and/or the

trauma. of part is most and the RV anterior commonly injured heart most in the

Key:

LV. anterior papillary of surface and 2/3 its of anterior LAD anterolateral muscle, interventricular septum, and supply branches Most commonly occluded.

septum, walls dominance), 1/3 posterior and node 2/3 on of posteromedial PDA papillary ventricles, posterior interventricular supplies muscle. of (dependent AV

(blood SA RCA dominance). node independent supply of supplies Infarct (bradycardia cause block). nodal dysfunction or may heart RV. (acute) artery supplies Right marginal

Dominance:

arises = (85%) PDA Right-dominant RCA. from circulation

LCX. circulation (8%) arises Left-dominant from PDA =

and RCA. LCX both from flow peaks diastole. Coronary early in blood

muscle of to is Force proportional (preload). of end-diastolic fiber length cardiac contraction

digoxin). (eg, contractility positive with inotropes catecholamines,

loss myocardium contractility channel blockers, of (eg, (acutely), functional MI), non-dihydropyridine Ca2+ dilated cardiomyopathy. β-blockers with

pressure, Resistance, flow

I Q × R (v) Ohm’s (Q) velocity ΔV ΔP × rate Volumetric law: R flow = to = = Similar flow ×

Q + vessels RT Total R2 . in R3 series: + of resistance πr4 = R1 . . vessels resistance 1 of in Total 111 parallel:

lowest have total cross-sectional highest velocity. area Capillaries and flow to pressure. pressure high low flow gradient Pressure from drives for TPR. Arterioles most account of storage Veins capacity. of provide blood most on hematocrit. mostly Viscosity depends hyperproteinemic Viscosity multiple polycythemia.  states in myeloma), (eg, anemia. in  Viscosity

return TPRCardiac Normal venous output/venous pressure TPR Vascularfunction tone output/venous ↓↓↓↓↓↓volume, venous Mean inotropy curve function tone volume, systemic return Cardiac inotropy curve Cardiac

return of point = are and heart equal, (ie, as Intersection CO venous curves system a is closed system). circulatory operating of

reinforcing to (eg, in to inotropy or retention to  and may HF CO)  CO).  (eg,  occur inotropy maintain compensatory exercise  TPR fluid tandem, preload be often Changes maximize and

black physiology. and loop normal cardiac loops Pressure-volume cardiac cycle represents The

valve of Phases—left opening; period O2 consumption ventricle: highest

Heart sounds:

closure. and tricuspid valve S1—mitral mitral area. at Loudest

S2—aortic valve and closure. pulmonary border. sternal at upper Loudest left

if palpable. abnormal Considered

(JVP): Jugular pulse venous wave—atrial a contraction. in (AF). atrial Absent fibrillation

phase. filling decubitus heard in left lateral apex at position. patient Best with HF, in (eg, with and  ventricles filling be adults, young (but AR, MR, children, Associated athletes, normal can pressures pregnancy).

(“atrial late S4—in diastole kick”). decubitus lateral patient left with apex position. at in Best heard pressure. High atrial ventricular hypertrophy). (eg, with noncompliance Associated

against push must LV atrium wall. stiff Left

atrium). bulging into

displacement ejection of J.V.P) closed phase. (aka descent—downward x or regurgitation right are in pressure gradients reduced. because Reduced absent tricuspid and HF against to 0.1 0 0.2 v valve. wave— tricuspid pressure 0.4 due 0.7 0.6 (“villing”) 0.3 filling 0.8 0.5 closed atrial right

into y emptying Time RV. (sec) descent—RA Prominent pericarditis, in cardiac constrictive tamponade. absent in

impaired because ESV and to  due   due volume/pressure of resistance ventricular filling 120 from to LA

of Splitting S2

pulmonic bundle right block). Seen emptying Wide delay branch in RV splitting (eg, conditions stenosis, that E delayed Causes S1 sound A2P2 pulmonic (especially on inspiration). Abnormal splitting. An normal exaggeration of delay

in splitting Heard ASD. Fixed flow through volumes pulmonic A2P2 S1 delayed shunt left-to-right  valve of  (independent valve and RA respiration). RV pulmonic ASD  closure  left block). P2A2 (eg, stenosis, aortic S1 bundle closure I branch occurs P2 before valve delayed semilunar A2 so reversed order closure sound. sound is that of Normal A2, to “paradoxically” later inspiration, P2 closer closes moves split. the On eliminating and splitting). can heard split be physiologic On (opposite expiration, the to

physiologic murmur) sclerosis PA Aortic M regurgitation 111234567777777 cardiomyopathy Where listen: Pulmonic of (eg, regurgitation T heart border: Aortic valve M APT sternal Auscultation Left to the

Systolic Aortic area: murmur

area: Pulmonic

Tricuspid area:

area Mitral (apex):

be murmur and S2 present). click systolic ejection may soft (ejection Crescendo-decrescendo systole. during >> LV aortic pressure heart carotids. base; radiates to Loudest at tardus”—pulses peak. “Pulsus delayed a parvus et are weak with Dyspnea (SAD). to lead and exertion Can Syncope, Angina, on bicuspid older with younger calcification or in commonly early-onset patients 60 of calcification valve. to (> aortic age-related years in due Most old) patients

axilla. toward Holosystolic, apex and “blowing murmur.” high-pitched Mitral—loudest at radiates dilatation. MR (post-MI), is ischemic due disease often to LV MVP, heart area. tricuspid at Tricuspid—loudest TR RV caused dilatation. by commonly TR. either can and or cause Rheumatic MR endocarditis infective fever

sudden due prolapse chordae cause LA (MC) tensing with with Late murmur (Chordae as crescendo of Click). the Crescendo midsystolic click to into leaflets tendineae mitral systolic frequent Most valvular lesion. Best apex. heard over just S2. Loudest before Usually benign. predispose endocarditis. infective Can to developing myxomatous such 2° (1° countries), chordae as Ehlers-Danlos be disease to caused (particularly in rheumatic syndrome), Can tissue or by fever connective Marfan degeneration or rupture.

“blowing” decrescendo early murmur. High-pitched diastolic heard sternal base Best or (valvular dilation) root border left disease). at (aortic when and and chronic. head Long murmur, hyperdynamic diastolic severe pulse, bobbing pulse pressure. Wide valve, fever (BEAR). Causes Bicuspid Endocarditis, aortic Aortic root Rheumatic dilation, include to left HF. Progresses

to (OS; at diastole, halt leaflet Follows tips). to in opening snap due in opening leaflet motion fusion after abrupt due rapid between severity). OS Delayed S2 ( rumbling mid-to-late  with diastolic correlates murmur interval and diastole. during pressure LA >> LV

sequela late Often highly of (and specific) a fever. rheumatic and fibrillation atrial Ortner MS Chronic and in dilation  result LA syndrome. pulmonary can congestion/hypertension

machine-like Patent murmur. Continuous arteriosus ductus Best left at infraclavicular heard area. at Loudest S2. Often congenital due to or rubella prematurity.

are of Displays (Public continuously “PDAs annoying.” Affection)

depolarization— channels Na+ rapid 0 Phase = open. upstroke voltage-gated and

initial Phase repolarization—inactivation voltage-gated channels. = 1 Na+ of K+ begin to open. channels Voltage-gated

Ca2+ voltage-gated = 2 K+ through plateau—Ca2+ Phase channels balances efflux. influx from release and influx sarcoplasmic contraction. Ca2+ triggers myocyte Ca2+ reticulum

efflux rapid 3 voltage-gated delayed-rectifier repolarization—massive and of closure of opening channels. due K+ = to channels Phase slow K+ voltage-gated Ca2+

Phase potential—high channels. K+ K+ 4 permeability through resting =

In contrast skeletal muscle: to

to action due K+ muscle Cardiac Ca2+ potential a plateau has influx efflux. and

Ca2+ Cardiac ECF release Ca2+ to (Ca2+-induced release). requires muscle sarcoplasmic contraction induce Ca2+ from from influx reticulum

coupled by to are each Cardiac gap other myocytes junctions. electrically

except the cardiac SA nodes. myocytes all in Occurs for AV and those in

SA AV the in nodes. and Occurs the from include: differences action potential Key ventricular

0 voltage-gated channels. Ca2+ Phase of = upstroke—opening because resting the cells. are potential inactivated channels voltage-gated Fast Na+ of permanently these of negative less the node transmission conduction from AV by in atria slow to velocity a Results ventricles. used is to the prolong that

are and 2 1 Phases absent.

Phase of Ca2+ channels the K+ and channels = K+ activation of repolarization—inactivation  3  efflux.

current”). diastolic = Phase due If 4 (“funny depolarization slow to spontaneous slow, action current; If 0 inward phase responsible a in from ventricular potential. channels different of mixed INa Na+/K+ for of for Accounts automaticity nodes. SA and AV slope in determines SA the of The node HR. 4 phase the rate  HR, and catecholamines HR.  and depolarization • while ACh/adenosine diastolic  of depolarization the HR. and If that thus open channels Sympathetic are chance  stimulation 

branches  right pathway: Purkinje bundle left atria left branch  and His of  posterior divides node fascicles. bundle anterior Electrocardiogram SA  and into bundle left fibers Conduction

dominance and of junction RA with of inherent SVC; slow node—located SA at “pacemaker” upstroke. phase

in posteroinferior interatrial septum. AV of part node—located RCA. from supply usually Blood for delay allows time 100-msec ventricular filling.

of rates: SA > Pacemaker AV bundle > Purkinje/ventricles. His/

AV node. His-Purkinje > Speed of Atria > Ventricles conduction: > Avenue. At He Ventura Parks

P depolarization. wave—atrial

to (normally from start depolarization interval—time start depolarization of 120-200 atrial msec). PR of ventricular

100 QRS msec). complex—ventricular (normally < depolarization

QT ventricular ventricles, contraction the mechanical of interval—ventricular depolarization, repolarization.

T repolarization. wave—ventricular indicate or ischemia T-wave MI. may inversion recent of between J start QRS and complex segment. ST point—junction of end ventricles depolarized. segment—isoelectric, ST wave—prominent U bradycardia. in hypokalemia hyp“U”kalemia), (think

of SA node Bundle node His AV

by to pointes progress characterized waveforms de Torsades sinusoidal ventricular on ECG; shifting Polymorphic (VF). tachycardia, fibrillation can ventricular pointes. to QT predisposes de interval torsades Long Ca2+,  K+, • congenital abnormalities. drugs,  Mg2+, Caused by sulfate. magnesium Treatment includes

AntiBiotics (eg, Drug-induced AntiArrhythmics ondansetron) Anti“C”ychotics (class (eg, long AntiEmetics QT III) (eg, TCAs) IA, haloperidol) AntiDepressants (ABCDE): macrolides) (eg,

the twisting Torsades de of points pointes =

males. Brugada syndrome common most Autosomal in disorder Asian dominant branch pseudo-right elevations ST bundle and in V1-V3. ECG block pattern of SCD. risk  tachyarrhythmias of and ventricular (ICD). cardioverter-defibrillator with SCD implantable Prevent

waves with P in fibrillation and baseline spaced erratic between Atrial Chaotic RR complexes. irregularly no RR˜ discrete ˜RR˜RR QRS heartbeat. irregular Irregularly Most hypertension coronary common risk (CAD). artery and disease factors include seen (“holiday Occasionally after heart syndrome”). drinking binge particularly events, Can stroke. lead to thromboembolic

and control rhythm anticoagulation, and/or cardioversion. rate Treatment:

(> is 200 msec). PR First-degree interval The prolonged asymptomatic. block AV and Benign required. treatment No

absent QRS absent QRS =PR1PR2P wave, <<PR1PR2PR3P wave,

transmits to Aortic nucleus (responds and medulla to via nerve • vagus changes Receptors: BP). chemoreceptors Baroreceptors of in arch solitary

bifurcation) solitary • transmits medulla glossopharyngeal via (dilated to BP). carotid in at of sinus nucleus region Carotid (responds to nerve changes

parasympathetic BP. Baroreceptors:  vasoconstriction, HR, stimulation contractility,    severe to hemorrhage. in Important the response

carotid  refractory massage— sinus Carotid baroreceptor AV pressure on HR. firing node  stretch   afferent period

induced central ischemia  depression)— respiratory Cushing arterioles  (triad pressure in of pCO2 and Component hypertension, stretch (hypertension) intracranial peripheral reflex • of cerebral bradycardia. baroreceptor–  pressure bradycardia, and sympathetic constricts pH  perfusion   reflex reflex

Chemoreceptors:

stimulated Peripheral—carotid  (< mm Hg). by  bodies Po2 Pco2, and aortic are blood, of 60 pH and 

and arterial in turn H+ stimulated changes the cannot of which as CO2 cross interstitial barrier. blood-brain influenced by in fluid, are Central—are by brain Pco2 pH Po2. respond Do not to directly chemoreceptors less Pco2 (eg, become peripheral dependence  drive COPD) responsive  • chronically Central detect chemoreceptors to respiration. on to O2 with

of Hg) mm in left approximation good is a pressures atrial pressure. LV diastolic PCWP > pressure. In stenosis, mitral end artery measured is with pulmonary catheter catheter). PCWP (Swan-Ganz

constant of range pressures. Autoregulation How wide a over perfusion organ to flow remains blood an

 Kf; pressure—pulls liver capillary to pressure—pushes flow fluid Kf failure, Edema—excess interstitial of capillary fluid Starling proteins • −πi)] syndrome, capillary capillary Pi) net  pressure protein) (measure into • eg, πi; lymphatic out fluid • toxins, pressure [(Pc interstitial fluid − nephrotic capillary out caused of determine protein plasma ( (• = permeability capillary colloid = interstitium HF) permeability Pc osmotic fluid • osmotic  fluid hydrostatic σ= = forces permeability  Kf Pc; coefficient capillary through = πc; fluid of • blockage) −σ(πc infections, movement Jv by: πi eg, burns) commonly ( membranes: eg, Capillary fluid (• capillary eg, outflow reflection exchange fluid colloid malnutrition) = to

of  LV of (posterior) D-transposition leaves separation systemic great vessels

Pulmonary pulmonary and circulations. a mixing (eg, PDA, VSD, shunt present life unless foramen Not blood of ovale). is to or allow with artery patent compatible

Left string” the failure to Due of spiral ventricle a on septum (“egg on appearance CXR). aorticopulmonary to

intervention, most months within of die Without life. infants ventricle Right surgical few the first

valve of hypoplastic requires and and tricuspid for VSD viability. RV; Absence ASD atresia Tricuspid both

of Fallot Tetralogy

displacement Caused of anterosuperior septum. by the infundibular childhood common Most cyanosis. cause early of CXR hypertrophy ventricular for (RVH)— stenosis Pulmonary on heart (most boot-shaped infundibular determinant important prognosis) Right

crying, and right-to-left to stenosis “tet RV outflow fever, exacerbation VSD obstruction). caused due by across  forces RVH, (often flow Pulmonary of spells” exercise

PROVe.

Squatting: cyanosis. shunt, right-to-left  improves  SVR,

syndromes. Associated with 22q11

cyanosis Acyanotic lEFT-TO-RIGHT Right-to-Left cyanosis. eaRLy SHuNTS shunts: may occur presentation; at later. years Frequency: PDA. ASD VSD > > shunts: Left-to-Right cyanosis. “LateR”

septal saturation birth, may weeks O2 manifest at  in Ventricular pulmonary RV artery. and Asymptomatic remain life. or throughout later asymptomatic defect B HF. LV larger to and lead lesions self resolve; may overload Most

C ; fixed S2. interatrial septum wide, Defect split in primum cardiac ostium other usually and defects most occur and secundum defects common usually finding; with an Ostium isolated anomalies. rarer none to range from Symptoms HF. patent tissue unfused. foramen missing ovale rather that than septa from Distinct are in

in pulmonary  RA, and RV, O2 saturation artery. systemic (systemic arterial paradoxical become lungs emboli ASD use and emboli May to venous lead emboli). to bypass

syndrome. with Associated Down

shunt fetal In left right (normal). is to period, and/or pulmonary neonatal and becomes  progressive  vascular In right RVH left resistance period, HF. shunt to  LVH

murmur. Associated continuous, “machine-like” with a by tension. synthesis Patency maintained and low is O2 PGE (differential can result cyanosis lower D extremities late in PDA Uncorrected in eventually the cyanosis).

normal normally birth. utero closes PDA and after in is only

left-to-right pulmonary of arterial shunt PDA) pulmonary pathologic vasculature ASD,  Uncorrected • (VSD, remodeling flow  blood hypertension. becomes shunt left. RVH to  occurs compensate right to E Causes cyanosis, polycythemia. and , clubbing late varies. of Age onset

the Coarctation aorta of

Aortic near narrowing arteriosus ductus F of (“juxtaductal”). insertion with valve, heart Turner Associated defects, syndrome. other bicuspid and aortic extremities and delayed (brachial-femoral lower upper extremities in Hypertension in weak, pulse delay). to CXR. ribs enlarge arteries age, appearance on With arteries intercostal  due erode collateral circulation; notched

aortic  (berry risk hemorrhage rupture, include possible Complications HF, endocarditis. and aneurysms), of cerebral

syndrome) utero VSD, PDA, ASD, alcohol defect of tetralogy (fetal associations exposure in Alcohol Fallot

Transposition VSD Infant great vessels, diabetic mother of of

aortic aneurysm syndrome and dissection, thoracic Marfan aortic regurgitation MVP,

aorta Fallot coarctation valve, aortic 22q11 tetralogy syndromes Bicuspid of of Turner syndrome arteriosus, Truncus

Hg. and/or 80 diastolic systolic Hg mm 130 ≥ BP BP mm Persistent ≥ Hypertension

Asian. inactivity, excess salt RISK American cigarette FACTORS Caucasian smoking, intake, family diabetes, excess intake, > physical obesity, > African history; age, alcohol 

of and is  to 90% TPR. hypertension  or related 1° CO FEATuRES (essential) of fibromuscular renal/renovascular as (characteristic dysplasia hyperaldosteronism. renal artery usually mostly Remaining 1° and child-bearing 10% seen beads” age) , artery to of women or A to diseases atherosclerotic renal 2° such “string in appearance stenosis of Hypertensive mm without damage. urgency—severe 120 end-organ 180/≥ Hg) acute hypertension (≥ aortic MI, hypertension encephalopathy, HF, papilledema, dissection, eclampsia). end-organ evidence retinal microangiopathic anemia, emergency—severe stroke, kidney damage of and Hypertensive acute exudates, with hemolytic injury, (eg, hemorrhages

CAD, aneurysm; aortic aortic (hypertensive nephropathy); retinopathy. fibrillation; atrial CKD LVH, TO PREdISPOSES stroke; HF, dissection,

the eyelids (xanthelasma lipid-laden A or in nodules skin especially Xanthomas composed histiocytes , of Plaques

B ).

Lipid tendon especially , in xanthoma deposit C Achilles. Tendinous

arcus deposit in Lipid Corneal cornea. in appears D life Common elderly hypercholesterolemia. earlier with but (arcus senilis ), in

Arteriosclerosis arteries, and of Hardening of with thickening loss elasticity. wall arterial

Arteriolosclerosis Common. arteries small Affects arterioles. and skinning” hypertension Two hypertension diabetes into hyaline A vessel leak proliferation with ) of endothelium walls mellitus cells). to hyperplastic types: smooth plasma essential of muscle 2° and or in in severe protein B (“onion (thickening

Very Atherosclerosis common. form Disease of muscular intima. medium-sized of in a by arteries; of and buildup cholesterol plaques largeand elastic arteries arteriosclerosis caused

> Abdominal Popliteal aorta artery > > circle artery lOCATION artery Coronary of Carotid > Willis. CoPy Willis. Cat A named

diabetes. smoking, RISK dyslipidemia Modifiable: FACTORS  LDL, hypertension, HDL), ( postmenopausal history. and family in age, Non-modifiable: men sex ( women),

but claudication, Angina, be SYMPTOMS asymptomatic. can

macrophage smooth streaks of   and content dysfunction fibrous cell muscle deposition plaque proliferation, A cell   and PROGRESSION  and correlates foam complex important FGF), Inflammation (calcium cell with fatty (involves accumulation formation migration LDL PDGF  matrix calcification extracellular endothelial risk complications). pathogenesis: in  atheromas

disease, infarcts, peripheral vascular Aneurysms, COMPlICATIONS emboli. ischemia, thrombus,

Aortic pathologic Localized the aorta. dilation of aneurysm back abdominal leaking, sign dissection, May cause pain, a of and/or or is imminent which rupture.

with atherosclerosis. aortic Abdominal associated Usually factors age, sex, of history aneurysm history. use,  family Risk include male tobacco May to abdominal calcified non-opacification to aorta of due mass palpable flap/ in clot). crescent-shaped aortic wall, pulsatile outer as (arrows point with present partial A dilated (distal to often infrarenal renal Most of origin arteries).

commonly Due and/or left (proximal aorta distal rupture at subclavian of deceleration descending just to to trauma origin Traumatic aortic injury, isthmus aortic artery). most mediastinum. may X-ray widened reveal

intimal lumen. a Longitudinal forming false tear syndrome). aortic valve, Associated inherited Marfan hypertension, tissue bicuspid (eg, connective disorders with arms. radiating to unequal markedly Can back +/− present with the chest sudden-onset tearing, in BP pain show CXR can widening. mediastinal ischemia, result in organ rupture, aortic Can death. Two types:

aorta involves type Stanford Ascending A arrow (red in (proximal):

A ). descending arrow extend in aortic or arch (blue to May aorta

A ). in or May aortic cardiac result acute regurgitation tamponade. surgery. Treatment:

(distal): involves left type Stanford artery). (Below B subclavian aorta only descending β-blockers, then vasodilators. Treatment:

spasm; due myocardium pain Angina ischemic artery to coronary Chest myocyte to narrowing no necrosis. 2° or

2° chest nitroglycerin. occlusion); depression to ECG), resolving (≥ on ST in atherosclerosis pain or Stable—usually rest (usually distribution 70% classic with exertional with

2° called Variant)—occurs transient Vasospastic at to elevation on coronary artery rest spasm; (also ECG. Prinzmetal or ST hypertension are Smoking factor; not. hypercholesterolemia is risk a and cocaine, triptans. alcohol, Triggers include and applicable). and Ca2+ (if channel blockers, smoking cessation with Treat nitrates,

intensity any of but frequency (unlike at elevation incomplete occlusion; on chest or coronary or and/or ECG pain inversion chest pain depression T-wave ST with rest. biomarker NSTEMI); in artery  +/− no Unstable—thrombosis cardiac

cardiac arrhythmia of Death onset hour a Sudden death within causes cardiac due VF). lethal 1 commonly symptoms, of most from (eg, to 70% CAD cardiomyopathy channelopathies syndrome). with (up Associated (hypertrophic, ion long Brugada of hereditary to dilated), (eg, syndrome, cases), QT and with ICD. Prevent

LAD of Evolution coronary > > occluded circumflex. Commonly RCA arteries: in fatigue. vomiting, breath, left diaphoresis, retrosternal severe jaw, of pain myocardial Symptoms: nausea, shortness and/or pain, infarction arm

hemorrhage, Dark edema, HF, Early hypercontraction Ventricular coagulative arrhythmia, cell 0–24 wavy mottling blood; hr  cardiogenic shock into  necrosis released content fibers of

tetrazolium stain stripes) Dark pale mottling; with

margins pericarditis to tissue rupture Tissue surrounding neutrophils  3–14 Macrophages, granulation acute inflammation infarct papillary then rupture at with muscle shows due tamponade; macrophage-mediated days Free wall

(risk thrombus) 2 complete mural true several of Contracted months of (risk HF, to aneurysm pseudoaneurysm scar syndrome, ventricular rupture) weeks arrhythmias, Dressler LV

return upper 48 hours. of normal Multiples of limit after to normal

CK-MB. troponin greater elevations Large I and lead to in MIs vary Exact with testing curves procedure.

inversion, include or T (peaked) block, (STEMI, new T-wave ST ST bundle hyperacute infarct), poor (NSTEMI, depression subendocardial elevation can Q waves, transmural and branch wave or transmural (evolving infarct), ECG R old waves left changes progression infarct). pathologic

thrombus. tissue days: rupture contained CO, wall  mural embolus scar pericardium or of arrhythmia, adherent by 3–14 ; B pseudoaneurysm from Ventricular free risk formation

C wall  free days: wall free cardiac rupture tamponade. 5–14 Ventricular hypertrophy against previous free wall MI LV and rupture protect rupture. form death. Acute leads to sudden usually

and encoding to in as due are familial, mutations β-myosin such binding sarcomeric of genes cases protein myosin autosomal heavy (most 60–70% proteins, C chain). commonly dominant (eg, during death to syncope may arrhythmia. athletes) and exercise young due sudden to ventricular in Causes lead

Findings: S4, systolic murmur. due valve see impaired regurgitation May to closure. mitral mitral

non-dihydropyridine high-intensity of Ca2+ β-blocker or of Treatment: blockers verapamil). use channel (eg, athletics, cessation syncope ICD if occurs.

Diastolic ensues. dysfunction

concentric ventricular parallel) hypertrophy Marked predominance. added septal often B in , (sarcomeres Myofibrillar fibrosis. disarray and

motion and of outflow dyspnea, of  valve septal mitral  systolic hypertrophy syncope. HOCM—asymmetric anterior possible Physiology obstruction

concentric HTN, chronic LV Friedreich Other of ataxia. causes hypertrophy:

young cardiomyopathy fibrosis, endocardium (thick LEASH). endocarditis, Postradiation fibroelastosis dilated tissue (Puppy in Löffler (although Hemochromatosis Sarcoidosis, fibroelastic of children), Amyloidosis, more is Endocardial common)

ensues. dysfunction Diastolic low-voltage ECG myocardium amyloidosis). in thick despite Can have (especially

endocarditis—associated hypereosinophilic histology syndrome; shows infiltrates with Löffler myocardium. in eosinophilic

Clinical perfusion. of failure cardiac syndrome congestion Heart  low pump and dysfunction signs distention rales, jugular S3 dyspnea, include include fatigue; sound, pitting orthopnea, edema venous (JVD), heart Symptoms

. A

dilated or contractility dysfunction—reduced EF, ischemia/MI cardiomyopathy. Systolic  often 2° to  EDV;

myocardial dysfunction—preserved often • Diastolic ( EDV; to EDP) EF, compliance hypertrophy. normal 2°

Right most results HF from left often HF. HF refers Cor pulmonary isolated pulmonale to due right cause. to

decompensated II in spironolactone or inhibitors ACE  receptor HF), (except β-blockers blockers, mortality. and angiotensin acute relief. mainly Loop thiazide diuretics used symptomatic are for and therapy Hydralazine patients. select mortality and improves in both nitrate symptoms with

of lungs. cells) hemosiderin-laden macrophages in (“HF” Right heart failure

normal and organ necessary delivery Inadequate tissue cellular nutrients and function. for Shock perfusion of if be but life promptly. may not treated Initially reversible threatening

 chambers. 4 in by pressures all Compression diastolic pericardial heart [arrows blood, of effusions the (eg, ] fluid A in space) Equilibration of CO. in Beck heart sounds), veins, Findings: HR, paradoxus.  (hypotension, distended neck distant triad pulsus of “swinging” ECG B in effusion). low-voltage electrical QRS movement large heart to and alternans shows (due

inspiration. mm by paradoxus— in amplitude of during Pulsus systolic BP 10 Hg > Tamponade constrictive Pericarditis, disease COAT). (eg, COPD), (Pea Croup, OSA, Asthma, Seen in pulmonary cardiac obstructive

(high endocarditis Acute—S aureus virulence). Bacterial vegetations on . Large A normal previously valves Rapid onset. streptococci Subacute—viridans virulence). (low abnormal vegetations on Smaller valves. congenitally or diseased Sequela of procedures. dental onset. Gradual sole) lesions (round nodes lesions toe new on on finger to or (Ouchy lesions retina , common), raised palm Osler (small, white hemorrhages bed. painless, Symptoms: deposition), surrounded B ), murmur, on (most E nail complex spots by D on pads immune fever C erythematous or Janeway due spots Roth hemorrhage splinter pulmonary with glomerulonephritis, emboli. septic arterial or Associated or state, malignancy, May lupus. to (marantic/thrombotic) 2° nonbacterial be hypercoagulable

Osler Murmur Nail-bed nodes Janeway ♥: spots Roth FROM with Emboli Fever JANE hemorrhage lesions Anemia

blood cultures diagnosis. for Requires multiple most culture likely ⊝, burnetii, If Coxiella

spp. Bartonella involved. is valve frequently most Mitral endocarditis associated Tricuspid with is valve

drug (don’t IV drugs). “tri” abuse Associated with and Pseudomonas, S Candida. aureus, prosthetic epidermidis cancer, present S on is in valves. S (gallolyticus) colon bovis

be endocarditis [formerly organisms Native Kingella). (Haemophilus, Cardiobacterium, valve due Actinobacillus], to Eikenella, Aggregatibacter may HACEK

A , the of arrows]. pericardium Inflammation red [ and pain, presents sitting relieved inspiration, aggravated forward. up leaning by and sharp Commonly with by [between Often ]. complicated pericardial effusion A in arrows by yellow with Presents friction rub. ST-segment changes widespread ECG depression. and/or PR include elevation

cardiovascular common; neoplasia, (most uremia, autoimmune syndrome), (eg, arthritis), radiation (eg, idiopathic therapy. Causes presumed rheumatoid SLE, STEMI (acute coxsackievirus confirmed include Dressler or B), infection viral),

colchicine, (uremia). dialysis NSAIDs, Treatment: glucocorticoids,

of chambers. of heart and all enlargement Inflammation myocardium of  Myocarditis global dilation in < Major SCD years of 40 adults old. cause is (persistent can pain, tachycardia fever chest arrhythmias include highly Presentation characteristic). dyspnea, proportion out variable, fever, of to causes: Multiple

viral adenovirus, HHV-6); coxsackie focal Viral myocarditis. (eg, of B, parvovirus indicative HIV, B19, with infiltrate highly necrosis lymphocytic

cruzi, Trypanosoma (eg, Parasitic Toxoplasma gondii)

(eg, pneumoniae, burgdorferi, Corynebacterium Borrelia diphtheriae) Mycoplasma Bacterial

(eg, widow Toxins carbon venom) monoxide, black

doxorubicin, Drugs (eg, cocaine)

Autoimmune (eg, sarcoidosis, polymyositis/dermatomyositis) SLE, Kawasaki disease,

with include Complications HF, sudden arrhythmias, thrombus mural dilated block, death, emboli. systemic heart cardiomyopathy,

< years Buerger smokers, males old. Heavy disease 40 vein and thrombosing vasculitis Segmental with Intermittent claudication. (thromboangiitis lead nerve May involvement. to obliterans) gangrene

of Treatment: autoamputation cessation. , digits, C smoking

nodular superficial phlebitis. present. phenomenon is often Raynaud

Asian 4 disease < old. years children Kawasaki and a on CRASH burn Kawasaki. Rash coronary artery ; (mucocutaneous (cervical), node rupture May (polymorphous  Adenopathy death. aneurysms thrombosis injection, desquamating), lymph develop or E Conjunctival can cause (oral tongue and D Strawberry aspirin. syndrome) mucositis) Hand-Treatment: , immunoglobulin IV changes fever. (edema, erythema), foot

men. Usually Polyarteritis nodosa middle-aged patients. in of 30% seropositivity Hepatitis B headache. malaise, loss, weight Fever, GI: pain, abdominal melena. neurologic renal dysfunction, eruptions, cutaneous Hypertension, damage.

and not vessels, renal involves visceral pulmonary Typically arteries.

of transmural necrosis. fibrinoid inflammation Different stages with

F spasms on pearls arteriogram renal appearance). (string of and microaneurysms Innumerable

cyclophosphamide. corticosteroids, Treatment:

(Wegener) Granulomatosis polyangiitis with

otitis nasal Upper respiratory chronic of mastoiditis. media, sinusitis, perforation septum, tract:

hemoptysis, respiratory cough, tract: dyspnea. Lower

hematuria, Renal: cell casts. red

Triad:

(anti-proteinase PR3-ANCA/c-ANCA glomerulonephritis Necrotizing H 3). densities. nodular large CXR: corticosteroids. Treatment: cyclophosphamide,

tumor heart melanoma). Most tumors is common Cardiac a metastasis (eg,

Myxomas ). Most cardiac in A 1° common (arrows in adults tumor occur in (mostly atria 90% left the atrium). multiple in described atrium “ball Myxomas a syncopal are episodes). valve” the obstruction left (associated with usually as fever, by  tumor loss). weight (eg, production IL-6 symptoms constitutional May sound. “tumor diastolic plop” early auscultate Histology: immersed gelatinous material, myxoma glycosaminoglycans. in cells myxed make Adults drinks.

blockers nimodipine diltiazem, Amlodipine, nicardipine, nifedipine, heart). (dihydropyridines, vascular channel verapamil act on smooth (non-dihydropyridines, clevidipine, on muscle); Calcium act

L-type voltage-dependent Block muscle smooth MECHANISM  cardiac channels muscle calcium and of contractility. > = > diltiazem muscle—amlodipine smooth nifedipine Vascular verapamil. > Heart—verapamil = = ventricle). diltiazem nifedipine > amlodipine (verapamil

nimodipine): Dihydropyridines uSE (including (except angina hypertension, phenomenon. ClINICAl type), Raynaud vasospastic hemorrhage subarachnoid (prevents cerebral Nimodipine: vasospasm). clevidipine: urgency or hypertensive emergency. Nicardipine, angina, hypertension, Non-dihydropyridines: atrial fibrillation/flutter.

EFFECTS AdvERSE Gingival hyperplasia.

flushing, dizziness. edema, Dihydropyridine: peripheral

AV constipation. (verapamil), depression, Non-dihydropyridine: block, hyperprolactinemia cardiac

smooth relaxation.  MECHANISM cGMP  muscle afterload veins; reduction. > Vasodilates arterioles

Severe acute), organic hypertension (particularly uSE nitrate). (with ClINICAl HF use pregnancy. during Safe to tachycardia. prevent coadministered a β-blocker reflex with Frequently to

retention, in (contraindicated angina/CAD), Compensatory AdvERSE EFFECTS tachycardia headache, angina, lupus. fluid drug-induced

isosorbide isosorbide mononitrate. Nitroglycerin, Nitrates dinitrate,

muscle Vasodilate and vascular in in NO by muscle  cGMP MECHANISM relaxation. smooth  smooth Dilate >> arteries. veins preload. 

ClINICAl coronary uSE Angina, edema. acute pulmonary syndrome,

week vasodilating headache, “Monday the hypotension, of • and action β-blockers), with (treat flushing, EFFECTS tolerance the tachycardia, during the work for exposure: development dizziness, industrial AdvERSE weekend over disease” reexposure. tolerance headache tachycardia in loss of Reflex upon with hypertrophic ventricular PDE-5 concurrent infarction, use. Contraindicated inhibitor and in cardiomyopathy, right

Verapamil is in to similar β-blockers effect. angina. β-agonists acebutolol that should be caution with used partial are and in Pindolol

phase late current sodium diastolic and tension of MECHANISM the reducing wall Inhibits inward oxygen thereby consumption. Does or heart blood affect rate not pressure.

Angina ClINICAl other uSE refractory therapies. to medical

AdvERSE EFFECTS nausea. Constipation, dizziness, headache,

substance angiotensin of inhibitor; MECHANISM and peptides, degradation volume. neprilysin vasodilation, natriuretic  P A II, prevents ECF 

in HFrEF. to with (an uSE Used valsartan ARB) treat ClINICAl combination

to AdvERSE ACE with due cough, inhibitors EFFECTS hyperkalemia, Hypotension, dizziness; angioedema. contraindicated

Cardiac glycosides Digoxin.

of inhibition Na+/K+ Direct Na+/Ca2+ MECHANISM exchanger. ATPase of inhibition

[Ca2+]i positive • inotropy. nerve  vagus HR. Stimulates

( SA contractility); atrial fibrillation HF ClINICAl and of ( conduction node). depression at AV uSE node

AV arrhythmias, (nausea, effects block. blurry Cholinergic diarrhea), (think van vision yellow Glow), EFFECTS AdvERSE vomiting, lead indicates poor prognosis. hyperkalemia, to Can which Factors renal quinidine).  failure (permissive tissue-binding and ATPase), hypokalemia digoxin toxicity: displace K+-binding verapamil, sites, that digoxin on at ( for excretion), binding Na+/K+ from (eg, drugs amiodarone, to site clearance predisposing

normalize Slowly K+, Mg2+. Fab anti-digoxin fragments, cardiac pacer, ANTIdOTE

Antiarrhythmics— depolarized cells). Slow in or () (especially conduction block of phase depolarization. 0  slope that tachycardia]). depress Are sodium depolarized frequently channel [eg, tissue (selectively dependent state is blockers I) (class

IA Disopyramide. Procainamide, Quinidine, Class

Queen Diso’s Proclaims pyramid.” “The

MECHANISM Moderate Na+ channel blockade.

duration, period channel  (ERP) ventricular effective in  AP interval, potassium action potential, QT  some blocking refractory effects.

and and uSE atrial SVT VT. especially and arrhythmias, ClINICAl re-entrant Both ectopic ventricular

(headache, torsades (procainamide),  to EFFECTS (disopyramide), interval. due with quinidine), QT syndrome AdvERSE pointes SLE-like tinnitus de thrombocytopenia, HF Cinchonism reversible

IB MexileTine. Lidocaine, Class mV Buy Mexican “I’d Liddy’s 0 Tacos.”

blockade. Weak MECHANISM Na+ channel

duration.  AP depolarized Preferentially Purkinje ischemic or and ventricular tissue. affect into fall the also IB Phenytoin can category.

ClINICAl arrhythmias ventricular uSE (especially post-MI), Acute arrhythmias. digitalis-induced is Best IB post-MI.

cardiovascular stimulation/depression, depression. AdvERSE CNS EFFECTS

IC Propafenone. Flecainide, Class “Can 0 Please.” have mV I Fries,

blockade. Na+ channel Strong MECHANISM bypass and tracts. AV node in ERP Significantly accessory prolongs and on No ERP tissue. ventricular effect Purkinje in AP Minimal effect duration. on

atrial including ClINICAl fibrillation. SVTs, uSE last a in as resort refractory VT. Only

Proarrhythmic, especially (contraindicated). post-MI EFFECTS AdvERSE IC heart structural Contraindicated ischemic disease. is and in

atenolol, Antiarrhythmics— carvedilol. propranolol, timolol, esmolol, Metoprolol,

nodal  Ca2+ by activity cAMP, and SA  AV currents. MECHANISM Decrease by phase pacemakers abnormal slope of Suppress  4. interval. PR sensitive— particularly node AV Esmolol very short acting.

rate fibrillation ClINICAl atrial ventricular atrial and for SVT, flutter. control uSE

and effects AdvERSE exacerbation COPD asthma, sleep (bradycardia, effects AV Impotence, block, of HF), cardiovascular EFFECTS CNS alterations). (sedation, hypoglycemia. May mask the of signs can cause Metoprolol dyslipidemia. can angina. exacerbate Propranolol in vasospastic vasospasm unopposed β-blockers and (except cocaine α1-agonism carvedilol for nonselective or for given cause β-antagonists toxicity pheochromocytoma labetalol) (unsubstantiated). the if αand alone saline, glucagon. Treat with overdose β-blocker atropine,

Dofetilide, Ibutilide, Antiarrhythmics— Amiodarone, Sotalol. AIDS. III) channel blockers (class potassium

 QT AP  interval. ERP,  duration, MECHANISM

ventricular uSE fibrillation, tachycardia sotalol). ClINICAl (amiodarone, Atrial atrial flutter;

calcium Diltiazem, channel Antiarrhythmics— IV) (class Verapamil blockers

 conduction • ERP, MECHANISM Velocity, PR interval. Decrease

SVT), atrial nodal fibrillation. arrhythmias in (eg, Prevention rate uSE ClINICAl of control

block, flushing, Constipation, (HF, AdvERSE cardiovascular depression). edema, AV effects node EFFECTS sinus

K+ conduction. the cells  Adenosine ICa, out hyperpolarizing decreasing of cell node   and AV of Drug choice diagnosing/terminating certain SVT. forms in of acting sec). (~ Very 15 short by theophylline (both adenosine are and Effects receptor caffeine antagonists). blunted hypotension, bronchospasm. flushing, sense effects Adverse chest impending of include doom, pain,

toxicity. and in torsades Magnesium de Effective pointes digoxin

depolarization IVabradine “funny” channels (If). slow (phase selectively prolongs MECHANISM “IV”) by sodium inhibiting

patients β-blockers. stable Chronic uSE who angina ClINICAl cannot in take Chronic HFrEF.

hypertension, bradycardia. brightness, phenomena/visual Luminous AdvERSE EFFECTS

a to pathways . autonomic nervous despair, mystical is and endocrinology the system, you an to learned of that lose “We insight, and the even in relation of have “If chemistry skew elation the a there system, and, endocrine meteorology you self.” . . behavior of glands “Chocolate moods.” Book Indulgences you Divine changing hormones —Elaine by making and to certain your of secrete Sherman, that causes happy.” endocrine astro-physics affect feelings an

in The a endocrine organs a comprises manner highly the work state distributed integrated widely that hormonal body. to within system of orchestrate equilibrium as of or classified of endocrine themselves conditions be or diseases either diseases involving overproduction, as can overproduction hormones. with speaking, underproduction be or mass development Generally associated the underproduction of lesions—which may first regulation, learning diagnosis Therefore, manifestations by integrating and disease by management. hormones, their then and study system glands, endocrine the their with the and learn Take to connections. time multisystem the

neck. arises floor Thyroid and primitive from of into pharynx descends diverticulum pyramidal of by Connected lobe as to cysts but may the thyroglossal disappears normally which tongue duct, thyroid. or persist remnant normal cecum is Foramen of duct. thyroglossal

thyroid). is tongue site common Most (lingual thyroid ectopic the tissue it the thyroid result present. only in Removal if may hypothyroidism tissue is

cleft cyst cyst an sinus or presents neck with (vs to Thyroglossal anterior leading lateral midline of neck). swallowing mass duct the in cervical that moves as A persistent protrusion pharyngeal tongue

cells derived Thyroid endoderm. follicular from

Superior surface of kidney

LH, derivatives—β-endorphin, prolactin, ACTH, FSH, and Proopiomelanocortin GH, Secretes TSH, β-endorphin. (MSH) Melanotropin and MSH. ACTH, BAM! pro with Go a from lobe pituitary. of secreted intermediate LH, PRL, ACTH, TSH, FSH, FLAT PiG: GH. Derived ectoderm (Rathke from oral pouch). ACTH, B-FLAT: LH, TSH. Basophils—FSH,

PiG: Acidophils common to subunit—hormone GH. PRL, α subunit — Acid FSH, hCG. TSH, LH, and

subunit—determines β hormone specificity. or hormone, in the via and oxytocin, both vasopressin and posterior proteins). to neurophysins paraventricular (supraoptic releases nuclei) ADH) (carrier (antidiuretic Stores pituitary made hypothalamus and transported and neuroectoderm. Derived from

and mesoderm) Adrenal crest). medulla (derived (derived from cortex neural from

Glucocorticoids CORTEX Cortisol Zona CRH ACTH, Fasciculata

CRHDHEA ACTH, Capsule

sympathetic NEChroma˜n Epi, Catecholamines Preganglionic fbers cells MEDULLA Zona Reticularis

Sex corresponds (glucocorticoids), with GFR (androgens). Salt Sugar (mineralocorticoids), and deeper go, sweeter gets.” “The the you it

Growth Protein GHRH IGF-1 stress and Cell synthesis Protein acid and uptake hypoglycemia, hormone RNA Somatostatin Aging, synthesis uptake Collagen synthesis pituitary acid sulfate Anterior size Glucose Lipolysis Amino Sleep, glucose pituitary obesity, DNA Chondroitin number uptake Posterior Amino

vasopressin. hormone called Antidiuretic Also

secreted hypothalamus stored posterior (supraoptic paraventricular in nuclei), and pituitary. Synthesized soUrce by and

(V2-receptors). osmolality Regulates serum and (V1-receptors) FUnction b1ood pressure osmolality) insertion channel via aquaporin is urine   serum (ADH function regulation cells collecting osmolality of osmolality, renal of regulation in principal serum Primary duct.

(1°); hypovolemia. osmolality regUlAtion Plasma

called somatotropin. Also by pituitary. anterior Secreted

muscle (somatomedin Stimulates secretion IGF-1 mass growth C) through and linear liver. by (diabetogenic). insulin resistance 

response pulses growth hormone–releasing (GHRH). in hormone Released in to

during CKD. puberty, deep  exercise, sleep, hypoglycemia, Secretion

secreted  somatostatin, GH to molecule in liver target response somatomedin (regulatory tissues). by glucose, by acting Secretion on

acromegaly gigantism secretion pituitary Excess or GH adenoma) may (children). of (adults) cause (eg, somatostatin (eg, Treatment: octreotide) or analogs surgery.

is DI. central  insipidus nephrogenic normal ADH level in in (DI), diabetes or 

by V2-receptor. be DI in caused mutation can Nephrogenic

a Desmopressin (ADH nocturnal for central is enuresis. treatment and DI analog)

rate. control hormones Thyroid (T3) body’s that triiodothyronine the hormones iodine-containing produces and metabolic thyroxine Thyroid (T4),

of Follicles soUrce thyroid. peripheral tissue (5, T4 product) 3). T3 thyroid converts major in to 4, (the 5′-deiodinase conversion glucocorticoids, β-blockers, is inhibited Peripheral (PTU). propylthiouracil and by T4 its by a the glucocorticoids. hormone and of metabolically byproduct growth T3 production peripheral (rT3) is increased of Reverse conversion is and inactive of Functions organification and iodine, (MIT) and of coupling oxidation, of monoiodotyrosine peroxidase include diiodotyrosine thyroid (DIT). PTU Inhibited methimazole. and by T4. = + DIT DIT MIT T3. DIT + = thyroid T3/T4 peroxidase production effect—excess turns autoregulatory (protective Wolff-Chaikoff  temporarily off effect). iodine

FUnction hormone is Only free active. with T3 than T4. nuclear binds affinity receptor greater —7B’s: functions T3

with growth (synergism GH) Bone effects. β-adrenergic contractility; HR, CO, in SV, heart β1 adrenergic β-blockers • receptors thyrotoxicosis in  alleviate symptoms

rate body Basal (via RR, temperature) Na+/K+-ATPase metabolic  activity O2 consumption, 

⊕ • ⊕ follicular (• regUlAtion cells. sugar gluconeogenesis) glycogenolysis, release TSH TRH Blood cells disease. in immunoglobulin follicular may Thyroid-stimulating (TSI) Graves ⊕ free primarily by Negative T3/T4: feedback

pituitary  Anterior TRH sensitivity to

Thyroxine-binding globulin in (TBG) most T3/T4 blood. binds T3/T4 = inactive. Bound • steroid  • syndrome total OCP in nephrotic TBG TBG) (estrogen T3/T4  use in   TBG pregnancy, use,

TSI T3, T4

TG I2 T4 Endocytosis T3 soUrce Oxidation PTU, MIT circulation) TG Thyroid TG + T3 T4 of thyroid I– Thyroglobulin I– Tyrosine Downstream > T4 T4 T3 DITDIT MIT TG Organifcation parathyroid TG DIT T3 MIT, (to Deiodinase MIT T3 DIT methimazole DIT Chief PTU Thyroid reaction cells Coupling peroxidase Proteases5'-deiodinase peroxidase Na+ DITMIT function

blood the activating Ca2+ to PCT in function) 1α-hydroxylase free production in by 1,25-(OH)2D3 FUnction  D3 (calcitriol) make PCT (1° Tri in the

urine  PTH PO43– PO43–, urine Ca2+,  , serum  cAMP serum 

Intestines D3 3–˜ and Ca2+ and inhibition ˜ precursors synthesis3 D3 and D or Ca2+ secretion 3–  causes RANK-L and lung, diarrhea, serum of PO PTH osteoclasts to Four Mg2+ PO4 ˜ Ca2+, 3– in the ˜ cells PO4 released Vitamin tubular D Reabsorption: 25-OH , Ca2+ 1,25-(OH)2 commonly  stimulate , osteocytes; ˜ ionized squamous increased  absorption (eg, osteoclasts Urine alcohol PTH ˜ 1,25-(OH)2 ˜ 1,25-(OH)2 , malignancies cell binds PTH activity 3–˜ • Renal their PTH ˜ bone Bone osteoblasts of 1,25-(OH)2 Mg2+ secreted and 1˜-hydroxylase PO4 include PO4 renal Ca2+ glandsFeedback D from circulation cell Common of (receptor carcinoma ˜ carcinoma) and of Ca2+ and PO4 3– para-thyroid serum ˜  RANK ˜ ligand) released abuse ˜ Ca2+ NF-κB on by secretion into ˛ ˜ of Ca2+ like (receptor) 3– is Mg2+ synthesis activator PO4 3– and diuretics, aminoglycosides, D3 PTH

forms: Calcium three Ca2+ Plasma exists in homeostasis

active Ionized/free form) (~ 45%,

to Bound albumin (∼ 40%)

(∼ pH Ca2+ • to  (less more 15%) spasm) H+) (eg, Ca2+ ionized carpopedal • cramps, pain, binds Bound PTH albumin anions paresthesias,

1° PTH; thyroid. cells) (C PTH Ionized/free of changes albumin is changes of cells not in in regulator Parafollicular concentration secretion, soUrce whereas do Ca2+ alter pH of PTH. opposes actions Calcitonin Ca2+ important Not in homeostasis normal

bone of resorption FUnction Ca2+. 

calcitonin  secretion. regUlAtion tones serum and • Ca2+ serum down Calcitonin levels Ca2+

α cells Made soUrce pancreas. by of

glycogenolysis, lipolysis, FUnction ketogenesis. Promotes gluconeogenesis, too glucose low sugar bloodstream fasting homeostasis to levels blood levels fall state). (ie, Elevates when maintain

response to Secreted regUlAtion in hypoglycemia. hyperglycemia, by Inhibited insulin, somatostatin.

secretory proinsulin  of of Preproinsulin RER in insulin granules) C-peptide  exocytosis and β (synthesized “presignal” (stored of in of pancreatic cleavage equally.  • cells) synthesis cleavage proinsulin in and C-peptide. insulin  Insulin lacks sulfonylurea whereas insulinoma C-peptide are use, exogenous and

the regulator major Glucose of regUlAtion insulin release. is [GLP-1], which polypeptide to β sensitivity response incretins (eg, 1 glucose-dependent glucagon-like insulin due insulinotropic released with IV cell [GIP]), to peptide oral vs and meals glucose. are after glucose •  channels by Release .  insulin) by  regulates (target = K+ α2, sulfonylureas) stimulation (2 of β2 closes channels insulin and exocytosis Ca2+ Voltage-gated open stimulation of

pathway transport) synthesis ), growth, Cell tissue transcription. gene protein DNAGlycogen, RAS/MAPkinasepathwayVesicles Tyrosine and lipid, containing insulin-dependent glucose GLUT4 synthesis uptake inducing into (carriermediated phosphorylationPhosphoinositide-3 kinase

cellular • glucagon synthesis insulin: protein  effects  transport tissue (muscles) • retention  release • triglyceride adipose  • lipolysis adipose • Anabolic and and glucose    • of tissue and amino acids storage synthesis Na+ glycogen of • K+ synthesis  muscle in in uptake • skeletal (kidneys)

glucose, does cross Unlike placenta. insulin not

Insulin-independent transporters: tissue, Insulin-dependent can glucose also • GLUT4 (exercise striated adipose transporters: muscle GLUT4: expression) •

cornea, brain, RBCs, GLUT1: placenta

cells, liver, islet GI GLUT2 β 2-way (bidirectional): (think kidney, street) tract

GLUT3: brain, placenta

GI GLUT5 tract (Fructose): spermatocytes,

kidney, (Na+-glucose SGLT1/SGLT2 small intestine cotransporters):

ketone starvation. glucose, but Brain bodies use may prefers during for glucose, aerobic they metabolism. utilize mitochondria lack as RBCs

Brain, Spermatocytes. cells, (insulin-independent Placenta, Kidney, Intestine, glucose BRICK LIPS (β) RBCs, Cornea, Islet uptake): Liver,

ZONA cortex Peripheral II 21-hydroxylation Cortisol Estradiol Androgens Glucocorticoids Dihydrotestosterone StARa) Androstenedione 11-deoxycortisol exemestane 11˜-hydroxylation 17,20-lyase17°-hydroxylase Cholesterol desmolase Finasteride Estrogens, dehydrogenase 3˜-hydroxysteroid (DHEA) ZONA Progesterone synthase 17,20-lyase 17-hydroxyprogesterone Aldosterone Cortisone ZONA (via acid step. Testosterone 17-hydroxypregnenolone Pregnenolone RETICULARIS aRate-limiting FASCICULATA GLOMERULOSA DHT Aromatase (DHT) Dehydroepiandrosterone Estrone 11-deoxycorticosterone 5°-reductase Aldosterone Anastrozole, letrozole, tissue Glycyrrhetinic Aromatase AMetyrapone Adrenal Mineralocorticoids Corticosterone Angiotensin Cholesterol 17°-hydroxylase

hypertension) renin bilateral infancy autosomal and XY: are MSH  Most testes BP) stimulation). ACTH) aAll XX: which 17-hydroxy-progesterone or gland by enzyme 17α-hydroxylasea hyperpigmentation (due in • adrenal to aldosterone activity  in   21-hydroxylasea congenital lacks ambiguous enlargement  (salt ACTH genitalia, adrenal (severe and XX: recessive coproduced infancy with characterized sexual  or are XX: undescended (results (precocious virilization (precocious puberty) common androstenedione skin production, virilization puberty) wasting) secreted childhood most is 11β-hydroxylasea Presents development 2° renin to Presents deficiencies  11-deoxycorti-costerone activity (due in and childhood disorders

virilization in If enzyme 1, 1, causes if females. with with deficient hypertension; deficient ends it causes it starts enzyme

Ghrelin GH (orexigenic secretagog hunger GH release and (via effect) Stimulates receptor). Produced by stomach. or fasting, production. Prader-Willi deprivation, Sleep  syndrome ghrelin ghrow. makes and you Ghrelin hunghre Acts of • lateral (hunger appetite. to on area hypothalamus center)

Leptin Satiety hormone. by adipose tissue. Produced gene obesity.  of leptin Mutation central tissue due adipose also effect.) to appear leptin’s to but  anorexigenic resistant have (Obese people leptin  deprivation starvation leptin or production. • Sleep keeps Leptin you thin. Acts  (satiety appetite. on center) to ventromedial area hypothalamus of

• hypothalamus Endocannabinoids intake cannabinoid hedonic accumbens, Act homeostatic food areas receptors control nucleus in two and appetite. at the of and for key brain munchies.” cannabinoids Exogenous “the cause

of Signaling pathways hormones endocrine

of hormones steroid Signaling pathways

to Binding receptor

solubility. binding bound globulins, and to their are  which must hormones therefore Steroid circulate specific lipophilic

(SHBG) men, In testosterone hormone–binding gynecomastia.  globulin sex lowers free raises free women, SHBG In hirsutism.  testosterone

OCPs, (eg, SHBG.  pregnancy) estrogen

inappropriate secretion hormone Syndrome antidiuretic of

by: Characterized

continued Euvolemic with excretion hyponatremia urinary Na+

Na+ osmolality normalization with responds and water  and hyponatremia. retention secretion fluid of osmolality • BNP urinary  extracellular ANP euvolemic Urine to >  Body serum aldosterone volume lead low cerebral Very to Na+ levels seizures. edema, serum can to Correct prevent (formerly central demyelination syndrome called osmotic slowly myelinolysis). pontine

SIADH causes include:

small Ectopic (eg, lung cell ADH cancer)

Drugs SSRIs, carbamazepine, cyclophosphamide) (eg,

saline, tolvaptan, line), fluid conivaptan, antagonists (first (eg, diuretics, restriction tablets, hypertonic Treatment: ADH salt IV demeclocycline).

2–3 plasma for and hourly of intake aNo well concentration urine osmolality by measurements hr and Na+ volume water followed osmolality. as as plasma despite osmolality analog mEq/L, 295–300 > serum Na+ ≥ administered rising does not or osmolality mOsm/kg, is 145 osmolality. plasma (desmopressin) urine a rise ADH if

Undersecretion of hormones due Hypopituitarism to: pituitary

adenoma, pituitary Nonsecreting craniopharyngioma

syndrome—ischemic to pituitary postpartum bleeding; pregnancy-induced hypoperfusion. susceptibility following  Sheehan of infarct pituitary growth lactate, with intolerance Usually to menstruation, cold failure presents absent

lies in intracranial or often idiopathic of women; the obese hypertension associated sella common with turcica), (which Empty syndrome—atrophy idiopathic, compression in sella pituitary

often of pituitary Pituitary adenoma. an in existing gland, pituitary apoplexy—sudden of the presence hemorrhage headache, hypopituitarism features with severe presents hemianopia, visual (eg, and bitemporal Usually III of onset impairment to due palsy), diplopia CN sudden

sex therapy thyroxine, hormone growth human hormone) (corticosteroids, replacement steroids, Treatment:

Excess in Acromegaly GH adults. Typically caused pituitary by adenoma.

and voice, GH large coarsening of deep hands facial gigantism ( bone furrows, tongue deep Large in  feet, children growth). Findings linear  with common of HF death. cause most with features aging

, tolerance diaphoresis resistance), (insulin impaired A glucose sweating), hypertension. frontal (excessive bossing, colorectal cancer. of risk polyps and 

to glucose  failure following pituitary diAgnosis IGF-1; mass MRI. GH suppress serum serum on tolerance brain oral seen test;

adenoma Pituitary treAtment resection. If receptor (GH agonists not treat (somatostatin dopamine pegvisomant (eg, cured, cabergoline). octreotide analog), antagonist), or with

( facies to  of (myxedema) basal nails; sKin/hAir fine  intolerance, interstitial skin  (due A metabolic to retention edema vasodilation); synthesis Heat sweating, in osmotic  metAbolic Cold hair; (due diffuse );  metabolic and Graves alopecia; brittle water puffy GAGs myxedema sweating, ( ( pressure • calorigenesis) generalized coarse, rate in due calorigenesis), clearance) intolerance, pretibial  free to disease weight hyponatremia • hair; cool basal rate Dry, onycholysis water Warm, weight nonpitting Na+-K+ blood brittle spaces ATPase • gain ( moist skin flow); loss

to Wolff-Chaikoff effect downregulation iodide). goiter (with causes • ), deficiency lithium), response gland amiodarone, E Other (eg, Iodine (thyroid goitrogens in

hyperthyroidism. of Most Graves cause disease common myxedema), receptors orbitopathy). diffuse (IgG, fibroblasts immunoglobulin and stimulates type II orbital cause (hyperthyroidism, neonatal transient Thyroid-stimulating (Graves hypersensitivity) on fibroblasts (pretibial hyperthyroidism; can thyroid dermal TSH goiter), exophthalmos hydrophilic muscle . (eg, of GAGs and of infiltration  • fibroblast lymphocytic inflammation, secretion osmotic count of muscle retroorbital IFN-γ) swelling, T-cells  space TNF-α,  Activation adipocyte  cytokines A pregnancy). during presents Often (eg, stress HLA-B8. with and Associated HLA-DR3

epithelial Histology: scalloped cells; follicular crowded tall, colloid.

Focal (due of with TSH follicular distended patches goiter independently in cases). to of TSH of Toxic multinodular 60% receptor colloid hyperfunctioning cells mutations working  T3 T4. of release and Hot nodules rarely malignant. are

is the trauma, hyperthyroidism in surgery. of such acute as stress untreated but setting when treated/ incompletely that and then Uncommon serious occurs significantly worsens Thyroid infection, storm complication coma, delirium, (cause fever, and diarrhea, death). agitation, tachyarrhythmia with Presents of May  see LFTs. Propranolol), 4 (eg, Prednisolone), with Potassium iodide iodine). (eg, corticosteroids Treat the β-blockers (Lugol Propylthiouracil, P’s: Wolff-Chaikoff T4 Iodide  effect. synthesis load 

hyperthyroidism. Jod-Basedow Iodine-induced autonomous tissue nodule) (eg, is iodine a with partially made and patient thyroid autonomous when replete. Occurs phenomenon iodine deficiency use. happen IV amiodarone after or iodine contrast Can to effect. Wolff-Chaikoff Opposite

Hashimoto deficiency, of disease, TSH-secreting pituitary Smooth/diffuse: goiter iodine Graves adenoma. Causes thyroiditis, thyroid thyroid thyroid toxic goiter, adenoma, multinodular Nodular: cyst. cancer,

Benign thyroid. solitary adenoma growth the Thyroid of thyroid are Most or nonfunctional “toxic”). production autonomous can (“hot” (“cold”), rarely hyperthyroidism cause via hormone Most common in vascular (arrows ); A of invasion absence carcinoma). is (unlike follicular capsular or histology follicular

with cancer fine treated with aspiration; needle Thyroid thyroidectomy. Typically diagnosed during nerve of loss external pedicle glands), of of branch inferior to and of of superior laryngeal dysphonia noticeable surgery lead vascular (due [hoarseness]), (leads injury thyroid Complications include parathyroid during ligation ligation of voice users). of artery to recurrent superior the professional usually in (may and laryngeal thyroid to removal hypocalcemia the nerve dysphagia tenor transection to

carcinoma prognosis. excellent Most Papillary common, with clearing , (“Orphan Moma eyes) and central bodies, Empty-appearing A grooves adopted nuclear OrphanAnnie). (Papi nuclei psamMoma Annie”

childhood mutations,  irradiation. with RET/PTC risk and rearrangements BRAF Papillary Prevalent, most Palpable lymph nodes. carcinoma: Good prognosis.

prognosis. Good carcinoma Follicular hematogenous common. is follicular uniform vasculature thyroid and Invades capsule follicles; adenoma), (unlike spread RAS PAX8-PPAR-γ with Associated translocations. mutation and

“C of amyloid (stains stroma cells”; produces Medullary polygonal in cells parafollicular carcinoma Congo red). sheets with From calcitonin, B an and MEN Associated 2A with (RET 2B mutations).

Undifferentiated/ carcinoma rapidly enlarging with anaplastic symptoms Older dysphagia, very hoarseness); presents dyspnea, neck  prognosis. patients; poor mass (eg, compressive with TP53 Associated mutation.

° intake, chronic disease) Ca2+ Ca2+ adenoma, cancer, vitamin autoimmune) kidney D) intake, resection, (excess (vitamin ˜ D carcinoma) 1° (hyperplasia, PTH-independent (surgical hypercalcemia defciency, hypoparathyroidism

or parathyroid destruction, supply syndrome. blood (usually during glands autoimmune injury to Due surgery), to their DiGeorge or Findings: hypocalcemia, tetany, hyperphosphatemia. Chvostek sign—tapping (tap contraction Cheek) facial facial muscles.  the of nerve of spasm. brachial sign—occlusion Triceps) the of  (cuff carpal with Trousseau BP artery cuff

Pseudohypoparathyroidism type mutations transmitted 1A—autosomal gene). maternally (imprinted GNAS dominant, resistance the that when its receptor and PTH. binds cyclase to α subunit   adenylate GNAS1-inactivating bone) PTH (coupled encodes receptor) end-organ to to protein mutation PTH Gs (kidney of inactivation developmental hereditary (shortened round face, short subcutaneous delay). 4th/5th , Physical A findings: osteodystrophy Albright calcifications, stature, digits PO43–. Ca2+,  Labs:  • PTH,

without renal maternal mutations to due to (imprinted GNAS maintaining PTH. gene) paternally but normal Pseudopseudohypoparathyroidism—autosomal transmitted resistance to PTH end-organ allele responsiveness dominant,

Albright hereditary as osteodystrophy. findings: same Physical normal Labs: PTH, Ca2+, PO43–.

Usually parathyroid hyperplasia. due to adenoma or hypercalciuria cAMP. urinary (thrones), polyuria  ALP,  hypophosphatemia, Hypercalcemia, PTH, (renal stones),  often asymptomatic. Most (“psychiatric bone pain abdominal/flank May overtones”). acute neuropsychiatric (“groans”), pain, (kidney with stones, disturbances pancreatitis), constipation weakness, present

consisting from causes tumor” spaces fibrosa deposited osteoclasts with of A fibrous hemorrhages; tissue bone filled bone (“brown hemosiderin Osteitis pain). brown cystica—cystic and Due also associated  with seen (but with hyperparathyroidism. 2°) 1° to PTH, classically

psychiatric and “Stones, thrones, bones, groans, overtones.”

(type polyuria, 2). AcUte DKA loss, Polydipsia, mAniFestAtions (type weight polyphagia, state hyperglycemic 1), hyperosmolar by of can epinephrine. and Rarely, caused be GH secretion unopposed on Also therapy (steroid seen glucocorticoid diabetes). in patients

chronic glycation: Nonenzymatic comPlicAtions

retinopathy thickening Small vessel of (hemorrhage, nephropathy. vessel glaucoma, basement (diffuse proliferation), microaneurysms, disease exudates,  membrane) arteriolosclerosis ARBs  renoprotective) • kidney proteinuria progressive (causing Nodular ACE (initially and glomerulosclerosis inhibitors and microalbuminuria; chronic are disease. hypertension)

vessel vascular limb gangrene Large peripheral cerebrovascular CAD, disease, atherosclerosis, disease. occlusive  loss, most of death. common cause MI

accumulation sorbitol absent reductase in damage  (sorbitol with aldose dehydrogenase): and or organs Osmotic

and (motor, sensory degeneration). autonomic [glove distribution], and stocking Neuropathy

Cataracts.

fatty Vomiting Hyperglycemia, Hyperventilation, of plasma glycosuria plasma acids water, ˜ tissue lipolysis serum ˛ mass, uptake and K+˛ Osmotic ˛ proteolysis glycogenolysis weight osmolality ˛˛ Coma/death Circulation Kussmaul gap perfusion respiration ketogenesis, thirst ketonemia, ˛ lactate Na+, acidosis loss metabolic Hypovolemia failure, gluconeogenesis ketonuria muscle glucose ˛ Anion tissue ˛ diuresis ˛ Loss ˜ ˛ free

complications). ketones (• ketoacidosis present Diabetic absent, Insulin   fat (eg, > from  bodies (β-hydroxybutyrate acetoacetate). • ketone  ketogenesis requirements breakdown acids infection) free and stress fatty excess or from • noncompliance Insulin

mucormycosis, comPlicAtions Life-threatening HF. edema, cerebral arrhythmias, cardiac

stores) IV fluids, treAtment intracellular to hypoglycemia. K+ +/– (to replete insulin, prevent glucose IV

and if death Can to untreated. comPlicAtions progress coma

IV treAtment (to stores). and intracellular K+ IV insulin, fluids, replete

cortisol of etiology  causes: due a to variety

bilateral  adrenal  corticosteroids Exogenous ACTH atrophy. cause. Most common

gland. adenoma, atrophy carcinoma of  or ACTH adrenal Primary uninvolved  hyperplasia, adrenal

(eg, adrenal disease); bilateral cell secretion bronchial paraneoplastic (Cushing ACTH hyperplasia. cancer, adenoma pituitary ACTH-secreting carcinoids) small lung of responsible of syndrome. for Cushing disease cases Cushing majority is the endogenous

Neoplasm Growth finding), (hyperglycemia, (a A cortisol, retardation free Syndrome: Skin • cause, CUSHING resistance). changes a (thinning, striae Findings (in Hypertension, not Cholesterol, Immunosuppression, ), Sugar • Urinary children), • insulin  buffalo B (truncal hump, facies moon osteoporosis, hirsutism. weight obesity), amenorrhea, Also, ,

cortisol tests urinalysis, low-dose salivary diAgnosis  dexamethasone include:  Screening free test. late cortisol, overnight no 24-hr on with suppression night and

(consider dexamethasone on to free inadequate urine cortisol, night test 1 suppression confrm) and/or 24-hr adrenal ˜ salivary CT late overnight mg cortisol, ˜

the chest/abdomen/pelvis MRI of the CT CT of chest/abdomen/pelvis pituitary of the

Cushing adrenalectomy refractory ACTH for after bitemporal syndrome bilateral mass pituitary adenoma of ACTH–secreting disease (hyperpigmentation), Enlargement effect Nelson pre-existing  hemianopia). (headaches, pituitary irradiation resection, Treatment: transsphenoidal tumor. for residual postoperative

needs. insufficiency the of glands adrenal enough to mineralocorticoids generate Inability Adrenal +/− body’s for glucocorticoids GI Symptoms loss, muscle include salt fatigue, weakness, hypotension, and/or orthostatic aches, weight sugar cravings. disturbances, Treatment: glucocorticoid/mineralocorticoid replacement.

↑↑ACTH cortisol ↑ conversion ↓↓11-deoxycortisol or Metyrapone test 2°/3° 11-deoxycortisol adrenal ↓ 2°/3° or insu˜ciency Indeterminate ↓AM results to ↓ stimulation ↑↑ACTH insu˜ciency adrenal or ACTH to ↓ stimulation cortisol ↑↑11-deoxycortisol insu˜ciency 1° serum cortisol) insu˜ciency AM Measure test random ACTH Normal ↓11-deoxycortisol ACTH ACTH stimulation ( cortisol peak or test 1° random ACTH Check cortisol, random cortisol, with ↓/−/↑ACTH of adrenal response adrenal

Most < the tumor of medulla children, common adrenal years old. usually in 4 crest cells. from Neural Originates along chain. the Occurs anywhere sympathetic

and irregular can and the smooth mass is midline common Most distension cross that presentation which unilateral). (vs firm, a tumor, Wilms abdominal is likely pheochromocytoma Less develop with than (Neuroblastoma hypertension to Normotensive). is present feet”). (“dancing also with syndrome Can eyes-dancing opsoclonus-myoclonus

VMA and HVA in urine. • (catecholamine metabolites) medulloblastoma. of neuroblastoma and ) central surrounding rosettes lumen (neuroblasts A Homer-Wright characteristic a NSE Bombesin and ⊕. N-myc with amplification oncogene. of Associated

with chromosome insulinomas, or Pituitary Associated suppressor, tumors a MEN of mutation adenomas endocrine angiofibromas, MEN1 collagenomas, tumor (prolactin Pancreatic (menin, glucagonomas GH) syndrome, Parathyroid (rare) 1 VIPomas, tumors—Zollinger-Ellison 11), meningiomas

tyrosine calcitonin; kinase) cells; parafollicular mutation prophylactic C with 2A required Pheochromocytoma MEN catecholamines) receptor thyroid Medullary carcinoma—neoplasm Associated of in (secretes RET (codes secretes thyroidectomy Parathyroid hyperplasia for

in gene habitus; mutation with Associated marfanoid RET

MEN and Pituitary, 1 P’s: Pancreas 3 Parathyroid, =

Parathyroid Pheochromocytoma P’s: MEN and 2A = 2

Pheochromocytoma P: MEN 1 2B =

Insulinoma insulin • pancreatic hypoglycemia.  cells of Tumor overproduction β of Whipple diplopia), low of hypoglycemia of resolution glucose lethargy, levels. symptoms plasma and symptoms May of glucose, blood after syncope, triad: normalization (eg, see levels patients exogenous • Symptomatic C-peptide insulin  use). and glucose (vs blood have cases syndrome. 1 with ∼ MEN associated 10% of Treatment: surgical resection.

glucagon. of of α Glucagonoma cells pancreatic Tumor  overproduction migratory D’s: DVT, Presents Diabetes (necrolytic 6 with weight, Declining Diarrhea. Dermatitis (hyperglycemia), erythema), Depression, surgical resection. Treatment: octreotide,

glucagon, δ cells Tumor insulin, overproduction somatostatin pancreatic inhibitory of peptide secretin, gastric of cholecystokinin,  Somatostatinoma of  secretion (GIP). gastrin, intolerance, achlorhydria. with gallstones, steatorrhea, May diabetes/glucose present octreotide) somatostatin symptom surgical Treatment: (eg, control. for resection; analogs

the most intestine tumors commonly from in Carcinoid arise or cells neuroendocrine lung. the is if not Rare occur limited to tumor GI does and tract. Prominent A chromogranin A ), in rosettes and (arrow synaptophysin ⊕). ⊕ heart pulmonic (pellagra). diarrhea, secrete Neuroendocrine 5-HT niacin stenosis), cells regurgitation, right-sided wheezing, deficiency recurrent → (eg, valvular tricuspid disease first-pass MAO the and enzymatic lung. undergoes breakdown metabolism 5-HT hepatic by in control. octreotide, resection, Treatment: somatostatin telotristat) for symptom analog surgical (eg,

2nd malignancy 1/3 Rule multiple with metastasize 1/3 present are of thirds: 1/3

Lispro, Aspart, protein lipodystrophy, hypersensitivity as storage Hypoglycemia, Glulisine glucose acting (tyrosine glycogen (1-hr Rapid gain LAG) glycogen,  synthesis (rare), peak):  reactions kinase receptor insulin weight (no Bind Muscle: Liver: activity)

  acting TG NPH hr hr regular Cell (4–10 peak): acting (2–3 Intermediate storage uptake peak): Fat: Short K+ membrane:

(no detemir, glargine Long acting real peak):

Lispro, Regular Glargine NPH glulisine aspart, Detemir

Chlorpropamide, tolbutamide

glyburide Glipizide,

Nateglinide, “-gliNs” Meglitinides

 membrane depolarizes channels in cell influx. pancreatic release via Ca2+ cell Close B K+ •  insulin

DisulFIRam-like (FIRst-generation reaction only).

used. Rarely

risk weight gain. Hypoglycemia renal ( insufficiency), in

• analogs glucagon emptying. gastric  release, Amylin nausea. Hypoglycemia, (often  satiety desired). Pramlintide

Propylthiouracil, Thionamides methimazole.

 inhibiting peroxidase, oxidation mechAnism thyroid the Block as and iodide as hormone iodine well thyroid of synthesis. of coupling organification the inhibition of blocks 5′-deiodinase also T3. PTU to of T4 Peripheral • conversion

clinicAl Hyperthyroidism. Use of methimazole and PTU second first risk in trimester to (due in of used pregnancy of teratogenicity); pregnancy (due hepatotoxicity). third PTU-induced to used methimazole trimesters ophthalmopathy corticosteroids). Not to (treated treat used with Graves

hepatotoxicity. eFFects (rare), Skin anemia, rash, aplastic AdVerse agranulocytosis teratogen cause possible Methimazole a aplasia (can is cutis).

Levothyroxine, Hormone T4 for (levothyroxine) mechAnism (liothyronine). liothyronine T3 replacement or

Hypothyroidism, myxedema. clinicAl Use loss. May for weight be abused from receptor blood flow a TSH hyperthyroidism ultrasound. combination and/or on exogenous endogenous measurement antibodies, hyperthyroidism Distinguish of by of thyroid radioactive using uptake, iodine

AdVerse eFFects intolerance, Tachycardia, heat tremors, arrhythmias.

mechAnism with effects. aldosterone little analog Synthetic glucocorticoid of

Mineralocorticoid Use adrenal in clinicAl 1° insufficiency. replacement

heart also glucocorticoids; Similar exacerbation edema, AdVerse failure, of hyperpigmentation. eFFects to

• receptor Ca2+ PTH. mechAnism circulating to gland parathyroid in Sensitizes (CaSR) Ca2+-sensing

parathyroid hemodialysis, 2° (if in carcinoma. in hyperparathyroidism or fails), with 1° patients Use hypercalcemia clinicAl CKD parathyroidectomy in receiving hyperparathyroidism

Hypocalcemia. AdVerse eFFects

phosphate Nonabsorbable GI that tract. absorption from mechAnism prevents phosphate binder the

CKD. Use in clinicAl Hyperphosphatemia

GI eFFects Hypophosphatemia, AdVerse upset.

“Man relaxed more than not the quantity to is of set good “All man any a “A all life.” right, panic. his of worth let’s strive to intestines his have should bowels of days brains.” selling by the one money I’ll make of livers. my with one.” I can by get

understand anatomy, and studying pathologic is the various and When sure be embryology, affected system, it the diseases. gastrointestinal how the physiology in to normal not disease entails, its findings, two Study only between similar differentiate what specific so a but also you can diseases. that makes disease? specifically example, what For ulcerative different Crohn colitis than understand bile process. or to decrease important is depending on and increase the it values Also, lab which disease metabolism scans, images. basic of comfortable endoscopic Be CT abdominal and with x-rays, interpretation

omphalocele, gastroschisis), (eg, caudal defects lateral wall cordis]), (eg, fold Ventral or exstrophy). (eg, bladder [ectopia to fold defects fold of failure Developmental sternal closure rostral closure defects due closure

umbilical Failure the close Congenital of after ring umbilical of midgut. physiologic herniation to close usually spontaneously. defects Small hernia

Tracheoesophageal anomalies to common fistula fetus is utero to fluid). of atresia (due amniotic swallow (TEF) (85%) often Esophageal (EA) and in polyhydramnios with inability distal most tracheoesophageal the presents as and feeding. choke, first vomit drool, Neonates with on TEFs (visible allow stomach air CXR). to enter laryngospasm reflux-related avoid Cyanosis aspiration). to (to 2° is tube test: to stomach. failure into nasogastric Clinical pass letter fistula EA, CXR H-type, pure gasless shows In resembles the In the abdomen. H.

Intestinal vomiting life. days first of Presents within with distension atresia 1–2 and bilious abdominal Duodenal to recanalize. atresia—failure duodenum). x-ray A proximal stomach, “double Abdominal (dilated shows bubble” syndrome. with Associated Down necrosis segmental (typically of  SMA) bowel of vessels atresia—disruption intestine mesenteric becomes ischemic fetal Jejunal discontinuous.  ileal and resorption: bowel levels. dilated loops with air-fluid small of X-ray shows

gastric cause Most (1:600). obstruction outlet of infants common in 2–6 ∼ peristaltic old. in visible projectile and Palpable region, mass weeks olive-shaped nonbilious epigastric at vomiting waves, with males; to common More in exposure macrolides. firstborn associated

Results volume hypokalemic (2° contraction). in alkalosis subsequent acid hypochloremic gastric of metabolic and to vomiting

thickened shows Ultrasound A pylorus and lengthened .

pyloric surgical of Treatment: muscles incision (pyloromyotomy).

peritoneal of) posterior A Retroperitoneal the structures structures cavity. are Retroperitoneal to outside (and retroperitoneal to structures or in accumulation space. retroperitoneal blood gas Injuries cause can

[not Colon (partially) shown] [not (adrenal) [not SAD Aorta through Duodenum (thoracic Suprarenal tail) (except (2nd and Rectum Esophagus shown] IVC glands [not and ascending) PUCKER: (descending 4th Pancreas Kidneys Ureters portion) shown] shown] parts)

foramen foramen Omental (epiploic of Winslow)

patent mesentery wall hepatis veins (derivative to paraumbilical umbilical Ligamentum of Liver vein), abdominal ligament teres fetal anterior Falciform ventral Derivative of

triad: ligament common portal vein, to artery, Hepatoduodenal duct Portal hepatic proper Liver duodenum bile

of a from vascular maneuver—ligament omental compressed bleeding in Derivative to foramen with ventral mesentery is hepatic or Pringle clamp inflow control source manually

sacs lesser connects omental which foramen, and greater the the Borders

omentum Part lesser of

Esophagus Nonkeratinized stratified epithelium. squamous striated middle transition. at the with some smooth Upper lower 2/3 and muscle; 1/3, overlap muscle,

plicae aggregates submucosa), in (arrow Peyer of propria, circulares ; D (proximal and ileum), patches Lieberkühn. Ileum in crypts lymphoid lamina small intestine. of in number goblet the Largest cells

of Crypts with E goblet villi . Lieberkühn Colon but no cells, abundant

anteriorly. structures GI branch are single supplying Arteries and

structures and paired branch laterally non-GI Arteries posteriorly. are supplying and

in from blood regions”) colonic of have areas distal ischemia: susceptible arterial dual the  supply Two branches (“watershed colon

artery from Rectosigmoid IMA the arterial superior rectal last and junction—the branch sigmoid

artery vein superior aorta. of mesenteric Nutcracker renal left and between syndrome—compression (from abdominal gross by Characterized varicosities). of pain rupture renal (flank) and thin-walled hematuria

SMA intermittent Superior of portion characterized pain) postprandial by compress duodenum. when symptoms mesenteric (third) syndrome— intestinal obstruction (primarily and transverse aorta artery (eg, in weight/malnutrition). mesenteric occurs body with associated fat conditions Typically diminished low

of Celiac trunk: left splenic, celiac gastric. trunk and Branches common hepatic, constitute of the the blood supply foregut. These main Strong anastomoses exist between:

re-establishing HTN portal normal blood TIPS, Flow through direction in fow Pathologic

commonly butt, portal caput and Varicesof are gut, (medusae) with seen hypertension.

the portosystemic the liver. with between portal hepatic to hypertension relieves shunt systemic vein bypassing circulation, (TIPS) by Treatment a portal transjugular blood vein and intrahepatic the shunting  TIPS of to ammonia shunting. hepatic precipitate encephalopathy due from can clearance

Pectinate Also called dentate line. line Formed ectoderm. meets (hindgut) endoderm where

pectinate adenocarcinoma. hemorrhoids, Above line: internal

not receive innervation and painful. therefore visceral Internal hemorrhoids are

pectinate squamous Below carcinoma. fissures, external anal line: cell hemorrhoids,

receive (inferior hemorrhoids innervation pudendal if somatic painful and therefore thrombosed. branch External nerve) are rectal of

line. fissure—tear mucosa anal below Pectinate Anal in on while toilet blood Pooping; Pain Paper. this Located Posteriorly because is Poorly area Perfused. Pudendal nerve. Innervated by diets with Associated low-fiber constipation. and

up the on arranged lobules made the vein with as unit vein, bile of portal lymphatics) functional The (consisting liver . ducts, edges of is triads hexagonally the well artery, A hepatic portal as central surrounding a of

canaliculi. faces of Apical bile hepatocytes surface faces Basolateral sinusoids. surface

in damaged ; clear (black or macrophages) yellow and sinusoids RBCs. B located arrows hepatic show senescent (specialized bacteria Kupffer cells venule) in arrows

produce vitamin of quiescent) matrix store (Ito) in cells A Hepatic (when extracellular (when stellate activated). and space Disse Responsible hepatic fibrosis. for

hepatic artery of Branch

vein portal Branch of

Zone I—periportal zone:

compromise to circulatory oxygenated, Best resistant most

cocaine) (eg, II—intermediate Ingested toxins Zone zone:

Zone (centrilobular) Yellow vein zone: III—pericentral fever

concentration of cytochrome High P-450

ethanol, (eg, Most toxins CCl4, rifampin, metabolic halothane, to sensitive acetaminophen)

Site alcoholic hepatitis of

cell Disse Space Stellate of

ampulla and both cholangitis and the reach sign), bile pancreatic the (double duct ducts common common ducts of bile of causing that Gallstones and Vater confluence pancreatic pancreatitis, at respectively. block the the both can

painless (Courvoisier pancreas can obstruction duct ductal enlarged gallbladder  adenocarcinoma) jaundice that Tumors cause sign). common with of arise (usually of bile in head

(blue duct gallbladder Cholangiography shows defects A cystic in . and arrow) (red arrow) filling

Femoral cm Fascial tube ligament. below inguinal 3–4 sheath inguinal femoral not nodes) but artery, vein, and (deep Contains nerve. femoral canal lymph

muscle oblique of Aponeurosis external

transversalis ring fascia of inguinal Genital deferens branch genitofemoral Ductus (vas) Internal (deep) of Evagination

weakness. Hernias of peritoneum a of usually opening, through Protrusion an at site be for at and (not Contents (ischemia reducible and back abdomen/pelvis) necrosis). risk may strangulation incarceration into with can Complicated present tenderness, erythema, fever. hernias

(Hesselbach) hernia inguinal triangle. Direct Protrudes inguinal through lateral parietal peritoneum vessels but abdominis. inferior rectus directly epigastric medial to through Bulges to the the through (superficial) only. external Goes ring inguinal fascia. by Covered external spermatic weakness older due occurs acquired of in Usually men to transversalis fascia. Direct don’t = epigastric hernia. inferior MDs LIe: to Medial vessels epigastric vessels Indirect Lateral inferior = hernia. to

ligament hernia Femoral tubercle. and below to canal pubic Protrudes below through lateral femoral inguinal hernias females, common. are most inguinal the More but common overall in present with incarceration inguinal or strangulation More (vs likely to hernia).

the due of membrane from structures defect thorax or occur congenital to pleuroperitoneal trauma. ; A Abdominal enter may right side to left relative on protection hemidiaphragm occurs of Commonly due liver. by of a hiatal commonly hiatus the Most the which stomach hernia, in diaphragm. through upward esophageal herniates

as hernia—gastroesophageal hiatal hiatus; cardia into is gastric junction Most type. displaced common Sliding upward stomach.” fundus “hourglass gastric slides Associated with GERD.

Paraesophageal into gastroesophageal fundus hiatal thorax. is gastric usually the normal hernia— but junction protrudes

(superficial) ring, through groin. internal and into (deep) external Goes the inguinal the inguinal ring, internal Enters inguinal to vessels. inferior epigastric ring lateral (can vaginalis failure close hydrocele). form by processus to of Caused discovered or May noticed adulthood. in in infants be more Much common males in

. B

the Follows descent. pathway of testicular fascia. by 3 of all spermatic Covered layers

in pylori) (eg, cells of atrophic H Gastrin (antrum gastritis G duodenum) chronic stomach,

parietal anemia.  of for pernicious B12–binding Vitamin in terminal Parietal chronic Intrinsic ) gastritis protein A cells B12 uptake cells Autoimmune and (stomach destruction (required ileum) factor  by histamine, (ACh), cells stomach by GIP, acid gastrin somatostatin, stimulation (stomach)  prostaglandin, pH Gastric Parietal  secretin vagal

to H+. local Chief is (active) (ACh), cells in the pepsin (stomach) presence stimulation Pepsin converted (inactive) digestion  of Pepsinogen Protein gastric pancreatic epithelium. acid the biliary and (stomach, by (duodenum) pancreas) secretion Brunner salivary duodenum, glands, secretin and with glands

(leading  (ECL) its through rather direct on effects its acid to histamine secretion Gastrin on than cells. enterochromaffin-like release) effect parietal primarily through cells

high Cl−, . − fluid; Pancreatic flow Isotonic flow high secretions  high HCO3  low

galactose, Only (glucose, monosaccharides are absorbed by fructose) enterocytes. SGLT1 and are by (Na+ taken up Glucose dependent). galactose taken via is Facilitated GLUT5. up by Fructose diffusion blood transported All by GLUT2. are to

for digestive does intact not absorption requires test: sugar simple mucosa but enzymes. absorption, that require d-xylose causes from other mucosal malabsorption. of distinguish GI damage Helps

as in Fe2+ duodenum Iron Fist, Iron Bro Absorbed

in relevant with or Clinically (eg, resection bowel vitamin B12 patients after small disease

salts, terminal Absorbed in requires Vitamin bile with along intrinsic ileum factor B

of IgA, Think Antibody the Intra-gut

Unencapsulated lamina lymphoid A in submucosa and of tissue propria found ileum. that antigens M cells to specialized immune and sample cells. present Contain

into centers lamina in germinal propria. cells, cells in B patches which IgA-secreting ultimately plasma of reside Peyer stimulated differentiate gut antigen. receives the protective deal secretory intraluminal IgA the across to then and with transported epithelium to component is

to Heme which by Bilirubin reduced heme biliverdin, bilirubin. is is subsequently oxygenase to metabolized removed bilirubin conjugated is Unconjugated from in liver, blood bile. and by with glucuronate, excreted conjugated in Direct bilirubin: water). acid; glucuronic soluble with (dissolves water water insoluble. bilirubin: unconjugated; Indirect

color) Excreted yellow (˜ in urine urobilin as

of stool) feces stercobilin color as (˜ brown in Excreted

and (80-85%). affect are Most commonly gland benign parotid malignant. tumors salivary minor and are sublingual submandibular half Nearly most neoplasms all of gland gland and present Typically painless as mass/swelling. paralysis Facial involvement. pain or suggests malignant

(benign A adenoma mixed tumor)—most salivary Pleomorphic gland common tumor . stroma excised and and of intraoperatively. epithelium ruptured recurs Composed chondromyxoid incompletely if or transformation. May undergo malignant

common carcinoma—most squamous components. Mucoepidermoid malignant mucinous and tumor, has

tumor centers. with lymphomatosum)—benign cystadenoma cystic (papillary germinal Warthin tumor smokers. Typically in found 10%; Bilateral 10%. in in multifocal smoking.” love Germany “Warriors from

cells distal columnar B blue intestinal of with squamous stratified goblet intestinal epithelium Specialized Barrett esophagus. in esophagus ]) —replacement in epithelium (nonciliated metaplasia nonkeratinized A [stained with gastroesophageal reflux to (GERD). Due chronic disease of esophageal adenocarcinoma. Associated with  risk

carcinoid (rare). gastric adenocarcinoma; tumor, lymphoma, commonly GI stromal Most aggressive Early local node/liver with spread metastases. pain, acanthosis sign. with presents loss, cases early some or nigricans weight Often abdominal satiety, in Leser-Trélat late, and blood Associated type A. with

chronic achlorhydria, nitrosamines foods), tobacco dietary H pylori, gastritis. with Intestinal—associated (smoked smoking, like lesser on margins. looks Commonly curvature; with ulcer raised

leathery to wall grossly cells A with due H cases ring nuclei) most cells thickened plastica). peripheral associated ; with pylori; Diffuse—not stomach and (mucin-filled mutation; (linitis E-cadherin signet

alcoholics can common Especially be and Erosions among by: caused

patients with PGE2 patients daily gastric rheumatoid NSAIDs—• arthritis)  mucosa taking (eg, NSAIDs protection

ulcer)—hypovolemia Burns the iron (Curling by Burned Curling

ACh  H+ Always ulcer)—•  Brain Cushion injury stimulation brain the (Cushing vagal production

( intestinal gastric cancers) and often Mucosal (hypochlorhydria • to of atrophy hypergastrinemia) leading metaplasia risk inflammation,

A (look rugae ). gastric mucosa brain Hyperplasia like of  hypertrophied gyri loss  and production. mucus production atrophy parietal Causes with acid excess cell protein resultant with Precancerous. Vomiting, loss, Weight pain, loss) Epigastric with Edema (WAVEE). Anorexia, (due Presents protein to

left of node—involvement stomach. by Virchow from node supraclavicular metastasis

tumor—bilateral metastases ovaries. Krukenberg to signet ring Abundant mucin-secreting, cells.

metastasis. nodule—subcutaneous periumbilical Sister Mary Joseph

Blumer Douglas). shelf—palpable mass to rectouterine metastasis on suggesting digital pouch of exam (pouch rectal

duodenal Gastric, > (posterior anterior). Hemorrhage complication. Most common the lesser gastric artery. curvature  from gastric of stomach Ruptured bleeding on left ulcer gastroduodenal duodenum posterior artery. on • from ulcer bleeding wall An of the

channel, Obstruction Pyloric duodenal.

(anterior Duodenal posterior). Perforation > ulcers the Anterior leading anterior pneumoperitoneum. perforate cavity, can potentially into duodenal abdominal to free with irritation referred see phrenic pain via under A air of (pneumoperitoneum) to May nerve. the diaphragm shoulder

pancolitis). with ( risk ComPliCations cancer colorectal Malabsorption/malnutrition,

enterovesical Fistulas megacolon, can (eg, toxic fistulae, which Fulminant perforation. colitis, phlegmon/abscess, strictures obstruction), (causing disease. and pneumaturia), perianal UTI cause recurrent

Diarrhea may or bloody. be maniFestation not may intestinal that Bloody diarrhea.

stomatitis), (peripheral, (pyoderma spondylitis). (aphthous inflammation arthritis erythema uveitis), eye gangrenosum, Rash ulcerations oral maniFestations eXtraintestinal (episcleritis, nodosum),

be hyperplasia (in lymphoid children). of by ) in appendix fecalith in A (red Appendicitis adults) or due inflammation can A to obstruction arrow ), Acute (in the arrows (yellow of obstruction stimulation irritates afferent T8-T10 peritoneum. to  Proximal closed-loop visceral of and lumen  serosa intraluminal pain appendiceal pressure  nerve inflammation produces initial parietal  extends at fibers obstruction diffuse periumbilical Pain distance superior McBurney anterior from umbilicus). iliac to the right to spine point RLQ/ (1/3 localized perforate Rovsing fever; signs, and psoas, obturator, and may exam. rebound guarding peritonitis; tenderness may on elicit  Nausea, pregnancy to ectopic pseudoappendicitis. diverticulitis (elderly), out), rule (use hCG Differential: appendectomy. Treatment:

the Zenker of tract Diverticula GI diverticulum

Pharyngoesophageal diverticulum . A false Killian the and constrictor. mucosal of inferior tissue between of dysmotility Esophageal triangle causes cricopharyngeal at pharyngeal the parts thyropharyngeal herniation foul neck aspiration, Presenting mass. gurgling, obstruction, symptoms: dysphagia, breath, common in elderly Most males.

Elderly breath: has pharyngeal dysmotility Inferior Killian Halitosis Males bad Esophageal Elder triangle constrictor MIKE

diverticulum. Meckel True diverticulum duct. vitelline the (omphalomesenteric) Persistence of and/or tissue. ectopic gastric acid–secreting contain May pancreatic mucosa congenital common anomaly Most tract. GI of Can cause terminal volvulus, or obstruction hematochezia/ near intussusception, (less RLQ pain, melena common), ileum. cyst cystic = duct. vitelline of omphalomesenteric with dilation Contrast uptake mucosa. heterotopic scan) Meckel by Diagnosis: gastric scan 99mTc-pertechnetate (aka for

as likely times rule 2 males. of 2’s: in The long. inches 2 the ileocecal from feet valve. 2 population. 2% of years 2 of Commonly in presents life. first of epithelia May 2 types have pancreatic). (gastric/

characterized Meissner of segment plexuses megacolon nervous plexuses) distal in of by colon. cells/enteric lack Congenital ganglion (Auerbach and failure cell Due migration. of crest to neural RET. with loss Associated mutations in function of

with constipation. Presents distention, chronic emesis, hours • pass abdominal failure bilious to 48 and meconium within a resulting the proximal segment dilated, to “transition zone.” in Normal is aganglionic of the colon portion

Risk with Down syndrome.  (squirt Explosive sign) digital expulsion on feces exam. of empty rectum  ganglionic on biopsy. suction Diagnosed cells absence by rectal of Treatment: resection. REcTum. in the RET mutation

side) A bands formation fetal fibrous the (small (Ladd on  positioning , Anomaly Malrotation clumped right bowel of midgut improper of bands). of rotation bowel development during duodenal volvulus, obstruction. Can lead to

portion obstruction bowel and to Volvulus its around of Twisting infarction. can of lead mesentery; tract. Can throughout occur GI the

angina”: loss. artery, Chronic pain mesenteric SMA, and atherosclerosis aversion or of ischemia celiac food  • epigastric “Intestinal IMA intestinal  hypoperfusion weight postprandial

ischemia. Reduction flow Colonic in blood ischemia intestinal causes Crampy by pain hematochezia. abdominal followed occurs Commonly rectosigmoid flexure, (splenic watershed at areas junction). Typically affects elderly. to sign imaging mucosal edema/hemorrhage. due on Thumbprint

without bowel abdomen flatus; obstruction sounds. constipation Intestinal with hypomotility  Ileus and  distended/tympanic  Associated with abdominal hypokalemia, sepsis. surgeries, opiates, Treatment: (stimulate electrolyte cholinergic rest, correction, drugs motility). bowel intestinal

polyps Growths the within colon of Colonic A tissue . flat, of into pedunculated protrusion lumen. or colonic on basis as the sessile, Grossly characterized by classified Generally histologic type.

lipomas, other lesions. fibromas, Submucosal May and leiomyomas, include polyps on pattern tooth” of potential Malignant crypts biopsy. sporadic to CRC. cases of of 20% Up A Cancer Polyp B Polyp C SessilePedunculated

(HNPCC). nonpolyposis called cancer hereditary Lynch syndrome colorectal Previously instability. MSH2) with MLH1, dominant of (eg, mismatch Autosomal subsequent repair microsatellite mutation genes 80% ∼ progress to CRC. always colon involved. is Proximal with Associated endometrial, skin cancers. ovarian, and

suspicion. deficiency 50 old) postmenopausal years > Iron and raises anemia in (especially males Diagnosis females Screening:

50 alternatives sigmoidoscopy, colonoscopy screen occult DNA, colonography with fecal Low flexible testing immunochemical CT (polyp in at fecal age seen (FOBT), include ); A risk: FIT-fecal testing (FIT), blood

with to who 10 with screen the relative colonoscopy, age prior or years Patients cancer: 40 a colon first-degree at has relative's presentation

barium protocol Patients “Apple screening with IBD: . seen x-ray lesion enema distinct core” B on recurrence, should for marker: used tumor monitoring good for be CEA screening. not

years 50 Most are patients > old. ePiDemiology have a ~ 25% family history.

ascending Presentation > descending. Rectosigmoid >

with occult side associated (rectosigmoid) bleeding; Right associated obstruction hematochezia ascending) left side lumen). (cecal, with (narrower and

deficiency iron loss. weight mass, anemia, Ascending—exophytic

obstruction, colicky mass, partial hematochezia. Descending—infiltrating pain,

with an S bovis diverticulitis. of as bacteremia/endocarditis episode (gallolyticus) Can or present

low cancer processed meat use, FaCtors polyps, IBD, serrated diet familial with risK fiber. tobacco Adenomatous of syndromes, and

FAP pathogenesis mutations events (firing and sporadic of is instability via of Chromosomal in cases sequence; most “AK-53”). of cause Molecular APC CRC adenoma-carcinoma pathway: order and syndrome pathway: (via cause instability mismatch colorectal or serrated repair of genes pathway). mutations MLH1) Lynch polyp methylation CRC Microsatellite some (eg, cancer sporadic of to cancer, be colorectal linked Overexpression may COX-2 has NSAIDs been chemopreventive.

Loss APC suppressor Loss tumor of mutation DCC) of KRAS (TP53, gene gene(s)

disrupt ). cells) bridging fibrosis in in normal hepatocellular carcinoma arrows arrows risk A (via (red ; architecture (white liver; stellate for and of Cirrhosis—diffuse nodules regenerative arrow show white B splenomegaly)  chronic alcohol, genetic/metabolic nonalcoholic disease, include hepatitis, disorders. biliary hepatitis, viral autoimmune Etiologies steatohepatitis,

pressure portal venous Portal in hypertension— system. in (eg, (most Western vein cirrhosis Etiologies countries), include obstruction common Budd- portal vascular thrombosis, cause

schistosomiasis. syndrome), Chiari

to estrogen portal hypertension Eects of *Due

vomiting pain Nausea, abdominal Anorexia Dull

of Serum markers liver pathology

fatal hepatic encephalopathy. Rare, syndrome often childhood Reye

influenza) with been viral treated infection (especially VZV with Associated aspirin. and that has β-oxidation inhibition of by • mitochondrial metabolites reversible enzymes. Aspirin

coma. fatty mitochondrial hypoglycemia, fatty liver abnormalities, vomiting, hepatomegaly, Findings: (microvesicular changes),

Avoid aspirin Kawasaki those in with disease. in except children,

Steatosis a kids: of awake Infection (Reye) Salicylates for of Hypoglycemia/Hepatomegaly liver/hepatocytes Encephalopathy Not sunSHINE aren’t ray (coma) (VZV, influenza)

Final usually cirrhosis and Alcoholic irreversible form. ) be central in (arrows around C disease. may seen vein early Sclerosis in injury  end-stage liver bands and fibrous portal by to nodules response chronic in Regenerative disease. hypertension liver surrounded

cellular Nonalcoholic disease • > (insulin fatty of necrosis. infiltration Metabolic AST fatty liver A “ballooning” ALT syndrome (Lipids) resistance); obesity hepatocytes  eventual and May cause cirrhosis and HCC. of use. alcohol Independent

in 1° tumor of liver Most adults malignant common

A . nonalcoholic α1-antitrypsin disease, from disease, (including liver causes alcoholic cirrhosis and Aspergillus). deficiency) HBV aflatoxin all cirrhosis) carcinogens and fatty other of and hemochromatosis, with disease, specific Wilson (eg, (+/− Associated HCV, autoimmune to lead syndrome. May Budd-Chiari

Findings: tender jaundice, ascites, anorexia. polycythemia, hepatomegaly, hematogenously. Spreads

CT/MRI or ultrasound contrast Diagnosis: α-fetoprotein; •

B , biopsy.

steroid or and oral spontaneously contraceptive (abdominal adenoma Hepatic shock). regress benign rupture may use; liver pain tumor, or anabolic often related Rare, to

cancer. and Metastases GI breast malignancies, lung Most rarely common are metastases solitary. overall;

liver necrosis hepatic congestive centrilobular compression pain, of veins ascites, syndrome varices, (hepatomegaly, Budd-Chiari congestion abdominal liver or Thrombosis with and  failure). disease Absence of JVD. Associated postpartum state, polycythemia states, hypercoagulable vera, HCC. with May cause appearance). nutmeg liver (mottled

uninhibited product In deficiency in panacinar lungs, 1-antitrypsin with aggregates ER PAS elastic  protein cirrhosis gene A in α1-antitrypsin  liver. alveoli • in Misfolded tissue globules ⊕  elastase hepatocellular • Codominant trait. emphysema.

in Often presents without smoking. patients liver of young and damage a with history dyspnea

A bilirubin causes of sclera deposition. HOT Liver—common yellowing bilirubin the of Abnormal Jaundice to and/or • skin due level:

or Hyperbilirubinemia Obstruction (impaired 2° production to uptake,  hepatic excretion).  conjugation, clearance Hemolysis Tumor

recessive. autosomal Hereditary All hyperbilirubinemias

uptake. syndrome Gilbert impaired bilirubin and  conjugation Mildly UDP-glucuronosyltransferase or illness, Asymptomatic jaundice mild usually with fasting. or stress, hemolysis.  overt bilirubin unconjugated without Relatively benign condition. common,

Dubin-Johnson Conjugated due to defective excretion. hyperbilirubinemia liver syndrome (Dark) metabolites. of due excretion impaired Grossly liver to black epinephrine Benign.

(Regular) but in black presentation Similar milder Dubin-Johnson syndrome, to without liver. hepatic to uptake and Due impaired excretion.

insoluble) (downstream) Conjugated canalicular INTRACELLULAR bilirubin Unconjugated Obstructive bilirubin diglucuronide, SINUSOID lumen bilirubin circulating TRANSPORT water UPTAKE soluble) Hepatocyte (macrophage) Hemoglobin Kuper fow cell of bound, Bile (bilirubin unconjugated, CONJUGATION (albumin RSTQQBILIRUBIN Bile water Disse Endothelial jaundice Space UDP-glucuronosyl-transferase HEPATIC cells

“onion of bile and strictures ERCP, extrahepatic cholangiopancreatography intraand fibrosis with concentric magnetic  on dilation alternating cause of ducts (MRCP). resonance “beading” duct Unknown skin” bile

called degeneration. hepatolenticular Also bile serum ceruloplasmin. Autosomal (ATP7B  • 13) recessive in apoceruloplasmin and into mutations gene; into incorporation chromosome hepatocyte ATPase copper-transporting copper excretion cornea, Copper kidneys; especially copper. brain,  urine liver, in accumulates,

, hemolytic (eg, rings renal disease tremor, liver with cirrhosis), (eg, disease, cornea) age (deposits anemia, failure, dysarthria, of disease acute Kayser-Fleischer membrane Descemet parkinsonism), before liver Presents syndrome). dystonia, (eg, 40 in neurologic disease Fanconi psychiatric A hepatitis,

penicillamine oral Treatment: or chelation with trientine, zinc. to disease. Wilson acute failure liver transplant in related Liver

recessive. Autosomal on HFE with associated On gene, located HLA-A3. chromosome 6; sensing TIBC  to Leads ( ferritin, iron abnormal absorption and saturation).  intestinal iron,  transferrin  Iron major). therapy overload chronic β-thalassemia (eg, also transfusion be can to 2° accumulates, liver, joints. in especially pituitary, pancreas, skin, Iron heart, on Prussian . biopsy MRI A can Hemosiderin be identified stain with liver blue (iron) or

Presents menstruation > g; after iron slows iron in 40 when progression body age 20 women. total loss through mellitus, (“bronze diabetes skin triad diabetes”). of pigmentation cirrhosis, Classic Also metacarpophalangeal dilated (reversible), hypogonadism, restrictive cardiomyopathy pyrophosphate deposition; or (calcium joints). (classic) arthropathy causes especially cardiomyopathy is HCC cause common death. of

deferiprone. phlebotomy, iron Treatment: chelation repeated with deferasirox, (Fe) deferoxamine,

present with urine, jaundice, dark light-colored stool, May pruritus, hepatosplenomegaly. conjugated cholestatic • • of pattern bilirubin, Typically LFTs GGT). ( cholesterol, with ALP, 

in men ulcerative with with Associated colitis. middle-aged Classically ulcerative colitis. p-ANCA ⊕. IgM.  Can lead to cholangitis. biliary 2° of  risk cancer. gallbladder and cholangiocarcinoma

⊕, infiltrate women. Anti-mitochondrial antibody Classically reaction middle-aged Autoimmune in IgM.  bile thyroiditis, autoimmune with (eg, of ducts. conditions +/– lobular granulomas Hashimoto Associated other arthritis, celiac rheumatoid disease). ursodiol. Treatment:

known with complicated Extrahepatic be ascending May cholangitis. Patients by  obstruction lesions (gallstones, biliary in obstructive intrahepatic pressure bile and  pancreatic stasis. injury/ biliary fibrosis ducts strictures, carcinoma).

Gender  and/or bilirubin, hemolysis, cholesterol salts, cause stones. bile gallbladder and  stasis (female), all Chronic obesity, infection tract age, 2 biliary stones: types genetics, of

(radiolucent due of opaque calcifications)—80% to with 10–20% Cholesterol stones. stones Associated with advanced Crohn American obesity, origin. therapy, rapid age, Native loss, weight estrogen multiparity, disease,

= Ca2+ infection). radiopaque, (black radiolucent, A stones hemolysis; Pigment bilirubinate, = brown cirrhosis, Associated age, total biliary hemolysis, chronic disease, (TPN). alcoholic Crohn with nutrition infections, advanced parenteral

factors F’s): 1. Risk (4

2.

3.

4.

acute pancreatitis, common cause complication also cholangitis. ascending Most is cholecystitis; can

ultrasound. Diagnose with if symptomatic. Treat cholecystectomy with elective

stasis gallbladder Supersaturation bilirubinate stones with calcium stasis bile of of ↑Unconjugated ↓cholesterol cholesterol salts, gallbladder Supersaturation bile ↓bile bilirubin, ↑Cholesterol, 7αhydroxylase Pigment with Cholesterol stones

common ALP, duct, bilirubin, in leading direct Choledocholithiasis and/or AST/ALT. GGT, of elevated bile gallstone(s) Presence often to

of Cholecystitis chronic gallbladder. or inflammation Acute in infection. inflammation duct gallbladder common due thickening the 2° B cystic impaction type; in ); to can wall in produce gallstone cholecystitis—most resulting Calculous (arrows and hypoperfusion, seen patients. critically (CMV); to ill stasis, cholecystitis—due in gallbladder Acalculous or infection pain. inspiratory sign: arrest to palpation Murphy due RUQ on phrenic nerve). irritation may to to right shoulder Pain (due of radiate bile (eg, duct  ascending involved cholangitis). if becomes ALP cholescintigraphy or scan). (HIDA with Diagnose ultrasound to on visualize scan HIDA Failure suggests gallbladder obstruction. (pneumobilia). lumen GI (narrowest can at tree Gallstone gallbladder air point); obstructs and  between biliary see enters ileus—fistula tract GI valve  ileocecal in stone iliac findings radiographic gallstone obstruction, bowel of in triad: small fossa). pneumobilia, (usually Rigler

on usually imaging due Porcelain cholecystitis; . gallbladder Calcified gallbladder found to chronic incidentally C to risk due of  generally gallbladder cancer (mostly Treatment: adenocarcinoma). cholecystectomy prophylactic recommended

tree obstruction Ascending usually due Infection overgrowth. cholangitis stasis/bacterial to of to that biliary leads RUQ includes of pain. fever, triad jaundice, cholangitis Charcot Charcot Reynolds pentad is shock mental status and triad plus altered (hypotension).

[yellow Autodigestion [red pancreas A arrows]). surrounded edema of arrows] ( enzymes by pancreatic by shows pancreas

Mumps, ERCP, NRTIs, Trauma, (> Ethanol, Causes: disease, (eg, mg/dL), sting, protease Hypercalcemia/Hypertriglyceridemia 1000 Autoimmune Idiopathic, Steroids, sulfa Scorpion Drugs drugs, inhibitors). Gallstones, SMASHED. I GET

of (more back, Diagnosis findings. or upper 3 criteria: acute epigastric pain to specific) by often limit 3×  serum to characteristic the normal, amylase lipase imaging of or radiating 2

necrosis, of B Complications: (precipitation infection, renal tissue, soaps). granulation epithelium), hemorrhage, shock, organ pseudocyst (ALI/ARDS, not abscess, Ca2+ failure hypocalcemia by failure), (lined

. pancreas Chronic the pancreatitis A Chronic inflammation, atrophy, calcification of be include fibrosis); idiopathic. (ie, Major cystic genetic predisposition abuse and causes alcohol can and include pseudocysts. Complications insufficiency pancreatic steatorrhea, Pancreatic <10% diabetes insufficiency deficiency, when with fat-soluble manifest function) vitamin (typically may pancreatic mellitus. acute may be not lipase and elevated (almost pancreatitis). Amylase always in or may elevated

pancreatic glandular survival presentation, arising often Very aggressive year structure A with tumor average from metastatic after 1 cellular ducts ); ~ at with infiltration (disorganized diagnosis. jaundice). (lead common to Tumors more in obstructive head B pancreatic (also specific). 19-9 CEA, CA less marker Associated tumor with

factors: Risk

males presents and Jewish Often African-American with:

Abdominal pain back radiating to

malabsorption (due Weight and anorexia) to loss

(Trousseau syndrome) tenderness and thrombophlebitis—redness Migratory palpation of extremities on

Whipple therapy. Obstructive sign) jaundice Treatment: (pancreaticoduodenectomy), nontender radiation procedure chemotherapy, with palpable, gallbladder (Courvoisier

after HCO3 acid blood ˜ pH secretion ”alkaline meals, gastric (eg, tide”— vomiting) after

Misoprostol K+ bismuth H+ Sucralfate,

Cimetidine, ranitidine, Histamine-2 famotidine, nizatidine. blockers before you Take blockers dine. H2 H2. “table to 2” for Think remember

Reversible histamine parietal H2-receptors secretion of cells. block  meCHanism H+ by

esophageal gastritis, mild ulcer, reflux. Use CliniCal Peptic

and can inhibitor P-450 also barrier Cimetidine has interactions); cross headaches) cytochrome (multiple antiandrogenic (prolactin of a dizziness, eFFeCts release, libido effects males); it in placenta. (confusion, blood-brain aDVerse is potent impotence, gynecomastia, drug  Both creatinine. ranitidine of  renal and cimetidine excretion blockers H2 effects. free relatively Other of are these

esomeprazole, dexlansoprazole. lansoprazole, Proton Omeprazole, pantoprazole, pump inhibitors

in Irreversibly meCHanism ATPase parietal stomach H+/K+ inhibit cells.

ulcer Peptic CliniCal syndrome, esophageal Use of reflux, stress Zollinger-Ellison H for prophylaxis. gastritis, therapy pylori, component ulcer,

C  difficile pneumonia, aDVerse risk of infection, eFFeCts nephritis. interstitial acute risk leading in Ca2+ Mg2+ malabsorption; fracture elderly). (potentially  B12 and increased absorption • Vitamin serum to

absorption, and by Antacids other delaying gastric drugs Can urinary altering affect gastric emptying. excretion of pH urinary or by bioavailability, or cause All hypokalemia. can problems: following Overuse the cause can also

and protection secretion pH reestablish Bismuth, providing allowing layer. HCO3 to meCHanism ulcer mucous the Bind sucralfate physical in base, gradient to not PPIs/H2 with Sucralfate requires given environment, acidic blockers.

(bismuth). healing,  Use ulcer diarrhea travelers’ CliniCal used pylori H Bismuth therapy also gastritis. for in quadruple

eFFeCts Diarrhea. aDVerse Contraindicated of potential in women (abortifacient). childbearing

meCHanism inhibits various of secretion analog; hormones. somatostatin vasodilatory Long-acting splanchnic

tumors. bleeds, Use CliniCal carcinoid VIPoma, acromegaly, Acute variceal

eFFeCts aDVerse Nausea, cramps, steatorrhea. of risk CCK cholelithiasis inhibition. to  due

sulfapyridine combination 5-aminosalicylic acid meCHanism (anti-inflammatory). (antibacterial) A and of bacteria. by colonic Activated

disease Use colitis, Crohn CliniCal (colitis Ulcerative component).

Malaise, nausea, oligospermia. eFFeCts toxicity, aDVerse reversible sulfonamide

at motility. Agonist gut slows receptors; μ-opioid meCHanism Poor CNS addictive penetration potential). (low

CliniCal Diarrhea. Use

eFFeCts Constipation, aDVerse nausea.

 stimulation. 5-HT3 antagonist; vagal meCHanism Powerful central-acting antiemetic.

in Control postoperatively vomiting chemotherapy. CliniCal undergoing and Use cancer patients

interval serotonin prolongation, QT eFFeCts aDVerse Headache, constipation, syndrome.

D2 meCHanism receptor antagonist. resting tone, emptying. motility,  gastric promotes LES contractility, tone, Does transport colon time. not influence

Diabetic Use antiemetic, GERD. gastroparesis, postoperative persistent and CliniCal

eFFeCts tardive dyskinesia. parkinsonian aDVerse • effects, diarrhea. Restlessness, drowsiness, fatigue, depression, interaction digoxin Drug agents. with diabetic and bowel patients disease Parkinson blockade), Contraindicated D2-receptor • seizure with to small in (due obstruction, threshold.

dietary and  fats. meCHanism of Inhibits pancreatic gastric absorption breakdown lipase and Taken with meals. fat-containing

loss. Use Weight CliniCal

Abdominal urgency/frequent fat-soluble steatorrhea; aDVerse pain, of eFFeCts flatulence, bowel bowel absorption  movements, vitamins.

Laxatives opiates regimen. for on or patients requiring Indicated bowel constipation a

meCHanism Substance P antagonist. (neurokinin-1) Blocks receptors NK1 in brain.

Antiemetic for chemotherapy-induced vomiting. Use nausea and CliniCal

type! always somebody’s “You’re blood mosquito.” best fool some time at will a type, that the of is)” into “The begin mind soarings blood.” “All or in a my my (blood get

the attention studying many to cross pay close connections hematology, When to immunology. sure the different Make types of master anemias. you smears. interpreting Be blood comfortable of on than effects clinical be reviewing uses, rather yield. adverse oncologic drugs, lower may focus mechanisms When details which and

in are that covered tumors chapters. their note respective organ Please system solid

in: Fetal Synthesizes Blood. Fetal Liver Young erythropoiesis erythropoiesis occurs

adult) to weeks Bone marrow (18

From hemoglobin globins: =αγ adult 2. ε. ζ hemoglobin: to and fetal Fetal Embryonic (HbF) 2

) Alpha Becomes Goes, Always; hemoglobin Adult =αβ Gamma (HbA Beta.

22. 1

higher and binding HbA2) to for due avid O2 O2 extract to maternal HbF (HbA1 hemoglobin placenta. across HbF of affinity the from allowing 2,3-BPG, has less adult HbA2 (α2δ2) a of is present amounts. small form in hemoglobin

% 50 of erythropoiesis Site of 30 20 total globin 40 synthesis

fetalis. as known Also of erythroblastosis Hemolytic disease the newborn

cells. response Acute inflammatory Neutrophils Numbers bacterial (nucleus  in infections. Hypersegmented neutrophils 6+ has Phagocytic. in vitamin B deficiency. / are folate seen lobes)

Multilobed A . A 12 nucleus shift left states (LAP), (eg, contain leukocyte and collagenase,  myeloid bacterial A alkaline phosphatase with infections, CML).  cells lysozyme, neutrophils) of Specific band proliferation (immature reflects granules lactoferrin. LTB4, (lysosomes) IL-8, neutrophil platelet-activating proteinases, Important C5a, kallikrein, chemotactic contain Azurophilic agents: acid phosphatase, granules factor. β-glucuronidase. myeloperoxidase, and

tissues to lungs. and Carry O2 CO2 to for biconcave and organelles; ratio rapid gas area-to-volume surface lack with large A , exchange. Anucleate span days. Life 120 of energy HMP is glycolysis, of in 10% (90% shunt). used Source in used glucose to the − HCO3 Cl−/HCO3 contain transport antiporter, export − CO2 Membranes periphery which from allow and RBCs for elimination. to the lungs

cyte = = red; cell. Eryth polycythemia Hct.  = Erythrocytosis = = Anisocytosis varying sizes. Poikilocytosis = varying shapes.

= erythroid reflects Reticulocyte RBC; immature proliferation.

stain residual on ribosomal color represents reticulocytes RNA. Bluish Wright-Giemsa (polychromasia) of

hemostasis. in 1° Involved from megakaryocytes. A cytoplasmic Small fragments derived days. span 8–10 of Life and platelets plug. fibrinogen platelet activated with endothelial form interact to injury, other aggregate by with When Serotonin, ADP, platelet Contain 4). Histamine; , fibronectin, fibrinogen, CASH) dense (vWF, granules (Ca2+ granules α factor and stored in 1⁄3 Approximately is platelet spleen. the pool of

petechiae. in receptor: vWF GpIb. GpIIb/IIIa. Fibrinogen receptor: proliferation. stimulates Thrombopoietin megakaryocyte granules fibronectin, factor Alfa four. contain platelet fibrinogen, vWF,

into = Mono Monocytes cell. (nucleus); blood, Found one cyte differentiate = macrophages in tissues. in A kidney-shaped nucleus Large, . Extensive glass” cytoplasm. “frosted

debris, and cellular RBCs. bacteria, senescent Phagocytose tissues. life in Long circulating blood Differentiate monocytes from

A . by Activated γ-interferon. MHC function via Can as II. antigen-presenting cell TB, granulomas component cellular sarcoidosis). of Important (eg,

= eater. phage = large; Macro

Kupffer in type tissue in connective naming cells by (eg, histiocytes microglial Macrophage tissue, Langerhans bone, liver, in in in varies skin, cells cells brain). osteoclasts specific

on from shock. to A Lipid binds septic macrophages LPS CD14 initiate bacterial

reaction. Basophils allergic Mediate stains. Basophilic—stains basic basophilic readily Densely with can a but heparin sign (vasodilator). be contain is and (anticoagulant) granules of A histamine uncommon, Basophilia particularly Leukotrienes disorders, CML. myeloproliferative on released demand. synthesized and

(APCs) antigen-presenting Highly cells A cells phagocytic Dendritic . adaptive innate link as immune between and Function systems. II surface. Fc class MHC receptors Express and on

protein). infections helminthic against basic Defend (major nucleus. Bilobate eosinophilic uniform of granules size Packed large with

. A complexes. for antigen-antibody Highly phagocytic

peroxidase, helminthotoxin), protein major protein, neurotoxin. and cationic Produce eosinophilderived basic (MBP, a eosinophil histaminase, eosinophil

Eosin philic = = dye; pink loving.

granulomatosis polyangiitis = Causes Eosinophilic Myeloproliferative Hodgkin of disorders (Churg-Strauss with (eg, Parasites Chronic PACCMAN: Neoplasia eosinophilia Allergic syndrome) adrenal insufficiency Asthma lymphoma) processes

and NK Refer cells, to B T Lymphocytes cells, cells. cells immunity. B cells and adaptive mediate T of NK are part response. immune cells innate the staining densely with nucleus of Round, cytoplasm amount small pale

A .

immunity, cells Natural in especially innate pathogens. against intracellular killer Important granzymes) T apoptosis. released, induce when and distinctive than granules cells, perforin Larger act with on (containing and target lytic B that, to cytoplasmic cells microbial infected surface malignant between cells and by identifying cell stress, by healthy (induced proteins or Distinguish transformation, infections).

immune Mediate response. humoral in cells from bone and marrow stem Originate marrow. in matures lymph nodes, pulp to Migrate tissue spleen, of white unencapsulated tissue). peripheral lymphoid of (follicles lymphoid and memory antibodies) cells cells cells. into plasma encountered, B produce differentiate When is (which antigen Can an as APC. function

B Bone marrow. =

immune response. Mediate cellular in stem Originate but cells the mature thymus. marrow, from the in bone helper cells recognize recognize T T Differentiate cytotoxic and II), CD4, MHC (express T I), (express regulatory cells. cells MHC into CD8, CD28 necessary for (costimulatory signal) activation. T-cell are cells (80%). lymphocytes circulating Most T

Thymus. T =

are the primary T cells of helper CD4+ target HIV.

MHC = 8: MHC Rule CD4 8; II = × I of 8. CD8 ×

antibody cells large Plasma dyscrasia. plasma of a amounts to cell is Multiple Produce specific myeloma

particular antigen. a abundant eccentric chromatin nucleus, “Clock-face” and distribution

(arrows RER, Golgi apparatus well-developed A ). in and bone normally Found in circulate not marrow in do peripheral and blood.

(specifc) to of bodies (released ACTIVATIONADP EXPOSUREvWF damage 4A bind ADHESIONPlatelets at of (necessary refex cell) platelets °-granules change ˜ from exposed collagen and receptor Ca2+ transient induces the GpIb vWF via TXA2 endothelial site injury surface cells expression is receptor stimulation at for coagulation vasoconstriction and to GpIIb/IIIa damaged neural platelet cascade), INJURYEndothelial ˜ Weibel-Palade from of ADP Platelets undergo P2Y12 binds platelets vWF only endothelin binding via conformational and release

Temporary easily stops unstable, plug bleeding; dislodged

Formation Thrombogenesis insoluble of mesh. fibrin thereby cyclooxygenase, TXA2 inhibiting synthesis. irreversibly Aspirin inhibits prasugrel, P2Y12 by of inhibit ADP-induced expression blocking receptor. and ticlopidine GpIIb/IIIa Clopidogrel, irreversibly GpIIb/IIIa directly. eptifibatide, inhibit Abciximab, and tirofiban vWF GpIb. bind to activates Ristocetin aggregation ristocetin Bernard-Soulier disease Willebrand and assay syndrome. in occurs Failure of von with vWF volksWagen Factories carries/protects VIII; factor gr8 make cars. endothelial cells 4A collagen 4B (vWF TXA2 vWF protein Bernard-Soulier GpIIb/IIIa Arachidonic disease Platelet GpIb ticlopidine eptifbatide, Abciximab, VIII) Fibrinogen GpIIb/IIIa Activated vWF acid syndrome tirofban Glanzmann Thrombin-thrombomodulin Clopidogrel, prasugrel, + receptor ADP endothelial Defciency: Inside (P2Y12) cells tPA, Thromboplastin Defciency: insertion von Aspirin factor Subendothelial PGI2 C Defciency: Vascular Fibrinogen Willebrand Inside COX C Protein thrombasthenia platelets complex

Hemophilia of (AR) Hemophilia of defciency C: B: defciency XI defciency (XR) Hemophilia factor IX of VIII factor factor A: (XR)

warfarin products * K activates Kallikrein degradation bradykinin = = vitamin by phospholipid; D-dimer) , (eg, Ca2+ antagonist Note: inhibited Fibrin require

stabilizes of Fibrin not but part = coagulation cascade mesh activates

acid dalteparin, (eg, ˜ thrombin Contact HMWK II ANTIFIBRINOLYTICS:aminocaproic (eg, –––** Tissue Fibrinolytic ANTICOAGULANT Kallikrein argatroban, # painKinin cascade apixaban) Fibrin X S (extrinsic) pathway tPA vWF direct IX Aggregation streptokinase, and activation * (intrinsic) enoxaparin) -heparin factor * -LMWH Va* with XIa ––– dabigatran) Ca2+ VII I C THROMBOLYTICS: acid, Plasminogen heparin V REGULATORY factor -proteins bivalirudin, # ˜vasodilation Tissue Collagen, * Thrombin pathway inhibitors inhibitors permeability ANTICOAGULANTS: XIIa pathway Bradykinin XII monomers inhibitor (eg, VIIa PROTEINS: -direct LMWH Prothrombin Combined Xa Fibrinogen ANTICOAGULANTS: XIII VIIIa fondaparinux tranexamic –C1-esterase membrane, ˜ Plasmin system activated basement reteplase, VIII IXa Xa tenecteplase * XIIIa alteplase, IIa platelets XI Ia

deficiency: S. K synthesis Vitamin of  II, VII, X, protein Procoagulation C, factors IX, protein

factors S Liver C, Mature, II, K-dependent) Inactive X, K Fibrinogen S Clotting VII, (inactive) vitamin Reduced IX, Oxidized reductase C, (vitamin vitamin Anti-coagulants Epoxide IX, -glutamyl K II, carboxylated (active) X, Fibrin carboxylase VII,

inhibits K epoxide Warfarin vitamin reductase. clotting warfarin inhibitory (delayed). on administration potentially K Vitamin reverse factor of effect can synthesis action be given can in of K of administration immediately FFP and PCC reverses warfarin bleeding. with cases or severe vitamin

of K deficiency/coagulopathy. overcomes lack bacteria, neonatal vitamin produce administration K. Early which vitamin Neonates enteric

VII half-life. Factor (seven)—shortest

Warfarin,

half-life. (tallest) (two)—longest II Factor

Xa, IXa, factors VIIa, XIIa. XIa,

Heparin enhances antithrombin. of activity the

of factor Principal Xa. antithrombin: thrombin targets and

ATIII Heparin-like protein resistant C activity) S VIIa, Cleaves Requires to XIIa) protein IXa, inactivates activated ProteinCpathway Thrombin-thrombomodulin Antithrombin XIa, (endothelial by pathway thrombin (and Activated Xa, C Inhibits Antithrombin VIIIa protein Protein complex inhibition cells) and (enhances III molecule Va, C.

used clinically a thrombolytic. as is tPA

(“spur abetalipoproteinemia Liver varying intervals. cells”) disease, size irregular Projections of at

ESRD, disease, and kinase (“burr Liver projections cells”) than more pyruvate deficiency Smaller acanthocytes uniform

home cells”) “sheds Bone a it’s of myelofibrosis) bone mechanically because infiltration its in the (“teardrop out marrow tear” (eg, RBC marrow squeezed

(eg, hemolysis mechanical (eg, cells) RBCs prosthesis) “helmet” valve Fragmented MAHAs HELLP DIC, TTP/HUS, (eg, heart syndrome),

splenic to bodies by deficiency cells”) removal of Heinz macrophages Due G6PD

RBC encoding Hereditary proteins Caused mutation (eg, spectrin) elliptocytosis by in membrane genes

spherical Small, spherocytosis, without hemolytic central pallor Hereditary cells anemia autoimmune

Asplenia, to his disease, hunter Thalassemia “HALT,” the disease, said Liver target HbC

low cell acidosis) (eg, with altitude, high occurs Sickle anemia O2 conditions Sickling

in be to sideroblasts) Prussian ring Require with (eg, Sideroblastic anemias sideroblasts) mitochondria in iron (eg, Perinuclear myelodysplastic alcoholism) lead visualized excess syndromes, blue stain poisoning, ringed ringed (forming

hyposplenia Basophilic sickle by contain remnants Usually macrophages nuclear (do iron) removed Functional disease), not cell asplenia splenic (eg,

not ribosomal anemias, (do thalassemias Sideroblastic precipitates iron) contain Basophilic

removal Denatured deficiency iron) and (contain hemoglobin Requires of bite cells bodies G6PD  crystal violet) be visualized Heinz (eg, Phagocytic to supravital precipitated stain

Reticulocyte Also count. index called reticulocyte corrected anemia. elevated count correct to falsely Used in reticulocyte Measures marrow erythropoiesis). (effective anemic conditions to appropriate response bone (RI) indicates production; RI compensatory response RBC reticulocyte inadequate High anemia. correct index to low indicates as: Calculated

fL. anemias hypochromic 80 MCV < Microcytic,

(eg, step malnutrition, iron GI final absorption or (eg,  in loss, pregnancy) due • disorders, chronic GI menorrhagia),  demand Iron to (eg, surgery deficiency bleeding heme gastrectomy), synthesis. protoporphyrin,  RDW, free  • RI. TIBC, erythrocyte  Labs: iron, •  ferritin, Microcytosis ( and pallor) central hypochromasia

A . compulsive craving substances), of fatigue, , and nails pica eating pallor spoon (koilonychia). (persistent conjunctival B nonfood Symptoms: glossitis, deficiency and as syndrome manifest esophageal May cheilosis, of (triad webs, iron anemia, Plummer-Vinson dysphagia).

on α-globin synthesis. gene deletions -thalassemia chromosome 16 • α-globin same African prevalent chromosome) on cis (deletions separate in populations; trans chromosomes) populations. deletion Asian occur deletion on occur prevalent (deletions in αα/αα. Normal is

Point (– hypochromic Hemoglobin H the β-globin carrier’s anemia (α forms fetalis; –; minor synthesis. life worsen promoter α-globin, γ-globin severe –/– for chromosome Hemoglobin excess -thalassemia α-thalassemia α) 3 cis) Barts excess • disease; β4 –; no or and may β-globin hypochromic with microcytic, outcome 2 on (– forms in to 4 sites deletion Mild Moderate sequences (αα/– –) microcytic trans) disease –/α 11 splice (HbH); –/– cis γ4 incompatible Hydrops anemia; offspring mutations Mediterranean Prevalent in populations.

minor β underproduced. -thalassemia chain is (heterozygote): asymptomatic. Usually • HbA2 Diagnosis (> 3.5%) on confirmed by electrophoresis.

chain β (homozygote): target blood anemia microcytic, (2° severe C cells transfusion anisopoikilocytosis is -thalassemia hemochromatosis). major increased  with hypochromic absent requiring and  skull expansion skeletal (“crew deformities “chipmunk” facies). (eg, on Marrow cut” x-ray) hematopoiesis hepatosplenomegaly. Extramedullary  crisis. aplastic  risk of parvovirus B19–induced  HbF HbA ). ), (αδ (αγ becomes HbF only after infant declines. disease and 6 fetal in symptomatic months, the hemoglobin protective is when HbS/β depending of -thalassemia amount disease moderate mild β-globin sickle to production. cell on heterozygote:

hypochromic (continued) anemias Microcytic,

Lead ferrochelatase heme and   poisoning protoporphyrin. dehydratase synthesis ALA RBC inhibits and Lead degradation rRNA stippling). retain of aggregates (basophilic inhibits  rRNA Also RBCs LEAD of Symptoms poisoning:

(Burton lines) bones x-ray. on on Lead Lines D and metaphyses on of gingivae long

and Erythrocyte Encephalopathy basophilic stippling.

Abdominal colic sideroblastic Anemia. and

foot drop. Drops—wrist and EDTA and Dimercaprol treatment. line 1st of are used be (It chelation for kid “sucks” who for eats Succimer a kids lead). to old with risk chipped paint. in  Exposure houses

ALA Sideroblastic also anemia drugs gene), reversible isoniazid, (eg, [eg, (alcohol (myelodysplastic acquired Causes: common; defect B6 copper syndromes), linezolid]). poisoning, is most genetic synthase vitamin and lead deficiency, in X-linked deficiency, • ferritin. Lab TIBC, normal/ • iron, findings: mitochondria) . sideroblasts Prussian marrow (with E iron-laden, seen bone Ringed in blue–stained of Peripheral blood RBCs. smear: basophilic stippling may normocytic variants or Some be acquired macrocytic.

for (B6, synthase). Treatment: cofactor pyridoxine ALA

 = iron 1° disturbance. of Interpretation studies

blood. in iron Transferrin—transports

transferrin. TIBC—indirectly measures

iron protein body. storage Ferritin—1° of

circulating to thrive. use iron aEvolutionary reasoning—pathogens iron stored and from The within a in acquiring body cells iron. the body prevents of adapted pathogens which the system is circulating has

anemias fL. Macrocytic > MCV 100

of in nucleus macrocytosis, synthesis Impaired neutrophils in bone hypersegmented (arrow DNA RBC cells of anemia marrow maturation Megaloblastic precursor 

A glossitis. ), relative cytoplasm. delayed maturation of to phenytoin, hydroxyurea, medications sulfa deficiency, folate drugs). B12 deficiency, methotrexate, (eg, Causes: vitamin

malabsorption Vitamin Causes: gastrectomy, (eg, (cobalamin) Diphyllobothrium Crohn intake pernicious pancreatic latum anemia, insufficiency, disease), (fish tapeworm). (eg, insufficient B12 deficiency veganism),

 methylmalonic • homocysteine, acid.

tract, subacute lateral (due reversible pathways dementia, column and dysfunction. combined acid to of synthesis): tract, degeneration Neurologic myelin corticospinal symptoms: involvement dorsal in spinocerebellar B12 fatty supplementation symptoms. but can B12 deficiency the correct worsens Folate neurologic in vitamin anemia,

insufficiency the if the with malabsorption. that dietary is diagnosed vs cause determines Historically test, test a Schilling

B12 to to due Anemia develop store 2° (as ability may deficiency). to insufficient several to years folate take intake to opposed liver’s

anemias normocytic Nonhemolytic,

Anemia of disease chronic

macrophages, (released and  gut. of liver, transport) thus IL-6) cells binds by iron  mucosal from iron intestinal Inflammation from iron (eg, macrophages absorption release • and inhibiting  hepcidin ferroportin on Associated kidney as arthritis). such diseases rheumatoid and conditions chronic neoplastic SLE, chronic with disease, (eg, infections, disorders, autoimmune

   TIBC, iron, ferritin. microcytic. Normocytic, but can become judicious Treatment: as chronic use disease). cause consider blood transfusion, in address of kidney agents underlying inflammation, erythropoiesisstimulating of such (eg, EPO

antimetabolites) destruction anemia or benzene, agents, Radiation chloramphenicol, Aplastic by cells hematopoietic and alkylating drugs failure (eg, Caused to: • stem due of

EBV, viruses) (eg, Viral agents HIV, hepatitis

count, • 1° EPO. defect); may  reticulocyte acute Idiopathic follow hepatitis (immune cell stem mediated,

confused only). (not with causes Pancytopenia crisis, and which anemia aplastic thrombocytopenia anemia, by characterized to be leukopenia, cell hypocellular with but fatty morphology, bone marrow Normal infiltration

marrow A bone (dry tap).

infection. pallor, Symptoms: bleeding, fatigue, purpura, malaise, mucosal petechiae,

GM-CSF). transfusion, globulin, offending withdrawal cyclosporine), bone RBC/platelet marrow (eg, regimens immunosuppressive stimulation of antithymocyte Treatment: agent, allograft, marrow bone (eg,

 valine). Mutant HbA is termed HbS. and intravascular Causes hemolysis. extravascular

HbS vaso-occlusive high disease. acidosis  sickling precipitates anemia, altitude, O2, or Pathogenesis: low polymerizes) (deoxygenated

asymptomatic and are HbF of initially Newborns   HbS. because to Heterozygotes trait) have cell malaria. resistance (sickle Americans 8% African carry HbS of an allele. cells crescent-shaped RBCs are Sickle A . “Crew on thalassemias). erythropoiesis  x-ray due in seen cut” (also expansion to from marrow skull

disease: cell Complications in sickle

Aplastic B19). of erythropoiesis crisis arrest to parvovirus (transient due

of  risk Autosplenectomy bodies) organisms pneumoniae). (Howell-Jolly by (eg, infection encapsulated S

infarct/sequestration Splenic crisis.

Salmonella osteomyelitis.

on cause death), avascular new Painful priapism, vaso-occlusive (respiratory (painful of necrosis, pulmonary chest swelling acute hands/feet), distress, stroke. infiltrates crises: common of dactylitis CXR, syndrome

hematuria. papillary necrosis • Hb HbF, • electrophoresis: HbS. HbA,   hydroxyurea hydration. Treatment: HbF), (

that Coombs usually A ⊕. is anemia and idiopathic normocytic Two types:

which RBC anemia in IgG agglutination. Warm AIHA–chronic causes drugs (eg, α-methyldopa). SLE and certain in with Seen and CLL Good.” cold to is agglutination “Warm complement RBC upon painful, and fingers toes. blue • weather causes + exposure Seen infections, Mononucleosis. pneumoniae CLL, in infectious Mycoplasma

blood smear. A Spherocytes on and agglutinated peripheral RBCs

steroids, AIHA rituximab, (if splenectomy Warm refractory). treatment:

cold treatment: avoidance, Cold rituximab. AIHA

to (Coombs antibody RBCs. Direct Coombs test—anti-Ig reagent) patient’s added with if are coated agglutinate RBCs RBCs Ig.

serum. test—normal Coombs RBCs to added comparison, For Indirect patient’s serum RBCs added. Ig, If Coombs anti-RBC has surface reagent agglutinate when

lymphopenia. eosinopenia cause aCorticosteroids causing neutrophilia, despite and the of molecules, inflammation. of neutrophil adhesion to sites activation out of Corticosteroids  migration vasculature impairing of sequester and lymphocytes. apoptosis in corticosteroids cause nodes eosinophils lymph In contrast,

peripheral precursors, is left more to cells band  as cell a immature shift in left shift a Neutrophil in shift A neutrophil metamyelocytes, such blood. and maturation the process.

with infection to the or in acute inflammation. Usually response neutrophilia seen shift is leukoerythroblastic immature when seen RBCs. with Called reaction left (eg, in tumor with severe marrow). taking response Occurs up fibrosis, space

dehydratase (blood) ALA Protoporphyrin, Ferrochelatase and ALA

smear Microcytic and anemia in bone sideroblasts in GI kidney peripheral stippling , marrow), A ringed disease. (basophilic

deterioration. lead Children—exposure  to paint mental

memory headache, Adults—environmental batteries, loss, (eg, neuropathy). • exposure (peripheral demyelination ammunition)

. B common porphyria. Most consumption. Exacerbated with alcohol (eg, Causes: phlebotomy, hydroxychloroquine). familial, C. Treatment: sun hepatitis antimalarials avoidance,

or A, defect B, A ( • PTT). pathway Hemophilia C Intrinsic — coagulation

of A: VIII; X-linked factor recessive. deficiency

deficiency B: X-linked of recessive. factor IX;

XI; recessive. C: factor autosomal of deficiency A (eg, knee dental procedures). trauma after ), Hemorrhage hemophilia—hemarthroses surgery joints, easy or (bleeding into bruising, in bleeding eg,

desmopressin factor concentrate concentrate concentrate + (B); VIII XI factor factor Treatment: IX (A); (C).

General coagulation defect. • Vitamin deficiency K time normal. Bleeding

 factors IX, C, II, X, S. activity of protein protein VII,

syndromes thrombosis leading to hypercoagulability Hereditary

hemochromatosis), include may transmission a lead transfusion Blood chelator), iron lyse Ca2+ transfusion old reactions, blood units). overload (RBCs hyperkalemia hypocalcemia (citrate 2° to infection risks and is (low), in (may

bone Leukemia involvement with or Lymphoid marrow. myeloid widespread neoplasm of Tumor cells are blood. found in usually peripheral

lymph nodes. Discrete arising from Lymphoma tumor mass often Presentations blur definitions.

loss. Both weight night fever, sweats, signs/symptoms: constitutional may low-grade (“B”) with present

lymph predictor strongest group spread contiguous common; (stage of spread. Localized, with involved; single nodes noncontiguous Multiple nodes extranodal is involvement prognosis). of prognosis. Better Worse prognosis.

by cells. Reed-Sternberg Characterized cells; B involve T-cell lineage. a few of are Majority

adulthood children occur distribution: in Bimodal and Can and young adults. type. 55 years; common sclerosing nodular in except for more men >

EBV. Associated with infections viral May and with associated be autoimmune (eg, EBV, HIV, diseases HTLV).

binucleate with Hodgkin cells: cells; distinctive giant tumor eyes” A the (“owl mirror as images Contains lymphoma bilobed 2 or halves ). Reed-Sternberg CD30+ CD15+ RS cells origin. and B-cell are 2 30. = eyes 15 owl ×

immunoglobulin cell overproduction monoclonal due disorder. plasma cell by (Ig) Plasma to Characterized dyscrasias Labs: (FLC) or monoclonal free serum tests protein on (M electrophoresis for SPEP overproduction a of Ig light spike represents fragment). (SPEP) initial assay chain as only detects albumin. protein to light urinalysis, routine electrophoresis urine chain, 24-hr (UPEP) urine use For detect dipstick Confirm marrow with bone biopsy.

cases) of Multiple of IgG Overproduction (55% myeloma IgA. > Clinical CRAB features:

Back Bone out” lesions on • (“punched X-ray lytic pain. ) A B smear shows blood (RBCs Rouleaux like poker Peripheral stacked formation chips). ⊖ proteinuria) light (Bence shows chains Ig Urinalysis Jones dipstick. with urine containing 10% intracytoplasmic > Bone C cells clock-face inclusions marrow shows analysis monoclonal IgG. chromatin plasma with and  (AL). Complications: infection risk, amyloidosis 1°

IgM largest IgM (macroglobulinemia Ig). of is Overproduction because the features: Clinical

syndrome: Hyperviscosity

vacuoles analysis shows with marrow lymphoma). IgM-containing (lymphoplasmacytic lymphocytes Retinal hemorrhages Bone small >10% thrombosis. Complication:

 A nuclei defects cell syndromes (“duet”) . hematopoiesis bilobed maturation in with lineages. Typically seen nonlymphoid of novo Caused by chemotherapy. after de (eg, or chemotherapy). radiation, exposure environmental benzene, mutations Risk transformation to of AML.

differentiation marrow mature ( Unregulated ( bone  of platelets).  WBCs marrow hemorrhage RBCs), and WBCs), infections ( and Leukemias growth anemia in failure circulating Usually WBCs. (malignant normal/• with cases blood); present WBCs  rare leukocytes in with presents (leukemia spleen, skin cutis) cell and infiltration Leukemic lymph of liver, possible. nodes,

D B on Chronic C A neoplasms impacts cell hematopoietic lines. myeloproliferative with Malignant myeloid WBCs E disorders and varying

cell often leukemias. lysis, tumor most in lymphomas/ K+ of hyperkalemia,  Release

of due release Arrhythmias, • hypocalcemia 3– sequestration hyperphosphatemia, PO Ca2+ to

Seizures, by PO43–. acute  injury. nucleic  acid hyperuricemia  breakdown kidney tetany

rasburicase. hydration, allopurinol, injury

Systemic T hepatosplenomegaly, serum ferritin macrophages fever, and  cells overactivation lymphohistiocytosis  Hemophagocytic cytotoxic of pancytopenia, levels. after to inherited EBV (eg, strong Can immunologic or be infection, activation malignancy). 2° marrow shows macrophages biopsy marrow phagocytosing elements Bone

. A

thrombin Direct oral class). Bivalirudin, in Argatroban, (only Dabigatran agent inhibits free clot-associated Directly and thrombin. of inhibitors activity mechanISm Venous fibrillation. USe clInIcal thromboembolism, atrial the used BAD is HIT, when patient. Can for heparin in be Does require not monitoring. lab adVeRSe reverse Bleeding; with idarucizumab. dabigatran can eFFectS if tranexamic Consider agent acid) PCC reversal (eg, antifibrinolytics and/or available. no

and Activates mechanISm IIa factor which (thrombin) of Xa. action  antithrombin, half-life. Short

anticoagulation (PE), acute deep venous Immediate thrombosis syndrome, MI, embolism clInIcal coronary (DVT). for USe pulmonary cross pregnancy Used placenta). (does not during PTT. Follow

adVeRSe interactions. Bleeding, eFFectS osteoporosis, (HIT), drug-drug thrombocytopenia rapid heparin). sulfate (antidote), protamine molecule binds (positively that negatively For charged use charged reversal

factor enoxaparin, Low-molecular-weight Xa. heparins on (eg, noteS predominantly dalteparin)—act Fondaparinux Xa. acts factor on only unfractionated can monitoring. 2–4× and without half administered and Have life subcutaneously heparin; better longer laboratory than bioavailability be and insufficiency. contraindicated clearance undergo heparin) in are LMWHs (vs hepatic of renal clearance renal unfractionated Not easily reversible.

4 Heparin-induced against 2—development of IgG factor (HIT) heparin-bound thrombocytopenia type (PF4). antibodies platelet platelets thrombocytopenia. complex activates and Antibody-heparin-PF4 • thrombosis Highest unfractionated heparin. risk with asymptomatic. nonimmunologic type by usually 1 milder drop count, platelet characterized in HIT

EX-PresidenT which Inhibits epoxide mechanISm interferes The war(farin). reductase, went to with C, factors IX, and vitamin X, K–dependent proteins VII, γ-carboxylation II, of clotting

by reductase K (VKORC1). complex in for vitamin the polymorphisms affected epoxide S. gene Metabolism pathway assay, and PT. EXtrinsic effect In on laboratory has  half-life. Long

thromboembolism prophylaxis, venous stroke USe of fibrillation). in (eg, and atrial prevention Chronic clInIcal anticoagulation used Not (because heparin, unlike in women placenta). pregnant crosses warfarin, Follow PT/INR.

Bleeding, drug-drug interactions. teratogenic, , necrosis A skin/tissue

C half-life than X. shorter Initial has risk of factors a II hypercoagulation: and protein deplete, factors X and before II reduce protein C X  before and factors production warfarin hypercoagulation. depletes can and Existing II existing large to vessel microthrombosis. of to small believed days few doses necrosis due Skin/tissue within first be

warfarin, give K. For vitamin reversal of

plasma For frozen rapid fresh reversal, PCC. (FFP) or give

starting frequently “bridging”: used heparin warfarin. Heparin when transient initial, state hypercoagulable antithrombin warfarin. enables activation Heparin’s anticoagulation by caused of during necrosis. risk venous thromboembolism therapy and recurrent reduces skin/tissue heparin Initial of

cytochrome P-450. Metabolized by

inhibitors Direct rivaroXaban. factor Xa ApiXaban,

Bind Xa. and to mechanISm inhibit directly factor

prophylaxis stroke USe fibrillation. and clInIcal and atrial Treatment prophylaxis for PE; patients with in DVT coagulation Oral usually require do not monitoring. agents

eFFectS Bleeding. adVeRSe with alfa. Reverse andeXanet

(tPA), streptokinase, reteplase Alteplase Thrombolytics (rPA), tenecteplase (TNK-tPA).

or Directly and to cleaves indirectly clots. plasminogen fibrin thrombin which mechanISm aid of conversion plasmin, PTT, no change platelet count.   PT, in

direct early Early severe USe ischemic MI, thrombolysis of PE. stroke, clInIcal

adVeRSe eFFectS Bleeding. history or bleeding, intracranial bleeding of in severe with surgery, hypertension. known diatheses, Contraindicated recent active patients bleeding, reversal PCC). (eg, tranexamic acid, transfusions, platelet (eg, factor corrections acid), aminocaproic antifibrinolytics cryoprecipitate, FFP, Nonspecific and with

inhibitors ticagrelor ADP Clopidogrel, receptor prasugrel, (reversible), ticlopidine.

mechanISm platelet Irreversibly ADP subsequent prevents which block aggregation. receptor, (P2Y12) glycoproteins Prevent expression platelet IIb/IIIa of on surface.

Acute USe coronary syndrome; coronary clInIcal stenting. or of thrombotic incidence  recurrence stroke.

Neutropenia eFFectS (ticlopidine). adVeRSe TTP may seen. be

Abciximab, tirofiban. eptifibatide, IIb/IIIa Glycoprotein inhibitors

mechanISm the on to aggregation. activated (fibrinogen platelets, Bind preventing receptor glycoprotein receptor) IIb/IIIa fragments. Abciximab antibody monoclonal from made Fab is

angina, coronary Unstable percutaneous intervention. USe clInIcal

thrombocytopenia. Bleeding, eFFectS adVeRSe

agents Platinum cisplatin) (eg,

Alkylating agents:Azathioprine

1 p53 Methotrexate Nitrosoureas point Ifosfamide Hydroxyurea carmustine) Rb, 6-mercaptopurine 5-fuorouracil modulate restriction G (eg,

inhibits DNA Irinotecan/topotecan: ˜thymidine inhibit topoisomerase cross-link reductase inhibits novo formation Alkylating intercalators ribonucleotide division DNA inhibits strand Nucleotide Etoposide/teniposide: Bleomycin: MTX, agents, topoisomerase Paclitaxel: synthesis alkaloids: DNA synthesis DNA RNA inhibits doxorubicin: ˜de breakage 6-MP: disassembly I Dactinomycin, microtubule agents: Vinca Hydroxyurea: purine Cellular synthesis II 5-FU: Protein platinum microtubule

analogs synthesis. GI, Azathioprine, de novo rejection, purine organ (thiol) Preventing 6-mercaptopurine liver Purine  Myelosuppression; rheumatoid toxicity. IBD, arthritis, Activated by HGPRT. Azathioprine 6-MP. by and 6-MP disease wean to in xanthine into Azathioprine metabolized steroids chronic are metabolized used SLE; patients is off treat disease. thus both have and steroid-refractory chronic to oxidase;  risk or of with toxicity febuxostat. allopurinol

• Cladribine analog Hairy leukemia. Purine cell multiple mechanisms nephrotoxicity, (eg, neurotoxicity. polymerase, inhibition Myelosuppression, DNA and DNA of strand breaks).

Cytarabine (AML), Leukemias Pyrimidine analog DNA lymphomas.  Myelosuppression with termination. (arabinofuranosyl chain anemia. megaloblastic At higher concentrations, causes polymerase. DNA inhibits CYTarabine cytidine) panCYTopenia.

covalently acid. 5-fluorouracil which folic analog 5-FdUMP, with complexes to bioactivated Pyrimidine and synthase thymidylate is a Capecitabine prodrug. synthase dTMP DNA   inhibits This complex synthesis. thymidylate

(topical). basal pancreatic keratosis, Colon carcinoma actinic cancer, cell cancer,

with addition of enhanced Effects leucovorin. the

palmarplantar Myelosuppression, erythrodysesthesia (hand-foot syndrome).

 competitively acid Folic dTMP Methotrexate analog that dihydrofolate synthesis. DNA  reductase inhibits

lymphomas, sarcomas. choriocarcinoma, (ALL), Cancers: leukemias

arthritis, (with abortion pregnancy, ectopic psoriasis, rheumatoid misoprostol), Non-neoplastic: vasculitis. medical IBD,

(folinic “rescue.” with leucovorin reversible is Myelosuppression, acid) which

Hepatotoxicity. ulcers). Mucositis (eg, mouth Pulmonary fibrosis. teratogenic without tube supplementation. deficiency, defects) may which Folate (neural be

Nephrotoxicity.

except cycle aAll which cell is nonspecific. specific cladribine, are S-phase

Cyclophosphamide, ifosfamide

hydration. prevented Myelosuppression; SIADH; and (ifosfamide); cystitis binds group with of adequate (sulfhydryl and bladder metabolites) hemorrhagic toxic mesna syndrome Fanconi mesna cancer,

Cisplatin, carboplatin, inhibitors oxaliplatin mechanISm Microtubule DNA. Cross-link

GI, Testicular, clInIcal USe carcinomas. ovary, bladder, and lung

syndrome), Fanconi neuropathy, ototoxicity. peripheral eFFectS Nephrotoxicity adVeRSe (including Prevent amifostine with scavenger) radical and (free nephrotoxicity chloride diuresis. (saline)

in degradation G2 teniposide Etoposide, and II DNA  phases). topoisomerase (cell mechanISm S cycle arrest Inhibit

testicular tumors cell lung cancer), (particularly USe and Solid small lymphomas. clInIcal leukemias,

alopecia. adVeRSe eFFectS Myelosuppression,

replication. Inhibit DNA topoisomerase prevent topotecan unwinding mechanISm and Irinotecan, I and

and lung small ovarian clInIcal cell (irinotecan); (topotecan). cancers USe cancer Colon

Severe eFFectS myelosuppression, diarrhea. adVeRSe

(S-phase Synthesis ribonucleotide Inhibits  mechanISm reductase DNA specific).

Myeloproliferative clInIcal vera), disorders USe HbF). polycythemia cell (eg, CML, sickle (• disease

megaloblastic adVeRSe Severe anemia. eFFectS myelosuppression,

antibody VEGF. mechanISm Monoclonal against Vessel angiogenesis (BeVacizumab inhibits formation). Inhibits Blood

colorectal (eg, clInIcal degeneration. Solid macular age-related renal USe tumors cell cancer, carcinoma), wet

Hemorrhage, eFFectS blood and clots, adVeRSe impaired healing. wound

inhibitor. kinase mechanISm tyrosine EGFR

cell lung Non-small USe cancer. clInIcal

eFFectS Rash, diarrhea. adVeRSe

antibodies panitumumab EGFR. Cetuximab, mechanISm Monoclonal against

cancer. neck clInIcal head IV KRAS), USe cancer Stage and (wild-type colorectal

eFFectS Rash, adVeRSe diarrhea. elevated LFTs,

in (encoded Imatinib, of tumors). fusion gene inhibitors by in Tyrosine and Philadelphia mechanISm GI CML) bcr-abl nilotinib kinase c-kit stromal dasatinib, chromosome (common

clInIcal (GISTs). CML, stromal USe tumors GI

retention. adVeRSe Fluid eFFectS

mechanISm neoplasms. which is against on CD20, antibody B-cell Monoclonal most found

TTP, Non-Hodgkin arthritis, clInIcal CLL, rheumatoid lymphoma, USe AIHA. ITP,

adVeRSe leukoencephalopathy. progressive of  multifocal eFFectS risk

and G2-M arrest induce phase mechanISm Bortezomib, carfilzomib apoptosis. inhibitors, at Proteasome

lymphoma. clInIcal USe Multiple myeloma, cell mantle

reactivation. neuropathy, Peripheral zoster adVeRSe eFFectS herpes

bone. modulators in in receptor Tamoxifen, and (SERMs)—receptor agonists raloxifene mechanISm breast Selective estrogen antagonists cells. binding ⊕ the of to Block estrogen ER

only) cancer prevention. clInIcal USe treatment and (tamoxifen Breast Raloxifene prevent osteoporosis. useful also to

which  Tamoxifen—partial eFFectS risk adVeRSe of agonist in endometrial the endometrium, cancer. Raloxifene—no endometrial  relax! (so carcinoma can you in it receptor tissue. because estrogen in ), an endometrial antagonist is kinase a Monoclonal DVT, thromboembolic (c-erbB2), (eg, “hot risk receptor. antibody flashes.” tyrosine against  Both of and events HER-2 mechanISm PE) antibody-dependent cancer kill of and signaling HER-2 cellular cells that through initiated HER-2 overexpress Helps inhibition cytotoxicity.

and ⊕ HER-2 breast USe clInIcal cancer cancer (tras2zumab). gastric

adVeRSe Dilated cardiomyopathy. eFFectS the heart. damages “Heartceptin”

allantoin. catalyzes metabolism vemurafenib uricase mechanISm to Dabrafenib, acid of Recombinant uric that

Prevention treatment USe of syndrome. clInIcal lysis and tumor

Bleomycin, Busulfan

vomiting, include alopecia. toxicities Nonspecific of chemotherapies GI (neutropenia, thrombocytopenia), common myelosuppression toxicity all mucositis), nearly anemia, (nausea, cytotoxic

function the Musculoskeletal, pull in “To Skin, except you but the human clear life not deep, Connective to to the and may be skeleton bone.” ugly “The frame.” tongue.” and the push, thrive skin the and in habit need case the goes Tissue “Beauty bones. muscle genitals “Rigid, to of upholds three is of of alone A wishbone. backbone. A And a funny bone.”

dermatologic information to diseases, provides rheumatic chapter you This conditions. dysfunctions, anatomical and certain need will understand interpret to able the 3D of context in radiologic Be imaging. anatomy the symptoms: For other create (eg, most include cases markers likely and presentation diseases, rheumatic or instructional important factors, risk gender, epidemiologic that autoantibodies), factors. the personas and on questions exam. to are asked the you will the to order Doing higher likely allow be answer that so

tissUE—anatomy physiology and and ConnECtiVE sKin, `mUsCUlosKElEtal,

that (small muscles form SItS cuff muscles the rotator teres minor). Shoulder Rotator cuff: for t is

initially (suprascapular tear Supraspinatus arm cuff action • of rotator most or nerve)— common abducts injury [arrow and (trauma in or deltoid); the degeneration the tendinopathy (before impingement

can” assessed “empty/full rotates by primarily C5-C6. nerves)—internally test arm A and Innervated adducts by ]),

and MUSCULOSKELETAL, anatomy AND TISSUE III CONNECTIVE SKIN, physiology 447 SECTION `

over Fractured humerus neck Loss (C5-C6) of (> Axillary of surgical deltoid Flattened lateral 15°) abduction Loss dislocation humerus of sensation shoulder of Anterior deltoid arm and arm at

trunk biceps (C5-C7) (C5-6) Weakness and of flexion reflex over Musculocutaneous forearm forearm Loss  sensation compression Upper of lateral supination

strength loss finger (wrist wrist, extension to with crutches and arm Radial of necessary grip drop: over chair palsy”) Wrist extension due sleeping axilla, of (C5-T1) elbow, (“Saturday or night Compression eg, for 

of dorsal of posterior of Repetitive flexors) due (“finger and arm/forearm sensation of hand fracture to Loss maximal over humerus Midshaft eg, use drop”) screwdriver action forearm, pronation/supination

Median “Ape fracture opposition, hand” wrist syndrome index and lateral of fingers flexion, (C5-T1) distal laceration wrist nerve lumbricals Carpal “Pope’s of lesion lesion of humerus flexion Supracondylar of the blessing” thumb and the of nerve fingers, proximal   middle and of Loss tunnel

and dorsal proximal thenar aspects eminence over fingers 31⁄2 of and lateral sensation Loss with palmar lesion of

Ulnar of from (proximal humerus outstretched medial Fractured of of bone” fall (distal (C8-T1) “funny on lesion) epicondyle hook hamate Fracture hand lesion)

lesion) upon flexion wrist of Radial deviation (proximal

and abduction actions wrist of fingers of adduction muscles flexion, lumbrical medial fingers, Loss of 2 medial of (interossei), flexion

including medial sensation fingers Loss 11/2 of hypothenar over eminence

to proximally the • Humerus fractures, • Radial follow ARM Median) (Axillary distally,

AND CONNECTIVE ` SECTION TISSUE anatomy 448 III physiology and MUSCULOSKELETAL, SKIN,

Deltoid blessing” palsy fexing (claw (“waiter’s “Saturday palsy” elbow, Erb drop) variable function, night drop thumb Decreased tip”) palsy Wrist scapula hand) Di⁄culty Klumpke Winged paralysis “Pope’s sensory loss (wrist

claw Intrinsic hand hand, of muscles

Flexion, hangs Abduction DIBs gets Herb Deltoid, neck (arm Erb by Biceps C5-C6 on and brachii tips on during Infants—lateral tear medially tip”) delivery trunk: palsy (arm (“waiter’s traction side) roots or rotated) supination supraspinatus extended upper pronated) of Traction

on Intrinsic palsy muscles: Infants—upward hand: MCP normally claw trunk: Total lumbricals, Klumpke tear of lumbricals arm force Traction hand C8-T1 joints during and or lower flex delivery roots

branch fall) extend PIP break interossei, DIP joints and a hypothenar thenar, (eg, grabbing Adults—trauma tree to a

Cervical as Atrophy outlet (arrows syndrome of lower Same Compression of trunk rib Thoracic Klumpke in intrinsic

edema due and muscles; ischemia, , A compression the to Pancoast scalene pain, vascular hand triangle tumor commonly vessels, and subclavian within most palsy

C5-C7 dissection of anterior above anchor roots after stab long Winged scapula to arm node cannot thoracic  to mastectomy, Lesion cage Inability abduct nerve, of Serratus thoracic (“wings horizontal scapula position heaven”) wounds Axillary

449 SECTION ` TISSUE CONNECTIVE anatomy AND III SKIN, and MUSCULOSKELETAL, physiology

Trapezoid, Pisiform, A. region Lunate, A Triquetrum, Capitate, Trapezium Scaphoid, Hamate, Wrist

most Long to fractured on To Pinky, typically due commonly hand. outstretched 1st the is a MC Thumb) The Here Hamate an bone, fall (So Trapezium Comes carpal

proximal of from branch of and to retrograde Complications blood necrosis fractures avascular scaphoid radial supply due nonunion the include artery. a not initial on x-ray. always seen Fracture

syndrome. cause tunnel may lunate acute Dislocation of carpal

of Plane section

SECTION SKIN, ` physiology CONNECTIVE 450 and anatomy AND III TISSUE MUSCULOSKELETAL,

MUSCULOSKELETAL, III ` anatomy 451 SECTION TISSUE physiology and AND CONNECTIVE SKIN,

a muscles of the the extrinsic balance the flexors Distortions as DIP and of joints). the the extension of as At hand, lumbrical of hand—particularly muscles extensors exists well the (flexion hand between and of PIP intrinsic MCP, rest, distal median with lesions nerves. “Clawing”—seen best ulnar or of extrinsic flex fingers digits flexors DIP at of exaggerate of and joints. at the the the  loss PIP lumbricals Remaining MCP, extend digits. less Deficits flexion the in during lesions; of deficits voluntary proximal present pronounced

eminence hypothenar hand”) lesions, seen the “ape Atrophy atrophy of be eminence thumb lesions. (unopposable seen while in ulnar nerve can nerve thenar the be  can of in median Note:

Actions muscles hip of

physiology MUSCULOSKELETAL, and SECTION TISSUE anatomy III CONNECTIVE AND SKIN, ` 452

Pelvic (L2-L4) thigh adduction ( pectineus, surgery adductor  and sensation thigh, externus, sartorius pectineus, gracilis, Sensory—anterior Sensory—medial reflex) (L2-L4) iliacus, adductor Pelvic fracture longus, brevis, leg Motor—obturator Femoral magnus  (medial) thigh leg patellar extension medial Obturator adductor Motor—quadriceps,

SKIN, MUSCULOSKELETAL, III physiology ` TISSUE CONNECTIVE 453 anatomy and SECTION AND

nerve: peroneal Superficial

webspace of peroneal foot and between (except brevis hallux digit) 2nd nerve: and Deep Sensory—dorsum

foot muscles Motor—biceps plantaris, (long triceps anterior popliteus, flexor surae, femoris Motor—tibialis head), of foot Sensory—sole of

aspect medius, or of fracture compression neck latae tensor fascia of minimus, lateral Trauma fibular Motor—gluteus gluteus leg,

lesion) Baker tarsal (proximal Knee tunnel trauma, (distal cyst lesion); syndrome

= foot injection region) during injured, and superomedial (prevent to gluteal region preferably Iatrogenic if dropPED choosing Everts Peroneal PED intramuscular anterolateral quadrant, Dorsiflexes; superolateral injury by

foot of dorsum of Loss on sensation

“steppage loss rest, gait” of plantarflexed eversion and dorsiflexion; Foot drop—inverted at and

Inverts TIP can’t and Plantarflexes; TIPtoes injured, on stand = if Tibial

inversion in with to Inability everted and proximal on sensation of at loss curl flexion plantar sole; toes rest foot of and loss lesions,

weight-bearing pelvis maintain tilts through hip of sign/gait— Trendelenburg cannot because leg alignment abduction pelvis

to which of the is contralateral side that on hip the drops, to ipsilateral stands patient Lesion the extremity

and AND physiology CONNECTIVE TISSUE MUSCULOSKELETAL, ` anatomy SKIN, SECTION III 454

exam condyle Lateral anterior ACL. femoral to Knee tibia: PCL. femoral to posterior Medial condyle tibia: LAMP.

SECTION AND SKIN, TISSUE 455 ` CONNECTIVE physiology anatomy MUSCULOSKELETAL, and III

common as sprain sprain. sprains ankle classified Anterior a Ankle ankle ligament—most low TaloFibular overall, overinversion/supination of to foot. Due ankle ligament—most sprain. common Anterior high inferior tibiofibular Tears Always First.

associated. the which are by with Neurovascular arteries together named they bones/regions are frequently and Nerves pairing following naming are to this convention. exceptions The

humerus neck circumflex of Axillary Posterior Surgical

SECTION physiology and ` TISSUE anatomy MUSCULOSKELETAL, SKIN, III 456 CONNECTIVE AND

contact for the to T-tubules action are of striated reticulum, extensions in muscle of sarcoplasmic membrane Motoneuron muscles. with coordinated allowing contraction potential plasma contraction

(ACh) inducing potential acetylcholine presynaptic channels, opens voltage-gated Ca2+ release. Action muscle end leads the binding ACh Postsynaptic at motor to plate. cell depolarization entire muscle the deep over travels the cell Depolarization the into T-tubules. via and muscle (RR) reticulum sarcoplasmic conformational induces Ca2+ changes the receptor coupled into the from (DHPR) depolarization the Membrane ryanodine • voltage-sensitive receptor dihydropyridine release and its mechanically cytoplasm. in actin blocking the Tropomyosin myosin-binding is sites on filament. to (TnC), binds Ca2+ the myosin-binding expose troponin shifting tropomyosin Released to sites. C forming binds strongly myosin actin, a to head crossbridge. The initiating is power released, then Pi the stroke. stroke, During is as the produced power pulls force thin the myosin on filament

A . Muscle occurs, shrinkage). between H of lines shortening and shortening bands (HIZ Z I and with length). remains band same band length (A Always same the The the A is power is end the ADP released of the at stroke. myosin head filament. molecule causes Binding detachment from new ATP of of actin Ca2+ resequestered. is and ATP (cocked). returning to in high-energy Pi ADP myosin head into position hydrolysis results Ca2+ to a bind can remains crossbridge new The a to actin myosin on head site available. form if

to Sarcomere line (Z line) Z

MUSCULOSKELETAL, physiology SKIN, TISSUE and III CONNECTIVE AND anatomy 457 SECTION `

Types of fibers muscle

bradykinin, Acetylcholine, etc

physiology AND and CONNECTIVE ` anatomy SKIN, III SECTION 458 TISSUE MUSCULOSKELETAL,

Specialized relay dynamics. Muscle receptors that about muscle information sensory proprioceptors

clavicle. and of Membranous calvarium, bones, facial Bones formed Woven bone directly cartilage. without to remodeled Later ossification bone. lamellar

MUSCULOSKELETAL, pathology 459 SECTION SKIN, III TISSUE ` CONNECTIVE AND

bone Cell of biology

catalyzing Builds alkaline Osteoblast by in and mineralization bone secreting collagen environment via ALP. periosteum. cells stem from Differentiates in mesenchymal Osteoblastic propeptides of activity by measured type procollagen. ALP, I osteocalcin, bone

secreting by Dissolves bone Osteoclast collagenases. (“crushes”) H+ and of from monocyte/macrophage Differentiates precursors. fusion a lineage by osteoblasts). on receptors ligand, (RANK stimulated on osteoclasts expressed are RANKL RANK OPG RANKL decoy osteoclast to  interaction a RANKL prevent RANK-RANKL activity. binds receptor) (osteoprotegerin,

and sKin, `mUsCUlosKElEtal, tissUE—pathology ConnECtiVE

elbow Overuse the injuries of

Also called neck fracture. boxer’s Metacarpal closed punching fracture a Common by caused from direct with wall). fist a (eg, fracture blow and metacarpals 4th seen in Most 5th commonly

A .

(between Entrapment of ligament nerve distribution pain, nerve and bones) in and  compression carpal of in carpal paresthesia, numbness carpal median  median transverse nerve. tunnel atrophies eminence Thenar

enters because external spared, branch cutaneous tunnel. to sensation B palmar carpal hand but

Tinel of (90° wrist tingling). (percussion sign of Phalen wrist by tingling) Suggested causes causes and maneuver ⊕ flexion

diabetes, pregnancy repetitive with with associated edema), may arthritis, hypothyroidism, dialysis-related use. acromegaly, be (due amyloidosis; Associated rheumatoid to

SECTION III CONNECTIVE ` SKIN, 460 MUSCULOSKELETAL, TISSUE AND pathology

and birth trauma. in children fractures Common as Clavicle Usually trauma by a outstretched by shoulder. hand caused to on or fall direct common. middle of at lateral point middle the thirds; segment Weakest are most junction fractures at and the third arm to weight (lateral by fragment drop, due adductors major]). pectoralis rotated Presents medially and clavicle shortened [eg, depressed arm shoulder as is

sports to in planted foot. applied triad” “Unhappy a contact to force injury due lateral Common Consists damage and MCL, to MCL). medial A of to meniscus ACL , (attached the involvement common ACL MCL is and with more However, than lateral injury. meniscus and joint pain acute of signs with instability. Presents

pathology TISSUE MUSCULOSKELETAL, III ` CONNECTIVE SECTION SKIN, 461 AND

heel steps in with morning inactivity) characterized first of period by tenderness. and (worse the Plantar fasciitis after aponeurosis pain or plantar Inflammation of

acetabulum newborns. Abnormal Developmental in development breech risk includes Major presentation. factor Results hip instability/dislocation. hip of in dysplasia the and maneuvers of “clunk”). newborn a Ortolani hip with tested reveals Barlow (manipulation Commonly because not Confirmed used cartilage ultrasound ossified). months ~4–6 is until (x-ray via not

necrosis of femoral Legg-Calvé-Perthes Idiopathic head. avascular 5–7 onset hip presents may years limp. pain child of to that Commonly with insidious disease cause between ratio). males common (4:1 More in x-ray normal. Initial often

Also traction Osgood-Schlatter apophysitis. called the repetitive Overuse ossification injury strain of secondary disease caused center by tubercle. chronic tibial avulsion of proximal and Occurs growth after spurt. adolescents in Common running and in athletes. jumping progressive with Presents knee anterior pain.

TISSUE III MUSCULOSKELETAL, ` SECTION pathology CONNECTIVE 462 SKIN, AND

longitudinal limbs. bone Achondroplasia (endochondral  of short Failure growth ossification) not large is relative Membranous ossification head  affected limbs. to of chondrocyte proliferation. fibroblast Constitutive growth receptor inhibits factor activation (FGFR3) actually (homozygosity is occur mutations dominant with > full autosomal 85% of lethal). sporadically; penetrance age. Associated with paternal  cause common short-limbed of Most dwarfism.

(spongy) lose mass normal PO43−). Trabecular bone lab and and and Ca2+ mineralization values despite bone (serum cortical

resorption age. to levels  bone Most related due commonly  and to estrogen old thyroid drugs to (eg, steroids, anorexia). conditions be therapy) malabsorption anticonvulsants, hyperthyroidism, myeloma, alcohol, Can or (eg, replacement hyperparathyroidism, anticoagulants, other multiple 2° syndromes,

or by minimal lumbar spine, T-score hip, by at Diagnosed mineral standing neck, hip (dual-energy with total ≤−2.5 vertebra. measurement of absorptiometry) (eg, X-ray femoral density fall from the DEXA height, fragility a or by at and a trauma) bone fracture in ≥ women screening years old. time One 65 recommended

Ca2+ Prophylaxis: and weight-bearing vitamin adulthood. and adequate intake D throughout regular exercise

denosumab against RANKL). calcitonin; antibody Treatment: teriparatide, bisphosphonates, SERMs, rarely (monoclonal

height, —acute back loss vertebral fractures pain, compression lead to of A Can kyphosis. distal fractures neck, with femoral fracture). radius (Colles can present Also of

intervertebral expansion disc intervertebral Restricted foramen Central of

CONNECTIVE MUSCULOSKELETAL, TISSUE pathology AND 463 III ` SECTION SKIN,

defective due are dense Failure osteoclasts  to that normal to resorption bones fracture. Osteopetrosis bone of thickened, prone Mutations osteoclast carbonic for to impair of environment II) anhydrase generate (eg, ability acidic resorption. necessary bone bone extramedullary cortical of hematopoiesis. space fills  marrow pancytopenia, Overgrowth Can due and impingement palsies nerve result to in cranial narrowed foramina.

show diffuse symmetric ). bone” “stone sclerosis X-rays (bone-in-bone, A curative marrow monocytes. osteoclasts from derived potentially as is transplant Bone are

cartilaginous (rickets, in mineralization osteoid only of or Defective (osteomalacia) growth children). plates D deficiency. vitamin commonly Most to due

in osteomalacia, zones” (pseudofractures) and “Looser epiphyseal osteopenia rickets. in and metaphyseal widening cupping/fraying show X-rays varum Children (genu legs rickets bow pathologic have with

craniotabes ), B bead-like costochondral (rachitic skull). ), rosary junctions A (soft

 . PO43− serum ALP. osteoblasts  of Hyperactivity

disease Also Paget of called bone. forms osteoblastic osteoclastic activity Common, by poor-quality remodeling of bone. that  activity by  bone followed localized caused disorder levels , Serum phosphorus, PTH Ca2+ and are normal.  ALP. chaotic Mosaic woven juxtapositions); long within fractures. chalk-stick of in (osteocytes bone lacunae lamellar bone and pattern  from • shunts high-output failure. flow cause heart blood may arteriovenous risk of  osteosarcoma.

due be Hat to is auditory hearing ; loss can to foramen due common size A thickening increased skull narrowing.

Stages bisphosphonates. Paget of Treatment: activity disease:

of necrosis bone Avascular

usually of marrow, Infarction and bone very painful. (due insufficiency to femoral femoral (watershed zone) artery). medial common Most circumflex head A is site of disease SLE, femoral Trauma, Causes disease, cell Corticosteroids, LEgg-Calvé-Perthes Bends” Gaucher “the disease), LEGS. (caisson/decompression (idiopathic), epiphysis—CASTS Slipped capital Sickle disease, Bend include Alcoholism,

Branch obturator artery of

AND MUSCULOSKELETAL, pathology 464 CONNECTIVE TISSUE ` III SKIN, SECTION

III SECTION ` pathology 465 MUSCULOSKELETAL, CONNECTIVE AND TISSUE SKIN,

of cells neuroectodermal small lymphocytes) Anaplastic origin (resemble blue

. F

(fusion (eg, morphology chronic from osteomyelitis) with lymphoma, conditions EWS-FLI1). testing Differentiate protein similar t(11;22) for by

skin” in reaction bone. periosteal “Onion

with Aggressive early responsive chemotherapy. but metastases, to

33 Ewing’s number). 11 (Patrick jersey 22 + =

` CONNECTIVE pathology MUSCULOSKELETAL, SECTION TISSUE AND III 466 SKIN,

spurs), joint (bone subchondral and space narrowing, sclerosis cysts. Findings Joint Osteophytes 2000/mm3). noninflammatory Synovial fluid < (WBC (at (at PIP), MCP. Heberden DIP) and 1st nodes C of not CMC; B and nodes Development Bouchard

subchondral soft space narrowing. Erosions, joint tissue juxta-articular osteopenia, swelling, cysts, swan deviation, Deformities: subluxation, ulnar finger cervical neck

E . boutonniere D , not PIP, Involves MCP, wrist; CMC. or 1st DIP

include of syndrome), neutropenia palisading rheumatoid (Felty syndrome), anemia (fibrinoid carpal and nodules amyloidosis, lung tunnel (+ + Sjögren pneumoconiosis AA pleuritis, • disease, pericarditis, *Extraarticular manifestations splenomegaly syndrome, syndrome. with interstitial subcutaneous disease, histiocytes) necrosis lung tissue Caplan in chronic scleritis,

467 MUSCULOSKELETAL, SECTION CONNECTIVE AND SKIN, pathology TISSUE ` III

in precipitation caused of A monosodium inflammatory . Acute Findings urate crystals by monoarthritis joints male obesity, alcohol use. sex, hypertension, factors: diabetes, Risk dyslipidemia, caused can hyperuricemia, be is by: risk which Strongest factor

be renal exacerbated of patients)—largely (eg, can by diuretics). idiopathic, acid by medications potentiated (90% of Underexcretion certain thiazide failure; uric

Overproduction von lysis of acid (eg,  excess, Gierke uric PRPP syndrome, patients)—Lesch-Nyhan cell turnover disease. syndrome), (10% of tumor

under needle birefringent light light light, (yellow under shaped and ⊝ are parallel blue under perpendicular B ). polarized Crystals an attack. during may normal levels acid uric be acute Serum

distribution. symptoms Asymmetric joint is red, swollen, Joint painful. and joint big MTP (podagra). is manifestation of toe Classic painful on C olecranon ear, Achilles bursa, tendon). formation or external (often Tophus in for Acute purines alcohol a attack dehydration, compete acid subsequent (eg, to foods or in sites tends after buildup metabolites with in meal acid uric uric occur meat, excretion same red large kidney trauma, rich as  and surgery, secretion consumption diuresis, blood). (alcohol seafood),

(eg, Acute: colchicine. tREatmEnt NSAIDs glucocorticoids, indomethacin), oxidase (eg, Chronic allopurinol, inhibitors xanthine (preventive): febuxostat).

pseudogout. Previously called The Deposition space. Parallel), Positive (when P’s—blue crystals blue within of pyrophosphate calcium joint birefringence, the calcium Pyrophosphate, Pseudogout both 50 patients years sexes affected old; Occurs in > equally. joint associated idiopathic, Usually trauma. hyperparathyroidism, sometimes with hemochromatosis,

degeneration chronic (pseudo-osteoarthritis). swelling (pseudogout) and/or with inflammation and Pain acute joint commonly Most is affected knee. the

(cartilage calcification) Chondrocalcinosis x-ray. on

light when weakly ⊕ light) birefringent Crystals are rhomboid and to under polarized (blue parallel

. A

colchicine, treatment: glucocorticoids. NSAIDs, Acute Prophylaxis: colchicine.

TISSUE MUSCULOSKELETAL, SECTION pathology III AND 468 CONNECTIVE SKIN, `

Septic common are gonorrhoeae arthritis causes. and Streptococcus, S Neisseria aureus, painful. is joint swollen and , A red, Affected fluid > Synovial (WBC purulent 50,000/mm3). pustules). purulent (eg, that arthritis either knee) dermatitis polyarthralgia, tenosynovitis arthritis—STI (eg, as or triad (eg, of Gonococcal presents hand),

III CONNECTIVE ` SECTION MUSCULOSKELETAL, pathology 469 AND TISSUE SKIN,

AND III 470 ` pathology SECTION MUSCULOSKELETAL, TISSUE SKIN, CONNECTIVE

can either and Libman-Sacks surface Endocarditis—nonbacterial, valve mitral or usually undersurface). on (but usually present of on aortic on be valve the thrombi verrucous LSE SLE. in

hematuria DNA-anti-DNA nephritis complexes) proteinuria). nephrotic or be or can Lupus of (glomerular (causing immune deposition nephritic Most diffuse common is proliferative. type and severe

SLE: Cardiovascular (most causes of disease common), in (accelerated Infections, Renal death disease Common CAD).

anti-SSA block,  newborn of and ⊕ woman, transaminitis, an lupus at neonatal cytopenias In heart congenital rash, risk developing birth.  pregnant periorbital/diffuse

(malar OR Rash RASH PAIN:

Photosensitivity (eg, antibodies painless) Neurologic discoid disorder or ) ulcers A Oral/nasopharyngeal psychosis) Immunologic (eg, antiphospholipid) anti-Sm, cytopenias) Hematologic disease B disorders pericarditis) (usually (nonerosive) disorders (eg, pleuritis, seizures, Arthritis Antinuclear Renal Serositis (anti-dsDNA,

Cheeks. die their with patients Lupus In Redness

connective tissue of Features SLE, polymyositis. systemic disease sclerosis, Mixed and/or with Associated RNP ANA). antibodies anti-U1 (speckled

in (most autoimmune disorder or 1° commonly 2° SLE).

(arterial laboratory based history with thrombosis on of along anticoagulant, venous) glycoprotein Diagnosed anti-β2 criteria of anticardiolipin, abortion spontaneous clinical findings lupus antibodies. including I or or

systemic Treatment: anticoagulation.

Anticardiolipin can antibodies false-positive cause VDRL/RPR.

Lupus can not platelet-free corrected anticoagulant that by cause plasma. is addition the of PTT normal prolonged

in malaise, and Pain with fever, proximal symptoms hips), muscles stiffness weight shoulders, often loss. (eg, Does weakness. cause muscular not giant in 50 More > associated cell years old; women (temporal) with arteritis. common

ESR, normal CK.   Findings CRP,

corticosteroids. tREatmEnt to Rapid response low-dose

AND 471 MUSCULOSKELETAL, pathology SECTION ` TISSUE CONNECTIVE SKIN, III

MUSCULOSKELETAL, SKIN, TISSUE AND III pathology CONNECTIVE ` 472 SECTION

color flow change vessel) (small skin in (ischemia) due cold arteriolar to Raynaud (reperfusion). blood white (hypoxia)  phenomenon vasospasm stress: response to red to or from to to blue in fingers often A Most and the toes. to mixed when syndrome sclerosis). when 1° or Raynaud as such SLE, of systemic 2° disease disease tissue form process Raynaud (idiopathic), a syndrome CREST connective disease, (limited Called in seen 2° Raynaud syndrome. (critical Digital ischemia) ulceration with blockers. channel calcium2+ Treat

dERmatology SKIN, MUSCULOSKELETAL, AND III SECTION CONNECTIVE TISSUE 473 `

Scleroderma sclerosis. Systemic vasculopathy, Triad deposition collagen autoimmunity, fibrosis. noninflammatory of with and as manifesting A skin pitting without of fingertip puffy, wrinkles, Commonly skin, taut B sclerosis . renal renal eg, GI other fibrosis, reflux), ACE pulmonary pulmonary Can crisis; treat and systems, inhibitors), cardiovascular. (esophageal (scleroderma dysmotility involve (interstitial HTN), with female. 75% 2 major types:

early skin visceral rapid involvement, scleroderma—widespread progression, involvement. Diffuse antibody) and with anti-RNA (anti-DNA Associated antibody anti-Scl-70 polymerase III. topoisomerase-I

Limited skin confined face. to involvement and fingers scleroderma—limited Sclerodactyly, Esophageal with CREST Telangiectasia. and cutis , phenomenon, anti-Centromere Also dysmotility, Raynaud C Calcinosis antibody, syndrome: course. clinical More benign

ConnECtiVEtissUE—dERmatology ` sKin,and mUsCUlosKElEtal,

Skin dermis, subcutaneous layers subcutis). epidermis, 3 fat (hypodermis, Skin has layers: Epidermal Come, Burned. layers: Let’s Get Sun

474 TISSUE SKIN, III AND dERmatology MUSCULOSKELETAL, CONNECTIVE ` SECTION

A (zonula and junctions occludins. claudins composed of Tight solutes; paracellular movement of occludens) –prevents

proteins). adhesion (Ca2+-dependent CADherins connecting zonula adherens) (belt junction adjacent cytoskeletons actin cells of “belt” Adherens desmosome, B –forms with metastasis. promotes of E-cadherin Loss

via C Desmosome filament macula interactions. intermediate desmosome, adherens) (spot –structural support Autoantibodies and/or • desmoglein 1 pemphigus to vulgaris. 3

connexons communication –channel and permit proteins called between cells. D chemical electrical

cells –connects E to basement basal in underlying keratin membrane. Autoantibodies bullous pemphigoid. • down “bullow.”) are (Hemidesmosomes

proteins collagen, basement and maintain membrane in Integrins–membrane by integrity membrane. that binding fibronectin of basolateral laminin, to

CONNECTIVE AND III dERmatology 475 SECTION ` TISSUE MUSCULOSKELETAL, SKIN,

III ` SKIN, MUSCULOSKELETAL, 476 dERmatology TISSUE CONNECTIVE SECTION AND

with rich dermatitis region. as areas scales well-demarcated and such Seborrheic in sebaceous plaques glands, face, yellow periocular Erythematous, A scalp, in greasy in cap) both disease. Common and infants Parkinson with associated (cradle adults, in not role play Sebaceous development. but glands are inflamed, a disease spp. associated Malassezia with Possibly and antifungals topical Treatment: corticosteroids.

SKIN, 477 dERmatology III ` TISSUE SECTION AND MUSCULOSKELETAL, CONNECTIVE

Acne colonization (papules/pustules sebum/androgen and desquamation, production, A inflammation etiology—• abnormal Cutibacterium keratinocyte , the nodules, of (comedones), unit Multifactorial pilosebaceous acnes cysts). and retinoids, benzoyl antibiotics. peroxide, Treatment:

by facial and firm, Pseudofolliculitis characterized painful pruritic. Foreign and are pustules barbae inflammatory body that papules skin disorder hyperpigmented Located on cheeks, neck. jawline, and a African-American shaving Commonly bumps”), affects result (“razor males. primarily as of occurs

especially knees H on Psoriasis and elbows. scaling with silvery , Papules plaques and with Acanthosis corneum), parakeratotic microabscesses. scaling (nuclei in stratum Munro still  stratum  stratum granulosum. spinosum, spots exposure from ( scraped dermal sign are Auspitz off. when of scales )—pinpoint bleeding papillae I arthritis. pitting Associated with nail and psoriatic

erythematous no by Inflammatory comedones. skin facial pustules J , papules disorder but characterized and Rosacea with alcohol, in stimuli response (eg, external facial to May be heat). flushing associated (bulbous of Phymatous rosacea can cause rhinophyma deformation nose).

immature of greasy, keratin-filled epithelial cysts keratosis K squamous keratinocytes pigmented with proliferation Seborrheic . cysts) (horn Flat, head, on Looks “stuck trunk, occur on.” extremities. Lesions and neoplasm older Common of benign persons. possible (eg, Leser-Trélat indicates multiple keratoses, GI L —rapid sign adenocarcinoma). onset seborrheic malignancy of

low-risk caused Warts; Verrucae by strains. HPV hyperkeratosis, koilocytosis. M. cauliflower-like tan-colored, hyperplasia, Soft, Epidermal papules anus on acuminatum genitals or N . Condyloma

Urticaria Hives. mast wheals cell form Pruritic after . O degranulation that superficial lymphatic by edema and dilation. dermal channel Characterized

CONNECTIVE AND ` SECTION 478 MUSCULOSKELETAL, TISSUE dERmatology SKIN, III

tumors skin Vascular of

painful, under commonly Glomus tumor, C fingernails . Benign, tumor red-blue glomus smooth thermoregulatory cells from the body. modified of muscle Arises

dERmatology AND SKIN, CONNECTIVE III MUSCULOSKELETAL, ` SECTION TISSUE 479

dermis of and painful, spreading Cellulitis deeper tissues. Acute, infection subcutaneous S S Usually pyogenes aureus. or from D skin starts infection Often trauma in break or from another . a with

(shingles). and varicella virus (chickenpox) zoster zoster Causes Varicella stages to presents in with Varicella crops multiple lesions of vesicles various from crusts. is reactivation (unless it disseminated). virus of dermatomal Zoster in distribution the is a

plaques that off leukoplakia cannot be lateral Hairy scraped painless tongue on white, Irregular,

J . mediated. EBV HIV-positive in organ Occurs recipients. patients, transplant (precancerous). with and leukoplakia thrush Contrast (scrapable)

dERmatology CONNECTIVE fatal. pathophysiology SKIN, MUSCULOSKELETAL, AND III Potentially SECTION TISSUE ` 480 Most commonly seen in adults. older II hypersensitivity Type reaction. keratinocytes stratum desmoglein-1 (component in and/or spinosum). desmosomes, of against desmoglein-3 which antibodies connect IgG the

pemphigus severe Less vulgaris. than adults. Most older in commonly seen Type II reaction. hypersensitivity

are antibodies epidermis). “bullow” the hemidesmosomes antibodies (epidermal against IgG membrane; basement

C eosinophils; acantholysis moRphology mucosa containing Flaccid oral spared. bullae A keratinocytes, caused gRoss blisters “row Tense by intraepidermal (separation of sign Nikolsky ⊝. stain); mucosa tombstones” H&E is oral involved. on of ⊕. Nikolsky sign

immUnoFlUoREsCEnCE . Reticular around cells epidermal pattern B D epidermal-dermal . at junction Linear pattern

TISSUE AND dERmatology III SKIN, ` MUSCULOSKELETAL, SECTION 481 CONNECTIVE

. D

drug adverse reaction. is more surface > necrolysis of area. involving Toxic epidermal SJS severe (TEN) form EF 30% body involvement 10–30% denotes SJS-TEN.

AND SKIN, III CONNECTIVE ` SECTION dERmatology TISSUE MUSCULOSKELETAL, 482

Acanthosis thickening axilla skin, nigricans causing Epidermal hyperpigmented in hyperplasia especially symmetric, of

AB . insulin Cushing obesity, diabetes, syndrome, Associated resistance with (eg,

adenocarcinoma). malignancy PCOS), (eg, visceral gastric

Actinic keratosis caused by lesions Premalignant exposure. sun or papules brownish or rough, Small, erythematous

CD . epithelial degree Risk to proportional carcinoma cell squamous is dysplasia. of of burn injury Rule 9’s body a extent of surface of of area. the as a can be The estimated percentage

. H

CONNECTIVE 483 AND TISSUE ` dERmatology III SKIN, MUSCULOSKELETAL, SECTION

Entire (R) (L) head 9 4.5 Perineum 1% 18% Entire Entire 1 9 4.5 4.5 Entire (R) (L) 4.5 9 Total 9% 4.5 9 18% Entire arm 100% abdomen 18% Entire torso leg 9% 9 leg 9 4.5 arm 9 18% 9 Entire 9%

dERmatology SKIN, III TISSUE SECTION CONNECTIVE AND 484 MUSCULOSKELETAL, `

carcinoma cell cancer. lower Basal skin lip common strongly more cell common cancer exposure above Skin upper predisposes Squamous below more to carcinoma lip Sun

Basal carcinoma Most cancer. skin cell common sun-exposed (eg, body face). of areas in Found Locally but metastasizes. rarely invasive, ulceration. pink, , A telangiectasias, crusting borders or nodules, pearly rolled with Waxy, commonly central BCCs a scaling C as appear plaque also as (superficial . or ulcers nonhealing infiltrating BCC) B with growth Basal tumors D nuclei have (aligned) “palisading” cell .

individuals. in Keratoacanthoma and middle-aged Seen elderly squamous resembles cell carcinoma. Rapidly growing, dome-shaped as center. Presents keratin-filled nodule with may (4-6 weeks) rapidly spontaneously and Grows regress

. E

Common Melanoma with metastasis. risk of tumor significant S-100 marker. tumor with risk. at Associated dysplastic nevi; are persons fair-skinned  with tumor thickness) metastasis. of Depth correlates of (Breslow risk over Look irregularity, Asymmetry, for Diameter Evolution time. mm, 6 > and the Color Border ABCDEs: variation, superficial I including lentiginous . maligna prevalence acral At African-Americans least (highest lentigo different types nodular , in , spreading of , and and melanoma, 4 H G F Asians) in by driven kinase. mutation activating BRAF Often with excision treatment appropriately Primary wide is margins. may melanoma patients mutation unresectable a BRAF benefit BRAF inhibitor. or V600E from in Metastatic vemurafenib, kinase with

MUSCULOSKELETAL, SKIN, `mUsCUlosKElEtal, and III tissUE—phaRmaCology ConnECtiVE vasodilation. 485 TISSUE phaRmaCology SECTION sKin, ` CONNECTIVE AND

(reversible) Diclofenac COX-2 •uterine CarboprostAlprostadil ENDOPEROXIDE agent. NSAIDs Other COX-2 ThromboxaneProstaglandinsProstacyclin neutrophil PGE1 Indomethacin COX-2 I˜B aggregation Aspirin ONLY •vascular endoperoxides •platelet COX-1 •vascular tone Cyclic tone •uterine COX-1, SYNTHESIS chemotactic NF-˜B aggregation (corticosteroids) tone PGI2 •vascular Naproxen (irreversible) •platelet Ketorolac (cyclooxygenase)KetorolacNaproxenGlucocorticoids a is tone DinoprostoneEpoprostenol Celecoxib TXA2PGF2˜PGE2 Ibuprofen tone inhibits aggregation “B4” arrive Neutrophils others. and platelet promotes Inhibitor. Platelet-Gathering

mostly inhibits mEChanism Reversibly cyclooxygenase, CNS. in peripherally. Inactivated

not but CliniCal UsE anti-inflammatory. analgesic, Antipyretic, with children Reye in avoid aspirin syndrome viral of to Used instead infection.

necrosis; liver. in (NAPQI) and hepatic tissue byproducts glutathione toxic EFFECts Overdose acetaminophen metabolite depletes produces forms adVERsE N-acetylcysteine glutathione. is antidote—regenerates

that TISSUE  COX-2) inhibits ` and 486 mEChanism irreversibly III MUSCULOSKELETAL, covalent synthesis CONNECTIVE SECTION of prostaglandins. NSAID TXA2 and COX-1 AND acetylation by cyclooxygenase (both phaRmaCology SKIN, time.  bleeding PTT. PT, on No effect produced. are lasts Effect until platelets new

Low 300 mg/day): (<  UsE dose CliniCal platelet aggregation. Intermediate mg/day): antipyretic analgesic. (300–2400 dose and (2400–4000 High dose anti-inflammatory. mg/day):

tinnitus reactions (CN allergic or adVERsE polyps). VIII), EFFECts asthma with Gastric nasal ulceration, in (especially patients to acute injury, Chronic interstitial can lead bleeding. use kidney GI nephritis, for Risk in treated of with Reye viral syndrome infection. aspirin children respiratory alkalosis. doses mixed early, transitions alkalosis but acidosis-respiratory metabolic cause Toxic to NaHCO3. of Treatment overdose:

inflammatory inhibits (“Selecoxib”), mucosa. the mediates and helps spares Reversibly vascular gastric (COX) and maintain inflammation is cyclooxygenase and which cells and endothelium selectively isoform found in pain; mEChanism which 2 COX-1, the effects lining. NSAIDs not of the have corrosive Thus, on other GI does production Spares dependent on COX-1. platelet is TXA2 function as

osteoarthritis. arthritis, UsE Rheumatoid CliniCal

 thrombosis, allergy. EFFECts sulfa risk adVERsE of

naproxen, Ibuprofen, diclofenac, ketorolac, piroxicam. indomethacin, meloxicam, Nonsteroidal mEChanism inhibit (both anti-inflammatory and drugs Reversibly COX-1 COX-2). cyclooxygenase synthesis. prostaglandin Block

CliniCal Antipyretic, analgesic, UsE anti-inflammatory. Indomethacin close to is used PDA. a

gastric renal protect ulcer (prostaglandins nephritis, vasodilate Interstitial adVERsE arteriole), EFFECts afferent anemia. aplastic ischemia mucosa), (prostaglandins gastric

preventing synthesis. dehydrogenase, mEChanism Reversibly pyrimidine inhibits dihydroorotate proliferation. T-cell Suppresses

arthritis, psoriatic UsE Rheumatoid CliniCal arthritis.

teratogenicity. Diarrhea, EFFECts hypertension, adVERsE hepatotoxicity,

zoledronate. ibandronate, Bisphosphonates risedronate, Alendronate,

bind activity. hydroxyapatite in bone, analogs; mEChanism osteoclast inhibiting Pyrophosphate

imperfecta. Osteoporosis, UsE disease, bone, bone hypercalcemia, metastatic disease CliniCal of osteogenesis Paget

take atypical to upright of fractures. remain water stress patients are orally, jaw, femoral adVERsE and for with osteonecrosis advised EFFECts Esophagitis minutes), (if taken 30

487 SKIN, AND analog. TISSUE Recombinant CONNECTIVE mEChanism MUSCULOSKELETAL, SECTION ` phaRmaCology PTH III osteoblastic  in activity pulsatile fashion. when administered

CliniCal Osteoporosis. UsE to compared (eg, Causes antiresorptive therapies bisphosphonates). growth  bone

alkaline phosphatase). of in the unexplained or elevation patients with of bone EFFECts of risk Paget (avoid osteosarcoma disease use adVERsE  or Avoid cancers have had who radiation therapy. patients prior in Transient hypercalcemia.

xanthine to Allopurinol hypoxanthine Competitive  conversion inhibitor of of urate. oxidase and xanthine leukemia nephropathy. lysis–associated in and used tumor lymphoma prevent Also urate to oxidase metabolites, 6-MP. xanthine concentrations active and azathioprine,  of

allantoin more acid product). water-soluble Pegloticase Recombinant uricase catalyzing uric to (a

proximal reabsorption in uric APainful Inhibits Flare. Prevent acid Probenecid of inhibits secretion tubule (also convoluted penicillin). of acid uric Can precipitate calculi.

Allopurinol, Febuxostat

Febuxostat xanthine oxidase. Inhibits

Any NSAID. NSAIDs caution decrease Use acid excretion, salicylates with uric particularly at (may

Diuretics,low doses). low-dose salicylates

intra-articular, or Glucocorticoids Oral, parenteral. polymerization, to chemotaxis and Binds tubulin microtubule and impairing degranulation. Colchicine inhibit neutrophil stabilizes Acute value. and prophylactic neuromyopathic GI, side effects.

Tubular Probenecid, salicylates high-dose Urine reabsorption

DNA. produced IgG1 recombinant Fc), Etanercept protein receptor TNF-α (decoy Fusion by for + intercepts TNF. Etanercept

adalimumab, certolizumab, golimumab Infliximab,

Anti-TNF-α antibody. monoclonal

spondylitis psoriasis, Rheumatoid arthritis, ankylosing

reactivation spondylitis, including bowel TB, infection, psoriasis Inflammatory arthritis, granuloma ankylosing of to TNF stabilization. since important disease, formation Predisposition and in latent rheumatoid is

also lead to lupus. drug-induced Can

connected all by Internet, like neurons brain.” enough nerve.” are II the giant phaRmaCology got now a AND “Anything’s ` MUSCULOSKELETAL, you’ve TISSUE 488 CONNECTIVE —J.K. if in “We SKIN, SECTION possible “I —Dr. Rowling, the Potter brain and Phoenix the up the like of it wakes cells.” nonsense; Order Harry how secrets, [the not but the believe more operates an brains in brain unsolved it of its the so fall that open we one your “The “Exactly the mind, find.” body mysteries, open seems probe remains “I function more the of to around.” surprises biggest the is chief and Seuss we brain] carry out.”

lower anatomy. and neuron neuron motor the and between the findings (UMN) difference (LMN) motor upper Understand underlying and and their the in motor, the Know pathways CNS. respective sensory, cerebellar major locations visual associations pathologies manifestations, with key stroke lesions, Connect neurological syndrome). Brown-Séquard (eg, certain cerebellar CT neuropathology Lewy on bodies). hemorrhagic and findings MRI/ Recognize tangles (eg, common and stroke) neurofibrillary on and ischemic (eg, treat to migraine, and High-yield epilepsy, Parkinson pain disease, those medications used opioids). (eg, include

plate. and to form overlying ectoderm into Notochord induces neuroectoderm neural Neural differentiate development

Neural neural plate cells. neural gives and to rise crest Neural plate tube

nucleus 18 in of disc pulposus Day intervertebral becomes Notochord adults. fold Notochord Neural

plate Alar (dorsal): TGF-β (including by protein bone regulated [BMP]) sensory; morphogenetic

orientation Same as spinal cord

by plate regulated (ventral): motor; Basal

Telencephalon the specification part. is Regional 1st Diencephalon is part. the 2nd mesencephalon, The developing of brain myelencephalon. arranged metencephalon, are alphabetically: rest

fail between spinal  canal. fuse week) to defects cavity Neuropores (4th Neural persistent connection amniotic and tube folate with maternal deficiency. and Associated diabetes bifida α-fetoprotein and normal (AFP) fluid spina = in occulta (except maternal serum amniotic AFP). amniotic test. helpful in confirmatory is fluid acetylcholinesterase a (AChE)

of Spina Failure caudal no occulta but to neuropore herniation. close, bifida seen lower levels. at vertebral Usually intact. is Dura dimple Associated hair defect. of skin of with bony at level or tuft

no neural herniate through defect. bony tissue) (but Meninges Meningocele

through herniate Meninges Myelomeningocele equina) and (eg, neural defect. tissue bony cauda

Myeloschisis called rachischisis. Also tissue without Exposed, covering. unfused neural skin/meningeal

Failure open no neuropore calvarium. close  Anencephaly of to rostral forebrain, brain). (no swallowing center Clinical in findings: polyhydramnios

hair thin defect/thinning or Skin Skin Skin of Tuft +/− absent

occurs of 5–6. Failure into weeks (prosencephalon) Holoprosencephaly during to forebrain 2 the separate embryonic hemispheres; cerebral usually pathway. related be hedgehog sonic May in mutations signaling to form) (severe Associated cyclopia cleft lip/palate ★ defects form). other midline (moderate and with including (eg, insipidus). dysfunction risk diabetes for pituitary Can with be Patau 13). (trisomy syndrome seen monoventricle ). A of fusion basal A ganglia in MRI (star Monoventricle reveals and

and sulci resulting lacks a gyri. Failure migration in “smooth brain” neuronal Lissencephaly that of with microcephaly, be May ventriculomegaly. associated

to inferior foramen magnum cerebellar Chiari (1 . of malformation I Ectopia A tonsils structure) cerebellar adulthood in with symptoms. asymptomatic usually childhood, manifests and Congenital, in headaches Associated spinal (eg, cavitations with syringomyelia).

(2 foramen stenosis hydrocephalus. with malformation cerebellar structures) tonsils magnum Chiari of II through vermis Herniation and noncommunicating  aqueductal present loss level myelomeningocele (may at and of lumbosacral with below associated Usually lesion). as the the paralysis/sensory usually presents I, severe early in life. than More Chiari

that fills malformation cystic cerebellar enlargement Dandy-Walker posterior  vermis ventricle enlarged of the (arrow in Agenesis ) of B 4th fossa. Associated with noncommunicating spina hydrocephalus, bifida.

(syrinx) cavity Syringomyelia cord A spinal of central Cystic canal in within (yellow arrows ). commissure anterior white crossing in first. damaged are typically (spinothalamic tract) Fibers touch and is loss preserved). temperature a of extremities sensation upper in symmetrical bilateral, “capelike,” sensation in Results pain (fine with malformations; in tumors. other acquired causes and trauma shows tonsils), (red low-lying include A Chiari congenital I and cerebellar malformation arrow Associated scoliosis location common thoracic lumbar. >> Most > cervical tube, = Syrinx “syringe.” in as

fossa Posterior malformations malformations malformations malformations (can malformations syrinx (pain, fossa spinothalamic fossa Posterior A˜erent Posterior malformations Lateral dermatomes) fossa fossa commissure Anterior Posterior fossa malformations Posterior Posterior fossa fossa Posterior Posterior malformations malformations malformations Posterior Posterior fossa Posterior fossa malformations Posterior ganglion fossa malformations fossa Expanding malformations fossa Posterior fossa Posterior malformations malformations fossa compressed multiple temperature) fossa Posterior fossa white malformations malformations Posterior Posterior root fossa syrinx malformations fossa a˜ect Posterior Posterior fossa malformations Posterior by tract malformations Dorsal

CN arches temperature 1st 2/3 at of CN (thus taste dermatomes 2nd VII). sensation and here) shown and pain a˜ected pharyngeal V3, (C5-T4 via anterior form sensation Loss via

3rd posterior pharyngeal form CN 4th and and mainly sensation extreme arches 1/3(thus via CN IX, taste posterior via X).

to genioglossus of a create tongue), (protrudes tongue), and tongue is hyoglossus via for (draws swallowing). trough to styloglossus upward CN and (retracts depresses XII innervation Motor sides

swallowing). is during via CN (elevates Motor posterior tongue X palatoglossus to innervation

nucleus). X Taste—CN IX, VII, (solitary Motor—CN IX, X, XII. X. Pain—CN V3,

in comes Genie of The the out lamp style.

system. Neurons the of cells Signal-transmitting nervous cells—do divide Permanent adulthood. not in Signal-relaying cell bodies, cells output). dendrites (receive input), axons and (send with (stains Nissl staining seen can Cell bodies RER). and on dendrites be is the not in RER present axon. protein, markers: Neuron neurofilament synaptophysin.

in Most cell CNS. Astrocytes type common glial neuroectoderm. from Derived Physical

Astrocyte marker: extracellular support, K+ buffer, GFAP. repair, removal

of component fuel of barrier, buffer. excess glycogen reserve blood-brain neurotransmitter, to injury. gliosis in response Reactive neural

and cord. of columnar glial line canal Ependymal ventricles simple spinal the central cells Ciliated cells help (which microvilli absorption). in surfaces with CSF cilia are CSF) (which circulate and Apical covered ependymal (choroid plexus) Specialized CSF. cells produce

axons of transmitted of saltatory the at conduction conduction action Na+ concentrations there signals velocity Ranvier, where potential high  of down nodes channels. Myelin  of are Schwann (including (including CN is PNS oligodendrocytes; III-XII), CN synthesized by myelin by in myelin In II), CNS is synthesized cells.

velocity. A ): axons insulates  in  conduction (arrow and space and constant Wraps

cells. = = Schwann PNS COPS: CNS Oligodendrocytes,

axonal Promote regeneration. Schwann cells from Derived Each “Schwone” myelinates PNS crest. only neural cell 1 axon. Guillain-Barré in syndrome. Injured

axons Myelinate CNS. in of Oligodendrocytes neurons neuroectoderm. Derived Each from axons oligodendrocyte many histologically. appearance myelinate can “Fried egg” (∼ 30). white in of sclerosis, type Predominant matter. in Injured progressive multiple cell glial multifocal leukodystrophies. (PML), leukoencephalopathy

fibers; High-frequency corpuscles Pacinian myelinated joints skin ligaments, pressure Deep Large, quickly adapt layers, vibration,

adapt position slowly (eg, shapes, static sense superficial touch Merkel discs tips, myelinated edges), Finger skin Pressure, fibers; deep Large,

and nerve connective ensheathes Peri supportive that = tissue Endo myelinated Endoneurium—thin, supports around individual = inner fibers. outer = Epi

(blood-nerve a fascicle nerve Perineurium barrier)—surrounds fibers. Permeability of

blood (fascicles surrounds tissue and Epineurium—dense vessels). entire that nerve connective

cell Reaction injury. neuronal of to axonal body protein effort repair damaged in axon. the reflect synthesis to  Changes by: Characterized

Displacement the periphery nucleus to of the

the site sheath cytoplasm distal removing injury substance of Dispersion debris. of of axonal throughout axon and Nissl Wallerian degeneration—disintegration macrophages to myelin with

the injury, for neurons toward protrusions other retracts, that to body grow and Proximal reinnervation. axon sprouts new potential cell the the for as recovery. preparation axonal a regeneration Serves and functional

with disease changes Neurotransmitter

nucleus Basal Meynert of Acetylcholine

arachnoid space, membranes cord: brain and spinal and flows and the located subarachnoid in the Three surround between protect that CSF pia mater.

outer space—potential to Epidural layer skull. mater—thick Dura closest between space from mesoderm. Derived and the skull/vertebral mater column dura

layer, blood fat mater—middle and Arachnoid vessels. containing contains of connections. blood web-like Site neural associated Derived meningeal crest. collection from with middle injury. artery

and adheres fibrous firmly Pia that brain spinal cord. mater—thin, layer inner to neural Derived crest. from

blood substances barrier organs reaching drugs) from capillaries no circulating bacteria, and with Circumventricular (eg, the Prevents CNS. fenestrated blood-brain CSF/ structures: in allow 3 by molecules brain affect to blood Formed

nonfenestrated function between postrema—vomiting endothelial (eg, after Tight junctions chemotherapy; vasculosum cells [organum OVLT capillary area

by foot neurohypophysis—ADH cross neurosecretory release). to slowly Glucose enter amino Astrocyte processes and circulation acids carrier-(eg, products transport mechanisms. mediated cross vasogenic edema. cell Infarction tight rapidly endothelial neoplasm • and/or junctions Nonpolar/lipid-soluble destroys substances

diffusion. via Hyperosmolar agents (eg, • can medications. the mannitol) of disrupt permeability BBB

Coordinated in trigger located (CTZ, by (NTS) nucleus in area which ventricle), solitarius GI tractus chemoreceptor and medulla, receives system, the vestibular (via CNS. vagus postrema within information the 4th tract from nerve), zone

and (D2), dopamine neurokinin histamine vomiting (M1), receptors: serotonin and adjacent input receptors. (5-HT3), center 5 nuclei major CTZ (H1), from receive muscarinic (NK-1)

to D2, NK-1 used antagonists chemotherapy-induced vomiting. treat 5-HT3, and

H1 motion gravidarum. treat sickness; treat H1 antagonists and antagonists M1 hyperemesis

physiology Sleep hypothalamus. of by the is the regulated driven suprachiasmatic cycle circadian (SCN) Sleep is rhythm, nucleus by which release rhythm melatonin, ACTH,  gland Circadian controls release of • nocturnal prolactin, norepinephrine: SCN melatonin. norepinephrine pineal • SCN by light). regulated (eg, is environment non-REM. and rapid-eye (REM) Two stages: movement benzodiazepines, and associated N3 REM with sleep;  barbiturates are sleep. REM Alcohol,  norepinephrine sleep also and for by and REM sleep. night are  N3 sleepwalking and useful terrors Benzodiazepines

Major ascending sensory all Thalamus information olfaction. for relay except system The in famous F’s. structures 5 Collection Limbic neural of involved

memory, function. ANS behavior emotion, long-term modulation, olfaction,

bodies, arrows amygdalae, ), of anterior hippocampus A in gyrus Consists nuclei, arrows (red mammillary thalamic in cingulate (yellow

A ), entorhinal cortex. Responsible and Fighting, Sex. Fleeing, Feeling, Feeding, for

A .

spinal peduncle cerebellar from cord Output: inferior Input:

nuclei The contralateral cerebellar of output via of cortex  cells Purkinje cerebellar deep cerebellum peduncle (always cortex inhibitory)  only superior =

Globose, Emboliform,  nuclei medial)—Dentate, Fastigial (lateral Deep

propensity structures); (ipsilateral) voluntary when extremities side. to fall of movement injured (lateral toward Lateral injured, lesions—affect

Medial fastigial (eg, nuclei, flocculonodular (widebased cerebellar vermis, lobe)—truncal lesions gait), tilting. head nystagmus, ataxia bilateral Generally in structures). affecting result musculature and deficits proximal (medial limb motor axial

movements voluntary and adjusting A . posture in Important to cortical feedback negative pathway. input, D1Rect to Receptor cortex Receives = provides D1

modulate movement. Indirect Inhibitory. (D2) = (motor) (cognitive). = + Caudate Striatum putamen putamen + = pallidus. globus Lentiform

inhibits which release nigrostriatal releases (excitatory) Direct the from (• striatum disinhibiting dopaminergic via the via Thalamus pathway—SNc GABA, GPi, the the motion). GPi GABA to input the pathway

stimulates motion). to pathway input via inhibit (inhibitory) thalamus striatum the inhibition, Indirect to via releases STN STN (• GPe dopaminergic GPi the the pathway—SNc disinhibits and GABA nigrostriatal that

to Dopamine to pathway, stimulating pathway binds  motion. D2, and inhibiting the excitatory the D1, inhibitory

tight autoregulation. Cerebral perfusion Relies on (Po2 Pco2 modulates in Primarily hypoxia). driven by severe also perfusion

and relies pressure pressure arterial on Also between (ICP). mean intracranial pressure (MAP) a gradient  cerebral (CPP). perfusion blood pressure  ICP  or pressure

flow vasoconstriction cerebral  blood  ICP.  interventions. unresponsive acute 2° to other May to edema used be treat to stroke) (eg, cerebral

CPP ICP. – = MAP 0, brain CPP there = death. If perfusion • cerebral no is CPP Po2 50 Hypoxemia < Hg. increases only mm if Hg. to is mm Pco2 Pco2 proportional until CPP 90 directly >

ForearmWrist HipLeg ElbowWristHandLittleRingMiddleIndexThumbNeckBrow FingersFingers Genitals lip Upper Face MiddleIndexThumb Swallowing eyeball gums TongueIntra-abdominalPharynx lipTeeth, HipTrunk Toes RingLittle TongueJaw Ankle Lower KneeShoulder Nose TrunkEye Foot & NeckHeadShoulderArmElbow Lips Toes Eyelid

motor representation sensory of Homunculus cortex. cerebral areas Topographic in the and body thus being due to  richly and having cortical certain innervated appearance Distorted regions more representation. is

(blue arteries zones areas middle posterior Watershed cerebral Cortical and cerebral middle in occur and zones arteries between ). A border and anterior in areas cerebral middle occur and Internal vascular between border zones the the territories of superficial (red artery deep

A ).

posterior visual (if (“manin-the-barrel due order extremity lower upper severe • zone cortical syndrome”), stroke). weakness cerebral Infarct to proximal and cerebral/middle hypoperfusion dysfunction higher border

to Willis anterior between posterior blood and Circle brain. anastomoses of of supplies System

channels mater. venous Dural of A that and Large through layers run venous meningeal dura the periosteal the sinuses cerebral and CSF blood from granulations. receive veins arachnoid from Drain (arrow) jugular Empty internal vein. into

neurologic ICP headache, thrombosis—presents signs/symptoms • (eg, with seizures, of papilledema, deficits). focal sinus Venous to venous lead May hemorrhage. with pregnancy, Associated states OCP Leiden). (eg, factor V use, hypercoagulable

return CSF arachnoid of location granulations) (main via

Galen of ophthalmic vein vein Great Superior cerebral

the sinuses Confuence of sinus Sigmoid

via foramina ventricles  Lateral 3rd and ventricle left right of interventricular Monro. via 4th of Sylvius. 3rd cerebral  aqueduct ventricle ventricle  space via: ventricle subarachnoid 4th

of = Foramina Lateral. Luschka

= Medial. Foramen of Magendie

and located choroid by plexuses lateral made in ventricles. CSF fourth the Magendie, to granulations, of is space via Luschka drains then arachnoid reabsorbed Travels sinuses. by into and and venous dural foramina subarachnoid

are CN 4 IV). view (I, stem—ventral Brain pons above II, III, (V, CN pons 4 exit VIII). the VI, VII,

(IX, X, (CN CN I) XI, in medulla XII). 4 are are (III, XII). tract VI, CN medial 4 IV, nuclei Olfactory except and 1 2.” “Factors 12, CN of II

Middle fourth wall of peduncle ventricle Anterior cerebellar

Pineal circadian gland—melatonin rhythms. secretion,

movements interest. eye objects stimuli to or Superior of (noise/movements) colliculi—direct

Inferior colliculi—auditory.

above (visual) your the (auditory). Your inferior ears, above the superior eyes and is colliculus are colliculus

vertebrae. of ends at cord border L1–L2 In lower adults, spinal to extends contains border CSF) (which of the S2 vertebra. Space Subarachnoid lower usually puncture L4–L5 between of L3–L4 is cauda equina). performed or (level Lumbar

is CSF without cord. lumbar sample of Goal obtain puncture spinal to of damaging keep alive, the needle between L3 cord To spinal the and keep L5.

arachnoid occurs stops fascia collection needle passes Needle here) through: ligament ligament here) interspinous (epidural subarachnoid and mater fat ligamentum anesthesia epidural skin mater space space flavum dura supraspinous (CSF

tract synapse and Ascending tracts cross. then anatomy Spinal and functions

vibration, proprioception Pressure, column Dorsal touch, fine

pain, Lateral: temperature tract Spinothalamic

  columns dorsal ascends body ganglion cell  crude ending enters in cord Sensory spinal pressure bypasses root pseudounipolar nerve in touch, ipsilaterally Anterior: dorsal

cuneatus (ipsilateral medial in ascends as ending the and lemniscus fibers) spinal (Aδ cell body ganglion Nucleus  medulla) C nerve  contralaterally cord pseudounipolar nucleus bypasses enters • Sensory gracilis, root dorsal

anterior in spinal white as the commissure Decussates cord

nerve reflexes Reflexes S2 S3, reflex up (“buckle = in L2 order = Cremasteric root reflexes: Anal L1, (main reflex Clinical S4 S1, shoe”) (“testicles bold): move”) Additional = in Achilles galore”) reflex my C5, count 6 wink (“winks

reflex = Biceps L2-L4 C5, (“kick C6, sticks”) (“pick door”) the 8 brachioradialis C6 up reflexes Patellar 7, and =

4 3, L2,

C8 reflex C7, Triceps them C6, straight”) = 2 (“lay S1,

intact adult. absent but Primitive infant, CNS reflexes that present neurologically a in in are are reflexes healthy a within disappear 1st life. Normally year of are These developing mature/ primitive lobe. a by frontal reflexes inhibited in loss adults of  frontal may lobe They inhibition following reemerge lesions these reflexes. of

life” reflex then startled, for “Hang draw reflex—abduct/extend together when arms on Moro and

mouth stroked toward Movement head is if one reflex Rooting or (nipple cheek of side seeking)

of is response mouth reflex when Sucking touched Sucking roof

Palmar of stroked palm if is Curling fingers reflex

Plantar toe of which other an Babinski large of fanning lesion sign—presence adult, this UMN a reflex and Dorsiflexion signify reflex with of in may toes plantar stimulation

body ventral the one down) (face Stroking flexion stimulated along lower of toward causes side in suspension is while reflex lateral of side spine newborn Galant

skull C2 half of Posterior

right phrenic C3, 4, gallbladder the nerve keeps turtleneck C3 and to Diaphragm via alive 5 referred pain the shirt shoulder High diaphragm

pore T4 T4 at the the At teat nipple

At T7 xiphoid letters process 7 in xiphoid the

Point in appendicitis early (belly At butten) T10 referred of the pain umbilicus

the L1 Inguinal At Ligament

4’s ALL on Includes kneecaps L4 Down the

Sensation 4 3, S3, off anal S2, S4 the zones keep S2, penile and floor the of penis

injury Irreversible begins of neuronal minutes hypoxia. 5 after (Purkinje (“vulnerable pure need neocortex, cells), vulnerable: Most watershed hippos cerebellum hippocampus, water”). areas hemorrhage be given). can (before imaging: noncontrast CT Stroke exclude to tPA CT hr. detects in 6–24 ischemic changes ischemia MRI 3–30 Diffusion-weighted can within detect min.

infarction and necrosis.  ischemia disruption subsequent of vessels Acute blood  blockage flow of types: 3

site plaque. atherosclerotic (commonly MCA ), of Thrombotic—due directly a a at the usually forming A over clot ruptured to infarction

obstructs the of body from vessel. part Embolic—embolus another multiple territories. affect vascular Can fibrillation, carotid endocarditis. infective patent stenosis, Examples: DVT atrial with foramen ovale, artery

or hypoperfusion Hypoxic—due hypoxemia. to watershed areas. Common surgeries, to affect tends cardiovascular during

hemorrhage/risk of within thrombectomy (if tPA (if hr no onset Treatment: 3–4.5 artery of and and/or hemorrhage) occlusion). large lipids; therapy artery sugars, blood risk (eg, clopidogrel); aspirin, smoking atrial of stenosis). risk  blood treat fibrillation, (eg, control pressure, optimum that and Reduce with cessation; conditions medical carotid

minutes; infarction Brief, ischemic (eg, without reversible small of Transient resolving dysfunction < neurologic stenosis). 15 (⊝ attack MRI), focal vessel episode the embolus, majority with in ischemia acute

blood in ventricles periventricular into shows right space, transcranial into (arrow ultrasound intraventricular matter). Bleeding extending A coronal white in in premature Increased infants. low-birth-weight risk and Originates matrix, zone. the within in highly germinal a vascularized layer subventricular glial of to BP autoregulation impaired support infants. and in fiber premature reduced Due altered present level consciousness, Can with hypotension, coma. of fontanelle, seizures, bulging

maxillary Rupture to the of pterion skull). artery), (thinnest the A middle meningeal (branch 2° lateral in Epidural artery hematoma of of ) fracture skull involving (circle area often due present consciousness  transient expansion. with of hematoma to recovery Might (“lucid loss  interval”) deterioration rapid in hematoma (arrows Scalp

intracranial rapid A herniation, CN (arrows in and systemic pressure B under  transtentorial arterial expansion ) ) III palsy. crossing biconvex not hyperdense blood B shows suture (lentiform), lines. CT collection

Rupture bridging hematoma Subdural veins. of hyperdense  trauma, or alcoholism CT) Can with be mild hypodense atrophy, on  chronic impact CT). on cerebral (traumatic, elderly, high-energy (associated acute in shaken seen Also babies. brain atrophy, Predisposing trauma. factors:

suture in C arrows D (red crosses hemorrhage that and ) Crescent-shaped lines. shift chronic” arrows ), D midline on of “acute C in ). (yellow Can arrow hemorrhage cause in findings (blue

or or a an to saccular of rupture due ) malformation. EF aneurysm aneurysm as E (such arteriovenous trauma, course. time Rapid my life.” Patients or complain yellow headache “worst of Bloody puncture. lumbar of (xanthochromic) breakdown due infarct; used Vasospasm blood occur to prevent/reduce to can ischemic nimodipine  vasospasm. risk developing hydrocephalus. obstructive of and/or  communicating

by systemic hypertension. commonly Most caused lobar neoplasm. hemorrhagic elderly), stroke with (recurrent angiopathy in Also amyloid seen vasculitis, injury to ischemic reperfusion May stroke. 2º in be

most Hypertensive and pons, ), microaneurysm) followed G putamen thalamus, of cerebellum basal (Charcot-Bouchard (lenticulostriate by often in hemorrhages ganglia vessels occur

. H

strokes Effects of

Middle artery and Motor and cerebral cortices face. —upper Anterior circulation limb A sensory (Wernicke area). lobe frontal area); Temporal lobe (Broca

and limb. Contralateral loss—face and sensory paralysis upper

(usually dominant left) Aphasia in if hemisphere. hemisphere. right) Hemineglect if lesion (usually affects nondominant

right with Wernicke lobe to superior quadrant is involvement. field aphasia associated visual due temporal defect

capsule. Striatum, internal Lenticulo-striate artery paralysis. Contralateral visual of Absence field neglect, aphasia, cortical signs loss). (eg, motor Pure stroke. arteriosclerosis 2° location lacunar infarcts to hyaline due of , unmanaged B (lipohyalinosis) Common hypertension. to Posterior circulation

XI) medulla: Lateral Nucleus ambiguus X, (CN IX,

spinal nucleus Lateral spinothalamic Vestibular trigeminal tract, nuclei

reflex, Dysphagia, hiccups. hoarseness, • gag

ipsilateral  body, and face. temperature contralateral vertigo, pain nystagmus sensation Vomiting, from

syndrome. Horner Ipsilateral ataxia, dysmetria. Ipsilateral

Lateral syndrome. (Wallenberg) medullary

Nucleus ambiguus specific are to lesions PICA effects

C .

can’t pick “Don’t (dysphagia).” a (hoarseness) horse that eat (PICA)

cerebellum). supplies inferior cerebellar peduncle (part Also of

pons: nucleus Lateral Facial

Vestibular nuclei spinal trigeminal tract, nucleus Spinothalamic

tongue. from of (LMN face of  stroke), UMN cortical lesion  vs • in taste 2⁄3 lesion salivation, anterior Paralysis lacrimation, Vomiting, face. temperature vertigo, ipsilateral  contralateral from pain nystagmus body, sensation and

Ipsilateral syndrome. Horner Ipsilateral ataxia, dysmetria.

sensorineural deafness, vertigo. Ipsilateral

pontine syndrome. Lateral AICA are specific effects Facial to nucleus lesions. means “Facial droop pooped.” AICA’s

and middle cerebellar of peduncles cerebellum). supplies inferior (part Also

strokes of (continued) Effects

midbrain. lower Basilar Pons, artery medulla,

and tracts. Corticospinal corticobulbar

Ocular nerve paramedian pontine nuclei, formation. reticular cranial

If spared, is consciousness RAS preserved.

voluntary mouth, of loss tongue facial, and Quadriplegia; movements.

but eye movements. Loss horizontal, of not vertical,

(locked syndrome Locked-in basement). the in

cerebral D lobe Occipital artery Posterior . hemianopia agraphia sparing; alexia (dominant Contralateral hemisphere). without with macular

brain injury of by the and/or during (eg, vehicle deceleration forces Caused motor Diffuse traumatic accident). rapid axonal acceleration shearing coma state. often devastating Usually or persistent neurologic vegetative results causing in injury, multiple A matter involving white shows MRI hemorrhages) tracts. the (punctate lesions

appropriately); Aphasia—higher-order (inability deficit hemisphere by left). Aphasia Good comprehension to pathology (usually language language Poor dominant in comprehension caused cerebral understand/produce/use produce inability speech Dysarthria—motor (movement to speech deficit).

(expressive) Broca frontal inferior in frontal of gyrus Broca area lobe. appears frustrated, Patient intact. insight = Broken = (boca Boca mouth in Broca Spanish).

area Wernicke in lobe. of gyrus Wernicke (receptive) temporal temporal superior insight. not have do Patients sense. Word Wernicke is salad no makes a and

to by arCuate be damage Can fasciculus. caused Conduction

Wernicke Global Broca areas affected. and

spared. area, is lobe but Affects Broca Transcortical frontal around motor area Broca

Transcortical Affects sensory temporal Wernicke is lobe spared. around area area, but Wernicke

Broca intact; watershed surrounding remain areas mixed areas and affected. Transcortical Wernicke arcuate and fasciculus

due weakening dilation of Aneurysms an vessel of wall. Abnormal to artery

called A Also . aneurysm berry circle Occurs at in the of Willis. bifurcations ACom and junction ACA. of site is Most common Ehlers-Danlos with Associated ADPKD, syndrome. in age, advanced Other African-Americans). race smoking, hypertension, ( risk risk factors:

clinically “thunderclap neurologic  focal deficits. life” until hemorrhage my subarachnoid (most of common (“worst silent headache”) complication) • headache Usually rupture or cause growing by structures aneurysm. surrounding via also compression symptoms of direct Can

hemiparesis, ACA in  of ischemia ACom—compression (compression rupture extremity deficits. acuity bitemporal hemianopia visual distribution  • deficits; contralateral lower chiasm); optic sensory

MCA—rupture MCA extremity ischemia  in contralateral upper deficits. sensory  and distribution hemiparesis, lower facial

palsy III may  PCom—compression see • pupil”); eye. also (“blown and ipsilateral ptosis, “down CN mydriasis out”

synchronized, neuronal firing. Seizures Characterized by high-frequency of forms. Variety

Impaired consciousness?

of due extracranial structures. Headaches dura, structures to as nerves, cranial such or the irritation Pain headaches. cluster common females, in except More

pain headache”) Excruciating (“suicide repetitive lacrimation and periorbital rhinorrhea. hr; Unilateral min–3 15 with May present syndrome. with Horner males. More common in

hr 4–72 with or photophobia, nausea, Unilateral Pulsating phonophobia. pain P, May (release gene-related neuropeptides vessels “aura.” peptide]). substance Due meninges, of of calcitonin irritation [eg, blood V, have vasoactive to or CN

pain. Bilateral > 30 Steady, “band-like” min 4–6 (typically No phonophobia. photophobia or No constant aura. hr);

Acute: sumatriptan, O2. 100% verapamil. Prophylaxis:

triptans, NSAIDs, Acute: dihydroergotamine.

valproate, amitriptyline, diet), Prophylaxis: (eg, changes exercise, toxin, antibodies. lifestyle monoclonal β-blockers, topiramate, anti-CGRP botulinum sleep,

Disabling. duration, POUND–Pulsatile, Unilateral, One-day Nausea,

analgesics, acetaminophen. NSAIDs, Acute:

TCAs (eg, Prophylaxis: therapy. amitriptyline), behavioral

headache of subarachnoid hydrocephalus, hemorrhage arteritis. Other giant life”), (“worst meningitis, headache cell neoplasia, (temporal) causes of my include

talking, touching certain by of unilateral, shooting/shock-like distribution trigeminal repetitive, face. pain chewing, in produces the which aCompare of with the V. neuralgia, Triggered CN parts but episodes (typically) often increase to seconds Lasts frequency for time. in intensity over and minutes, therapy: carbamazepine. First-line

Slow, Athetosis Basal ganglia. snake-like, writhing Seen in disease. Huntington in seen especially the movements; fingers.

Slow, motion when tremor zigzag dysfunction. Intention Cerebellar pointing/extending toward target. a

subthalamic Sudden, Contralateral “Half-of-body side of wild Hemiballismus the of body. flailing one Pronounce lacunar (eg, stroke). nucleus ballistic.”

(micrographia) TRAPSS Shuffling Akinesia handwriting Tremor gait (cogwheel) bradykinesia) rest) Parkinson Postural your (pill-rolling Small Rigidity (or instability body: tremor at

which metabolized drugs, a substantia toxic is nigra. to illegal contaminant is to MPP+, MPTP, in

or consciousness. with cognitive in  function intact ability, memory,

Must depression (called cause dementia of rule as pseudodementia). out causes neurosyphilis, B12 pressure dementia: of normal reversible hypothyroidism, vitamin deficiency, Other hydrocephalus.

(ie, pars of nigra of Loss compacta. substantia neurons dopaminergic depigmentation)

Lewy inclusions (intracellular composed α-synuclein bodies: eosinophilic of

). A

in the 4 trinucleotide letters). (CAG)n (HTT) gene chromosome expansion on Autosomal huntingtin dominant (4 repeat chorea, 50: aggression, athetosis, (sometimes initially substance between for depression, ages 20 and Symptoms dementia mistaken manifest abuse).

repeats. results Anticipation CAG from expansion of ACh GABA. Caudate loses and

with caudate putamen of vacuo ventriculomegaly. ex Atrophy and

GABA, •  ACh in dopamine,  brain. glutamate NMDA-R and binding death Neuronal excitotoxicity. via

cause Most of dementia elderly. in common is on located 21. APP patients chromosome developing risk of syndrome disease,  as Alzheimer have Down

ACh. following the with altered Associated proteins:

form risk  sporadic ApoE-2: of

form risk APP, sporadic of with onset (10%) presenilin-2: ApoE-4: forms • familial earlier  presenilin-1,

(normal cortex B in hippocampus ; cortex ), C especially Alzheimer cortical B in ). Widespread (arrows C and atrophy disease widening Narrowing sulci. and of gyri of

gray angiopathy hemorrhage; Senile matter: intracranial may  cleaving cause amyloid in protein by Aβ β-amyloid (APP). amyloid D core; extracellular precursor synthesized plaques (amyloid-β)

correlates of elements; E hyperphosphorylated of protein : insoluble tau = tangles number intracellular, cytoskeletal dementia. degree with

in bodies—intracellular rods proteinaceous eosinophilic Hirano hippocampus.

Formerly Pick called disease. in degeneration changes Early lobe Frontotemporal

F . or aphasia). and of (primary (round variant), behavior tau aphasia hyperphosphorylated progressive (behavioral personality Inclusions Pick bodies

TDP-43. ) ubiquitinated G or

May disorders. movement have associated

hallucinations Lewy bodies primarily (“haLewycinations”), A Lewy Visual in Intracellular cortex. body dementia

disorder, and fluctuating behavior sleep dementia cognition/ REM alertness, with parkinsonism. Lewy apart, to otherwise body considered if dementia 2° dementia Called

disease. Parkinson

cerebri. called Also pseudotumor  with no imaging. ICP obvious on findings A TOAD). excess, Risk Tetracyclines, include Danazol factors sex, female (female vitamin Obesity, sinus with cerebral Associated venous stenosis. palsy), mental in change headache, Findings: no CN from (usually tinnitus, VI diplopia status. optic  papilledema. flow axoplasmic nerve Impaired testing enlarged Visual constriction. and blind shows field peripheral spot • Lumbar opening puncture reveals relief. pressure temporary and provides headache

invasive weight loss). fenestration acetazolamide, cases CSF nerve loss, optic surgery (eg, placement, for procedures shunt Treatment: visual for sheath refractory

+/−  ventricular volume • ICP. CSF Hydrocephalus dilation 

system cyst within Caused of by ). foramen B structural ventricular Sylvius, Noncommunicating (eg, Monro, CSF of aqueduct hydrocephalus blocking circulation tumor of stenosis of colloid blockage

and sclerosis cord) CNS axonal (brain damage. with of inflammation Multiple spinal demyelination subsequent and Autoimmune with: present Can

visual loss optic with (painful neuritis unilateral Marcus Gunn Acute pupil) associated

Brain scanning speech, syndromes intention ataxia, diplopia, [bilateral (eg, unilateral]) nystagmus/INO tremor, stem/cerebellar >

tract Pyramidal demyelination (eg, weakness, spasticity)

(eg, or sensory on cervical flexion, affecting one neurogenic manifestations along the spine trunk cord shock-like extremity) more electric Spinal neck sensation syndromes paraparesis, or bladder,

body temperature Symptoms (eg, increased with bath, exacerbate hot may exercise). most and is Relapsing course. remitting clinical common affects women 30s; Most common in levels. serum often equator their and more vitamin and farther in living low with D individuals 20s from

basic IgG CSF. Findings  level and protein in myelin are diagnostic. bands Oligoclonal MRI standard. is gold and A plaques gliosis). reactive (areas of Periventricular loss oligodendrocyte and time. in white matter lesions space disseminated Multiple

relapses β-interferon, therapies Stop natalizumab). glatiramer, with and treAtment disease-modifying (eg, progression halt/slow flares acute steroids. with Treat IV (catheterization, treatment bladder (TCAs, agonists), neurogenic muscarinic for receptor GABAB spasticity pain (baclofen, Symptomatic anticonvulsants). antagonists),

central Also myelinolysis. demyelination called Osmotic pontine shifts (eg, osmolytes Massive glucose). syndrome but A other correction demyelination pontine rapid also rapid commonly changes, iatrogenic hyponatremia most of axonal osmotic to 2° matter in white of dysarthria, dysphagia, diplopia, Acute consciousness. of paralysis, loss serum will edema/herniation) (cerebral to to pons “From high too syndrome) will “From demyelination brains low, high, your low your “locked-in fast: Na+ (osmotic Correcting syndrome.” blow” cause die” Can

Also hereditary neuropathy. motor called Charcot-Marie-Tooth and sensory the peripheral progressive disease defective and of function the the to sheath. nerve production in Group or of disorders involved nerves related hereditary structure proteins of myelin and deformities Typically autosomal foot sensory with weakness drop), (eg, extremity and toe), (eg, dominant associated hammer cavus, deficits. lower foot pes Most type, common gene caused CMT1A, by PMP22 is duplication.

Progressive destruction infection). JC virus of CNS to Demyelination to of B due (2° reactivation latent of leukoencephalopathy oligodendrocytes multifocal 2–4% with in Seen patients AIDS. of fatal. usually progressive, Rapidly occipital Predominantly symptoms involves areas; are and parietal common. visual  associated with natalizumab. risk

Other disease, metachromatic disorders leukodystrophy, Krabbe adrenoleukodystrophy.

common of Most Guillain-Barré subtype syndrome.

cells (including via condition that demyelination fibers, peripheral nerves Schwann and sensory CN destroys of Autoimmune inflammation motor III-XII). fibers, Likely mimicry facilitated or triggered molecular and stress. by inoculations by with Campylobacter no definitive (eg, jejuni, association to Zika]), viruses any causal [eg, Despite infections link pathogen.

weakness/paralysis symmetric in in Results DTRs lower and beginning ascending depressed/absent muscle extremities. respiratory and Facial failure (usually common. paralysis bilateral) are cardiac irregularities, or see hypertension, hypotension) sensory abnormalities. dysregulation autonomic (eg, May after all to completely recover patients Almost weeks majority survive; months.

(albuminocytologic dissociation). protein • count normal cell CSF with

Respiratory recovery. support until critical is immunoglobulins. IV plasmapheresis or treatment: Disease-modifying role No for steroids.

of derivatives. anomaly neural Congenital crest nonhereditary in of of an Somatic GNAQ gene. one the copy mutation activating mosaicism

disability; episcleral intellectual glaucoma. B early-onset  seizures/epilepsy; • hemangioma IOP 

Also called angiomatosis. encephalotrigeminal

Epilepsy. Sporadic, track port-wine calcifications (opposing Unilateral, Stain, Tram intellectual Glaucoma, SSTURGGE-Weber: disability GNAQ gyri), gene, (Retardation),

AD, expression. variable Tuberous sclerosis chromosome on tumor (hamartin), (tuberin). TSC1 Mutation 9 genes chromosome TSC2 on in 16 suppressor

skin, in and Angiofibromas Hamartomas CNS

renal Mental D dOminant; spots (intellectual cardiac , retardation autosomal Ash-leaf Angiomyolipoma , Mitral C Rhabdomyoma, disability), sclerosis), regurgitation, (Tuberous

E Shagreen , patches. Seizures,

HAMARTOMASS.

fibromas. cell giant ungual  and Subependymal incidence astrocytomas of

penetrance. 100% AD,

gene regulator). 17 Mutation in RAS chromosome negative NF1 (encodes suppressor tumor neurofibromin, on a

Cutaneous neurofibromas F Café-au-lait Intellectual spots disability, ,

gliomas, neurologic dysplasia). from (often nodules Lisch hamartomas lesions meningioma), Pheochromocytomas, H sphenoid G Seizures/focal iris Optic ), (pigmented (eg, bone Signs ,

Recklinghausen called Also disease. von Recklinghausen.” CICLOPSS. letters “von 17 in

cells . D

H .

anterior (subfalcine) artery. cerebral Cingulate herniation under compress Can cerebri cerebri falx Falx

herniation lobe. = Uncal medial Uncus temporal transtentorial Early compression), herniation contralateral hemiparesis. due herniation Late compression  phenomenon (misleading contralateral Kernohan contralateral hemiparesis pupil ipsilateral notch). to and Kernohan coma, blown against

hemorrhages. transtentorial Central/downward  of displacement stem rupture Caudal mass of brain fatal. Usually

brain foramen the Coma and these herniation stem. death the herniations result Cerebellar compress into magnum tonsillar when

reflexes, mass,  muscle tone, muscle (less 

up • toes) Upper neuron = motor everything DTRs, Reflexes • (tone, Tone

= Babinski Positive +− Fasciculations is infants twitching muscle normal Babinski in

(fecal-oral poliovirus by transmission). Caused Poliomyelitis small spreading Replicates CNS. to via in and oropharynx bloodstream intestine before cord (LMN destruction causes anterior Infection death). of cells spinal in horn of atrophy), in hyporeflexia, muscular asymmetric (vs hypotonia, weakness atrophy. paralysis, lesion: of LMN fasciculations, spinal symmetric flaccid Signs weakness muscle to involvement failure. Respiratory respiratory leads muscle etc. headache, nausea, of Signs infection: fever, malaise, slight  no (lymphocytic in protein change  shows (with CSF CSF glucose). pleocytosis) WBCs and of Virus recovered from throat. stool or

cord. Hemisection of spinal tract and proprioception, damage) damage) lesion (eg, level lesion Findings: Ipsilateral lesion (due of (due vibration, all below signs at (due temperature, touch light level of loss Contralateral signs level below of sense Ipsilateral dorsal touch, to damage) spinothalamic paralysis) and lesion below tactile of pain, UMN at level (2-point Ipsilateral crude corticospinal column of tract lesion LMN of sensation loss Ipsilateral flaccid (non-discriminative) loss discrimination) of to of level to

oculosympathetic syndrome If above damage patient ipsilateral with to present of pathway. T1, due Horner lesion may occurs

Level lesion of

signs sensation Loss of LMN

sense Impaired light tactile proprioception, vibration, touch,

temperature, pain, crude Impaired sensation touch

frataxin Autosomal disorder in chromosome 9 encodes protein). trinucleotide gene on (iron-binding recessive that repeat (GAA)n to in mitochondrial functioning. Leads impairment (loss spinocerebellar DTRs). (ataxia), proprioception), dorsal vibratory (spastic ( tract dorsal lateral of Degeneration corticospinal paralysis), and sense, root columns tract ganglia of pes (cause falling, diabetes dysarthria, gait, cardiomyopathy mellitus, nystagmus, death). cavus, hypertrophic of hammer Staggering toes, frequent frat falling Presents in has staggering Fratastic a your (frataxin): favorite brother, Friedreich but and heart. big sweet, always he’s is

B .

GAAit. Ataxic

toward to lesion of opposite due muscle. deviates from Jaw force side V CN lesion unopposed pterygoid the motor deviates CN side Uvula from away lesion. lesion of X uvula side away. points and collapses Weak XI (SCM). contralateral Weakness head lesion turning CN side lesion to of on droop (trapezius). lesion side of Shoulder turn help contracts head to The the the SCM right. left to CN lesion. LMN XII lesion wounds”) side. lesion due muscles toward on weakened Tongue your to side affected tongue of deviates (“lick

nerve lesions palsy . cause most A peripheral Bell Facial the common of facial palsy is HSV reactivation. develops after Usually corticosteroids +/– Treatment: acyclovir. occur. can gradually Most recover function, patients but aberrant regeneration herpes (eg, facial causes palsy mellitus. (Ramsay Other Lyme sarcoidosis, gland), Hunt parotid peripheral include zoster of syndrome), tumors diabetes disease,

inVolVed of lower muscles loCAtion facial along Facial CN VII Lower nucleus, connection in facial musCles anywhere of cortex, cortex facial from muscles Motor expression pons nucleus motor expression lesion and to Upper

ForeheAd inVolVed? eyes, Affected due corneal UMN eye anterior ulceration), innervation (dry to closure other loss Spared, tongue symPtoms sensation hyperacusis, Incomplete bilateral to of None taste

motor of area cortex Face

tympanic canal auditory membrane. of portion includes and ear ear Visible Outer (pinna), waves membrane. tympanic vibration via Transfers of sound

bones Air-filled three called with ear ossicles (malleus, the incus, stapes). space Middle from tympanic membrane amplify Ossicles ear. inner conduct to and sound

ear Inner cochlea. Snail-shaped, fluid-filled 2° waves. membrane to Contains basilar that sound vibrates  transduced stem. specialized nerve signaling Vibration auditory brain cells via hair • location vibration membrane leads on at specific frequency basilar Each to (tonotopy):

helicotrema near apex Low and flexible). (wide heard at frequency

(thin heard base best cochlea of at and frequency rigid). High

Rinne fork ˜ una˜ected No in ear skull (bone all noise on front fork to Weber on background (air process Tuning ˜ a˜ected ear transmission > transmission sound ear of Tuning Localizes of test test conduction, BC) mastoid AC), Tuning BCAC fork > Localizes BC BC of localization of conduction, to AC > AC vertex

hearing Types loss of

conductive ossicles, debris ear keratin A cells space middle within desquamated air ( of hearing loss. mastoid  erode Overgrowth arrows); , the Cholesteatoma may with Often presents painless otorrhea.

of Inflammation A red Conjunctivitis eye conjunctiva  . the bilateral. Allergic—itchy eyes, treat antibiotics. Bacterial—pus; with common, preauricular swollen discharge, • mucous sparse lacrimation; self-resolving. adenovirus; Viral—most node, often

lens often often of night. in at resulting Painless, A vision, ,  opacification and especially glare Cataract bilateral, risk excessive diabetes factors: infection. sunlight, smoking, alcohol use, corticosteroid trauma, age, Acquired excessive  mellitus, use, prolonged trisomies Alport Congenital galactokinase deficiency, 2. galactosemia, (eg, (13, 21), syndrome, 18, syndrome, rubella), risk factors: Marfan TORCH neurofibromatosis classic dystrophy, myotonic infections

zonule Lens fbers. body ciliary Iris by Suspended from position. Muscular fbers and prostaglandin uvea chamber Trabecularmeshwork chamber Sphincter Posterior vasculature canal agonist Aqueous Ciliary of (10%) eye humor outfow through outfow of (eg, episcleral Schlemm Iris into sclera muscle bimatoprost) meshwork Sclera Drainage latanoprost, muscle Schlemm agonists Trabecular with (M3) (eg, and body (α1) Drainage pilocarpine) Dilator Cornea Canal “Angle” ↓↓↓Uveoscleral Anterior the Lens (90%) carbachol, of trabecular

body (eg, (eg, acetazolamide) and carbonic α2-agonists by epithelium nonpigmented by (eg, β-blockers timolol), brimonidine), Produced anhydrase on ciliary inhibitors

outer characteristic nerve pressure of rim thinning progressive field Glaucoma B cupping ), (normal with disc elevated Optic head of loss and versus optic with visual untreated. (IOP) atrophy peripheral intraocular if usually A IOP. or surgical Treatment of pharmacologic through is lowering

Associated African-American history. age, with  race, family Open-angle glaucoma in more common Painless, US. unclear. Primary—cause detachment). (eg, elements uveitis), (eg, (eg, retinal trabecular retinal from vitreous meshwork Secondary—blocked WBCs hemorrhage), RBCs

specific within eye. uvea; Inflammation of based affected on Uveitis name location retinitis. uveitis: and/or uveitis: posterior choroiditis iritis; Anterior (accumulation of in hypopyon conjunctival redness. ) or May pus anterior have chamber A rheumatoid Associated HLA-B27–associated arthritis, with conditions). inflammatory disorders (eg, sarcoidosis, systemic idiopathic arthritis, juvenile

of area Degeneration (central macula retina). of central (scotomas). (metamorphopsia) eventual vision loss distortion and of Causes

pigment vision. Bruch gradual with A membrane  between > retinal epithelium (nonexudative, of in 80%)—Deposition yellowish material extracellular in and Dry (“Drusen”) antioxidant and Prevent with supplements. multivitamin progression

neovascularization. vision due Wet of choroidal loss bleeding to 10–15%)—rapid (exudative, 2° to endothelial injections ranibizumab). (eg, bevacizumab, factor) anti-VEGF (vascular growth Treat with

hyperglycemia. damage to chronic Diabetic due Retinal retinopathy ) Two (arrows types: A edema. and in macular Treatment: blood control. sugar

formation vessel in Proliferative—chronic new • on with detachment. retinal traction resultant results retina blood hypoxia Treatment: peripheral surgery. photocoagulation, injections, anti-VEGF retinal

HTN. Retinal to Hypertensive damage chronic uncontrolled due

microaneurysms, arrow (exudate, (blue ), in retinopathy retinal red A arrow spots ). arteriovenous nicking, Flame-shaped A hemorrhages, in macular star cotton-wool BP. papilledema lowering requires of immediate Presence of with kidney  CAD, disease. stroke, Associated risk of

to atherosclerosis. central compression vein occlusion nearby from branch or retinal Blockage due of vein Retinal arterial thunder affected appearance”; ), venous and and (“blood A Retinal area. arrows edema in in hemorrhage engorgement

photoreceptors layer with pigmented from  vision neurosensory (normally epithelium outermost supports (photoreceptor  retina) of cones) rods of shields loss. excess degeneration retina light, layer Separation and of breaks, retinal traction, to be diabetic effusions. 2° May inflammatory of direction. Visualized vessel on fundoscopy as crinkling A in changes retinal tissue and

history more and/or patients in common myopia high of trauma. Breaks head with down.” like vision loss detachment of monocular emergency. preceded a “floaters”) Surgical eventual (“flashes” Often vitreous drawn and by and posterior “curtain

Central loss. painless vision artery retinal monocular Acute, “cherry-red” occlusion at macula) of (center attenuated Retina with . fovea vessels A and cloudy spot artery (eg, source for ovale). vegetations, patent cardiac carotid Evaluate atherosclerosis, foramen embolic

retinal pigmentosa Inherited degeneration. progressive Retinitis loss. peripheral  (night blindness) vision Nyctalopia deposits spicule-shaped Bone

. A

effect). disc Optic to ICP (usually (eg, bilateral) mass 2° to due Papilledema swelling  . elevated disc spot blind and Enlarged with blurred margins A optic

the Leukocoria (whitening) red of Loss reflex. A congenital retinoblastoma Important include children toxocariasis. in cataract, , causes

via 1st shorten to to ciliary Short ganglion pupillae Miosis neuron: pupil 2nd Edinger-Westphal parasympathetic: neuron: CN ciliary Constriction, nerves sphincter muscles ciliary diameter. the short nucleus nerves III

in CN nuclei signal constrict pupils (direct light Edinger-Westphal Pupillary to nuclei; sends in (dashed II via bilaterally that and either bilateral midbrain activates consensual reflex). image) reflex a pretectal retina lines Light in eye pupillary in Result: constriction. illumination bilateral of 1 results

along at nerve cervical 3rd T1 as 1st sympathetic: muscles. neuron: Dilation, enters orbit superior ciliospinal vessels) Budge ciliary apex, chain 2nd internal long dilator through lung (travels pupillary plexus to cavernous to subclavian carotid, exit Mydriasis near cervical sinus; center hypothalamus neuron: along of to ganglion neuron: (C8–T2) sympathetic and innervate (minor also fibers smooth eyelids forehead face. Sympathetic retractors) sweat muscle of glands of and

diameter Long nerves the make longer. pupil ciliary

Also Gunn Marcus relative pupil defect (RAPD). pupillary afferent called light ipsilateral When into the eye, of constriction reflex) eye (consensual contralateral reflex) the (direct normal shines and observed. is a conduction optic nerve. the the both eye, the dilate constrict is light instead of along light signal swung affected to impaired of to then pupils injured due When neuritis, early sclerosis. Associated optic with multiple

PAM denervation is Sympathetic of : (Horner). face horny

Ptosis (slight drooping superior eyelid: of 

muscle) Ophthalmic divisiontarsal trigeminal of Hypothalamus nerve

of Long glands of side ciliary sweating) face forehead flushing Anhidrosis (absence nerve and of To affected sweat of

muscle To eyelid smooth of

cord medullary spinal carotid lesions artery To of pontine glands 1st the with hemorrhage, lesion sweat  face chain: Internal syndrome, sympathetic along Associated neuron: lateral

neuron: Brown-Séquard lateral 2nd (eg, cord Third syndrome, compression neuron 3rd First (painful) dissection horn above stellate carotid Spinal T1 neuron: ganglion neuron

VI Superior innervates Lateral Rectus. CN Superior Superior the oblique rectus oblique

Superior Oblique. innervates the CN IV

III CN Rest. innervates the

“chemical LR6SO4R3. formula” The Medial rectus muscle

IO tested SO Obliques looking patient right). (left and with Opposite go IO IOU: tested Up. looking

III, VI CN palsies IV,

motor CN components. (peripheral) damage III both and has III CN (central) parasympathetic causes include: Common

thrombosis Cavernous IV, involvement CNs V1/V2, proptosis, sinus of VI •

glucose sorbitol) from extraocular to vascular to of muscles—affected of  outside to disease fibers the oxygen that interior and output by primarily on due (eg, vasculature  nerve. mellitus: diffusion compromised Motor diabetes resides nutrients gaze. ptosis, “down-and-out” Signs:

by uncal compression are the (eg, aneurysm, output—fibers Parasympathetic periphery on herniation). PCom first affected pupil” absent light “blown with pupillary “down-and-out” or reflex, often Signs: diminished gaze

. A

field Visual 1. defects (monocular Macula Right optic tractVisual Optic 4Opticchiasm7 vision 13 52Dorsal anopia loss) Rt.Lateralgeniculatebody Opticnerve radiation(parietallobe)Lt.

L Defect of R eye in visual eye feld 2.

lesion, hemianopia chiasm) 3. Bitemporal (pituitary

4.

(right 5. lesion, temporal quadrantanopia upper MCA) Left

(temporal MCA) loop(right parietal lesion, 6. 7. macular (right Left with occipital sparing lesion, PCA) hemianopia 6 macular cortex (eg, Calcarine infarct) degeneration) sulcus scotoma PCA Central

Lateral horn retina; Meyer of ventricle. Loops Loop—Lower inferior around

and cortex, it left-right visual image radiation—superior takes retina; reversed. an Note: 1° is down optic upsideDorsal When hits

via capsule. internal shortest path

of Collection venous sinuses pituitary. of side on Cavernous either sinus from eye Blood and internal  sinus  cavernous vein. superficial jugular cortex sympathetic all pass and through fibers V1, plus orbit sinus. cavernous IV, to V2, en CNs VI postganglionic III, pupillary route Cavernous of is artery here. internal also portion carotid

Cavernous syndrome—presents decreased variable sensation. maxillary with Horner and syndrome ophthalmoplegia, sinus sensation, occasional corneal  carotid-cavernous sinus pituitary to thrombosis effect, cavernous tumor fistula, to mass 2° or related infection.

n. chiasma Trochlear II) ventricle IV) n. space (CN Ophthalmic V2) Optic cerebral 3rd Pia Dura a. (CN Oculomotor V1) n. Maxillary (CN Arachnoid n. sinus Sphenoid (CN (CN Anterior Pituitary III) Subarachnoid Abducens sinus (CN carotid a. n. Cavernous VI) Internal

Medial III CN for nuclei. that CN pair of between fasciculus longitudinal crosstalk and VI allows (MLF): tracts Coordinates horizontal same both to in move eyes direction. eyes at (must same so communicate Highly quickly move time). myelinated multiple unilateral or stroke). (latter bilateral Lesions seen be classically may sclerosis, in

gaze in palsy. = ophthalmoplegia MLF conjugate Lesion a (INO), internuclear horizontal medial to rectus, contralateral nucleus ipsilateral VI such communication III not that contract. rectus of activates does lateral CN CN Lack stimulate nucleus when III). Abducting CN (CN nystagmus to eye VI overfires displays stimulate normal. Convergence

MLF in MS.

contracts the of left contralateral nucleus the which medial lateral of fires, the right left, to III rectus left (right) rectus. MLF via VI contract stimulates and CN the looking nucleus the right When CN

term to (eg, INO, to refers eye right unable adduct. is the Directional INO) that left

adduction failure, INO Ipsilateral = Nystagmus Opposite.

tolerance, Sedation,

MgSO4) is Also eclampsia depression dependence, seizures (1st line for respiratory

(cleft liver SIADH, bifida), dyscrasias anemia), of (agranulocytosis, blood cytochrome Diplopia, 1st SJS lip/palate, aplastic for teratogenesis trigeminal induction spina P-450, ataxia, neuralgia toxicity, line

SJS causes (absence) (and to Itching have urticaria), Headache, Silent Sucks Fatigue, GI distress, Seizures

P-450 induction, (fetal folate PHENYTOIN: Neuropathy. Enlarged Osteopenia, hydantoin syndrome), gums, Teratogenicity Inhibited Yellow-brown skin, Hirsutism, absorption, Nystagmus, cytochrome SLE-like syndrome, DRESS syndrome. Rare: SJS, leads Toxicity sedation. diplopia, ataxia, to

slow Sedation, cognition,

difficulties prophylaxis (wordfinding) used for sight Also kidney (weight (glaucoma), skinny speech loss), threatened migraine stones,

distress, fatal but rare GI

prophylaxis Also seizures, for (measure disorder, migraine used myoclonic hepatotoxicity bipolar

gain, tube in defects, weight contraindicated neural pancreatitis, tremor, LFTs),

Vision  GABA. with all bad gone line Irreversible 1st ** * GABA = Common use, *** for seizure line recurrent acute, = = for prophylaxis. 1st

pentobarbital, secobarbital. thiopental, Phenobarbital, Barbiturates

channel meChAnism duration). duration firing  by (barbidurates GABAA Facilitate thus of • action neuron opening, • Cl−

of for insomnia, anxiety, Sedative anesthesia induction use CliniCAl (thiopental). seizures,

be exacerbated alcohol P-450). (can eFFeCts and dependence; use); (induces by cardiovascular depression (can depression Respiratory AdVerse CNS drug be cytochrome fatal); interactions maintain Overdose is (assist respiration supportive and BP). treatment Contraindicated porphyria. in

lorazepam, Benzodiazepines alprazolam. temazepam, chlordiazepoxide, midazolam, triazolam, oxazepam, Diazepam,

opening GABAA frequency). channel • of • action by meChAnism Cl– (“frenzodiazepines” Facilitate frequency

sleep.  REM and half-lives long active have and [ATOM]: metabolites potential).  addictive Most are Oxazepam, (exceptions short Triazolam, higher Alprazolam, acting Midazolam

night relaxation), detoxification DTs), sleepwalking, (especially withdrawal– (lorazepam, diazepam, alcohol (insomnia). CliniCAl hypnotic anesthetic midazolam), muscle panic status terrors, general (amnesia, disorder, use eclampsia, Anxiety, epilepticus spasticity, with be used drink can disease liver a LOT those due and first-pass minimal who to Temazepam Lorazepam, Oxazepam, metabolism. for

GABAA and CNS additive eFFeCts barbiturates depression bind the effects AdVerse Dependence, with alcohol (all receptor). coma than of with respiratory Less and depression barbiturates. risk receptor). Treat antagonist GABA (competitive overdose flumazenil at with benzodiazepine by benzodiazepine Can withdrawal. seizures causing acute precipitate

Zaleplon, esZopiclone. Zolpidem, Nonbenzodiazepine the “These of to GABA sleep.” receptor. you Act the meChAnism ZZZs via hypnotics BZ1 subtype put reversed Effects flumazenil. by Sleep less as compared hypnotics. benzodiazepine cycle affected with

use CliniCAl Insomnia.

headaches, eFFeCts Ataxia, AdVerse confusion. Short liver duration enzymes. because rapid metabolism by of depression sedative-hypnotics, day-after effects. only older modest amnestic cause and Unlike psychomotor few risk  dependence benzodiazepines. than

(hypocretin) Orexin meChAnism antagonist. receptor antagonist. is orexin Suvorexant an

use Insomnia. CliniCAl

depression headache, activities. CNS abnormal (somnolence), AdVerse sleep-related eFFeCts with inhibitors. combination Contraindications: CYP3A4 strong narcolepsy, patients with in disease. recommended Not liver dependence physical abuse or potential. Limited

Dizziness, fatigue, eFFeCts nausea, AdVerse headache. dependence controlled a (not substance). No

agonists. 5-HT meChAnism head. nerve trips Inhibit trigeminal falls his and sumo wrestler on A

release, prevent vasoconstriction. induce activation, peptide vasoactive

CliniCAl Acute attacks. migraine, headache use cluster

agonists). (in or paresthesia, other angina), patients with in mild AdVerse combination eFFeCts (contraindicated Coronary serotonin syndrome vasospastic CAD with 5-HT vasospasm

meChAnism dopamine in • brain. by is dopamine, decarboxylase can l-DOPA in the Unlike dopa cross CNS to barrier dopamine. and blood-brain converted is in to DOPA and limit brain l-DOPA with the bioavailability to decarboxylase given peripheral a inhibitor, Carbidopa, of side l-DOPA  peripheral effects.

use Parkinson CliniCAl disease.

hallucinations, eFFeCts postural hypotension. AdVerse Nausea, periods poorly off. “off” impaired during lead periods, function wears With then can “onoff” motor patient medication l-DOPA disease, or progressive l-DOPA mobility when improved to phenomenon “on” to with during responds

(metabolize Selectively • rasagiline dopamine) Selegiline, availability. meChAnism inhibit dopamine MAO-B is Selegiline inhibits Brain and periphery. in the the than MAO-B more selectively in commonly found

Adjunctive CliniCAl in disease. agent to l-DOPA of Parkinson treatment use

enhance of AdVerse eFFeCts May l-DOPA. effects adverse

sevoflurane, anesthetics isoflurane, Desflurane, methoxyflurane, halothane, N2O. enflurane, Inhaled

meChAnism Mechanism unknown.

 eFFeCts Myocardial blood flow, postoperative cerebral cerebral nausea/vomiting, metabolic depression, respiratory depression,  demand.

gas epileptogenic), (N2O). cavity nephrotoxicity proconvulsant eFFeCts of (enflurane, AdVerse expansion (halothane), a (methoxyflurane), body in Hepatotoxicity trapped

contractions inhaled hyperthermia. hyperthermia—rare, in condition induce severe anesthetics life-threatening which muscle Malignant succinylcholine or and is as variable autosomal penetrance. often Susceptibility dominant with inherited sarcoplasmic Ca2+ in release receptor • (RYR1 reticulum. voltage-sensitive ryanodine Mutations cause gene) from

ryanodine Treatment: dantrolene antagonist). receptor (a

tetracaine, anesthetics chloroprocaine. benzocaine, Local Esters—procaine, mepIvacaIne, name). (amIdes have I’s 2 ropIvacaIne Amides—lIdocaIne, in bupIvacaIne,

Block on portion binding to channel. inner meChAnism Na+ specific of receptors by channels neurons. rapidly firing effective Most in channels membrane anesthetics as to bind charged ion then in penetrate form. form, local uncharged amine 3° epinephrine) action— with  by enhance local  (usually to anesthesia be Can concentration. bleeding, vasoconstrictors given systemic cannot more alkaline (acidic) and charged anesthetics tissue, infected In penetrate are effectively  need anesthetic. membrane

large nerve of small-diameter blockade: > Order diameter. fibers fibers Myelinated unmyelinated fibers. > unmyelinated factor myelination predominates fibers over Overall, that fibers unmyelinated > size > myelinated myelinated large > large small fibers such small fibers.

touch, (2) Order (3) (4) temperature, pressure. loss: of (1) pain,

Minor anesthesia. procedures, CliniCAl spinal surgical use give allergic amides. esters, If to

excitation, severe (cocaine), AdVerse (benzocaine). hypotension, toxicity CNS cardiovascular (bupivacaine), methemoglobinemia arrhythmias hypertension, eFFeCts

(μ β-endorphin, channels, Act opioid K+ dynorphin) antispasmodics agonists receptors open modulate  transmission—close = Ca2+ as transmission. enkephalin, δ at presynaptic channels meChAnism κ synaptic to = Spasmolytics, = synaptic postsynaptic ACh, substance norepinephrine, glutamate, of release P. Inhibit 5-HT,

fentanyl. Full morphine, meperidine, eFFiCACy methadone, agonist: codeine, heroin, agonist: Partial buprenorphine. nalbuphine, Mixed pentazocine, agonist/antagonist: butorphanol. naloxone, Antagonist: naltrexone, methylnaltrexone.

edema, + maintenance buprenorphine (methadone, (loperamide, pain, programs or use diarrhea CliniCAl diphenoxylate), heroin refractory severe pulmonary for naloxone). acute addicts to Moderate

of pruritus, mydriasis), other drugs. miosis addiction, with  AdVerse sphincter additive respiratory depression, Oddi (except depression constipation, spasm, Nausea, meperidine vomiting, eFFeCts CNS develop constipation. to does and not Tolerance miosis opioid once receptor with naloxone (competitive Treat prevent and with toxicity detoxified. antagonist) relapse naltrexone

reuptake weak and agonist, opioid a agonist; is Slight opioid a Very the also Tramadol meChAnism of serotonin. norepinephrine inhibits and reuptake and norepinephrine inhibitor. Serotonin It but is for used pain, Stubborn

CliniCAl use Chronic pain.

lower can cause Seizure may and threshold,

AdVerse Similar decreases eFFeCts to threshold; opioids; seizure

Serotonin Syndrome.

serotonin syndrome.

of amount (inhibit • IOP Glaucoma drainage).  humor aqueous synthesis/secretion or  via therapy Correct. Politically be BAD may humor not

or synthesis vision via aqueous use carteolol foreign apraclonidine, not vision, humor  pupillary ocular body glaucoma Epinephrine betaxolol, brimonidine) synthesis changes Timolol, ocular sensation, ocular  aqueous (α1); pruritus humor  do in (α1), hyperemia, (apraclonidine, reactions, allergic brimonidine α-agonists closed-angle Mydriasis No synthesis humor β-blockers (epinephrine) vasoconstriction (α2) Blurry aqueous

of or vision via  humor Diuretics synthesis No anhydrase carbonic inhibition Acetazolamide pupillary changes aqueous

eyelash (PGF2α) aqueous resistance through Bimatoprost, outflow iris of pathway uveoscleral humor latanoprost of Prostaglandins flow growth  via Darkens color  (browning), of

opening going canal aqueous at opening “Words physostigmine, in make echothiophate yesterday, carbachol die has may meshwork muscle) ciliary weep.” skillfully meshwork men which Wonderland oldest of ciliary of of then.” from, sphincter was (contraction to to are pilocarpine man.” into in no pupillary Cholinomimetics Direct: no Indirect: —Lewis other before Carroll, to running therapy should Schlemm they muscle angle of “The back “All the to, via what in of sorrow “It’s glaucoma—very and and why.” vent comfort, trabecular Alice organs (contraction and strive contraction person and different administered, humor I of use  (M3) closure a pilocarpine, cyclospasm tears known outflow learn muscles) acute because effective they of are Use Miosis

This psychiatry, chapter and psychopharmacology. encompasses sociology, psychology, areas in overlapping topics disorders, disorders, antipsychotic High-yield disorders, disorders, and schizophrenia, mood abuse, somatic substance personality symptom include agents. eating for diagnosing disorders. common criteria DSM-5 psychiatric Know the

action which because or elicited in conditioning it Learning punishment particular is a Operant produces a reward. elicits Usually voluntary responses.

reward (negative reinforcement) stimulus behavior aversive is conditioning Reinforcement followed of (positive desired (response) Target quadrants: removal operant reinforcement). by Skinner or

(positive application Repeated punishment) or punishment) desired extinguish unwanted reward stimulus Punishment of behavior. aversive of removal (negative to

or Extinction eventually (positive Discontinuation negative) of reinforcement behavior. eliminates occur operant conditioning. or in classical Can

important is onto (eg, Transference feelings projects physician psychiatrist parent). or persons formative as other about Patient seen

projects about Countertransference Doctor sibling). other physician onto reminds persons patient younger important or (eg, feelings patient formative of

to resolve (voluntary feelings or Ego prevent behaviors anxiety, depression). conflict involuntary) (eg, undesirable Thoughts and defenses and used

painful the of Denial awareness reality. some Avoiding being with a warned fatigue plans cancer chemotherapy. work A despite of significant full-time schedule patient during

wear Mature SASH. adults a

trust Lack basic of

to Reactive (infant comfort) withdrawn/unresponsive disorder attachment

attaches indiscriminately strangers) social engagement Disinhibited to (child

affection. Failure and/or education, with food, adequate shelter, neglect a child Child supervision, to provide Most form child of common maltreatment. Signs: impaired thrive. to poor failure malnutrition, development, social/emotional hygiene, withdrawal, services. with neglect suspected be must child child As protective local to reported abuse, child

Onset 12. before age attention and/or span months impulse 6 limited of poor control. ≥ of hyperactivity, by inattention impulsivity, settings home, Characterized places ≥ and/or (eg, worship). school, 2 in intelligence, coexists with Normal difficulties school. commonly in but into Often adulthood. persists disorder. Commonly with coexists oppositional defiant +/– therapy; methylphenidate) guanfacine, behavioral alternatives clonidine. Treatment: atomoxetine, (eg, stimulants include

or behavior animals, pervasive rights property, Conduct destruction of (eg, norms people theft). societal basic disorder the violating and toward Repetitive, others of aggression age as often disorder. After 18, reclassified personality antisocial Treatment: (eg, [CBT]). cognitive behavioral psychotherapy therapy

learning. deficits (vs reasoning, language, learning specific Intellectual judgment, disorder) abstract disability thinking, cognitive that memory, affect Global independence. with impaired, is functioning leading difficulties education, socialization, employment, Adaptive communication, to major special psychotherapy, education. therapy, occupational Treatment:

pattern vindictive, and defiant of Oppositional irritability defiant toward anger argumentative, with disorder behavior Enduring authority and figures. CBT). Treatment: psychotherapy (eg,

5. Onset mutism before Selective age in month situations speech from despite in other, comfortable disorder certain 1 ≥ situations. involving more usually Anxiety refraining lasting speaking typically speech not impaired. (eg, Development language) and Interferes tasks. with academic, occupational social, and Commonly with disorder. coexists social anxiety behavioral, and Treatment: play therapy; family, SSRIs.

Tourette age syndrome 18. Onset before > recurrent, nonrhythmic, year. tics vocal Sudden, stereotyped Sudden, that and for motor persist 1 speech) Coprolalia obscene (involuntary some in patients. found and OCD with ADHD. Associated Treatment: psychoeducation, therapy. behavioral tics, antipsychotics antipsychotics. α2-agonists or fluphenazine), high-potency (eg, clonidine), distressing and haloperidol, intractable atypical For tetrabenazine, guanfacine, (eg,

know  person). to they and are, (order they Patients’ where time are Orientation date ability loss: place of and time,  who the trauma, imbalance, loss nutritional orientation: infection, Common fluid/electrolyte head hypoglycemia, of drugs, alcohol, causes deficiencies, hypoxia. of

body, perceptions, detachment derealization thoughts, actions (depersonalization) estrangement feelings of (derealization). or and Persistent from own or one’s Depersonalization/ one’s environment testing Intact reality disorder psychosis). (vs

acute Delirium arousal. consciousness span, with level level onset,   of and attention of waning” “Waxing (eg, sleep-wake disturbance Characterized thinking, agitation. cycle, (often disorganized by cognitive misperceptions dysfunction, illusions), visual), hallucinations in Reversible. infection, 2° identifiable trauma, Usually especially disease, other hemorrhage, (eg, metabolic/electrolyte illness CNS to disturbances, urinary/fecal (eg, retention), in withdrawal, the substance medications elderly. or anticholinergics), abuse/ altered hospital setting, status presentation the prolonged ICU during common mental in especially or inpatient Most in of stays. diffuse slowing. rhythm show may background EEG

sensorium. Delirium changes in =

Treatment: underlying condition. of management and identification Orientation keeping calendar and  protocols disturbances, clock to symptoms. manage or  nearby), stimulation cognitive (eg, a sleep as Antipsychotics needed. opioids). delirium and anticholinergics, benzodiazepines, restraints worsen drugs unnecessary may (eg, Avoid that

Distorted of characterized perception disorganized reality delusions, and/or by hallucinations, Psychosis thought/speech. illness, medical psychiatric Can with or illness, occur both. in patients

that False, reading culture a believes persist contrary fixed, of idiosyncratic patient beliefs Delusions evidence that his to typical or religion others are (eg, not patient’s despite the thoughts). who and are a jealous, grandiose, somatic, erotomanic, Types persecutory, unspecified. and include mixed,

may tangential, thought or incoherent (“loose Speech salad”), (“word associations”). derailed be Disorganized

Hallucinations actually Perceptions that the a absence seeing not of stimuli external is (eg, light in present). stimuli. of Contrast with misperceptions real (eg, illusions) external Types include:

illness schizophrenia) Auditory—more psychiatric to commonly than medical illness. (eg, due

due medical commonly illness delirium) (eg, to Visual—more illness. intoxication, psychiatric than drug

a parasitosis). and in delusional alcohol withdrawal of Tactile—common type stimulant use “cocaine (eg, crawlies,”

and tumors. (eg, temporal occur of burning an in aura Olfactory—often as lobe rubber) epilepsy brain

in seen Gustatory—rare, but epilepsy.

while Hypnagogic—occurs going to sleep. narcolepsy. seen in Sometimes

waking from while pomped up Hypnopompic—occurs sleep the morning”). in (“get Sometimes narcolepsy. seen in

Chronic functional Schizophrenia profound causing impairment. illness categories include: Symptom

bizarre behavior processes, Positive—hallucinations, disorganized unusual thought speech, delusions,

social blunted affect, Negative—flat withdrawal anhedonia, alogia, apathy, or

memory, understand plans, diminished working ability or Cognitive—reduced make inattention to

2 #1–3: Diagnosis symptoms, including from active 1. the following 1 requires ≥ ≥ symptoms of

2.

Hallucinations, 3. often auditory

4.

5.

≥ over months; months onset diagnosis. ≥ 6 symptoms Requires prior active of month 1 6 past the to

with Associated activity,  dendritic serotonergic altered branching. activity, and dopaminergic  Ventriculomegaly imaging. brain on females). prevalence—1.5% Lifetime > (males early men 20s to Presents earlier 20s) teens in than early to (late 30s). (late women in risk. suicide 

Heavy adolescence psychotic, worsened with cannabis anxiety is mood,  and and incidence in use disorders. associated of course

atypical (eg, are risperidone) antipsychotics first Treatment: line. Negative symptoms. resolution despite positive symptoms after of persist treatment, often

disorder—≥ symptom(s) positive stress-related. 1 < 1 psychotic lasting usually month, Brief 1–6 Schizophreniform months. symptoms lasting disorder—≥ 2

bipolar both or Schizoaffective disorder). symptoms mood disorder depressive Shares with schizophrenia (major and disorders > a a disorder symptoms weeks depressive To patient from with psychotic must without manic episode. have differentiate 2 of or features, psychotic mood

1 a lasting disorder mood disorder delusion(s) other without psychotic but ≥ > 1 Delusional month, symptoms. or belief the be Daily fixed unaffected. but including functioning, may socialization, pathological, is by otherwise impacted be (folie deux). in à Can close individuals by shared relationships

Cluster on that falls personality also spectrum. personality the schizophrenia A disorder Schizotypal in schizophrenia. May disorder frequent delusions) (eg, severe episodes and include brief psychotic are that less than

them. emotional Mood disorder over Characterized of or states moods abnormal loss range of by and control internal an causes functioning. occupational of social and in impairment distress and Severity moods depressive, Includes cyclothymic and dysthymic, bipolar, major disorders. (delusions, may hallucinations, present. superimposed disorganized Episodic be speech/behavior) psychotic features

and elevated, Manic episode irritable mood ≥ lasting expansive, of week. or persistently or 1 period and activity  Distinct abnormally energy 3 FAST): Diagnosis functional with ≥ impairment marked the of requires DIG or hospitalization following (manics

Distractibility of Flight thoughts ideas—racing •

pleasure to without Agitation • goal-directed consequences  Impulsivity/Indiscretion—seeks Activity/psychomotor regard (hedonistic)

to social Hypomanic severe episode Similar in marked necessitate manic and/or not to impairment disturbance cause episode except hospitalization. a enough is functioning or mood occupational to activity usually present. or energy  Abnormally psychotic No features. consecutive Lasts 4 ≥ days.

of length time). episode history a of and (no episodes). II—a manic Bipolar depressive hypomanic normalize mood between and usually functioning Patient’s episodes. antidepressants of can mood. Use destabilize High risk. suicide Treatment: (eg, lamotrigine), acid, lithium, mood stabilizers carbamazepine, antipsychotics. atypical valproic

fluctuating of form mild disorder Cyclothymic hypomanic depressive between and symptoms. disorder—milder bipolar ≤ years with any Must least last time, remission 2 ≥ present months. of with symptoms the 2 at half lasting

≥ anhedonia) episodes 2 5 or diagnostic characterized lasting (must include ≥ depressed 9 weeks by mood (DIGS symptoms Recurrent SPACE): of

or of feelings worthlessness Guilt

or episodes manic previous disorder. for out hypomanic rule Screen to bipolar line. and are SSRIs Treatment: first CBT SNRIs, (ECT). bupropion, Also electroconvulsive mirtazapine, therapy

than disorder children), milder years any ≥ months. 2 symptoms depressive 2 year in remission 1 Often Persistent depressive (dysthymia) 2 (≥ MDD; with lasting ≤ lasting ≥

seasonal affective disorder. with called MDD Formerly seasonal episodes occurring season and pattern Major years in 2 (usually a ≥ years during in only particular winter) consecutive across most lifetime. depressive a Atypical symptoms common.

atypical features with Depression

improvement by positive paralysis a leaden long-standing to (heavy response hypersomnia, (transient Characterized feeling rejection interpersonal arms and mood in hyperphagia, event), in legs), reactivity sensitivity. subtype common Most of depression. line. CBT are and Treatment: first SSRIs risk line because profile. but of first inhibitors not (MAOIs) MAO their effective are

peripartum rate. incidence 10–15% MDD with called Formerly postpartum depression. onset onset MDD after no with than criteria year delivery. later Meets 1 and SSRIs CBT first are Treatment: line.

Postpartum 0.1–0.2% rate. psychosis incidence mood-congruent baby hallucinations, by and Characterized delusions, thoughts or of harming self. the psychotic disorder, history, include medication family change. disorder, Risk pregnancy, recent first bipolar factors used. if hospitalization Treatment: may of be initiation ECT antipsychotic; atypical insufficient, and

order). any stages grief of in are per anger, occur Grief model the Kübler-Ross The bargaining, denial, acceptance (may five and depression, yearning, shock, that somatic symptoms grief symptoms normal sadness, occur include waves. usually anxiety, and Other in guilt, deceased of (eg, hallucinations person the the deceased Simple common are speaking). hearing limited complicated (vs of are thoughts joining grief). the Any to dying deceased 6–12 months. usually Duration within varies resolves widely; deceased the involves impairment, months months obsessive in functional lasting Persistent and disorder (6 complex least with causes children). preoccupation at 12 bereavement for Can meet criteria episode. major also depressive

SAD PERSONS likely more complete suicide. to are

Most US access risk guns of method firearms; common completion. to in is suicide 

complete try often; Women more men often. more

risk factors recent Other completed psychiatric family and history include suicide. hospitalization of

their incongruent experiences physical Anxiety of and magnitude the fear/worry stressors. disorders the Inappropriate manifestations of with Symptoms to another not are (eg, condition hyperthyroidism), disorder, abuse. or medical psychiatric substance attributable Includes and phobias, anxiety mutism. generalized selective panic disorder, disorder,

(≥ to a months) or situation. 6 or anxiety anticipation fear or due Severe, Phobias persistent object presence specific of Person excessive. fear recognizes is often exposure with Treatment: therapy. CBT

of disorder—exaggerated situations social public (eg, fear restrooms). in anxiety public embarrassment Social speaking, using venlafaxine. CBT, SSRIs, Treatment: anxiety For needed. performance β-blockers speaking), to use as benzodiazepines type public or restricted (eg,

open/ while (eg, lines, fear/anxiety crowds, 2 situations spaces, transport). public closed Agoraphobia—irrational facing specific anticipating ≥ or severe, leave homes. to If may their refuse patients disorder. panic Associated with CBT, Treatment: SSRIs.

pulling Compulsively one’s out hair. Trichotillomania distress Causes and persists attempts despite significant stop. to of scalp with commonly of baldness body, the thinning areas Presents hair area any most or the on

A . spans but ages. all in highest Incidence childhood Treatment: psychotherapy.

ended. 6 stressor behavioral of that an once divorce, illness) psychosocial (eg, Emotional months identifiable or anxiety, < has 3 Adjustment within occur lasting outbursts) the symptoms (eg, disorder stressor months > ends, symptoms is stressor GAD. months it after If persist 6 Symptoms not meet MDD. do for criteria antidepressants may line; and is considered. anxiolytics be first Treatment: CBT

Schizoid emotional with expression, social isolation limited (Aloof), avoidant). (vs withdrawal Voluntary content social

Symptoms is disorders are unconscious. intentional, Factitious motivation get to physical [internal] order assume and and/or Patient to (1° symptoms sympathy and psychological role” creates attention in gain). “sick consciously medical

Conversion functional called symptom disorder. disorder neurologic Also sensory acute patient Loss indifférence); belle in toward symptoms motor more (la stressor; but females, adolescents, mutism), often following indifferent (eg, aware adults. blindness, paralysis, an may young of function and common or be of

despite minimal symptoms. illness, evaluation having medical disorder Preoccupation with anxiety often a somatic reassurance; serious no acquiring and or Illness to

Bulimia eating behaviors at over the purging with Recurring compensatory nervosa episodes 3 binge of weekly least months. last slightly or normal (vs anorexia). overweight often BMI sign). see dorsal with Mallory-Weiss alkalosis, electrolyte from (Russell amylase), parotid enamel serum erosion, , • (eg, metabolic hand calluses vomiting K+ induced disturbances (may hypertrophy Cl−), Associated gland syndrome, •  rehabilitation, nutritional Treatment: SSRIs). antidepressants psychotherapy, (eg, risk. due seizure contraindicated to is Bupropion

the middle of disorder screaming Sleep terror in of with inconsolable night. the terror Periods common children. Most in Occurs N3) with during dream). no the sleep arousal to as that (stage non-REM (remembering sleep of scary a memory occur during nightmares opposed REM episode, slow-wave/deep emotional of sleep. and include Triggers lack stress, fever, limited. self Usually

old. for ≥ 3 Enuresis times/week months years > Nighttime incontinence in 2 urinary 5 ≥ person restriction) treatment: fluid and First-line reinforcement. nighttime modification (eg, behavioral scheduled voids, positive over preferred effects). fewer refractory due imipramine side desmopressin to bedwetting oral For (ADH analog; cases: alarm,

recurrent ≥ last sleepiness times/week sleepiness awakening Narcolepsy with daytime 3 episodes for rapid-onset, 3 months. the of well-rested) overwhelming (despite Excessive hypothalamus and (hypocretin) lateral in cycles. production sleep-wake • to dysregulated orexin Due with: Associated

going (just morning) in pomped hallucinations. to Hypnagogic awakening; (just sleep) before or hypnopompic the get up before

Nocturnal sleep narcoleptic with episodes (sleep REM that start paralysis). and sleep

of (loss laughter). muscle emotional stimulus, all such Cataplexy as following tone strong

good Treatment: hygiene naps, sleep schedule), modafinil) oxybate stimulants (eg, daytime nighttime regular and/or sleep (GHB). (scheduled sodium amphetamines,

Stages change in of addiction overcoming

involving following 2 the substance past pattern Maladaptive ≥ of in of use year: the

distracting cravings Intense,

than intended longer, more, or Using

but cut down inability desire to Persistent

or Time-consuming substance use, acquisition, recovery

sex, use work, at unsafe danger functioning involving (eg, Impaired while > or impaired) driving school, 1 home of episode

1. Continued harm use of despite awareness

2.

unwilling to change Contemplation—acknowledging 3. but problem,

4.

5.

6.

returning abandoning and behaviors applicable) Relapse—(if changes to old

tremor, seizures, depression. mood elevation, anxiety,  disinhibition, respiratory Nonspecific: behavioral Nonspecific: anxiety, sedation, insomnia.

lability, slurred blackouts. Alcohol ataxia, speech, coma, Emotional of (GGT)—sensitive use. Serum indicator alcohol γ-glutamyltransferase ALT (“ToAST is ALcohol”). value value 2× 2 AST benzodiazepines. Treatment:

sleep  appetite, post-use insomnia, agitation, anxiety. elevation, appetite, tachycardia, arrhythmias, lethargy, depression, including Nonspecific: Nonspecific: cardiac mood • “crash,” psychomotor vivid nightmares. disturbance,

with alcohol on symptoms Physiologic interrupted. tolerance and use disorder dependence of when withdrawal intake Alcohol is neuropathy, deficiency, B1 pancreatitis, atrophy. alcoholic peripheral Complications: cirrhosis, (thiamine) vitamin testicular hepatitis, abstain (reduces to acamprosate, condition Treatment: use). alcohol the naltrexone from patient disulfiram (to cravings), are groups such helpful Anonymous and Alcoholics family. and patient as supporting sustaining Support in abstinence

vitamin Wernicke-Korsakoff deficiency. from Results B1 can B1. Symptoms syndrome vitamin dextrose by administering before precipitated be ophthalmoplegia, confusion, (Wernicke of Triad encephalopathy). ataxia loss, change confabulation, to progress (Korsakoff personality May irreversible syndrome). memory vitamin B1 Treatment: (before dextrose). IV

Teaches Behavioral how or maladaptive reactions to identify to stimuli. therapy and behaviors patients change systematic desensitization include for of phobia. treatment Examples

tolerance Teaches coping emotional recognize Cognitive of thought maladaptive skills, • to therapy develop distortions behaviors distress. behavioral and and their patients constructive processes, control coping greater • in include triggers alcohol for consumption. Examples recognizing

conditions used but psychiatric in Designed therapy Dialectical personality in borderline other disorder, well can as be behavioral (eg, for depression). use

improving interpersonal on Focused and Interpersonal therapy skills. relationships communication

maintain of Utilizes time Supportive empathy help individuals optimism hardship to a or hope. during therapy to

Stimulants (methylphenidate, selected for ADHD amphetamines) conditions psychiatric

chlordiazepoxide, diazepam) lorazepam, Alcohol withdrawal (eg, Benzodiazepines

anxiety Generalized SNRIs disorder SSRIs,

clomipramine venlafaxine, SSRIs, Obsessive-compulsive disorder

disorder SSRIs, venlafaxine, benzodiazepines Panic

SSRIs, PTSD venlafaxine

 the synaptic in dopamine. and especially cleft, catecholamines norepinephrine MEchaNisM

ADHD, narcolepsy, disorder. binge-eating cliNical UsE

hypertension, anorexia, weight Nervousness, EFFEcts loss, agitation, aDVErsE insomnia, bruxism. anxiety, tics, tachycardia,

thioridazine, chlorpromazine. Haloperidol, fluphenazine, antipsychotics trifluoperazine, pimozide, Typical

(• Block D2 cAMP). MEchaNisM receptor dopamine

Schizophrenia OCD. Tourette cliNical disorder, (1° bipolar Huntington UsE symptoms), positive delirium, syndrome, disease, psychosis, dementia. Use in caution with

(Hal Trifluoperazine, Haloperidol, High side PotENcy extrapyramidal potency: Fluphenazine High)—more to Fly symptoms [EPS]). (eg, Tries effects neurologic low)—more Low Chlorpromazine, Thieves are potency: anticholinergic, Thioridazine effects. (Cheating antihistamine, α1-blockade

Lipid soluble in stored body. EFFEcts body  be  to removed fat aDVErsE slow from oligomenorrhea, antagonism hyperprolactinemia Endocrine: receptor  gynecomastia. dopamine • galactorrhea, gain, weight dyslipidemia, Metabolic: hyperglycemia. dry Antimuscarinic: constipation. mouth, sedation. Antihistamine: orthostatic hypotension. α1-blockade: QT prolongation. Cardiac: deposits; Chlorpromazine—Corneal Thioridazine—reTinal deposits. Ophthalmologic: Neuroleptic syndrome. malignant Extrapyramidal ADAPT: symptoms—

Dystonia crisis). days: Acute Hours to stiffness, oculogyric spasm, (muscle benztropine, diphenhydramine. Treatment:

months: Days to

Akathisia (restlessness). Treatment: β-blockers, benzodiazepines. benztropine,

Parkinsonism (bradykinesia). benztropine, Treatment: amantadine.

orofacial). years: dyskinesia Months Tardive (chorea, to especially Treatment: antipsychotics clozapine), valbenazine, deutetrabenazine. (eg, atypical

-TCAs, Mirtazapine adrenergic SNRIs, receptor (autoreceptor) Metabolites reuptake 5-HT NE ˜2 5-HT 5-HT bupropion receptorNE AXON MAO NEURON MAOIs POSTSYNAPTIC receptor ----NE TCAs, SSRIs, AXON -MAO SNRIs, trazodone reuptake Metabolites

reuptake sertraline, Fluoxetine, paroxetine, serotonin escitalopram, citalopram. fluvoxamine, inhibitors Selective

MEchaNisM reuptake. 5-HT Inhibit 4–8 show weeks appreciable to for It takes normally effect. antidepressants

ejaculation, cliNical binge-eating premature UsE anxiety dysphoric anxiety generalized panic social OCD, disorder, disorder. premenstrual disorder, disorder, disorder, bulimia, Depression, PTSD,

Fewer than EFFEcts aDVErsE TCAs. Serotonin SIADH, distress, GI libido). (anorgasmia, syndrome, sexual dysfunction 

inhibitors Serotoninnorepinephrine reuptake levomilnacipran, duloxetine, milnacipran. Venlafaxine, desvenlafaxine,

5-HT NE reuptake. and MEchaNisM Inhibit

generalized anxiety disorder, neuropathy. Depression, UsE cliNical diabetic PTSD, anxiety also panic disorder, is OCD. indicated social Venlafaxine for disorder, indicated for and fibromyalgia. milnacipran are also Duloxetine

stimulant EFFEcts aDVErsE  nausea. effects, BP, sedation,

amoxapine. imipramine, Tricyclic clomipramine, Amitriptyline, desipramine, doxepin, nortriptyline, antidepressants

reuptake. TCAs inhibit and 5-HT NE MEchaNisM

neuropathy, although MDD, (imipramine, may cliNical adverse migraine use). (clomipramine), enuresis pain, nocturnal limit OCD peripheral chronic neuropathic prophylaxis, effects UsE

postural effects and retention, urinary α1-blocking hypotension, including EFFEcts atropine-like (anticholinergic) Sedation, mouth). dry (tachycardia, side aDVErsE effects effects more than have TCAs (nortriptyline). TCAs 3° 2° anticholinergic (amitriptyline) QT Can interval. prolong Na+ Convulsions, due channel to Coma, (arrhythmia also depression, hyperpyrexia. inhibition); Tri-CyCliC’s: Cardiotoxicity respiratory tolerated). (2° side nortriptyline] and in to are anticholinergic hallucinations common more better [eg, due amines Confusion the effects elderly arrhythmia. prevent Treatment: NaHCO3 to

oxidase inhibitor). Isocarboxazid, MAO-B (selective Monoamine Selegiline Tranylcypromine, Phenelzine, Takes (MAO In Shanghai). inhibitors Pride

dopamine). 5-HT, inhibition MAO  neurotransmitters MEchaNisM Nonselective levels (norepinephrine, of amine

UsE anxiety. Atypical depression, cliNical (selegiline). Parkinson disease

crisis, hypertensive notably of stimulation; with EFFEcts CNS tyramine. aDVErsE most ingestion precipitating serotonin SSRIs, John’s dextromethorphan, with St. TCAs, wort, Contraindicated syndrome). meperidine, avoid (to linezolid after MAOIs drugs stopping 2 Wait weeks dietary before starting or stopping serotonergic restrictions.

and NE DA Inhibits reuptake. Bupropion Also for used cessation. smoking and seizures in anorexia effects (tachycardia, patients stimulant headache, nervosa. with bulimia insomnia), Toxicity: effect Favorable profile. side sexual

antagonist, receptor Mirtazapine antagonist. and potent 5-HT), release of 5-HT3 and α2-antagonist ( H1 NE and 5-HT2 in dry be may gain weight patients depressed appetite, (which Toxicity: desirable be with underweight • patients), in sedation mouth. desirable (which may insomnia),

also Primarily 5-HT blocks Trazodone reuptake. receptors; inhibits weakly and α1-adrenergic, H1 5-HT2, antidepressant primarily for doses Used as for effects. high insomnia, are needed postural Toxicity: priapism, hypotension. nausea, sedation, side to and male-specific due traZZZobone effects. Think sedative

Varenicline Nicotinic receptor ACh partial agonist. smoking Used cessation. for disturbance, mood, depressed sleep Toxicity: suicidal ideation. nicotine cravings helps Varenicline decline.

or Methadone Long-acting maintenance heroin detoxification used oral for therapy. long-term opiate

to used (partial Buprenorphine form agonist) Sublingual prevent relapse.

as particularly depression. reverse a or overdose, Naloxone antagonist spray treat IM, opioid Short-acting and to to nasal IV, acute opioid CNS respiratory given

used detoxification relapse. to opioid oral Naltrexone after antagonist prevent Long-acting trex the Use to long sobriety. naltrexone for back

I all know “But about already. love —Aldous precious “This Hay know I still too about pass. Huxley, kidneys.” shall little Antic stone.” much. “I too Just kidney like a drink last in gave sample it.” olive I a had The time it an urine

able will physiology to apply be Being understand for the exam. renal and critical ACE AT-II acute urine include disorders, topics (including Important electrolyte diuretics, and and inhibitors, derangements, kidney glomerular receptor blockers. casts, disorders disease, acid-base histopathology), chronic also to with about high-yield various when pediatric anomalies associated defects Renal think are vignettes. congenital associations evaluating

4; Kidney Pronephros—week then embryology degenerates. Mesonephros—functions male kidney genital to system. later contributes as trimester; for 1st interim of appears continues in of weeks 32–36 gestation. nephrogenesis 5th gestation; first Metanephros—permanent; through week

collecting canalized ureter, diverticulum)— ducts; 10th (metanephric to derived caudal fully pelvises, gives calyces, week of duct; mesonephric bud by rise Ureteric from end

and metanephric glomerulus blastema)—ureteric (DCT) tissue; (ie, formation Metanephric through convoluted induces interaction with distal mesenchyme to this differentiation of tubule bud interacts

kidney several may agenesis, 2 of in dysplastic interaction kidney) tissues Aberrant congenital between multicystic renal the malformations result these (eg,

canalize obstruction. congenital Ureteropelvic to  junction—last common hydronephrosis. prenatal of cause Most prenatal Detected by ultrasound.

facial (cause  Oligohydramnios of pulmonary of  ears of flattened nose), compression fluid limb lungs and fetus retrognathia hypoplasia death). low-set into chest ,  amniotic deformities, of and anomalies A aspiration developing compression (eg, fetal lack

include obstructive renal uropathy insufficiency. urethral valves), chronic Causes (eg, agenesis, posterior ARPKD, bilateral placental

sequence. in develop who Potter utero Babies “Pee” can’t

hypoplasia (in Pulmonary POTTER defects Twisted Twisted utero) failure with: (trigger) face associated sequence Extremity skin Oligohydramnios Renal

. abnormally A of Inferior kidneys both poles fuse from they trapped and fetal low the mesenteric abdomen. As under kidneys horseshoe during inferior ascend in pelvis get artery development, remain Kidneys normally. function infection, cancer. risk with junction Associated hydronephrosis obstruction), (eg, renal of  ureteropelvic renal stones,

trisomies (eg, 21). 18, 13, aneuploidy syndrome, in incidence Turner Higher chromosomal

*Components barrier. of fltration glomerular

glomerulus of Cross-section

Left living is it during donor a kidney taken longer because has renal vein. transplantation

Afferent = Arriving.

= Exiting. Efferent

flow: artery artery segmental blood Renal artery artery • interlobar arcuate   renal

vasa capillaries efferent •  outflow. recta/peritubular • arteriole A venous additional left veins. renal veins: gonadal suprarenal Left vein two and left receives

to to  flow very  ischemic renal damage. receives than overall sensitive hypoxia high medulla renal renal significantly blood vulnerable less flow, cortex blood Despite

travels over A iliacs of (uterine ureter arises the bridge gonadal arteries renal and vas ureters • (ureters) pelvis, the of common under : artery flows from Course or Course deferens). Water under over

(retroperitoneal).

obstruction (eg,  or procedures ureteral leak. Gynecologic of ligation female) (in

ureter, reflux. the intravesical preventing contraction Bladder compresses urine

ureter: Blood to supply

junction. common junction, internal obstruction: common of inlet, 3 iliac Middle—gonadal points arteries artery, ureteral aorta, pelvic ureterovesical ureteropelvic and

kg HIgh HIKIN’: mass: K+ 70 INtracellularly. Body

ECF, (eg, of 40% of of mass 40% (% 60–40–20 28 organic body 20% 42 = body mainly K+, kg of person): phosphates Cl–, of 60% composed Mg2+, for rule mass = ICF, Na+, composed weight body ATP) mainly L kg 42 average

kg fuid of 2.8 Blood fuid 10.5 3.5 kg volume volume (ECF)~ L kg 6 Plasma kg kg) 75% Interstitial kg) = 14 70 = ECF 10.5 Extracellular ECF Intracellular (20% (ICF)~ L 28 3.5 fuid L of L RBC (40% 70 25%

45% Normal [Hb] by albumin. g/dL Hct Plasma radiolabeling in = be Hct HCO3–, albumin volume 3 can measured (%)

mannitol. or = H2O. Serum mOsm/kg 285–295 osmolality × TBV – = Plasma volume Hct). (1

and for size of Charge charge selectivity. ⊝ filtration charged plasma to 3 Glomerular barrier barrier—all layers filtration Responsible according contain charged glycoproteins entry of ⊝ that prevent

Composed of:

heparan Basement IV chains and sulfate membrane type with collagen

molecules processes epithelial consisting (eg, of Visceral podocyte (FPs) albumin). layer foot

basement podocyte interpose foot nm > of endothelium > molecules (GBM); cells); molecules/blood capillary entry entry 100 slit Size diaphragm of barrier—fenestrated with processes (prevents (prevents nm). glomerular membrane 50–60

used nor Glomerular be rate freely and 14 Inulin secreted. is to filtration calculate it is reabsorbed can neither filtered GFR because clearance 12

GFR. Creatinine of approximate an is measure clearance creatinine by overestimates secreted Slightly 2 renal moderately because tubules. GFR is

coefficient). GFR mL/min. 100 ≈ Normal

fraction Filtration = GFR/RPF. (FF) Filtration be can 20%. with Normal creatinine FF GFR estimated = clearance. clearance. with best load estimated GFR RPF (mg/min) (mL/min) Filtered = PAH is

plasma concentration × (mg/mL). Afferent Dilate (PDA). Prostaglandins arteriole II arteriole (ACE). Angiotensin Efferent Constricts

˜ layer) capsule Bowman preferentially aƒerent no (parietal arteriole dilate GFR, so FF) Prostaglandins

RPF,

RPF,

GFR, so

GFR Calculation P. × = load of Filtered

rate V = reabsorption Excretion Ux. and ×

rate Reabsorption = – excreted. rate filtered secretion – filtered. rate = Secretion excreted = fractional FeNa sodium. of excretion

level at (PCT) mg/dL) convoluted reabsorbed cotransport. normal (range Glucose in plasma Glucose proximal tubule 60–120 Na+/glucose is by clearance completely a glucose (threshold). of In begins adults, glucosuria ∼ mg/dL, at 200 plasma transporters ∼ At are mg/min, 375 (Tm). all rate of fully saturated GFR. is with Normal pregnancy associated  threshold at levels. occurs plasma substances, glucose lower including normal filtration of all glucosuria glucose at plasma glucose the   With concentrations glucose, inhibitors glucosuria result at drugs) cotransporter (SGLT2) -flozin 2 200 concentrations mg/dL. < plasma Sodium-glucose (eg, in

mellitus. clue diabetes is clinical important an to Glucosuria

and of threshold heterogeneity sharply is gradually reached curve the T by of to Tm phenomenon—Tm titration rather the Splay than different nephrons (ie, represented glucose due the portion points); for . between

Early PCT—contains brush border. acid. PO43–, Na+, most H2O, Cl–, and amino and uric K+, Reabsorbs and all HCO3–, glucose acids absorption. Isotonic more NH3, the secretes kidney and Generates to which enables H+. secrete

Na+/PO43– excretion. •• PO43– cotransport PTH—inhibits

Na+/H+ exchange II—stimulates •• HCO3− alkalosis). AT and H2O, reabsorption Na+, (permitting contraction

H2O and Na+ 65–80% reabsorbed.

medullary of reabsorbs hypertonicity Thin Na+). H2O descending to via loop (impermeable Henle—passively Concentrating segment. hypertonic. urine Makes

blood Interstitium Mg2+, Ca2+

the down electrochemical gradient Diusion

Cl−. K+, Henle—reabsorbs loop Thick Na+, and ascending of and induces paracellular lumen backleak. Mg2+ through K+ by reabsorption of generated ˜ Ca2+ potential Indirectly Impermeable H2O. to it ascends. Makes concentrated as less urine

Na+ 10–20% reabsorbed.

Na+, Early DCT—reabsorbs Cl−. Impermeable H2O. to

Makes urine (hypotonic). fully dilute exchange Ca2+/Na+ reabsorption. PTH—• Ca2+ •• 5–10% Na+ reabsorbed.

secreting H+ exchange K+ in aldosterone). for Collecting tubule—reabsorbs by Na+ and (regulated synthesis. mRNA Aldosterone—acts receptor on • • protein mineralocorticoid negativity • • principal activity • epithelial secretion. conductance, (ENaC) cells: K+ In Na+/K+ channel • pump, apical • Na+ lumen K+ ˜-intercalated H+ In •• activity. lumen HCO3−/Cl− •• •• secretion cells: activity H+ negativity ATPase exchanger

V2 ADH—acts apical of side. insertion receptor on channels at H2O aquaporin • Na+ 3–5% reabsorbed.

tubular Order: syndrome BaGeLS syndrome syndrome, SAME Liddle Bartter Gitelman Renal Fanconi’s defects

Mineralocorticoid Syndrome Excess of Apparent

solute mineralocorticoid % is reabsorbed Cl−Glucose Treatment: (exogenous less 0% Na+ quickly 1.85 (• clearance acids Osmolarity, or – • 1.90 = PAH • receptor mineralocorticoid 100% endogenous Creatinine Inulin GFR corticosteroids effects) length K+-sparing when K+ Amino 75% corticosteroid 1.80 50% activation) 25% Distance HCO3 diuretics cortisol Urea production along PCT

amount) concentration along the water in result not of  inulin PCT Tubular (but a reabsorption. as the and at rate reabsorption slower a then in occurs Cl− early reabsorption than Na+ PCT distally. rate more matches Na+ of relative before  concentration Thus, it its plateaus.

type Principal Na+ (when pituitary) Renal cell cell PCT reabsorption and secretion α-intercalated ↑BP cell Vasoconstriction H⁄O I cells , ↑activity HCOƒ , H⁄O GFR ) H+ reabsorption Preserves ↑FF arteriole RBF Na+ ↑receptor secretion

Na+/K+ and activity) ENaC ATPase,

JG afferent  renal macula by Renin renal Secreted cells. to (β1  densa in delivery perfusion sympathetic baroreceptors response pressure in arteriole), NaCl renal discharge by and to • cells effect), (detected

and pressure. Helps AT II blood volume maintain blood its Affects limits function; bradycardia, reflex would baroreceptor normally effects. pressor accompany which

 in (ANP) and via smooth (BNP) BNP renin-angiotensinaldosterone vascular ventricles  cGMP response Released relaxes GFR, from inhibits • renin. ANP, muscle to atria system; volume; arteriole, Dilates afferent promotes natriuresis.

volume osmolality; ADH also blood Primarily states. responds serum regulates low to water reabsorption ducts. Stimulates of in collecting of urea gradient. osmotic reabsorption maximizes in stimulates ducts corticopapillary collecting Also to

and states. in release volume content; ECF Aldosterone regulates  Na+ blood  volume Primarily  by K+ excretion. Responds to hyperkalemia

alkalosis) ( conductance, activity) contraction K+

renin-angiotensinaldosterone system. JGA GFR maintains via

 JGA to release. properties, of vasodilatory renin In can the by β-blockers β1-receptors BP inhibiting decrease addition

cells PCT (OH)2 D3 D D Calciferol to (calcitriol, form). vitamin 25-OH (vitamin 1,25-25-OH convert D) active vitamin D 1,25-(OH) (calcitriol) (calcidiol) 1˜-hydroxylase

response to pressure. atrial in Secreted ° loss. with reabsorption loss Causes Na+ + fltration and ° and GFR compensatory ° volume Na+ no

reabsorption and Synthesized to in nephron. distal response in proximal e˜ect: Net BP. and ° e˜erent arteriole˜ Causes to but simultaneous GFR Na+ of (° reabsorption Na+ compensatory function with proximal ° renal distal) in low-volume circulating with preservation FF state (both and volume. FF) maintain response to salts) K+ Ascending Secreted 2CI– H Proximal Ca2+ tubule Ca2+ Cortex Collecting Henle tubule loop of Mg2+ D3. convoluted Amino limb, Loop Na+ Parathyroid acids in to plasma plasma 1,25-(OH)2 Glomerulus or Na+ ° Na+ convoluted Sugars of CI– hormone [Ca2+], ˜ [PO43–], Medulla duct (permeable plasma Henle ˜ Mg2+ vitamin [PO43–] and reabsorption ° (DCT), (° gut Ca2+ production PO43– [Ca2+] ° absorption from ˜ reabsorption D3 1,25-(OH)2 D). via Causes and (PCT), to H+ ]; causes ° (via response ° secretion, Secreted ° Aldosterone AT ˜ and [K+ blood Na+ plasma reabsorption, II) ° volume in K+ secretion. in osmolarity response plasma volume. (vasopressin) ADH ˜ to ° and Secreted blood to ° and on Binds number receptors reabsorption. principal causing of H2O cells, aquaporins ° corticopapillary osmotic ° to maximize of urea ducts reabsorption in gradient. collecting Na+ K+ H+

of Features disorders renal

• Key: compensatory response. =

log = pH P2 −]Henderson-Hasselbalch equation: [HCO3 + 0.03 6.1

formula. calculated metabolic for can Winters simple Predicted respiratory acidosis a using compensation be the measured Pco2 respiratory < concomitant predicted alkalosis: acidosis; measured Pco2 if • Pco2 concomitant predicted respiratory >  Pco2 If

± 2 = 1.5 8 [HCO3–] + Pco2

Diabetic mm Na+ anion ketoacidosis Respiratory respiratory Lactic Hg Pco2 HCO3 – acid) > acid) lung alkalosis )– lung anion Airway (late) obstruction •Anion Acute gap or Check tablets Weakening HCO3 Metabolic 20 (CI disease mEq/L Salicylates glycol Ethylene Acidosis (oxalic disease Chronic gap of Propylene pH gap Normal Opioids, pH glycol < INH acidosis + sedatives MUDPILES: Uremia Check 7.35 (formic _ muscles 44 acidosis HARDASS:= and Iron – Hypoventilation < acidosis arterial Acidemia Methanol

(early) Salicylates 7.45 7.57.6 Hypoxemia attack 7.9 7.77.8 > Pulmonary 7.37.4 Tumor 7.17.2 (eg, pH altitude) Anxiety/panic 6.97.0 high embolism

acidosis. Disorder anion Renal causes renal (hyperchloremic) normal metabolic that tubular the of tubules gap acidosis

for Inability acidosis congenital kidney urine stones  to toxicity, Distal phosphate (type • α-intercalated > cells B 1)  of calcium nephropathy, anomalies new secrete to (due tubular renal analgesic H+ Amphotericin 5.5 no risk 

 and urinary diseases to HCO3 bone buffering) turnover related generated pH tract, is acidosis SLE) of metabolic (obstruction) autoimmune • (eg,

Defect PCT when in > 5.5

excretion reabsorption  resorptive threshold of HCO3

α-intercalated cells syndrome, Urine resistance to • hyporeninism, TMP-SMX) can ACE myeloma, be adrenal rickets when (eg, heparin, insufficiency) K+-sparing anhydrase  hypophosphatemic 5.5 HCO3 NSAIDs, carbonic overcome Fanconi risk syndrome) < acidified Fanconi multiple (in aldosterone cyclosporine, diabetic due (eg, by depleted inhibitors collecting but to exceeded; duct, or enough ARBs, obstruction, not in for diuretics, nephropathy inhibitors,

casts in Presence glomerular of Casts of or origin. that urine indicates tubular is renal hematuria/pyuria hematuria, kidney cancer,  Bladder casts. no stones Acute casts. cystitis no  pyuria,

hypertensive emergency. Glomerulonephritis, A

pyelonephritis, B transplant inflammation, Tubulointerstitial acute rejection.

azotemia, GBM into HTN Nomenclature  urine disorders RBCs hematuria Glomerular damage Hematuria, in RBC  urine glomerular of •  casts of diseases loss oliguria, release,

the 3.5 (< Proteinuria g/ range in subnephrotic cases be day) range often nephrotic but in may severe in

Massive g/ proteinuria 3.5 edema (> with day) hypoalbuminemia,

Frothy with urine fatty casts

and antithrombin (podocyte podocyte hypercoagulable (eg, (loss process): in to edema) by tissue soft or due urine III May damage) of with urine compromise 1° be loss Associated  direct 2° systemic risk state infection from of in damage and IgGs

pyelonephritis, and hydronephrosis, such complications to injury. acute as severe Kidney kidney lead Can radiating tenderness, flank with hematuria. pain presents stone unilateral groin, to stones Obstructed colicky intake. fluid by prevent encouraging Treat and

Radiopaque Calcium oxalate: envelope like Calcium Radiopaque Shaped

more shaped calcium Calcium stones. common Calcium phosphate pH than common • most oxalate (80%); prism Radiopaque stones calcium Radiopaque Wedge-phosphate:

with C  (antifreeze) from disease). result pH), abuse, hypocitraturia glycol vitamin urine (eg, ingestion, Crohn ethylene Can (associated malabsorption

citrate, thiazides, diet. low-sodium Treatment: low-sodium diet, Treatment: thiazides.

of for Account 15% B stones. magnesium ammonia hydrolyze saprophyticus, ⊕ (struvite) Proteus urine by with infection mirabilis, alkalinization. bugs (eg, that Caused Staphylococcus  phosphate to urease urea Klebsiella) form Commonly calculi staghorn

. C infection, of Treatment: eradication of surgical removal stone. underlying

About 5% stones. of all D climates, arid rosettes Risk pH. urine visible volume,  or factors: acidic

gout). Strong (eg, with hyperuricemia association turnover cell diseases leukemia). with Often in seen  (eg,

allopurinol. of alkalinization Treatment: urine,

which transporter causing function, cystinuria. PCT radiopaque loses opaque Cystine-reabsorbing Ornithine, Arginine of Lysine, reabsorption defect results in also Transporter poor (COLA). soluble, in Cystine form poorly is thus urine. stones begins childhood. in Usually calculi. staghorn Can form test nitroprusside cyanide Sodium ⊕.

stones “SIXtine” SIX have sides.

penicillamine) chelating Treatment: urine, of agents diet, if refractory. sodium low (eg, alkalinization

renal of and A Hydronephrosis calyces . Distention/dilation pelvis include other vesicoureteral urinary ureter); Usually reflux. caused cancer, (eg, obstructions, to congenital severe tract stones, cervical causes retroperitoneal fibrosis, renal BPH, injury by obstruction pathology. occurs Dilation site of proximal to elevated Serum is has patient if kidney. bilateral obstruction or if solitary creatinine an becomes obstructed cortex possible compression of and Leads to and renal medulla. atrophy

features Urinary has of incontinence Mixed incontinence. both stress urgency and incontinence

bladder. of urinary cystitis Inflammation Acute frequency, as Presents pain, urgency. suprapubic dysuria, urinary signs high absent. (eg, chills) are fever, usually Systemic mellitus, sexual impaired sex intercourse, catheter, bladder female emptying. Risk include diabetes factors indwelling urethra), (short Causes:

coli group) sexually this in common Staphylococcus is in active still women saprophyticus—seen young (E more

scent esterase. Proteus leukocyte has mirabilis—urine Labs: ammonia ⊕ gram organisms). (indicate ⊝ nitrites ⊕ urethritis Chlamydia pyuria gonorrhoeae Neisseria with could urine by or ⊝ Sterile trachomatis. suggest (pyuria cultures) antibiotics (eg, TMP-SMX, Treatment: nitrofurantoin).

. pyelonephritis A Neutrophils interstitium infiltrate renal Acute Affects cortex of sparing glomeruli/vessels. with relative pain nausea/vomiting, Presents with fevers, (costovertebral chills. flank tenderness), angle ascending to hematogenous is include Causes spread UTI kidney. (E common), most coli WBCs +/− Presents in with urine WBC casts. . enhancement CT parenchymal show striated B would obstruction, pregnancy. urinary reflux, vesicoureteral factors tract indwelling include diabetes Risk mellitus, urinary catheter, papillary necrosis, Complications urosepsis. renal include chronic perinephric pyelonephritis, abscess, antibiotics. Treatment:

Also nephritis. tubulointerstitial called Acute interstitial inflammation. renal pump after NSAIDs, of rifampin, penicillin administration (eg, as haptens, occurring inhibitors, Pyuria inducing and quinolones, (classically sulfonamides). azotemia act that hypersensitivity eosinophils) derivatives, diuretics, proton drugs to SLE, syndrome, commonly Less sarcoidosis). Mycoplasma) may (eg, as (eg, be other Sjögren processes or systemic autoimmune 2° infections such diseases

but fever, angle pyuria, asymptomatic. can and with rash, Associated be costovertebral tenderness, hematuria,

5P’S: these Remember

of injury in hospitalized acute tubular kidney Most cause common patients. Acute necrosis cases. many resolves Spontaneously in initial be during Can especially phase. fatal, oliguric FENa.  Key . granular brown (often in finding: muddy A casts appearance) 3 stages: 1.

2.

Maintenance 1–3 phase—oliguric; hyperkalemia, metabolic of acidosis, weeks; 3. uremia risk lasts

and fall; electrolytes injury: of renal Recovery and serum of by BUN wasting caused nephrotoxic be phase—polyuric; minerals and or creatinine hypokalemia risk ischemic Can other

blood to renal hypotension, flow sepsis, hemorrhage, Ischemic—2°  HF). (eg, shock, to Results slough and lumen are injury). in B that of into susceptible tubular (PCT thick tubular limb death may cells highly ascending

hemoglobinuria. (eg, to cisplatin, substances Nephrotoxic—2° injury ethylene lead, from injury toxic crush agents, (myoglobinuria), radiocontrast resulting aminoglycosides, glycol), to susceptible tubules are Proximal injury. particularly

(eg, Diffuse kidneys. of with cortical catastrophes Acute necrosis Associated infarction both generalized obstetric cortical abruptio Likely placentae), due combination of septic shock. a to vasospasm DIC. and

and Sickle renal with: Sloughing papillae or Renal trait, Associated proteinuria. hematuria cell of • disease necrotic necrosis gross papillary A or recent pyelonephritis, May be immune infection by Acute (NSAIDs), Analgesics stimulus. triggered papa papillary necrosis). mellitus Diabetes with (SAAD

renal of failure Consequences

renal nitrogenous in disturbances. waste to retained electrolyte filtration can excess products and Decline lead

HUNGER): (MAD Consequences

syndrome by: marked Uremia—clinical

hypertension) forms diabetes Na+/H2O chronic (HF, (eg, ATN) of renal retention failure: (eg, and anomalies). hypertension, mellitus, pulmonary 2 edema, acute congenital

disease. GFR reductions stages kidney of define chronic Incremental the in

and with kidney  Hypocalcemia, Renal hyperparathyroidism failure disease poorly 3° osteodystrophy  vitamin of associated chronic managed). hydroxylation D hyperparathyroidism (if 2° 2° hyperphosphatemia,  tissue Ca2+ Ca2+.  bind phosphate High serum with deposits can serum absorption.  • Ca2+ intestinal 1,25-(OH)2D3 bones. thinning Causes subperiosteal of

B dilation of Autosomal . recessive ducts Cystic collecting Often infancy. presents in hepatic with kidney congenital Associated polycystic fibrosis. in oliguric renal to utero failure can sequence. lead Potter Significant hypertension renal portal congenital include fibrosis. period systemic insufficiency, progressive Concerns beyond disease hypertension, neonatal hepatic from and

Autosomal Also dominant disease. medullary kidney cystic called to Causes renal concentrate tubulointerstitial and urine. with fibrosis insufficiency inability progressive tubulointerstitial kidney disease kidneys Medullary visualized; smaller on not usually ultrasound. cysts prognosis. Poor

cells carbohydrate. accumulated Polygonal A lipids Renal filled with cell and carcinoma clear golden-yellow Often

due B to content. • lipid hematogenous (may vein • develop IVC PCT spread lung left metastasis and  from if bone.  sided) invades renal varicocele to  Originates palpable pain, polycythemia, masses, fever, weight loss. Manifests flank hematuria, with 2°

for localized surgery/ablation disease. Treatment: curative. disease, metastatic (eg, rarely aldesleukin) for or targeted therapy Immunotherapy and therapy. Resistant to chemotherapy radiation

. C common 50–70 in incidence smoking Most and with obesity. years • old, men

with PTHrP, EPO, eg, Ectopic ACTH, Renin paraneoplastic (“PEAR”-aneoplastic). Associated syndromes,

common von as or inherited deletion 3 (most subtype) associated chromosome (sporadic, cell gene Clear syndrome). on with Hippel-Lindau

RCC letters chromosome 3. = 3 =

scar). A arising Benign well-circumscribed to with from cell (arrows in epithelial collecting mass ducts point central tumor Large eosinophilic with perinuclear abundant clearing mitochondria without cells

cell (vs renal carcinoma). B chromophobe hematuria, painless flank pain, Presents abdominal mass. with

renal Often resected malignancy to cell exclude carcinoma). (eg,

Also called tumor. Wilms 2–4). Most (ages of common renal childhood early malignancy embryonic Contains structures. glomerular and unilateral HTN. A mass possible with flank palpable, and/or hematuria large, Presents

function” suppressor of chromosome WT2 genes tumor or mutations WT1 on “Loss of 11. part be May a syndromes: of several

of complex—Wilms Genitourinary Retardation/intellectual (absence WAGR disability mental (WT1 tumor, Aniridia iris), deletion) malformations,

sclerosis Diffuse gonads (early-onset WT1 mutation Dysgenesis syndrome), mesangial (male syndrome—Wilms tumor, pseudohermaphroditism), Denys-Drash of nephrotic

syndrome—Wilms (WT2 hemihyperplasia Beckwith-Wiedemann organomegaly, tumor, mutation), omphalocele macroglossia,

carcinoma. carcinoma called cell transitional Also Urothelial of Most tumor the (can common occur tract renal . A system of bladder) and calyces, B pelvis, bladder in ureters, urinary renal painless suggested (no be by Can hematuria casts).

Phenacetin, Aniline Pee Associated in SAC: your and problems dyes, Smoking, Cyclophosphamide. with

tubule limb, Proximal CI– convoluted (permeable Cortex K+ of Collecting Mannitol mEChANism loop Na+ Na+ convoluted (permeable Descending sparing Henle diuretics 5Glomerulus to Acetazolamide HCO3 34K+ action Loop of duct Mg2+ 2CI– Ca2+ K+ Na+ Amino Henle to diuretic. loop Loop 1234Sugars Thiazide 5521E°erent H2O Ascending – Distal of water) A°erent Na+ diuretics Osmotic acids H+ Medulla of Henle salts) limb, tubule Diuretics Na+ diuretics site Ca2+  osmolarity  urine  intracranial/intraocular fluid flow, pressure. tubular

Drug UsE CLiNiCAL elevated intracranial/intraocular overdose, pressure.

hypernatremia. edema, hypoor dehydration, ADVERsE Pulmonary EFFECts anuria, Contraindicated HF. in

mEChANism inhibitor. anhydrase Carbonic  self-limited stores. total HCO3 diuresis body − NaHCO3 Causes and urine. Alkalinizes

intracranial CLiNiCAL Glaucoma, hypertension. metabolic UsE idiopathic alkalosis, sickness, altitude

causes acidosis, ADVERsE renal tubular Proximal “Acid”azolamide EFFECts Acidosis. paresthesias, hypokalemia. NH3 allergy, toxicity, sulfa stone high calcium Promotes phosphate (insoluble pH). formation at

mEChANism Furosemide, loop bumetanide, Sulfonamide torsemide diuretics. system of Henle. loop (Na+/K+/2Cl−) cotransport thick ascending of of Inhibit limb hypertonicity concentration preventing medulla, of of Abolish urine.  on arteriole); by NSAIDs. Associated afferent with effect inhibited PGE (vasodilatory excretion.  Ca2+ Loops Ca2+. Lose

Edematous (HF, states cirrhosis, CLiNiCAL edema), nephrotic hypertension, UsE syndrome, pulmonary hypercalcemia.

CLiNiCAL Diuresis UsE allergic sulfa drugs. to patients in

more ADVERsE EFFECts to but furosemide, ototoxic. Similar earrings hurt your ears. Loop

chlorthalidone, Thiazide metolazone. Hydrochlorothiazide, diuretics

 early NaCl mEChANism capacity in DCT reabsorption nephron. diluting of Inhibit excretion. • Ca2+

insipidus, UsE CLiNiCAL hypercalciuria, osteoporosis. nephrogenic HF, diabetes Hypertension, idiopathic

ADVERsE metabolic Hypokalemic hyperUricemia, alkalosis, hyponatremia, hyperLipidemia, EFFECts hyperGlycemia, hyperCalcemia. allergy. Sulfa

HyperGLUC.

Eplerenone, Potassium-sparing Triamterene. SEAT diuretics Keep Amiloride, Spironolactone, your

aldosterone competitive and in eplerenone receptor collecting cortical mEChANism tubule. antagonists Spironolactone are of amiloride part the Triamterene tubule. channels the block and same Na+ at

Hyperaldosteronism, HF, ascites CLiNiCAL UsE hepatic depletion, antiandrogen. DI (amiloride), (spironolactone), K+ nephrogenic

Hyperkalemia endocrine to antiandrogen (can gynecomastia, with arrhythmias), effects ADVERsE spironolactone EFFECts lead effects). (eg,

Diuretics: electrolyte changes

all (strength with  potency on effect). diuretics diuretic varies of Urine based NaCl Serum decrease a may as result. NaCl

 with  Ca2+ loop Urine reabsorption paracellular Ca2+  diuretics: hypocalcemia.

reabsorption. thiazides: Ca2+ with  enhanced

Angiotensin-Captopril, enalapril, lisinopril, ramipril. GFR ACE  converting constriction efferent enzyme II AT inhibitors mEChANism by  of arterioles. preventing Inhibit to negative loss due feedback. renin  of ACE prevents of also potent inactivation of vasodilator. bradykinin, Inhibition a

cough, (eg, disease HF, intolerance chronic ACE nephropathy) Hypertension, proteinuria, UsE diabetic with to kidney or (eg, inhibitors angioedema). CLiNiCAL

EFFECts GFR, Hyperkalemia, ADVERsE teratogen. hypotension; •

conversion angiotensinogen I. inhibitor, angiotensin Direct to Kills Renin. renin blocks of Aliskiren mEChANism

Hypertension. UsE CLiNiCAL

ADVERsE EFFECts • angioedema. GFR, hypotension, Hyperkalemia, pregnancy. ACE patients inhibitors taking or contraindicated in contraindicated ARBs already in and Relatively

the instead cow is “Artificial farmer does when of to the insemination the it bull.”

to mistake are are they about Make babies no here why here replace these us.

men was a that one God poor at a “Whoever of is and anatomy.” problem necking enough a and gives penis, only brain called time.” judge it run “See, blood the a to

embryologic, first aspects you and oncologic the concepts The endocrinologic, is be the organize pregnancy, manageable at into but system can intimidating of reproduction. once reproductive together, questions contraception, of reproductive menstruation, pathologies. the and of Study many mastery sexual because the to is and endocrine key ovulation, hypothalamic-pituitary-gonadal chapters on disorders development, axis answering

Embryology multiple subject nuanced that organ a systems. covers is for clinical from Approaching perspective a will understanding. allow better it For development. 3rd/4th the connection make sexual Müllerian/Wolffian the presentation between DiGeorge and and and syndrome of the between disorders instance, pharyngeal the pouch, systems of

screening for about don’t guidelines. As remembering worry treatment or oncology, and factors. and present these and signs risk It is to their how symptoms) more labs, (eg, histopathology, important know associated cancers of exam patterns AFP, In of hCG, some LH, cancers FSH have addition, or in that as clues testicular derangements distinct the questions. and ovarian serve helpful

genes of embryogenesis Important

Types errors of in morphogenesis

 multiple Extrinsic period. (eg,  after gestations foot disruption embryonic Deformation crowding deformities); occurs

Malformation during embryonic (weeks Intrinsic period 3–8). occurs disruption;

1° (eg, embryologic sequence). Abnormalities oligohydramnios Sequence Potter result  event from single a

pregnancy. weeks period—organogenesis) 3rd–8th in Teratogens of Most susceptible (embryonic effects. week Before “all-or-none” 3, and growth function week affected. After 8,

failure, hypocalvaria. oligohydramnios, Renal ACE inhibitors

Ebstein anomaly. Lithium

(congenital of Methimazole on Aplasia skin, absence scalp). congenita particularly cutis

alcohol Fetal Alcohol syndrome.

or (cretinism). excess) goiter Congenital (lack Iodine hypothyroidism or

diabetes VSD), tube macrosomia, neonatal islet hypoglycemia defects defects, neural regression (eg, Maternal polycythemia. hyperplasia), to (due cell Caudal cardiac syndrome,

Neurotoxicity. Methylmercury shark, swordfish, Highest in king mackerel. tilefish,

Extremely cardiac). for (cleft risk defects and abortions palate, spontaneous birth Vitamin excess high A

X-rays Microcephaly, intellectual disability. shielding. lead by Minimized

causes the the intellectual in of of US. leading One preventable disability postnatal any of A mothers  defects. preand of congenital border, philtrum, heart limb pregnancy microcephaly, thin abnormalities, vermillion developmental of (eg, palpebral including during Newborns alcohol stage small retardation, facial smooth dislocation, consumed who abnormalities incidence have fissures), and in form. most fistulas holoprosencephaly Heart-lung severe migration cells. mechanism glial and is neuronal One impaired of due to

fertilized (“fraternal”) placentas (chorions). by are 2 arise separate amniotic different twins that sperm (always 2 zygotes) and eggs will separate have from 2 Dizygotic 2 separately and Twinning 2 sacs

(1 egg + in egg fertilized twins splits (“identical”) 1 pregnancy. early 1 from sperm) Monozygotic that arise The chorionicity (SCAB): of amnions) amnionicity (number cleavage (number and timing chorions) of determines of

days: 0–4 and Separate Cleavage chorion amnion

Chorion 4–8 shared Cleavage days:

Cleavage shared Amnion days: 8–12

sperm egg, sperm 1 2 (conjoined) 1 Cleavage Body days: eggs, 13+ 2 shared

exchange mother and between gas Placenta site nutrient of and 1º fetus.

basalis from Derived endometrium. Decidua lacunae. blood in Maternal

CO2 villus Chorionic O2 Maternal Fetal vein waste Branch vein blood (O2 Amnion Endometrial Drugs rich) Nutrients circulation Decidua Umbilical circulation arteries Endometrial Maternal basalis Syncytiotrophoblast H2O products cell electrolytes Umbilical Urea, Endothelial plate Maternal IgG poor) Hormones Viruses Cytotrophoblast H2O, artery circulation Hormones (O2

forms from extends into hindgut urogenital sinus. Allantois and Urachus and between the fetal umbilicus. urachus, bladder a Allantois becomes duct urachus if anomalies and/or infection increase may of that malignancy not involute can to Failure risk to (eg, of adenocarcinoma) treated. lead peritoneum. the median Obliterated is of fold by covered umbilical which urachus umbilical represented is median birth, ligament after by the

urachus Slight Vesicourachal obliterate outpouching bladder. of  failure of to diverticulum

sac Vitelline lumen. connects which (omphalomesenteric midgut vitelline of week—obliteration yolk duct), 7th duct duct to

Vitelline discharge meconium Vitelline  fails umbilicus. fistula duct from to close

diverticulum, arrow B portion patent diverticulum with ). attached Partial of ileum white duct, vitelline Meckel to in closure (true asymptomatic. be May May  hematochezia, and/or heterotopic pain. abdominal pancreatic tissue gastric melena, have

into Develop arterial arch Aortic system. derivatives

is Common (branch 4th 6th and and and arteriosus of of arch the maximal is right Part Proximal 4th left left, systemic proximal arch 3rd Carotid of pulmonary C of aortic (4 1st pulmonary-tosystemic carotid) = arteriosus) artery of alphabet letter right, (on part part = only) maxillary on artery proximal part 1st artery On shunt pulmonary arch 6th of ductus arch; arteries 3rd (ductus internal external limbs) artery subclavian Carotid

Composed CAP pharyngeal outside arches, Pharyngeal clefts, to inside: pouches. apparatus covers of from clefts—derived ectoderm. Clefts Pharyngeal ectoderm = grooves. called Also crest pharyngeal mesoderm Arches + = neural = (muscles, neural arches—derived and from (bones, Pharyngeal Pouches cartilage). arteries) mesoderm crest endoderm pouches—derived from Pharyngeal endoderm.

Mandible,  • Maxilla, zygoMatic

and ligament sphenoMandibular Malleus incus,

tensor of belly Stylohyoid tensor tympani, anterior of veli pterygoids), ligament Reichert 2/3 leSSer Styloid of Mylohyoid, digastric, process, of Masseter, Medial palatini lateral horn anterior (temporalis, hyoid, Muscles tongue, cartilage: and Mastication Stapes,

posterior platySma, Stylohyoid, Muscles expression, belly Stapedius, of of facial digastric

micrognathia, airway sequence— chew glossoptosis, obstruction palate, CN cleft V3 Robin Pierre

laryngeal hyoid developmental Arches mandibular no muscles swallow sing arch 6th abnormalities Cricoid, CN glossopharyngeal (facial craniofacial levator to arch: larynx form of 4th X innervated except Arch pharyngeal of nerve) (recurrent/ IX Greater pharyngeal arch: (used (superior motor 3 stylopharyngeus constrictors; 5 intrinsic makes loss, are Arytenoids, 4th pharyngeal Cuneiform, swallow bone and CN 4 cricothyroid contributions compromise • (styloarch palatini speak inferior by X expression) pharyngeus) derivatives. ACCCT) hearing and arches Thyroid pharyngeal (think veli zygomatic 4th hypoplasia), airway arch: smile tongue (eg, CN posterior cricothyroid, 6th stylishly CN Stylopharyngeus most and Corniculate, major 3rd simply aSensory branch) arch: of not and and laryngeal horn 1/3 all branch) nerves 6th VII of grow derived neural from the into (sensory) and arches and (motor). They crest neuroectoderm are

smile first golden then chew the arches, tend stylishly When the (6). swallow swallow (4), at (2), simply and of to speak restaurant (3) (1), children or then then

of mastoid wings 1 1st palatine thyroid to Ear, lining (thymus, parathyroids structures 3rd bottom-to-top: ear structures and pouch pharyngeal air (C) pharyngeal contributes left (ear) cavity, 2nd tube, • Middle Epithelial ear 3 dorsal 1st 3rd pouch of of tonsils, (bottom (tonsils) pouch to pouch 3 inferior pharyngeal pouch Dorsal eustachian cells endoderm-lined contributes inferior 2 cells for

lip but cleft etiologies, Distinct, multifactorial occur Cleft and often together. palate

Cleft of palate). nasal failure to (formation the Due of fusion medial of 1° and processes maxillary merged lip

the septum lateral shelf failure palate of or lateral shelves Due of palate). two palate of fusion (formation the palatine 1° to with failure of palatine of 2° and/or Cleft fusion nasal

Maxillary palate) shelves palate) Nasal (1° Roof mouth of segment (2° Intermaxillary prominence Palatine septum

Default Female development. and develops. degenerates Mesonephric duct paramesonephric duct

duct of Degenerated Uterus Ovary portion Epididymis kidney Urogenital No deferens Vagina vagina Metanephric Urinary Mesonephric mesonephric uterus, duct MIF fallopian sinus). Vas Oviduct Degenerated urogenital Paramesonephric Androgens Gubernaculum Ureter factor duct Testis-determining tubes, duct (Müllerian) from (lower portion upper Mesonephros androgens Testis sinus bladder paramesonephric duct testis. remnant Male is appendix sexual characteristics syndrome)—may 2° (Mayer-Rokitansky-Küster-Hauser ovaries). (functional Müllerian agenesis present (Wolffian) duct Ejaculatory vesicles, Epididymis, prostate)—Seminal deferens Ductus duct, (SEED). is duct. remnant Gartner Female

determining testes • development. factor

that paramesonephric antimullerian Sertoli ducts. suppresses factor of also hormone) called (MIF, secrete development inhibitory cells Müllerian

development that secrete cells androgens of ducts. Leydig mesonephric stimulate amenorrhea structures— in uterine with fully females internal as Paramesonephric development) a to into lack developed female Develops of 1° (due

cells lack  or and male differentiation. of sexual inhibitory Müllerian of Sertoli Absence both develop factor female Sertoli Shuts (internal) differentiation. down sexual

ambiguous external genitalia until genitalia,

In Leydig (internal male to Leads testes: and external) the

uterus uterus normal Common anomaly vs Septate A . of B septum . Incomplete resorption miscarriage/pregnancy and loss. early  fertility with Treat septoplasty.

of Opening Anus Opening Scrotum of sinus

due folds Hypospadias than common urethra urethral of to failure penile penis is surface of of epispadias. ventral more on opening Hypospadias Abnormal hernia, with Associated inguinal to fuse. upward chordee cryptorchidism, penis). or of bending (downward

below. is Hypo

seen be deficiency. in 5α-reductase Can

of penile of of the due opening is surface Exstrophy Abnormal urethra Epispadias of dorsal Epispadias. bladder positioning on to faulty penis with associated tubercle. genital Eye hit you When you you have Epispadias, when pEE. your

and ovaries testes of Descent

tube of infundibulopelvic ligament of blockage and Twisting ligament and  infundibulopelvic in torsion ligament outflow. ovarian ovarian venous compression ovary lymphatic vessels Adnexal  and around of fallopian inflow of blockage  hemorrhage.   arterial complete edema local arterial necrosis, Continued ovarian perfusion

ovarian masses. with Associated Presents nausea/vomiting. with adnexal mass, pain, acute pelvic

Stratified epithelium, squamous Vagina nonkeratinized

Ectocervix nonkeratinized epithelium, squamous Stratified

phase epithelium secretory long columnar with phase; in in glands coiled Uterus tubular Simple proliferative glands

during of ejaculation— Pathway sperm

UP: (Nothing) Penis tubules deferens Vas SEVEN Ejaculatory Seminiferous ducts Epididymis Urethra

response Autonomic male innervation of sexual

in Occurs men. almost exclusively Suspect meatus. if blood urethral seen at relatively contraindicated. catheterization Urethral is

scrotal urethral is meatus into torn, perineal Blood Blood at at fascia escapes prostate space Buck hematoma and high-riding urethral and If urine meatus

(pelvic nervous splanchnic system S2-S4): Erection—Parasympathetic nerves,

smooth  vasodilation   cGMP muscle proerectile. NO  relaxation

antierectile. Emission—Sympathetic nervous nerve, system T11-L2). (hypogastric

and (pudendal nerve). nerves Expulsion—visceral Somatic

and Shoot. Squeeze, Point,

S2, keep floor. penis 4 the off 3, the

(eg, PDE-5  breakdown. inhibitors cGMP sildenafil)

androstenedione aromatase in seen between cells of local tubules, FSH and  levels female temperature Seminiferous testosterone Sertoli Synthesis, Sertoli Produce seminiferous testosterone MIF B estrogens inhibin cells with cryptorchidism inSide tubules cells junctions Sperm  Convert cells Support are adjacent granulosa  varicocele, via and Non-germ to Line Tight temperature of inhibit Homolog

LH; of of temperature Interstitium the Leydig interna Secrete presence testosterone cells cells female Homolog theca in

puberty Spermatogenesis with Begins spermatogonia. at is a 2 months. sperm; to development is “Gonium” going “Zoon” be takes Full in to egg. Occurs “Zooming” seminiferous tubules. undergo spermiogenesis mobility in infertility.  that Tail ciliary dyskinesia/ Kartagener Produces spermatids of syndrome (loss impaired acrosomal (in to gain mobility in spermatozoa. mature cytoplasmic Tail normal cap) form CF, of contents, cystic fibrosis

(2N, 2° Haploid spermatocyte 2C) Diploid Diploid Spermatogonium infertility). (2N, vas deferens 4C) 2C)  absent (1N, spermatocyte 1°

Haploid (1N, Haploid spermatozoon (1N, Mature 1C) 1C)

Potency: estrone (17β-estradiol), (estriol), SOURCE estradiol adipose Ovary placenta > > estriol. aromatization). tissue via (estrone

of and FUNCTION genitalia breast, Development female distribution. fat excitability.  myometrial of Growth follicle, endometrial proliferation,

inhibition prolactin estrogen, secretion. LH stimulation then feedback Upregulation of receptors; FSH of LH, and surge; progesterone LH, and of

 LDL.  transport SHBG;  proteins, HDL;

1000-fold fetal  in estriol Pregnancy: of (indicator wellbeing)

cytoplasm; to bound translocate Estrogen receptors by nucleus expressed in estrogen. when

adrenal Corpus placenta, luteum, SOURCE cortex, testes. progesterone delivery disinhibits after in Fall

prepares uterus During luteal FUNCTION phase, fertilized for egg: of implantation

artery secretions glandular spiral development Stimulation and endometrial of

mucus Production thick cervical of

 of receptor   Prevention FSH) • gonadotropin • (LH, estrogen secretion endometrial body temperature expression hyperplasia •

prolactin  • intensity myometrial of pregnancy and  breasts • frequency excitability  During pregnancy: contraction on prolactin action Maintenance • lactation.  indicative is ovulation. of  progesterone is pro-gestation. Progesterone Prolactin pro-lactation. is

I ovulation. oocytes prior meiosis begin I to and Oogenesis meiosis life just complete during fetal 1° arrested until (1° for years I in is oocytes). prOphase I Meiosis Ovulation arrested metaphase fertilization II until in is (2° II oocytes). Meiosis not oocyte 1 “An the fertilization If 2° met sperm.” egg degenerates. occur day, a within does

(1N, 2C) 2° Diploid 1° oocyte Oogonium 2C) Diploid 1C) 4C) oocyte Haploid Ovum (2N, Haploid (2N, (1N,

ploidy = = # N chromatids of C

in phase Menstrual length. can Follicular cycle vary 14 Luteal days. is phase days 14 menstruation. = Ovulation day + fastest follicular week Follicular is the during phase. growth of 2nd Estrogen stimulates proliferation. endometrial to support implantation. endometrium Progesterone maintains

progesterone  fertility. •

menstrual bleeding intermenstrual oligomenorrhea uterine either heavy or bleeding bleeding, Characterized Abnormal no longer as such are as dysfunctional (AUB/IMB). menorrhagia, (AUB/HMB) uterine Terms bleeding recommended. subcategorized PALM further by are These

COEIN:

hyperplasia Polyp, Adenomyosis, Malignancy/ or Structural causes (PALM): Leiomyoma,

Endometrial, Not Iatrogenic, Coagulopathy, Non-structural yet classified Ovulatory, causes (COEIN):

Pregnancy tube ampulla). (the of commonly most end fallopian in upper occurs Fertilization 1 Occurs within of ovulation. day

wall 6 the of occurs Implantation the days after within fertilization. uterus

conception. Syncytiotrophoblasts secrete which is hCG, age—calculated last from date period. Gestational menstrual of

Physiologic adaptations in pregnancy:

GFR  generally creatinine, pregnancy pregnancy, afterload, course • • (• hCG  of peaks Weeks BUN • hormone  secretion but increases weeks. at of glucosuria output 8–10  and cardiac preload, threshold the Placental over

preserves plasma, hypoglycemia for to maternal glucose resistance) insulin utilization   and fetus Anemia utilization and (due ( lipolysis amino • • and acids the by RBCs) fat

of SOURCE Syncytiotrophoblast placenta. no  8–10 abortion). of like first thus Maintains weeks luteum (and acting (otherwise by for stimulation corpus LH FUNCTION cell pregnancy progesterone) luteal degenerates. and After placenta corpus weeks, synthesizes estriol luteum its and 8–10 own progesterone in (see early to it Used pregnancy appears because urine above). detect  hyperthyroidism). TSH can α (states as Has subunit cause hCG LH, of FSH, identical unique is (pregnancy tests detect β subunit β subunit). choriocarcinomas, syndrome; Edwards syndrome, Down hCG hydatidiform is ectopic/failing pregnancy, multiple syndrome.  gestations, hCG moles, and in and in Patau is 

called placental chorionic Human Also somatomammotropin. lactogen

SOURCE placenta. Syncytiotrophoblast of

insulin insulin resistance. overall FUNCTION  production; Stimulates occur Gestational if diabetes pancreatic insulin resistance. can maternal overcome the function cannot

5 scale Assessment of newborn 10-point via delivery 1 signs a at minutes. evaluated vital and minute following Pulse, on Appearance, based Grimace, score is Apgar

Respiration. and Activity, 7 evaluation. require Apgar may further scores < remains later score the If will time points, there risk  is at Apgar child low develop neurologic damage. long-term

are approximated vary and been that by have ranges source. Milestone dates developmental for assessment Children not may potential milestones delay. meeting need

(by 20 fork with first takes steps and (by = ball Cutlery—feeds spoon self × (yr) 24 Cruises, 3 mo) mo) age (by Kicks

2500 growth intrauterine < prematurity Caused (IUGR). as Defined restriction g. by or of  (SIDS) with syndrome sudden overall infant and mortality. with risk death Associated 

rapid of prolactin progesterone •  placenta, parturition in initiation After of lactation. delivery Lactation and disinhibits to is  and nerve Suckling milk stimulation and  ejection, prolactin. required oxytocin since production maintain lactation and maintains  function. and reproductive Prolactin—induces contractions. promotes letdown; uterine also Oxytocin—assists milk in for is < months milk infants nutrition ideal the 6 old. Breast (conferring IgA), Contains passive immunity; mostly immunoglobulins macrophages, lymphocytes. maternal allergies, develop associated diabetes to risk obesity. mellitus,  infections infant for child Breast and reduces milk with and asthma, is supplementation. recommend infants Guidelines D breastfed and exclusively vitamin possibly get iron risk mother-child breast and facilitates  of maternal bonding. cancer Breastfeeding and ovarian

amenorrhea months. for 12 Diagnosed Menopause by

to number of follicles. • production decline age-linked due in estrogen ovarian Average onset in smokers). at age (earlier is years 51

years cycles. Usually menstrual 4–5 abnormal by of preceded hirsutism. of  menopause androgens, peripheral Source conversion (estrone)  after becomes of estrogen androgens

to FSH negative estrogen). menopause for due of is   (loss on specific FSH feedback

  surge), LH Hormonal GnRH.  (no FSH, changes: estrogen, 

Vagina, HAVOCS: of artery Sleep Hot disease, flashes, Atrophy the Coronary Causes Osteoporosis, disturbances.

women and/or have in (premature may before failure); age suggests received ovarian 40 occur Menopause ovarian who 1° chemotherapy insufficiency therapy. radiation

androstenedione. dihydrotestosterone (DHT), Testosterone, Androgens

androstenedione. > DHT and DHT (ADrenal) (testis), testosterone Potency: SOURCE testosterone AnDrostenedione >

Testosterone: FUNCTION

of seminal except Differentiation vas epididymis, vesicles (internal genitalia, prostate) deferens,

muscle, seminal spurt: penis, vesicles, RBCs Growth sperm,

of Deepening voice

Closing of plates converted epiphyseal testosterone) estrogen from (via

Libido DHT:

prostate Early—differentiation scrotum, penis, of

sebaceous growth, Late—prostate gland activity balding,

5α-reductase, is by which converted by finasteride. to Testosterone DHT inhibited is

tissue (primarily to aromatase In adipose converted male, testis). by and the androgens are P-450 estrogen in cytochrome

of conversion androgens Aromatase the estrogen. enzyme to key is in

mass, muscle  anabolic steroid to abuse—abuse performance. and of fat-free steroids strength, Androgenic present gynecomastia, intratesticular (exogenous (eg,   men who testosterone size, acne, •  inhibition sperm in • hypothalamic-pituitary-gonadal testes axis count, changes Hb with and aggression), azoospermia). testicular in Hct, testosterone behavior small Suspect may breast (eg, acne, with atrophy, baldness). Women present male hirsutism, virilization pattern

development Tanner of stages sexual

Tanner (eg, genitalia, breast independently 2 pubic pubic Tanner hair, stage to stage hair). stage Tanner assigned can and 3 have is person genitalia, a girls, detectable secondary Earliest breast characteristic in in boys. sexual development testicular enlargement is bud

across (pubarche) hair Coarsening across with Coarse and pubic Coarse pubis, hair pubis hair of Flat-appearing chest

fattens on contour, Adult areola, Breast mound raised breast adult size enlarges, forms mound (thelarche), mound areola

15 ~ years ~ ~ 13–15 11.5–13 811.5 > years Usually years years Pre-pubertal

in before of adrenarche, characteristics Precocious 2° boys. puberty and years age 8 Appearance (eg, menarche) sexual years in girls 9 thelarche,    (eg, and stature). somatic sex maturation growth, epiphyseal closure production premature plates exposure short or linear skeletal of hormone Types include:

gonadal ( precocious of (most CNS secretion): idiopathic early GnRH puberty axis), activation Central hypothalamic-pituitary common; tumors.

McCune-Albright cell tumor  exposure hormone production granulosa steroids): exogenous adrenal or sex (GnRH-independent; tumor, to syndrome. ovarian Leydig sex hyperplasia, precocious tumor), Peripheral congenital (eg, estrogen-secreting cell puberty

most nondisjunction. to due commonly chromosome Aneuploidy meiotic Sex disorders

Klinefelter syndrome 47,XXY. Male, Dysgenesis seminiferous of tubules

FSH. B inhibin shape, atrophy,  Testicular body eunuchoid 

testosterone gynecomastia, Abnormal tall, extremities, cell long Leydig function female 

A . May estrogen.  LH present  with

delay. developmental inactivated of Presence

body). X (Barr chromosome infertility in seen hypogonadism cause Common work-up. of

XYY. Double 47, males Y undiagnosed), very tall. Phenotypically normal (usually fertility. Normal learning be with May disorders. disability, spectrum acne, severe autism associated

45,XO. Female,

ovarian dysgenesis aortic (streak high-arched shield with coarctation chest palate, or pulse), feet, Short therapy), (femoral , bicuspid shortened (result defects cystic (associated the lymphedema preventable in neck brachial aorta B hormone hygroma; hands), gene, metacarpals. webbed valve, SHOX < of kidney, with in ovary), lymphatic stature 4th horseshoe growth

amenorrhea. 1° Most cause common of No body. Barr

Menopause menarche. before

  to FSH. LH, leads estrogen due or loss Sex mitosis. often chromosome nondisjunction to (X, meiosis Y) rarely during or missing in usually sperm paternal  sex chromosome. occur Meiosis the errors gametes

 some zygote mosaic karyotype loss chromosome of cells formation but  all sex after in errors not occur (eg. Mitosis 45,X/46XX). gonadoblastoma. associated with (45,X/46,XY) for risk mosaicism increased

some cases and exogenous possible progesterone). is estradiol-17β in Pregnancy (IVF,

⊕⊝ receptor hypogonadism androgen syndrome) exogenous lesions, dysgenesis) Testosterone-secreting Hypergonadotropic • mosaicism, hypogonadism gonadal CNS Hypogonadotropic Kallmann Turner (eg, pure (eg, • genetic Defective tumor, syndrome,

a hypogonadotropic Failure of complete syndrome puberty; Kallmann form to hypogonadism. GnRH of to LH, bulbs GnRH, Defective testosterone. the subsequent hyposmia/anosmia; in hypothalamus; failure neurons  migration synthesis FSH, develop of of  olfactory and sperm Infertility count females). in males; (low amenorrhea in

or uterine separation delivery infant. placenta Premature from before Abruptio (partial wall placentae of of complete) factors: trauma motor abuse. preeclampsia, hypertension, (eg, smoking, vehicle cocaine accident), Risk activation), abrupt, or shock, Presentation: tissue (mediated maternal by bleeding (concealed fetal factor possible trimester; DIC distress. painful third in apparent) for mother threatening be and May life fetus.

(blue hemorrhage Partial (red Complete abruption abruption arrow) apparent with arrow) hemorrhage concealed with

separation decidual attachment after  Defective and delivery. abnormal layer Risk involving inflammation, placenta age, prior surgery C-section uterine myometrium, or advanced previa, factors: maternal multiparity. by penetration: Three distinguishable the of depth types

myometrium common Placenta without type. to attaches most penetrating it; accreta—placenta

myometrium. increta—placenta into Placenta penetrates

myometrium wall); uterine entire hematuria). uterine placental percreta—placenta result or into attachment result penetrates in and rectum (invades can (can in to through serosa Placenta bladder (“perforates”)

Presentation: detected ultrasound often delivery. to prior on  delivery of syndrome). cause Sheehan separation bleeding placenta (can No after postpartum

of Attachment Placenta previa os. over internal cervical placenta C-section. factors: prior multiparity, Risk third-trimester with bleeding. painless Associated through cervix. “preview” the placenta of visible is A from but is it) previa. managed (< placenta os, cm over cervical placenta 2 not Low-lying differently internal from

in in fertilized Isthmus riskInterstitium ovum Implantation (highest uterus, of a ampulla most site than the often other of

tube of tube tubal Fallopian fallopian rupture)

A . in and extraovarian show history confirm with sudden hCG which lower-than-expected Suspect mass. with adnexal pain; rise abdominal ultrasound, amenorrhea, on of dates, lower based may clinically for mistaken appendicitis. Often

Pain bleeding. +/− Risk factors:

infertility of History

Cystic chorionic proliferation chorionic Hydatidiform villi swelling of mole of and trophoblast). (only epithelium bleeding, pressure/ vaginal with uterine pain. more expected, Presents than pelvic enlargement emesis, weeks), hCG-mediated preeclampsia Associated 20 with sequelae: early (before hyperemesis hyperthyroidism. theca-lutein cysts, gravidarum, and and Treatment: methotrexate. curettage dilation Monitor hCG.

pregnancy after develop in Rare; during mother or baby. or can Malignancy of trophoblastic tissue

present. villi (cytotrophoblasts, no A syncytiotrophoblasts); chorionic theca-lutein bilateral/ frequency cysts. multiple  of hemoptysis. hCG, breath, shortness of • abnormal Presents with to Hematogenous lungs spread

. B Treatment: methotrexate.

due Incidence cervical; > cancer cervical (US)—endometrial more vaccination. worldwide to ovarian common or HPV of > lack is screening

45 prognosis, 65 Endometrial old) about Cervical prognosis, Ovarian years). (best > > < years > Prognosis: years old) 55 (middleaged, (worst diagnosed

CEOs to older. from they as often best go get worst

Due fluid. causing blockage Bartholin cyst of to duct accumulation of gland Bartholin gland and and abscess obstruction to inflammation A . abscess 2° lead May to females. reproductive-age Usually in

Lichen sclerosus with of epidermis of Thinning fibrosis/sclerosis dermis. a plaques red violet border. with porcelain-white Presents with or . observed fragility Skin can B be with erosions in common postmenopausal women. Most but increased Benign, risk slightly SCC. for

Hyperplasia simplex squamous vulvar of epithelium. Lichen vulvar due chronicus with to skin skin rubbing enhanced or leathery, chronic scratching. Presents markings with thick SCC. Benign, risk of no Neoplastic

C of carcinoma from squamous Carcinoma vulva lining epithelial Vulvar . Rare. often biopsy from Presents other carcinoma distinguish with leukoplakia, to causes. required high-risk 16, with HPV-related types 18. carcinoma—associated vulvar HPV coitarche. Risk factors: partners, multiple early in females. Usually reproductive-age vulvar Non-HPV from carcinoma—usually sclerosus. lichen long-standing > old. 70 Females years

Imperforate of the the Incomplete portion degeneration central hymen. of hymen self-resolving of birth introitus. vaginal mucus in Accumulation bulge at  hematocolpos menstrual of cyclic 1° If untreated, and  vagina membrane). leads hymenal (accumulation amenorrhea, pain, bulging blood abdominal to in bluish

Vaginal SCC; rare. cervical Usually vaginal to squamous 1° 2° cell carcinoma carcinoma

growth; at extends of begins (transformation epithelial junction zone) outward. and layer basal squamocolumnar Disordered as irreversible or on depending CIN dysplasia. of extent 2, carcinoma 3 Classified situ), CIN 1, in (severe, dysplasia or CIN (inhibits before (inhibits both produce TP53) R). Associated P product with the HPV-16 E7 and which gene and HPV-18, (6 before E6 product gene 7; pRb) infection. Koilocytes HPV pathognomonic A of are May invasive if untreated. progress carcinoma to left slowly bleeding Typically (detected vaginal smear) asymptomatic as (often presents with postcoital). or Pap abnormal

DES Risk exposure, smoking, (eg, sexual immunocompromise partners, HPV, HIV, transplant). factors: early coitarche, multiple

carcinoma. carcinoma Invasive cell Often squamous to progresses detect smear carcinoma. it Pap can invasive cervical before dysplasia Diagnose via biopsy. and colposcopy Lateral can • • failure. ureters hydronephrosis renal invasion block

hyperprolactinemia, disorders, chromosomal thyroid insufficiency, of Cushing ovarian common adrenal competitive Pregnancy, syndrome, HPO Turner abnormalities/immaturity, syndrome). (eg, eating abnormalities axis causes athletics, polycystic failure, syndrome, Most ovarian disorders, anovulation premature obesity,

exercise-induced called amenorrhea. Also functional and/or expenditure, restriction, secretion  pulsatile   LH, disruption estrogen. energy GnRH stress caloric Severe of FSH, exercise). (due (stress, leptin Pathogenesis cortisol to fat)   and includes excessive 

disorders calorie dysfunction). bone mineral availability/excessive eating “female exercise, ( athlete menstrual density, and Associated  triad” with

Hyperinsulinemia cells, response  from • to unruptured  insulin interna  rate testosterone) theca feedback of hormonal androgens LH:FSH, hypothesized hypothalamic alter (eg, + follicular maturation anovulation. resistance and/or (cysts) follicles fertility in of • cause women. Common

amenorrhea/oligomenorrhea, fertility. A presents with Enlarged, acne, ovaries  ; cystic hirsutism, bilateral nigricans. acanthosis obesity, Associated with repeated cancer cycles. unopposed risk estrogen endometrial from of to 2° anovulatory 

(ovulation (prevent ( hyperplasia clomiphene unopposed OCPs estrogen); regulation treat induction); formation), cycle to due spironolactone, peripheral hirsutism. reduction endometrial estrone to finasteride, weight via Treatment: flutamide

contractions by menses, pain. ischemic Primary to caused • dysmenorrhea loss blood  uterine Painful Mediated prostaglandins. by Treatment: NSAIDs.

mAlIgNANT? TyPE E arrow in CHARACTERISTICS ). AFP. Tumor marker:

Endometrium-like bilateral), commonly glands/stroma (yellow-brown (frequently most in “powder outside ovary endometrial Endometriosis burn” the pelvis, lesions). peritoneum cavity, (blood-filled In endometrioma structures appears asterisks in ]). above and below as ovary, cysts” “chocolate [oval A to tissue lymphatic metaplastic endometrial transformation via May due transportation multipotent retrograde cells, system. of flow, be of dyschezia cyclic dysmenorrhea, uterus. (pain pain, with defecation), bleeding, infertility; normal-sized Characterized by dyspareunia, pelvic removal. danazol, agonists, NSAIDs, Treatment: progestins, laparoscopic OCPs, GnRH

(eg, of miscarriage, Inflammation following abortion, endometrium with conception retained B associated or delivery, with body IUD). of Endometritis foreign products vagina from GI Retained for is or bacteria material nidus tract. plasma histology. shows cells endometritis Chronic on gentamicin Treatment: + clindamycin +/− ampicillin.

postmenopausal. Commonly palpable A as outer often quadrant. a upper in Often the presents most mass hard overlying Cooper become pectoral skin dimpling. to retraction/skin ligaments, nipple deep fascia, fixed muscles, can Invasive cancer and 

arises Usually from duct lobular terminal unit. aggressive. negative triple PR and receptor) Amplification/overexpression (ER HER2/neu of receptors (HER2, EGF ⊝, ⊝) common; c-erbB2 is or more an estrogen/ form ⊝, progesterone

at breast intake. breastfeeding; BRCA1/BRCA2 for cycles;  pregnancy; of menstrual of factors age estrogen Risk  exposure mutations; alcohol risk to women:  tissue (eg, later history African converts highest estrone); (adipose at history  cancer; total first Americans number postmenopausal family nulliparity); race triple hyperplasia; (Caucasians cancer); ⊝ risk, of in age; absence obesity breast androstenedione of of atypical syndrome. In mutation, men: Klinefelter BRCA2

node prognostic lymph factor disease. in early-stage metastasis important Axillary most

with stroma. Firm, “rock-hard” mass sharp cells fibrous, desmoplastic Invasive duct-like in ductal glandular, margins small, and

aAll breast older or lack types seen subtype (abundant that invasive (well-differentiated of can myoepithelium) mucinous carcinoma extracellular mucin, tubules in women). tubular be subtype either of

A due tunica penis curvature Abnormal fibrous to albuginea. within Peyronie plaque disease of erectile with dysfunction. Associated Can pain, anxiety. cause collagenase or Consider injections treatment once repair stabilizes. curvature surgical with due Distinct (rupture penile of corpora to forced fracture cavernosa bending). from

Painful 4 lasting hours. erection > priapism sustained Ischemic cavernosum drainage venous channels), (eg, (sickled corpus sildenafil, disease trazodone). block vascular with RBCs cell Associated sickle medications of corporal to intracavernosal prevent Treat phenylephrine, or decompression surgical aspiration, ischemia. with immediately

US, Asia, cell common more the Seen but in in South Africa, America. Squamous situ Precursor erythroplasia Queyrat presents (in carcinoma in penile leukoplakia disease Bowen shaft, as “white plaque”), lesions: of

erythroplakia (carcinoma as of , “red the situ B in B glans plaque”). presents malignant reddish of (carcinoma papulosis Bowenoid situ in papules). presenting unclear as potential, Associated uncircumcised and HPV. with males

(Leydig with Descent levels risk testes; mostly are germ cell have A testosterone can failure best or 37°C); develop < sperm spermatogenesis of tumors. normal temperature); cells associated (since of unaffected both one temperatures by Cryptorchidism  at impaired risk  of Prematurity cryptorchidism.

 B, FSH,   in in testosterone normal bilateral unilateral. LH; cryptorchidism,  inhibin years performed of otherwise, age. before resolve Most 2 cases orchiopexy spontaneously;

of and vascular Rotation Testicular testicle pedicle. torsion cord around spermatic old. 12–18 males in presents Commonly years occur after (eg, trauma) inciting event or May an spontaneously. and absent Characterized reflex. by high-riding pain, testis, acute, severe cremasteric manual (orchiopexy) unavailable Treatment: in correction option within surgical hours, surgical detorsion 6 timeframe. if orchiectomy. viable, testis If not is is subsequent performed, risk be when for should because Orchiopexy, torsion. at the testis bilateral contralateral

often pampiniform augmented on of left cause in exam/Valsalva on drainage males; of not by venous A transilluminate.  temperature; to renal (distension in veins from Valsalva) cause side due most adult left infertility into Varicocele can does vein “bag enlargement left ; scrotal Dilated vein; maneuver of worms” to because of • or standing ultrasound because plexus pressure; diagnosed clinical inspection most palpation; gonadal  resistance common flow by and on pain ligation associated with or surgical infertility. or consider embolization Treatment: if

germ midline in Extragonadal cell Arise locations. most regions. adults, tumors commonly in and retroperitoneum, In pineal, suprasellar mediastinum, children, and most young sacrococcygeal infants common. are In teratomas

testicular testicular as masses (vs transilluminated lesions scrotal tumors). be that masses present solid Benign Scrotal can

scrotal in Common A Congenital Transilluminating hydrocele swelling. swelling of infants, cause processus of incomplete vaginalis. obliteration to due spontaneously resolve Most 1 year. within

testicular for of tumors. Germ 95% all cell ∼ account tumors that produce germ Arise cells sperm. from Most occur men. young in often syndrome. Risk Klinefelter factors: cryptorchidism, cell a present Can germ mixed as tumor. Do transilluminate. not via not seeding scrotum), orchiectomy. of (risk biopsied radical Usually removed

Sex embryonic of (develops cells Sertoli develop cord and Leydig and cord from follicle) cells tumors theca into derivatives. sex tubules, seminiferous granulosa of stromal of all testicular 5% tumors. Mostly benign.

Inflammation Orchitis testis. of Presents pain swelling. with testicular and  orchitis Mumps risk. infertility boys < Rare in 10 old. years

urgency, back by pain. low Characterized frequency, Prostatitis dysuria, prostate. tender, enlarged Warm, prostatitis—in coli; trachomatis, in Acute common men C young men older N bacterium E gonorrhoeae. bacterial most consider is previous bacterial Chronic nerve infection, prostatitis—either (eg, chemical to 2° nonbacterial problems, irritation). or

50 > men old. in years Common elastic, vertical urethra (hyperplasia smooth, the of hypertrophy) lobes, compress middle) by enlargement into periurethral which Characterized a (lateral firm and slit. not nodular Not premalignant.

Often urination, and presents with difficulty nocturia, of dysuria. urine  stream, starting frequency stopping and lead UTIs. distention of May to hydronephrosis, bladder, hypertrophy

prostate-specific (PSA).  free antigen

Treatment: ablation). surgical PDE-5 TURP, cause tamsulosin), of (eg, 5α-reductase finasteride); (eg, muscle; (terazosin, resection inhibitors which tadalafil); smooth inhibitors α1-antagonists (eg, relaxation

Control hormones reproductive of

Goserelin, mECHANISm GnRH leuprolide analogs. of pulsatile in When GnRH. be Leuprolide lieu used in can used

GnRH as fashion act agonists. transiently continuous first fashion in used When act as

but GnRH (downregulate GnRH antagonists subsequently flare), act as • LH). agonists (tumor

cancer, ClINICAl fibroids, puberty, Uterine prostate precocious USE infertility. endometriosis,

vomiting. dysfunction, Hypogonadism, erectile EFFECTS  nausea, ADVERSE libido,

mECHANISm antagonist. GnRH start-up flare. No

cancer. ClINICAl Prostate USE

ADVERSE Hot EFFECTS flashes, liver toxicity.

Ethinyl mestranol. DES, Estrogens estradiol,

mECHANISm estrogen receptors. Bind

hormone Hypogonadism USE failure, replacement (combined in ClINICAl or menstrual ovarian therapy women. postmenopausal OCPs), abnormalities

risk females without of cell in in given risk exposed cancer DES of utero,  (when adenocarcinoma EFFECTS women,  progesterone), postmenopausal thrombi. clear bleeding of in endometrial to vagina ADVERSE > ⊕ old. cancer, in use tobacco 35 history women years Contraindications—ER of breast DVTs,

of cancer of osteoporosis. bone; with at risk Raloxifene used thromboembolic increased agonist uterus; no (vs smoking) risk endometrial Antagonist  at breast, (especially but treat primarily to events tamoxifen);

Anastrozole, exemestane. inhibitors Aromatase letrozole,

conversion peripheral Inhibit androgens estrogen. to of mECHANISm

postmenopausal cancer ER breast USE women. ClINICAl in ⊕

mECHANISm  mucus. thicken growth vascularization Bind cervical endometrium, and of  receptors, progesterone

device, depot (forms bleeding. cancer, injection), uterine intrauterine implant, pill, ClINICAl Contraception USE endometrial include abnormal defects presence excludes Progestin (eg, withdrawal estrogen. Asherman anatomic and syndrome) bleeding of anovulation chronic without challenge:

ulipristal. Antiprogestins Mifepristone,

Competitive inhibitors of receptors. progestins at mECHANISm progesterone

ClINICAl emergency with Termination misoprostol); contraception (ulipristal). USE of pregnancy (mifepristone

and Produces mECHANISm to fertilization implantation; toxic ova, inflammatory free. and reaction local hormone preventing sperm

reversible Long-acting USE contraception. ClINICAl Most contraception. emergency effective

dysmenorrhea. Heavier EFFECTS ADVERSE or menses, longer insertion active PID pelvic in Risk with infection). of (contraindicated

uterus; Tocolytics channel indomethacin (Ca2+ (β2-agonist action), nifedipine blocker), Medications relax the that (NSAID). terbutaline include promote to transfer (to maturity) Used preterm center time steroids medical and fetal appropriate  in administration or of labor obstetrical for frequency allow care. with to contraction lung

Synthetic mECHANISm androgen androgen acts that agonist at receptors. as partial

Endometriosis, ClINICAl hereditary USE angioedema.

levels, hirsutism, hypertension. acne, hepatotoxicity, edema, idiopathic gain,  HDL EFFECTS ADVERSE masculinization, intracranial Weight

Testosterone, at receptors. Agonists androgen mECHANISm methyltestosterone

anabolism hypogonadism sex Treat or injury. ClINICAl characteristics; to development promote burn of and stimulate promote 2° recovery USE after

of inhibiting females; (via intratesticular atrophy. testosterone EFFECTS negative ADVERSE in  feedback) in Masculinization LH release gonadal  by males plates. of closure epiphyseal Premature • LDL, HDL. •

Finasteride inhibitor 5α-reductase ( Testosterone conversion of

DHT (more potent). DHT). to testosterone Used for male-pattern baldness. and BPH sexual effects: Adverse dysfunction. and gynecomastia

used inhibiting BPH to Tamsulosin by α contraction. -antagonist treat smooth muscle on prostate) Selective vascular receptors. receptors α1B for α vs (found

arteriolar vasodilator. Direct mECHANISm

ClINICAl (pattern USE refractory hypertension. severe Androgenetic alopecia baldness),

for to start I be now so soul.” all.” feel of “Freedom it it is weren’t I the blue, breathing “Whenever pollution place much lungs, our no put that in —L. the there’d air the if oxygen “There’s again.” the Frank your Smith, breath breaths Baum moments is that take; away.” Hitch take of —Will amount you not the it’s “Life

for together respiratory, concepts Group and cardiovascular, whenever renal key possible. study and physiology. vs obstructive V˙/Q˙ mismatch, restrictive hemoglobin Know of volumes, respiration, lung mechanics disorders, lung causes are cancers high lung yield. Lung of and other masses CT x-rays, comfortable PFTs. chest reading scans, Be basic and

secretory with granules. Nonciliated; Club columnar/cuboidal cells low Located bronchioles. in toxins; Degrade reserve surfactant; act secrete as component cells. of

pneumocytes Squamous. I Type surfaces. of alveolar 97% optimal arrows in alveoli ) for black the exchange. (two Thinly line gas A

A . radius (surface 2 tension) functions: 2

. A < is predictive 2 of 1.5 foam (≥ NRDS), healthy;

diabetes surfactant-albumin maternal stability ratio. prematurity, Risk factors: index, (due  low O2 Persistently delivery  of insulin), PDA. to fetal risk release tension C-section ( fetal of delivery). glucocorticoids; than vaginal stressful less

for birth; exogenous infant. before maternal Treatment: steroids surfactant

prematurity, Bronchopulmonary Retinopathy of hemorrhage, dysplasia (RIB). Intraventricular

bronchi. consist larynx, pharynx, Large Conducting zone airways nose, of trachea, and highest largeto in resistance medium-sized bronchi. the Airway terminal parallel Small airways  consist of airway bronchioles into divide further (large least numbers resistance). that in bronchioles

Warms, does but “anatomic not humidifies, the participate in space.” and filters air  bronchi. Cartilage cells exchange of gas extend to end goblet dead and ciliated transition primarily up to and epithelium columnar to beginning of Pseudostratified cells. bronchus cells bronchioles, terminal extend make cuboidal then of debris lungs escalator). and (mucociliary Clear mucus from bronchioles (sparse to extend beyond smooth this point). muscle terminal Airway of cells end

bronchioles, of parenchyma; Respiratory Lung ducts, respiratory alveolar and zone consists alveoli. Participates in exchange. gas

squamous then bronchioles, alveoli. up simple Mostly cells cells to respiratory in cuboidal respiratory in Cilia terminate bronchioles. clear debris Alveolar response. immune in participate macrophages and

has and Lobes lobe). lung (2) 3 has Left of Right Lingula (homolog lobes; middle Less right lobe, the A a middle space of Instead has . left heart lung occupied a by

by bronchus of to hilum pulmonary described the each is Relation RALS—Right lung artery Anterior; Superior. Left the at Carina and ascending is to . posterior anteromedial to aorta descending aorta B

for a shorter bodies site right lung more and inhaled left. main foreign than stem common is the Right wider, bronchus because vertical, is more a If you aspirate peanut:

enters lobe. lower supine—usually While superior of right segment

lobe. While right lying enters on side—usually right upper

While upright—usually right lower enters lobe.

diaphragm: Structures perforating

T8: right IVC, At nerve phrenic

(CN At esophagus, 10; T10: vagus trunks) 2

white, (“At the and red, vein At duct thoracic T12: aorta blue”) (blue) T-1-2 (white), azygos it’s (red),

5 (phrenic 4, is and innervated nerve). C3, Diaphragm by trapezius ridge (C3, be blood, (C5) air, pus Pain and to peritoneal cavity) referred (eg, diaphragm shoulder in can from irritation or 4).

of aortic vena (IVC) (O)esophagus T12: Number hiatus T = letters level: cava T8: T10:

twelve. at ten eggs (8) ate I 5 keeps C3, diaphragm the 4, alive. bifurcations: Other

common at C4. The bifourcates carotid

T4. The bifourcates trachea at

abdominal The bifourcates at aorta L4.

a volumes. Lung physiologic Note: is ≥ 2 a sum of capacity volumes

6.0

into Air typically FRC with quiet 500 volume each 2.2 2.7 Tidal moves inspiration, 1.2 mL lung that

dead physiologic Determination of space

of plus = of conducting = is lung of dead dead space. space alveolar physiologic airways space largest apex contributor healthy alveolar dead VD anatomic space; dead not that take gas inspired of exchange. Volume does part in air

VT = volume. tidal Pco2. arterial Paco2 = air = Peco Pco 2. expired 2

of (refers Paco, equation) order Paco Peco, in variables Taco, to

in normal to space space—approximately lungs. anatomic dead Physiologic equivalent dead than be greater lung anatomic dead V˙/Q˙ space in May with defects. diseases

values: breaths/min × minute = entering Normal RR rate = Minute volume Respiratory (RR) 12–20 VT lungs per ventilation VE of Total gas

that alveoli V each Alveolar 150 mL/breath gas T minute = ventilation of Volume reaches

for to Elastic recoil inward outward. lungs and wall Tendency chest collapse to spring

pressure pressures At is alveolar pressure atmospheric negative (preventing atelectasis). and airway FRC, (called and zero), equal intrapleural outward inward pull balanced The chest the wall. lung is the by the pull of of is atmospheric. pressure System minimum. vascular a (PVR) resistance at Pulmonary is

0.5 +2 0.0

in a volume Compliance in change pressure for (ΔV/ΔP). lung Change surfactant. by Inversely and wall stiffness increased proportional to = • compliance harder fibrosis, • 6 pneumonia, to = fill ARDS, (eg, aging) edema)  emphysema, pulmonary lung  fill to 4 pulmonary compliance lung easier (eg,

inflation. to than inflation overcome to need volume pressure-2 Lung lung tension Hysteresis due curve a deflation different in forces follows surface

content of Oxygen Hemoglobin blood

O2 of concentration; saturation = Sao2) = Sao2 O2 partial arterial in Pao2 = Pao2) blood × Hb (0.003 × (1.34 content Hb + = hemoglobin pressure × arterial O2

is Hb can normal g mL 1 15 1.34 O2; bind g/dL. Hb blood amount in Normally O2 O2/dL capacity blood. of ≈ binding mL 20 arterial no blood, is and saturation O2 of content Hb change  but there O2 Pao2.  in With content of blood. O2 tissues × cardiac output delivery to O2 =

has and shape for affinity molecule ODC higher subsequent can to Hb due cooperativity each molecules (ie, tetrameric O2 molecule positive has 100 bound). O2 sigmoidal bind 4 Myoglobin curve monomeric 80 60 appearance. is 70 thus cooperativity; and show lacks sigmoidal does not positive

to Hb maintain right to (facilitates for Po2 required  the unloading ODC affinity tissue) O2 O2 of 50% (higher P50 saturation). Shifting to 

O2 Shifting unloading to compensatory  the erythrocytosis. left ODC

and Hb shifted affinity (2 O2 mother to placenta diffusion of driving from than (due α has 2,3-BPG) the fetus. higher subunits) 2 across dissociation γ  left, for Fetal for to affinity Hb adult is curve O2 

carbon metabolism. via complex anaerobic poisoning oxidase) (cytochrome  O2 hypoxia IV vs correct c monoxide does inhibition metabolism of and supplemental not with that  Cyanide fully aerobic Both inhibit

Both cherry finding), (usually lead red skin can pink and to coma. or postmortem seizures,

car product gas heaters. (cyanogenic SOURCE glucoside gas synthetic combustion, or Byproduct Odorless amygdalin fires, of ingestion from exhaust, of seeds) or in found apricot cyanide.

TREATmENT O2, O2. hyperbaric Hydroxocobalamin (binds 100% cyanide

cyanocobalamin • excretion). • renal

(oxidize cyanide • • Hb binds cyanomethemoglobin  toxicity). methemoglobin less Nitrites 

(• Sodium excretion). conversion cyanide renal thiosulfate thiocyanate • to

cardiovascular SIgNS/SYmPTOmS Headache, has bitter almond Breath odor; dizziness. collapse. be in (eg, individuals winter). with may involved family similar Multiple symptoms , seen although A associated with Classically on rarely lesions well. cyanide as pallidus bilateral toxicity with globus MRI

initially. normal

Left for  in curve O2 unloading O2 in  affinity shift tissues.

• O2 %O2 form to with Hb saturation greater competitively 200× than Binds to carboxyhemoglobin of Hb. affinity

O2 to mL) O2 (mL /100 Hb bound

system. high-compliance Normally low-resistance, a A hypoxic poorly to of lung. well-ventilated causes a in lung ventilated shifts that regions  Pao2 away vasoconstriction blood regions of from

(normal CO2, limited—O2 Perfusion health), N2O. early Gas length along the the capillary. of equilibrates can only Exchange blood flow . if be 

reaches Diffusion (emphysema, blood equilibrate the fibrosis, limited—O2 of CO. the Gas capillary. does not exercise), time by the end

and subsequent cor pulmonale pulmonary consequence ventricular is of A right hypertension failure.

× 2 A × Dk Δ where P gas – P Diffusion: 1 V˙ =

– gas, in of P2 thickness, diffusion P1 coefficient Δ = Dk area, partial alveolar = wall difference = A = x pressures.

A emphysema.  in

 pulmonary x fibrosis. Δ in

of the which air sacs DLCO is into extent CO lungs blood. passes to from

is gas V˙/Q˙ perfusion 1) to Ideally, = (ie, ventilation for Ventilation/perfusion mismatch matched adequate exchange. zones: Lung

ventilation) of V˙/Q˙ (wasted at 3 = apex Q lung

the the (wasted of at and base are of ventilation at the perfusion) greater at apex of than the = 0.6 base lung. lung perfusion lung V˙/Q˙ Both

approaches ( there cardiac With of  V˙/Q˙ output), exercise apical is vasodilation capillaries 1. ratio

the in apex. high flourish organisms Certain thrive in that (eg, TB) O2

= (shunt). ˜˜ obstruction V˙/Q˙ “oirway” 0 = V foreign shunt, O2 improve not In Pao2 does 100% aspiration). (eg, body Q ∞ V˙/Q˙ blood = (physiologic dead obstruction space). flow = 100% improves Pao2 < Assuming (eg, O2 embolus). pulmonary space, dead 100%

tissues − is in transported forms: lungs 3 from (70%). HCO3 CO2 to (21–25%). or Carbaminohemoglobin HbCO2 Hb heme). CO2 of globin bound (not N-terminus to at form (O2 deoxygenated CO2 unloaded). favors CO2 Dissolved (5–9%).

In Hb. from dissociation oxygenation of lungs, of H+ Hb promotes This released (Haldane CO2 toward equilibrium effect). formation; is from shifts therefore, CO2 RBCs

shifts to H+ right, unloading tissue In O2 peripheral effect). (Bohr metabolism from tissue,  curve

Majority as CO2 is the blood of plasma. carried HCO3 in −

Response sickness. altitude to high in Chronic  ventilation.

erythropoietin and hypoxia). Hb chronic Hct (due to 

releases ODC Hb the 2,3-BPG more O2). shift causing rightward Hb that (binds so to of changes mitochondria). ( Cellular

alkalosis respiratory with to augment renal (can for of − HCO3 compensate excretion acetazolamide). hypoxic in results vasoconstriction hypertension RVH. Chronic pulmonary pulmonary and

to production. CO2 exercise  Response consumption.  O2 of shift Right ODC.

rate O2 demand. meet ventilation to more V˙/Q˙ apex base from ratio becomes uniform. to

output. blood cardiac due pulmonary to flow 

(2° during pH strenuous acidosis). exercise lactic to in and in change Pao2 content. Paco2, and CO2 venous content but in venous  No O2 

of drainage into pain affected and nasal cavity  sinus Obstruction area. inflammation over Typically sinuses, which ). gravity arrow against ostia superomedially to points due sinus (red in fluid-filled maxillary to located affects maxillary drain A right

meatus—drains meatus—drains duct. posterior Superior sphenoid, middle meatus—drains frontal, ethmoid; anterior inferior and ethmoid; nasolacrimal maxillary,

lead H catarrhalis. URI; pneumoniae, may bacterial commonly cause most M S superimposed to influenzae, infection, acute common viral is Most

the to sinus, complications (eg, may syndrome, cellulitis, meningitis). orbits, extend cavernous orbital infections and cavernous causing brain, Paranasal sinus sinus

neck squamous Mostly cell carcinoma. and cancer Head HPV-16 include (oropharyngeal), factors alcohol, (nasopharyngeal). EBV Risk tobacco, tumors exposure. multiple wide cancerization: damages after carcinogen that • Field area develop independently mucosal

a clot within redness  Blood deep swelling, vein

pain. A warmth, , by Predisposed Virchow triad (SHE):

long Stasis drive/flight) (eg, post-op,

use; V oral proteins, factor Hypercoagulability defect pregnancy) in as cascade such Leiden; coagulation contraceptive (eg,

deep emboli Most veins proximal of pulmonary arise from extremity. lower

test clinically low-to-moderate DVT (high used rule lab to sensitivity, in patients d-dimer risk specificity). out low

compression choice is test Doppler. Imaging of with ultrasound

or Use unfractionated for weight enoxaparin) management. heparins and low-molecular prophylaxis (eg, heparin acute

apixaban) (eg, and long-term rivaroxaban, for treatment oral Use prevention. anticoagulants

hypoxemia, emboli Pulmonary V˙/Q˙ respiratory mismatch, alkalosis. dyspnea, chest tachypnea, pleuritic tachycardia. Sudden-onset pain, may sudden due emboli dissociation activity). A electromechanical saddle cause to death (pulseless embolus Large electrical or for test of pulmonary imaging filling is (look PE angiography choice B defects) . for CT have S1Q3T3 ECG. on abnormality May red fibrin) pink only areas in (platelets, of and before thrombi. found death; interdigitating help of are distinguish (RBCs) thrombi formed Zahn C Lines preand postmortem Amniotic fluid, Bacteria, Air, Thrombus, Types: Fat, Tumor. like embolus BAT. FAT An moves a long triad fractures rash. of liposuction; hypoxemia, and with neurologic bone petechial classic abnormalities, emboli—associated Fat placement). with be precipitate (eg, O2; in disease/decompression to (caisson central iatrogenic divers line can sickness); 2° invasive Air emboli—nitrogen ascending treat procedures bubbles or, hyperbaric postpartum, to occurs labor be emboli—typically trauma. or due uterine fluid Amniotic can during but to Can DIC. lead Rare, mortality. but high

lymph and pathology nodes, aorta. esophagus, contains Mediastinal mediastinum heart, thymus, Normal

in pathologies cancer, occur there can compartment, any associations: lung masses lymphoma, but abscess) Mediastinal Some are common (eg,

Teratoma, Thyroid Anterior—4T’s: “Terrible” lymphoma. neoplasm, (substernal goiter), Thymic

hernia, carcinoma, hiatal cysts. Middle—esophageal bronchogenic metastases,

multiple myeloma. neurofibroma), tumor Posterior—neurogenic (eg,

tissues. mediastinal of Inflammation Mediastinitis spread of infection. days), of procedures esophageal due perforation, odontogenic/retropharyngeal (≤ cardiothoracic 14 postoperative Commonly complications or contiguous to of known proliferation fibrosing in mediastinitis—also mediastinum. Chronic due as tissue connective to mediastinitis;  Histoplasma capsulatum common cause. is chest and leukocytosis, sternal fever, tachycardia, pain, Clinical drainage. features: wound

air neck into show Pneumomediastinum arrows dissecting aorta, ). (black air) shows A around arrow red gas the air the in of Presence the mediastinum (usually rupture trauma, syndrome). iatrogenic, of spontaneous or to either (due 2° (eg, Can bleb) pulmonary be Boerhaave perivascular Ruptured the air and into alveoli mediastinum of via allow sheaths. tracking peribronchial (crepitus voice sign chest subcutaneous on pain, ⊕ cardiac features: Clinical change, auscultation). dyspnea, Hamman emphysema,

puffer”) Findings: emphysema pursed chest collapse). exhalation emphysema barrel-shaped (increases Panacinar pressure Centriacinar Emphysema , airway Normal and lips D through prevents airway (“pink

sparing distal bronchioles alveoli, with Centriacinar—affects while associated respiratory

. B in rises lobes up). upper Frequently (smoke

alveoli, respiratory α1-antitrypsin Panacinar—affects with and bronchioles deficiency. associated Frequently lobes. lower in

(arrow walls alveolar • destruction recoil, compliance, spaces in of Enlargement from of air

pulmonary capillaries. volume and blood )  C in

 Imbalance of elastase antiproteases fibers of loss compliance. proteases • lung elastic and activity •

• CXR: diameter, field • lucency. lung AP flattened diaphragm,

wheezing, paradoxus, tachypnea, pulsus Findings: expiratory ratio, dyspnea, • hypoxemia, inspiratory/ Asthma plugging mucus cough,

E . stress. Triggers: viral allergens, URIs,

Hyperresponsive bronchoconstriction. bronchi reversible • spirals and hypertrophy Curschmann Smooth hyperplasia, muscle

F plugs), Charcot-Leyden crystals mucous (shed whorled and epithelium forms

(eosinophilic, crystals sputum). double-pointed of hexagonal, eosinophils G in formed from breakdown normal DLCO . or

reaction. Type hypersensitivity I

by challenge. spirometry and Diagnosis methacholine supported

nasal of inhibition COX sinusitis polyps, constriction), respiratory airway • (leukotriene symptoms. overproduction NSAID-exacerbated with is asthma chronic combination disease a and

often (most purulent P Findings: PAThOlOgY OThER PRESENTATION TYPE sputum, clubbing. aeruginosa), hemoptysis, infections digital Bronchiectasis recurrent dilated bronchi airways. obstruction necrotizing or infection Chronic permanently of ciliary bronchial (eg, Associated poor Kartagener motility , fibrosis syndrome), smoking, aspergillosis. cystic allergic H with obstruction, bronchopulmonary B HF D G E A C

volumes Restricted  TLC). ( FVC and lung causes lung expansion ratio.  PFTs: FEV1/FVC with shallow breaths. Patient short, presents

Types:

breathing mechanics (extrapulmonary, A-a Poor DLCO, gradient): normal normal

muscular effort—polio, Guillain-Barré gravis, syndrome Poor myasthenia

Poor structural morbid obesity apparatus—scoliosis,

gradient): Interstitial A-a diseases (pulmonary,  DLCO,  lung

Pneumoconioses pneumoconiosis, workers’ coal (eg, silicosis, asbestosis)

Ca2+ ACE lymphadenopathy, and bilateral  hilar granulomas; Sarcoidosis: noncaseating

[blue with “honeycomb” lung bronchiectasis healing pulmonary and cycles collagen deposition, of in fibrosis lung injury in clubbing). traction Idiopathic and  digital ] A ], (repeated arrow [red appearance arrows A wound

with polyangiitis Granulomatosis (Wegener)

Drug methotrexate) toxicity busulfan, (eg, amiodarone, bleomycin,

reaction type hypersensitivity environmental Hypersensitivity antigen. pneumonitis—mixed to III/IV cough, chest headache. Causes tightness, fever, dyspnea, seen birds. those exposed farmers to Often in and in is early stages stimulus avoided. if Reversible

A bronchoalveolar Characterized widespread and elevated granulomas fluid. in ratio lavage levels, immune-mediated, Sarcoidosis CD4/CD8 , by serum elevated ACE noncaseating females. More common in African-American asymptomatic Often enlarged for lymph nodes. except adenopathy the CT B opacities hilar shows CXR C and . bilateral of demonstrates ; mediastinal extensive and adenopathy the reticular coarse chest better microscopic (due palsy, D Uveitis, on lesions face Lupus resembling Bell pernio fibrosis asteroid vitamin in nodosum, (noncaseating containing 1α-hydroxylase–mediated (restrictive Granulomas Schaumann Interstitial  arthropathy, lupus), hypercalcemia Associated (skin and bodies), Rheumatoid activation Erythema macrophages). epithelioid, with arthritis-like to lung disease), is droop A UGLIER. facial (if steroids symptomatic). Treatment:

(eg, of of inhalation stimuli noxious smoke). Complication irritants NH3) Caused heat, 1 (< diameter), chemical pneumonia, (eg, ARDS. by or tracheobronchitis, edema, µm  particulates arsenic or inhalation, patients 2° burns, Many cyanide to poisoning, CO present poisoning. or common in hairs oropharynx on soot nasal exam. Singed

after at severe soot Bronchoscopy shows B hours edema, bronchus, and injury). congestion deposition days after , resolution of injury; 18 11 A inhalation ( ,

lobes). (lower but Asbestos roof the base the from is insulation), Pneumoconioses in affects (was common the from are the (upper and coal Silica (earth), roof base affect lobes). but

Associated with plumbing. Asbestosis roofing, shipbuilding, are white,” of supradiaphragmatic calcified, plaques B and A “Ivory pathognomonic pleural asbestosis. Risk mesothelioma. bronchogenic of carcinoma risk > of with (rheumatoid and intrapulmonary syndrome Caplan arthritis nodules). pneumoconioses  of risk

lobes. Affects lower

(ferruginous) resembling rods bodies fusiform are dumbbells golden-brown Asbestos

found sputum in sample, by bronchoalveolar Prussian visualized lavage. C often blue , using obtained stain, alveolar

pleural risk effusions.  of

in with to Berylliosis upper lobes. Affects beryllium Associated exposure aerospace manufacturing and industries. (noncaseating) and D steroids. histology occasionally responsive therefore to Granulomatous on risk cor and  pulmonale. cancer of

of histology. bodies Mesothelioma the with seen pleura Psammoma Malignancy associated on asbestosis. May hemorrhagic (exudative), pleural in cytokeratin all Calretinin result effusion A pleural and . 5/6 in almost ⊕ thickening carcinomas. in most mesotheliomas, ⊝ a Smoking not factor. risk

(normal formation intra-alveolar membranes PCWP). oxygen in • endothelial PAThOPhYSIOlOgY pro-inflammatory pulmonary capillary cytokines (arrows  edema Alveolar alveoli activation, recruitment, insult noncardiogenic hyaline (eg, into ) leakage and damage mediators and proteases, species, of of release permeability toxic neutrophil A and vessel etc)  protein-rich  of of reactive  fluid release  of collapse. also surfactant to alveolar contributes Loss

common), trauma, Sepsis pneumonia, pancreatitis. (most aspiration, CAUSES

with (ARDS): criteria following the DIAgNOSIS of exclusion Diagnosis

1 alveolar week Respiratory insult of within failure

 (ratio hypoxemia < Pao2/Fio2 abnormalities) intrapulmonary Decreased shunting diffusion 300, and to due

HF/fluid Symptoms of due are failure respiratory to not overload

compliance;  gas CONSEQUENCES hypertension. lung exchange, pulmonary Impaired

mANAgEmENT cause. Treat the underlying • ventilation: volume,  tidal Mechanical PEEP.

 Repeated apnea seconds 10 sleep disrupted sleep Sleep daytime breathing  of cessation > during somnolence. sleep study. Diagnosis by confirmed arrhythmias hypertension, death. fibrillation/flutter), systemic/pulmonary Nocturnal (atrial hypoxia • sudden erythropoiesis.  release EPO Hypoxia 

effort opioids. HF, CNS Impaired sleep injury/toxicity, apnea due Central to respiratory be respirations apnea hyperpnea). between (oscillations Cheyne-Stokes and with associated May 3 toxicity, HF, CNS Cheyne-Stokes Congestive respirations. Think C’s: positive with pressure. airway Treat

hours and • (BMI (retention); during hypoventilation ≥ during Pao2 Obesity waking Paco2 •  sleep. hypoventilation • 30 kg/m2) Paco2 Obesity Pickwickian as syndrome. known Also syndrome

25 rest. pulmonary mm ≥ Hg; artery mm at pulmonary pressure = 10–14 hypertension mean Hg Normal of arteriosclerosis, arteries, Results intimal medial plexiform hypertrophy, pulmonary lesions. fibrosis in pulmonale. • from decompensated • Course: severe distress death respiratory cor RVH cyanosis and

of if side effusion None lesion large • Pleural if small from Dull Away •

Toward • side • of lesion Dull Atelectasis

from pneumothorax side lesion • Hyperresonant of Tension • Away

). collapse lobe Atelectasis against mediastinum collapse Alveolar (right in upper A causes: Multiple

from (eg, resorbed old is air obstruction new tumor) body, distal reaching mucous prevents foreign airways, Obstructive—airway plug, air

pleural on effusion) lung lung compression space-occupying volumes lesion, (eg, decreases Compressive—external

(cicatrization)—scarring distorts alveoli parenchyma lung that sarcoidosis) of (eg, Contraction

babies) (eg, to of surfactant in Adhesive—due lack premature NRDS

Scarring air, e˜usion, Pleural tumor

layers restricted  fluid Pleural expansion Excess between lung accumulation effusions of during pleural A inspiration. with Can remove/reduce to B treated thoracentesis . fluid be

Also Lymphatic chylothorax. known as or trauma injury from to thoracic malignancy. Due duct fluid;  triglycerides. Milkyappearing

(cellular). 2.9 protein (>  content cloudy Exudate g/dL), vascular in collagen malignancy, trauma to (occurs  (eg, disease), pneumonia, of Due permeability). states inflammation/infection vascular drained Must of due be infection. to risk

clear g/dL), (< content 2.5 (hypocellular).  Transudate protein Na+ cirrhosis). pressure (eg, to Due  pressure or (eg, HF, oncotic syndrome, hydrostatic  retention) nephrotic

A pleural of Pneumothorax . air in Accumulation space chest Dyspnea, expansion. uneven fremitus, breath and Chest affected pain, the side. on all  tactile hyperresonance, sounds, diminished

Primary spontaneous or rupture to apical Due cysts. of subpleural bleb young and pneumothorax males thin, tall, Occurs smokers. frequently in most

iatrogenic trauma. mechanical (eg, rib pneumothorax fracture), (eg, barotrauma central penetrating Caused or line blunt Traumatic placement, ventilation) to (eg, lung by gunshot), due biopsy,

Can any be above. the of from pleural enters cannot space Air but exit. air Increasing tension • pneumothorax. trapped Trachea affected lung deviates from away B . return   mediastinal IVC lead May cardiac to displacement pressure intrathoracic  kinking • venous increased output. of chest placement. and tube needle Needs decompression immediate

Intra-alveolar pneumoniae lobe Lobar A frequently, • consolidation pneumonia may also most Legionella, Klebsiella S involve exudate ; entire

B whole lung. the or

unknown. Etiology effects inflammatory rheumatoid is or pneumonia organizing (eg, arthritis) caused diseases by amiodarone). (eg, Secondary chronic side medication not responds ⊝ blood cultures, sputum antibiotics. and often steroids but to to

(BOOP). Formerly obliterans known pneumonia as organizing bronchiolitis characterized inflammation pneumonia structure. by and bronchioles surrounding of Noninfectious

lobar of history pneumonia Natural

of cause Lung cancer death. cancer Leading Boneheads fracture), Brain; CT. noncalcified from than Bone Affective lung, neoplasms. wheezing, cough, of (pathologic on metastases “coin” are (usually hepatomegaly), In lesions) nodule 1° CXR hemoptysis, common Adrenals, ‘mets’ cancer: more pneumonic bronchial Sites and multiple Presentation: lesion (jaundice, metastases or Love Liver on lung “Lung obstruction, Brainiacs.” the cancer. from breast, bladder and Most colon, often prostate,

Endocrine syndromes Pancoast Superior SPHERE Horner vena of laryngeal compression outlet Recurrent syndrome complications: cava/thoracic tumor (paraneoplastic) nerve

asbestos, history. family radon, secondhand Risk smoke, smoking, include factors carcinomas and Sentral and caused by (central) often Small cell Squamous are Smoking.

aggressive. Undifferentiated ChARACTERISTICS Central Small cell) very cell (oat  lOCATION Small cell TYPE carcinoma hISTOlOgY Antibodies encephalitis, channels ADH myelitis, presynaptic against cerebellar or subacute produce syndrome), degeneration). (SIADH), or ACTH (Cushing (Lambert-Eaton neurons Ca2+ May syndrome) (paraneoplastic myasthenic common. myc oncogenes of Amplification radiation. chemotherapy with Managed +/– of small dark blue Neoplasm  . cells A Kulchitsky cells neuroendocrine ⊕, ⊕. ⊕, neuron-specific enolase Chromogranin synaptophysin A Non-small cell

lung Adenocarcinoma cancer. 1° Most common Peripheral in arise to likely most nonsmokers. than More in women common men, KRAS, mutations Activating include EGFR, and ALK. (clubbing). with hypertrophic Associated osteoarthropathy situ): prognosis. to hazy subtype better in pneumonia; shows Bronchioloalveolar (adenocarcinoma CXR infiltrates often similar

pattern on mucin stains histology, ⊕ Glandular often

. B

of alveolar apparent along  grows septa alveolar subtype: Bronchioloalveolar “thickening” walls. mucus. columnar Tall, containing cells

Hilar mass carcinoma Squamous arising Cigarettes; C from bronchus; Central cell PTHrP). Cavitation; (produces hyperCalcemia and pearls intercellular D Keratin bridges. Large carcinoma cell prognosis. anaplastic Highly Peripheral undifferentiated tumor; poor removed chemotherapy; responsive Less surgically. to with smoking. association Strong Pleomorphic . cells giant E

parenchyma collection pus of within Localized

A . contents obstruction loss of (eg, [eg, oropharyngeal of to alcoholics, aspiration or consciousness cancer). bronchial patients in Caused by predisposed (especially epileptics])

seen B cavitation. on presence often suggests CXR; S (eg, aureus. to Fusobacterium, or Due Peptostreptococcus) Bacteroides, anaerobes

antibiotics, drainage, or Treatment: surgery.

in aspiration Lung abscess lung. to found right most is 2° often Location if if position upright, or on recumbent. during depends RLL RML aspiration: RUL patient’s

tumor. sulcus as known superior Pancoast tumor Also the that syndrome local lung invading/compressing cause Pancoast in by structures. occurs Carcinoma of apex A may of Compression locoregional findings: array may structures cause of

ptosis, Horner miosis, • ganglion syndrome Stellate (ipsilateral anhidrosis)

), head (edema). that blanching of A neck distention), plethora”; note extremities drainage pressure the fingertip (jugular (“facial An and in after impairs venous blood obstruction the upper from SVC caused (eg, from indwelling Pancoast B and mass, catheters thrombosis malignancy tumor) mediastinal by . Commonly Medical emergency. pressure rupture raise is risk aneurysm/ intracranial intracranial headaches, obstruction  arteries. of dizziness, • severe) (if of Can

inhibitors receptors. histamine blockers Reversible of H1 Histamine-1

usually or doxylamine. Diphenhydramine, generation “-en/-ine” “-en/-ate.” Names dimenhydrinate, First chlorpheniramine, contain

sleep aid. ClINICAl sickness, USE Allergy, motion

anti-α-adrenergic. EFFECTS Sedation, antimuscarinic, ADVERSE

cetirizine. in desloratadine, generation Second Names Loratadine, “-adine.” usually end fexofenadine,

USE Allergy. ClINICAl

less than into Far entry of sedating EFFECTS because  1st ADVERSE generation CNS.

respiratory reflex. not Expectorant—thins cough suppress Guaifenesin secretions; does

in by diseases bronchopulmonary bonds. mucus disrupting (eg, COPD, Mucolytic—liquifies N-acetylcysteine chronic disulfide CF) used Also an overdose. as for antidote acetaminophen

(antagonizes Dextromethorphan receptors). Antitussive NMDA glutamate analog. Synthetic codeine excess. in opioid when effect used mild Has for Naloxone be overdose. given can potential. Mild abuse agents. serotonin combined other with serotonergic if syndrome May cause

agonists. mEChANISm Pseudoephedrine, phenylephrine α-adrenergic

(used nasal edema eustachian tubes. hyperemia, Reduce as obstructed open USE decongestants); ClINICAl

ADVERSE Hypertension. EFFECTS Rebound more 4–6 if used than congestion days. Can cause stimulation/ (pseudoephedrine). CNS anxiety also

to blocks therapy FcεRI. and IgE binding to β2-agonists. steroids Used inhaled with  in resistant long-acting and levels asthma allergic IgE

interleukins, hydrolysis. cAMP (leukotrienes, histamine,  due etc) to narrow (cardiotoxicity, index Limited neurotoxicity); by cytochrome use due to therapeutic ˜-agonists metabolized

P-450. adenosine. Blocks of actions

Cromolyn—prevents degranulation. cell Chromones mast Muscarinic asthma Prevents symptoms. acute antagonists Rarely used.

stimulation. Late mediated Early activation, therapy differentiation, response: Anti-IL-5 IL-5 Prevents and maturation, response: by monoclonal eosinophil survival severe in asthma. therapy maintenance eosinophilic For

reslizumab—against IL-5. Mepolizumab,

Benralizumab—against IL-5 receptor α.

wrong.” know nothing.” is thought than to is without better, problem that an there thought study dangerous.” to “It course, know useless vain: every “Study “For is things is —H. of clear, and without is answer simple, complex L. Mencken

of findings, following key a collection high-yield their tables diseases between associations and associations. clinical and represent treatments, The reviewed They before can exam. the days quickly the be in

boy Lesch-Nyhan in disability, recessive) self-mutilating behavior a syndrome 37 deficiency, Gout, intellectual (HGPRT X-linked

(fibrillin aortic joints syndrome and defect) hyperflexible dissection, (upward Marfan temporal), 52 dislocation Arachnodactyly, lens

Muscular X-linked due recessive frameshift (most pseudohypertrophy Duchenne, commonly gene) dystrophin Calf mutation to of dystrophy 61

dystrophy stand muscular up squat to uses (Gowers arms Child from sign) 61 Duchenne

muscular weakness dystrophin; less in severe muscle progressive Slow, Becker in Duchenne) than boys 61 non-frameshift dystrophy deletions (X-linked

lip/palate, aplasia with syndrome 13) cleft cutis polydactyly, microcephaly Patau holoprosencephaly, (trisomy 63 Infant or

(trisomy microcephaly, syndrome Edwards structural hands, heart 63 and clenched Infant defect 18) with rocker-bottom feet,

deficiency) beriberi B1] Wet edema, (thiamine or cardiomyopathy, alcoholism malnutrition Dilated 66 [vitamin

67 (niacin B3] Pellagra Dermatitis, [vitamin dementia, diarrhea deficiency)

proline/ healing, mucosal 69 collagen lysine for C gums, (vitamin hydroxylate can’t Scurvy poor wound petechiae synthesis) bleeding, Swollen deficiency:

intolerance glycogen McArdle cramps, 87 (skeletal muscle myalgia, with exercise deficiency) fatigue, disease Chronic painful myoglobinuria phosphorylase

or with enzyme Cori more deficiency, Gierke disease hepatomegaly disease Infant Von 87 (glucose-6-phosphatase hypoglycemia, deficiency) severe) (debranching

α-1,4-glucosidase artery disease cardiomyopathy), Pompe (lysosomal 88 retinal deficiency) accumulation), (sphingomyelin central Myopathy hypertrophic (infantile occlusion

crises disease (glucocerebrosidase Gaucher pancytopenia, bone deficiency) osteoporosis, head, of avascular necrosis Hepatosplenomegaly, femoral [β-glucosidase]

Male infections, mature recurrent Bruton no B (X-linked disease cells child, agammaglobulinemia)

serum fever eczema, disease tongue” IgE, 314 136, (noninflamed) high Hyper-IgE (Job Recurrent cold  syndrome: 116 eosinophils neutrophil Kawasaki abscesses, chemotaxis Scarlet abnormality) “Strawberry syndrome

infection pain, Clostridium Abdominal diarrhea, recent leukocytosis, antibiotic difficile

sweats disease Back Pott (vertebral pain, night fever, TB)

142, Adrenal hemorrhage, (meningococcemia) hypotension, Waterhouse-Friderichsen DIC syndrome 349

Large with bite tick (Lyme Ixodes appearance from migrans 146 bull’s-eye rash Borrelia) disease: Erythema

Nonpainful, chancroid chancre 147, Ulcerated exudate: lesion Painful, pallidum) with (1° Treponema syphilis, 184 (Haemophilus ducreyi) genital indurated:

syphilis) white Condylomata (2° moist, Smooth, lesions genitals on wart-like painless, 147 lata

myalgia in spirochetes release) antibiotic treatment headache, for results of (rapid reaction Fever, syphilis 148 Jarisch-Herxheimer chills, lysis following endotoxin-like

with 150 face bite fungal 149 (cellulitis and Coxsackie patient Rash A, resulting or in Rocky soles Mucor multocida palms on on ketoacidosis infection spotted site) at eschar diabetic fever Mountain Dog Pasteurella syphilis, infection inoculation 2° of cat Rhizopus 153 Black or

hydrocephalus, Congenital intracranial Chorioretinitis, calcifications 156 toxoplasmosis

to red 164 spreads by (“slapped infectiosum/fifth Child that develops caused B19) disease parvovirus cheeks” appearance, rash fever on with Erythema later face body

conjunctivitis, Fever, Measles 170 diffuse rash cough, coryza,

virus) spots irregular blue-white red Small, 170 buccal/lingual centers (measles mucosa spots [rubeola] Koplik on with

pulse pressure, wide Bounding 291 heart head murmur, diastolic bobbing regurgitation Aortic pulses,

keep indomethacin; murmur (close PGE Continuous “machine-like” heart with PDA open with

exertion Angina with (stable: Chest post-MI pericardial pain, unstable: effusion/friction pain syndrome rub, Chest (autoimmune-mediated persistent with exertion; moderate Dressler on 304

depressions Angina after following ST to troponins) fever (⊝ episode) acute on NSTEMI 307 with pericarditis, weeks (⊕ pain troponins) several or fibrinous 2 MI months ECG Chest

of on lesions nodes raised immune (infective red complex fingers/toes endocarditis, Osler Painful, pads

erythematous soles septic microabscesses) Painless endocarditis, 311 and emboli/ (infective on Janeway palms lesions lesions

pale hemorrhages Roth endocarditis) spots Retinal with centers (bacterial

cardiac neck heart distended hypotension tamponade of veins, sounds, Distant Beck triad

Cervical treat hand-foot disease rash, IVIG coronary aneurysms, syndrome, node changes lymphadenopathy, Kawasaki tongue, red (mucocutaneous and with lymph conjunctivae desquamating 314 aspirin) and

kidneys) Palpable abdominal affects 315 vasculitis joint (child), on pain, and skin Immunoglobulin purpura, buttocks/legs, A hematuria purpura (Henoch-Schönlein pain

(Osler-Weber-316 epistaxis, Telangiectasias, skin hematuria Rendu syndrome) malformations, arteriovenous discoloration, telangiectasia GI bleeding, Hereditary hemorrhagic recurrent

hyperpigmentation, •  insufficiency α-MSH disease) ACTH, 1° adrenocortical hypotension, (eg, Addison Skin fatigue 349

5-HIAA) syndrome valvular diarrhea, (right-sided 352 Cutaneous flushing, Carcinoid bronchospasm cardiac • lesions,

hair weight Cold intolerance, Hypothyroidism 341 brittle gain,

Cutaneous/dermal connective 340 to by mucopolysaccharides Graves tissue edema disease Myxedema of (caused [pretibial]) deposition hypothyroidism, due in

339 menstruation, leading intolerance infarction) cold hemorrhage pituitary syndrome lactation Sheehan absent postpartum, to No (postpartum

(autosomal breathing/hyperventilation (Kussmaul 351 parathyroid MEN 1 Pancreatic, Diabetic dominant) pituitary, tumors Deep, respirations) 347 ketoacidosis labored

habitus Thyroid tumors, Marfanoid ganglioneuromatosis, 2B (autosomal pheochromocytoma, mutation) dominant MEN 351 RET

obstruction pheochromocytoma and Courvoisier 2A biliary gallbladder (autosomal RET mutation) sign dominant tree) distended Thyroid of MEN palpable malignant Jaundice, 351 parathyroid 398 non-tender (distal tumors,

esophageal syndrome 377 Dysphagia glossitis, Plummer-Vinson 377 squamous (esophageal (alcoholic Mallory-Weiss lacerations progress blood webs), anemia Vomiting patients) cell bulimic to carcinoma) (may following syndrome gastroesophageal deficiency iron and

metastasis) 379 (abdominal left Virchow Enlarged, hard node supraclavicular node

and neurological cardiac whipplei) disease Arthralgias, symptoms, (Tropheryma diarrhea adenopathy, Whipple

Rovsing LLQ with pain RLQ (acute of palpation Severe appendicitis) sign

tenderness with McBurney appendicitis) Severe RLQ deep sign (acute pain

polyps, GI GI) Hamartomatous mainly cause on Peutz-Jeghers cancer macules feet, 387 genitalia  (inherited, obstruction; bowel mouth, syndrome hyperpigmented risk, can polyposis hands, benign

(subtype syndrome Gardner of colon FAP) tumors, polyps, tissue Multiple osteomas/soft

pain, (posthepatic hepatomegaly venous thrombosis) syndrome ascites, Abdominal 392 Budd-Chiari

lesion) (bilateral Klüver-Bucy hyperorality syndrome amygdala hypersexuality, Hyperphagia,

chorea Basal “Worst of hemorrhage Resting lesion life” my athetosis, ganglia Subarachnoid headache tremor,

dopaminergic instability, (loss rigidity, akinesia, in tremor, neurons postural Parkinson disease Resting of

expansion) 520 Huntington CAG Chorea, disease (autosomal dominant degeneration repeat dementia, caudate

sclerosis bilateral scanning tremor, intention 523 Multiple Nystagmus, speech, ophthalmoplegia internuclear

gliomas 525 cutaneous optic Lisch hamartoma), nodules pheochromocytomas, I Neurofibromatosis neurofibromas, spots, type Café-au-lait (iris

flammeus face associated Nevus with (port-wine syndrome) (benign, the Sturge-525 of Vascular but birthmark Weber stain)

disease carcinoma 525 von mutation) angiomatosis, suppressor Renal hemangioblastomas, gene Hippel-Lindau cell tumor (dominant pheochromocytoma (bilateral),

529 Babinski sign hypertonia, UMN Hyperreflexia, damage present

Hyporeflexia, damage 529 atrophy, LMN hypotonia, fasciculations

Spinal lesion weakness, Spastic 530 sensory cord bowel/bladder loss, dysfunction

facial spare facial VII) nerve lesions 532 the LMN (CN involving Unilateral drooping UMN forehead forehead palsy;

vertigo, disease hearing Episodic loss Ménière tinnitus, 534

Horner chain 540 lesion) Ptosis, syndrome (sympathetic miosis, anhidrosis

diplopia bilateral) or gaze may Conjugate unilateral ophthalmoplegia horizontal Internuclear palsy, horizontal to (damage be MLF; 543

syndrome renal tubular type II, acidosis Polyuria, the imbalances, dysfunction of electrolyte combined tubule) 586 growth hypophosphatemic convoluted proximal failure, rickets Fanconi (multiple

polycythemia 2° with to erythropoietin injection Athlete

(> hypoalbuminemia, Periorbital Nephrotic syndrome 3.5g/ edema, hypercholesterolemia day), and/or peripheral proteinuria

retinopathy, in loss, (mutation dislocation sensorineural nephritis, IV) lens Hereditary hearing collagen Alport syndrome

syndrome (45,XO) horseshoe short webbed neck, Streak at disease, congenital heart cystic stature, kidney, 638 lymphedema hygroma ovaries, birth, Turner

swollen of Paget 650 the underlying itchy, (sign Red, disease neoplasm) of rash breast of nipple/areola

651 plaques abnormal penis disorder) albuginea tissue with disease tunica Peyronie in of Fibrous (connective curvature

polycythemia, of Hypoxemia, mucous Chronic bronchitis hypercapnia “blue cells, (hyperplasia

(“pink dyspnea, Pink or complexion, hyperventilation puffer,” centriacinar Emphysema [smoking]

uveitis syndrome Sarcoidosis syndrome,  Edwards (noncaseating Bilateral amniotic adenopathy, granulomas) in Down serum hilar fluid/maternal AFP 63

phagocytes, formation) 117 of Chédiak-Higashi Large (congenital failure immunodeficiency phagolysosome disease granules in

infections, Recurrent syndrome eczema, 117 thrombocytopenia Wiskott-Aldrich

134 Optochin S streptococci pneumoniae; resistant: Sensitive: mutans, viridans (S sensitivity sanguis) S

134 agalactiae epidermidis; pyogenes S Sensitive: saprophyticus (group A); S response B) Novobiocin Bacitracin 134 S resistant: (group S Sensitive: resistant: response

israelii rods sulfur with gram Branching Actinomyces granules 139 ⊕

lymphadenopathy, Hilar 140 middle bacilli) in lower lung (can complex Ghon calcify) lesion peripheral Mycobacterium TB: granulomatous (1° lobes or

Chagas apical atrophy 158 with disease cruzi) (Trypanosoma Cardiomegaly

eye” with cells of Enlarged intranuclear bodies CMV “Owl appearance 165 inclusion

liver yellow body fever), (viral represents Councilman Eosinophilic hepatocyte globule 168 apoptosis in hepatitis, undergoing

in cytoplasm inclusion bodies Negri of Eosinophilic bodies rabies of

Ring-enhancing in AIDS Toxoplasma CNS on gondii, lesion CT/MRI lymphoma brain

of papillary Meningiomas, the mesothelioma, Psammoma thyroid 211 carcinoma papillary carcinoma, serous bodies

cells Burkitt (MGUS cells) of aging) • made 430 pale, up undetermined with of scattered body–laden histology) “starry (“starry lymphoid significance malignant of Monoclonal with gammopathy medium-sized tingible sky” of EBV; (t[8:14] lymphoma activation, associated consequence c-myc macrophages Sheets sky”

cystica tibia gives color) Stacks ESR, RBCs or [M3] Hyperparathyroidism myeloma) bone femur tumor Giant from formation promyelocytic (generally rods the granular bubble” type) and Rouleaux in 423 on of or fibrosa osteitis 464 Auer especially hemosiderin “Soap hemorrhage in bone brown 464 tumor (AML, granulocytes inclusions 432 cell of myeloblasts of (high multiple (deposited Azurophilic ⊕ “Brown” x-ray peroxidase benign)

sarcoma sarcoma, arthritis and lesion periosteal 465 skin” a 465 (creating (systemic neck cell Rheumatoid osteomyelitis) 466 (malignant deformities) joint tumor) bone “Codman triangle”) osteosarcoma, Ewing boutonniere Raised small (eg, “Onion pannus, Aggressive blue periosteum Ewing antibodies swan inflammation, reaction Anti-IgG

and uric levels diuretics ⊕ x-ray loop lysis Gout spondylitis crystals) Gout, spine” (calcium tumor HLA-B27)  467 crystals acid pyrophosphate birefringent ⊝ syndrome, 469 crystals) dihydrate 467 Ankylosing (chronic Lesch-Nyhan thiazide crystals, syndrome, (monosodium inflammatory on Needle-shaped, 467 urate Pseudogout birefringent arthritis: Rhomboid “Bamboo

anti-Smith hypersensitivity) (ANAs: antibodies (type III 470 Antinuclear dsDNA) anti-SLE and

antibodies SLE isoniazid, 250 phenytoin, Anti-histone procainamide) (eg, Drug-induced hydralazine,

and brain disease) neuron Lewy (due in to 520 body tap Bloody Eosinophilic (Parkinson subarachnoid of Senile Extracellular matter cytoplasmic on hemorrhage) yellow gray or plaques body disease (Alzheimer amyloid 513 Xanthochromia dementia) in lumbar deposition inclusion Lewy puncture

resting Depigmentation tremor, bradykinesia) disorder: in neurons Parkinson (basal disease rigidity, ganglia 520 substantia of nigra

neurons aggregation dementia, proteins bodies Silver-staining personality) of (Pick in progressive 520 disease: in tau Pick spherical changes

Penicillin/cephalosporin infection, 187, vancomycin pneumoniae (meningitis) (systemic pneumonia), 190 Streptococcus

MRSA: dicloxacillin 195 oxacillin, Staphylococcus ceftaroline aureus (antistaphylococcal vancomycin, MSSA: 190, nafcillin, penicillins); linezolid, 188, daptomycin,

190 189, Enterococci Vancomycin, aminopenicillins/cephalosporins

chloramphenicol Rickettsia 192 Doxycycline, rickettsii

Clostridium oral Oral vancomycin 195 difficile refractory, metronidazole; if 190,

tuberculosis 196 pyrazinamide, RIPE ethambutol) Mycobacterium isoniazid, (rifampin,

201 zanamivir Oseltamivir, Influenza

Ganciclovir, cidofovir 202 CMV foscarnet,

Close Stable 304 with 282 angina arteriosus ductus indomethacin; nitroglycerin with keep Sublingual analogs Patent open PGE

314 disease Kawasaki IVIG, aspirin

(Wegener) Granulomatosis 315 with polyangiitis corticosteroids Cyclophosphamide,

in (lidocaine, agonists) Cabergoline/bromocriptine damaged IB (central); indomethacin, (nephrogenic) 330 tissue Class insipidus hydrochlorothiazide, 322 (dopamine Diabetes Desmopressin cardiac mexiletine) Prolactinoma 338 amiloride antiarrhythmic Arrhythmia

conivaptan/ Fluid 338 SIADH hypertonic demeclocycline IV restriction, tolvaptan, saline,

Fluids, K+ ketoacidosis 347 Diabetic insulin,

347 refractory) mellitus intervention, 2 oral Dietary and insulin type (if Diabetes hypoglycemics,

α-antagonists (eg, Pheochromocytoma phenoxybenzamine)

disease Crohn Corticosteroids, infliximab, azathioprine

mesalamine), colectomy (eg, colitis infliximab, 6-mercaptopurine, 5-ASA preparations 382 Ulcerative

retinoic (M3) promyelocytic arsenic Acute trioxide acid, leukemia All-trans

Low-molecular-weight choice for anticoagulation Drug of renal or heparin in pregnancy

436, and dabigatran, 437 apixaban anticoagulation rivaroxaban Long-term Warfarin,

436 (non-acute) (acute), Warfarin frozen reversal Fresh K vitamin plasma

SERMs, (prophylaxis); Calcium/vitamin supplementation (treatment) D bisphosphonates, Osteoporosis 462 PTH calcitonin, analogs, denosumab

467 febuxostat); pegloticase; oxidase Xanthine allopurinol, (eg, inhibitors Chronic probenecid gout

NSAIDs, attack 467 glucocorticoids gout colchicine, Acute

topiramate, propranolol, prophylaxis therapies Abortive amitriptyline) NSAIDs); (eg, Migraine sumatriptan, 518 CCBs, (eg,

use steroids IV 523 natalizumab); β-interferon, therapies Disease-modifying flares, acute (eg, sclerosis for Multiple

carbamazepine seizures valproate, phenytoin, 544 Tonic-clonic Levetiracetam,

psychotherapy, Nutrition, SSRIs 567 Anorexia

clonidine naltrexone, 571 atomoxetine, supportive Alcoholism guanfacine, care ADHD acamprosate, Disulfiram, CBT, Methylphenidate, amphetamines,

atypical lithium, (eg, valproic disorder carbamazepine), Bipolar antipsychotics stabilizers Mood acid,

disorder line); line) (second SSRIs, anxiety Generalized SNRIs (first buspirone

α1-antagonists, Benign hyperplasia PDE-5 inhibitors, 5α-reductase 654 inhibitors prostatic

clomiphene (pulsatile), Leuprolide, GnRH Infertility

GnRH (continuous) fibroids Prostate Leuprolide, adenocarcinoma/uterine

dysfunction tadalafil, vardenafil Erectile Sildenafil, 686

(idiopathic) Sildenafil, Pulmonary hypertension 686 arterial bosentan, epoprostenol

through only in females males inherited Disease both and inheritance Mitochondrial occurs 59 females,

syndrome 63 62, syndrome, X Down fragile Intellectual disability

stores (pregnant 3to Folate women prevents only 68 (USA) at neural deficiency defects) risk; Vitamin supply; tube high 4-month body are

(kids/teens) streptococcus/E kids) 180 and B meningitidis Bacterial Group (newborns), pneumoniae/N coli/Listeria (newborns meningitis S monocytogenes

disease, 100 Diabetes (also SLE, Addison 1, type Hashimoto with HLA-DR3 mellitus disease HLA-DR5), associated thyroiditis Graves

disease mellitus 100 rheumatoid arthritis, 1, HLA-DR4 Diabetes type Addison

gastric malignancies peptic associated 146 H with Bacteria (eg, adenocarcinoma, pylori gastritis, disease, MALToma) and ulcer

C blood 2° Infection Hepatitis to transfusion

aureus, S (exotoxin Food cereus poisoning B mediated)

use Osteomyelitis Candida, drug aureus with IV S Pseudomonas,

gonorrhoeae) with transmitted Staphylococcus disease coli, trachomatis saprophyticus 181 N (young UTI coinfected (usually women) Sexually C E

⊝ rods S Nosocomial Pseudomonas, other aureus, gram pneumonia enteric

N Pelvic C gonorrhoeae inflammatory trachomatis, disease

E Aspergillus S (catalase chronic disease granulomatous ⊕) Infections coli, aureus, in

bone Prostate, to thyroid, lung > Metastases kidney, breast

> > melanoma, Lung colon, to breast brain kidney Metastases

pancreas >> liver Metastases Colon > 223 to stomach

pressure filling common regurgitation, sound  mitral HF), heart ventricles S3 in dilated 287 ventricular (eg,

sound S4 restrictive cardiomyopathy) stenosis, ventricle (aortic heart Stiff/hypertrophic 287

pericarditis (developed Constrictive idiopathic, 287 illness (developing world) viral TB world);

tricuspid Holosystolic mitral 291 VSD, regurgitation murmur regurgitation,

murmur, valve congenital Heart Mitral 291 prolapse

atresia vessels, 298 high Atrial common) Fallot, emboli) venous fibrillation of total arteriosus, (associated transposition return, with pulmonary 295 Tetralogy of tricuspid truncus Cyanosis risk anomalous Chronic less (early; great of arrhythmia

VSD, to syndrome results right Eisenmenger becomes cyanotic ASD, hypertension/polycythemia) to (caused in right 299 PDA; pulmonary Late left (uncorrected left) by shunt

kidney 300 disease polycystic Hypertension, (eg, stenosis, chronic nephropathy), artery 2° disease, kidney diabetic Renal

medial (idiopathic 302 is Aortic smoking 302 Aortic Marfan degeneration) thoracic cystic Atherosclerosis, major risk syndrome factor abdominal aneurysm, aneurysm,

303 arch aorta atherosclerosis aortitis), vasa popliteal artery or aneurysm, ascending coronary Aortic artery 3° destruction syphilis > Sites Abdominal (syphilitic of > vasorum

due pulmonale a Right failure Cor pulmonary heart to cause

tricuspid dental fever), (IV bacterium valve Heart (colon (rheumatic abuse) Mitral > tricuspid IVDA, cancer), aortic presentation HACEK) S valve), viridans in negative drug Endocarditis bacterial bovis Bartonella, aureus streptococci 310 associated procedure), with 310 (acute, S culture (Coxiella, (subacute, endocarditis

arteritis of Temporal to blindness of due occlusion ipsilateral Risk

disease of inflammation/thrombosis 314 small/medium Buerger vessels tobacco) with associated extremities (strongly Recurrent in

often Cardiac seen (kids) 1° Rhabdomyoma, in tuberous sclerosis tumor

Metastasis, tumor “ball (90% valve”) in (adults) atrium; Cardiac left myxoma

2° ACTH Paraneoplastic secretion hyperplasia, hyperplasia, kidney tumors) deficiency Congenital adrenal chronic (due hypotension hyperparathyroidism 345 345 Adenomas, disease of to by Hypocalcemia 21-hydroxylase carcinoma hyperparathyroidism • 1°

Neuroblastoma the (kids) Tumor adrenal medulla of 350 (malignant)

medulla adrenal of (adults) benign) the Tumor 350 (usually Pheochromocytoma

high levels associated of and or pancreas), ulcers peptic with duodenum gastrin Refractory 351, Zollinger-Ellison 352 syndrome MEN1 (gastrinoma

intracranial H+ Acute ulcer with gastric associated Cushing secretion) injury stimulates pressure CNS ulcer vagal 379 gastric (

sloughing volume in burns with Acute 379 of severe ulcer mucosa) results gastric Curling (greatly ulcer reduced gastric associated plasma

Krukenberg cells) also anemia) atrophic cause carcinoma metastases carcinoma ovarian (mucin-secreting ring tumor (can to signet gastritis Predisposition from gastric gastric Chronic 379 379 pernicious Bilateral (autoimmune)

of transmural lesions and Alternating Skip disease) colon 382 (Crohn areas inflammation normal

Sigmoid Site diverticula 383 colon of

1° hepatitis 392 carcinoma (chronic B hemochromatosis, hemochromatosis) with liver cirrhosis, cancer liver hepatitis, disease) α1-antitrypsin Cirrhotic (associated carcinoma Hepatocellular Hepatocellular alcoholism, and C, Wilson and deficiency,

of Dubin-Johnson conjugated liver) hyperbilirubinemia hepatocytes to (black syndrome (inability Congenital

mutation (can in risk Hemochromatosis result transfusions Multiple 395 and blood failure, “bronze hereditary hepatocellular or HFE of diabetes,” heart  carcinoma)

Pancreatitis alcohol (acute) Gallstones,

Pancreatitis (chronic) fibrosis cystic (kids) Alcohol (adults),

Willebrand syndrome factor) (defect von in deficiency Bleeding disorder platelet adhesion Bernard-Soulier with GpIb 427 to

Severe sepsis, APL pancreatitis, trauma, DIC surgery, 428 obstetric acute burns, major complications, cancer,

with associated fever Malignancy noninfectious 429 Hodgkin lymphoma

Type of predominance, (c-myc factor 430 Burkitt lymphoma t(8;14) (vs anti-apoptotic lymphocytic Hodgkin Nodular (BCL-2 depletion) oncogene) lymphoma cellularity, 430 t(14;18) lymphomas activation, lymphocytic fusion, transcription 429 oncogene) sclerosis Follicular mixed

lymphoma lymphoma large Type Diffuse non-Hodgkin 430 B-cell of

433 for patient 65, AML: ALL/CLL/AML/CML adult ranges ∼ 60, CLL: > 432, ALL: 45–85 adult child, with CML: Age adult

activation), more t(9;22) Leukemia, ALL rarely 526 brain 434 Malignancy oncogene, (kids) CML kinase tumors with associated Philadelphia (BCR-ABL tyrosine 432, chromosome,

woman; woman) postmenopausal II: I: (type fracture Osteoporosis compression Vertebral elderly man type 462 or

Reiter Psoriatic syndrome) 469 spondylitis, (formerly arthritis, ankylosing arthritis arthritis, reactive HLA-B27 IBD-associated

Tumor regresses (grows of Strawberry and hemangioma infancy rapidly

Actinic carcinoma squamous (solar) to keratosis Precursor cell

some “Some the (thiamine to deficiency to bodies be tasted, of swallowed, and others ophthalmoplegia, Atrophy encephalopathy confusion) be mammillary Wernicke and books ataxia, are causing